0001104659-24-028810.txt : 20240228 0001104659-24-028810.hdr.sgml : 20240228 20240228172523 ACCESSION NUMBER: 0001104659-24-028810 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 106 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240228 DATE AS OF CHANGE: 20240228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bioceres Crop Solutions Corp. CENTRAL INDEX KEY: 0001769484 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38836 FILM NUMBER: 24697188 BUSINESS ADDRESS: STREET 1: PO BOX 309, UGLAND HOUSE CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 54 341 486 1122 MAIL ADDRESS: STREET 1: OCAMPO 210 BIS, PREDIO CCT CITY: ROSARIO STATE: C1 ZIP: 2000 6-K 1 biox-20231231x6k.htm FORM 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rules 13a-16 or 15d-16 under

the Securities Exchange Act of 1934

For the month of February 2024

Commission File Number: 001-38836

BIOCERES CROP SOLUTIONS CORP.

(Translation of registrant’s name into English)

Ocampo 210 bis, Predio CCT, Rosario

Province of Santa Fe, Argentina

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXPLANATORY NOTE

This Form 6-K is incorporated by reference into the Company’s registration statement on Form F-3 (Registration No. 333-268144), Form S-8 (Registration Nos. 333-255635 and 333-266333), and the following exhibits are filed as part of this Form 6-K:

Exhibit List


Exhibit No.		Description
99.1		Bioceres Crop Solutions Corp. unaudited interim condensed consolidated financial statements as of December 31, 2023 and June 30, 2023, and for the three - and six - month periods ended December 31, 2023 and 2022.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	BIOCERES CROP SOLUTIONS CORP.
	(Registrant)


Dated: February 28, 2024	By:	/s/ Federico Trucco
	Name:	Federico Trucco
	Title:	Chief Executive Officer

EX-99.1 2 biox-20231231xex99d1.htm EXHIBIT 99.1

Table of Contents

Exhibit 99.1

BIOCERES CROP SOLUTIONS CORP.

Unaudited interim condensed consolidated financial statements
as of December 31, 2023 and June 30, 2023,

and for the three and six month periods ended

December 31, 2023 and 2022.

Table of Contents

INDEX

Unaudited interim condensed consolidated financial statements as of December 31, 2023 and June 30, 2023, and for the three and six month periods ended December 31, 2023 and 2022.
Unaudited interim condensed consolidated statements of financial position as of December 31, 2023 and June 30, 2023	F-3
Unaudited interim condensed consolidated statements of comprehensive income for the three and six month periods ended December 31, 2023 and 2022	F-5
Unaudited interim condensed consolidated statements of changes in equity for the six-month periods ended December 31, 2023 and 2022	F-6
Unaudited interim condensed consolidated statements of cash flows for the six-month periods ended December 31, 2023 and 2022	F-8
Notes to the unaudited interim condensed consolidated financial statements	F-11

F-2

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

As of December 31, 2023, and June 30, 2023

(Amounts in US$)


	Notes	12/31/2023	06/30/2023
ASSETS
CURRENT ASSETS
Cash and cash equivalents	5.1	24,401,937	48,129,194
Other financial assets	5.2	17,040,207	12,135,020
Trade receivables	5.3	199,666,283	158,006,474
Other receivables	5.4	25,081,598	28,824,998
Income and minimum presumed recoverable income taxes		1,120,881	9,444,898
Inventories	5.5	123,738,148	140,426,975
Biological assets	5.6	938,370	146,842
Total current assets		391,987,424	397,114,401

NON-CURRENT ASSETS
Other financial assets	5.2	444,743	444,909
Other receivables	5.4	1,619,642	2,546,241
Income and minimum presumed recoverable income taxes		3,794	16,286
Deferred tax assets	7	9,273,827	7,312,964
Investments in joint ventures and associates	11	42,402,217	39,296,810
Investment properties	5.10	3,792,238	3,589,749
Property, plant and equipment	5.7	71,388,129	67,853,835
Intangible assets	5.8	172,743,513	173,783,956
Goodwill	5.9	112,163,432	112,163,432
Right of use asset	14	13,704,217	13,936,575
Total non-current assets		427,535,752	420,944,757
Total assets		819,523,176	818,059,158

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-3

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

As of December 31, 2023, and June 30, 2023

(Amounts in US$)


LIABILITIES	Notes	12/31/2023	06/30/2023

CURRENT LIABILITIES
Trade and other payables	5.11	164,003,202	150,807,674
Borrowings	5.12	113,520,778	107,639,659
Employee benefits and social security	5.14	8,218,657	9,606,707
Deferred revenue and advances from customers	5.15	22,099,378	24,875,662
Income tax payable		864,954	509,034
Consideration for acquisition		4,082,708	1,415,099
Lease liabilities	14	4,017,013	3,858,699
Total current liabilities		316,806,690	298,712,534

NON-CURRENT LIABILITIES
Borrowings	5.12	31,517,348	60,670,946
Deferred revenue and advances from customers	5.15	2,135,840	2,057,805
Joint ventures and associates	11	115,983	622,823
Deferred tax liabilities	7	43,024,592	35,785,347
Provisions		478,490	891,769
Consideration for acquisition		2,601,570	3,578,157
Secured notes	5.13	77,998,071	75,213,146
Lease liabilities	14	9,583,276	10,030,524
Total non-current liabilities		167,455,170	188,850,517
Total liabilities		484,261,860	487,563,051

EQUITY
Equity attributable to owners of the parent		300,541,772	298,594,088
Non-controlling interest		34,719,544	31,902,019
Total equity		335,261,316	330,496,107
Total equity and liabilities		819,523,176	818,059,158

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-4

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the three and six month periods ended of December 31, 2023, and 2022

(Amounts in US$)


		Three-month period ended		Six-month period ended
	Notes	12/31/2023	12/31/2022	12/31/2023	12/31/2022
Revenues from contracts with customers	6.1	140,293,827	94,548,714	256,476,632	221,391,962
Initial recognition and changes in the fair value of biological assets at the point of harvest		(72,785)	(138,529)	338,128	351,477

Cost of sales	6.2	(88,710,537)	(59,141,259)	(160,326,318)	(134,817,137)
Changes in the net realizable value of agricultural products after harvest		(746,242)	(1,509,023)	(2,192,558)	(1,736,959)
Research and development expenses	6.3	(3,643,077)	(3,457,892)	(8,224,318)	(7,309,906)
Selling, general and administrative expenses	6.4	(31,164,937)	(28,413,577)	(65,097,785)	(60,318,488)
Share of profit or loss of joint ventures and associates	11	2,052,296	40,048	3,560,967	882,288
Other income or expenses, net	6.5	(1,166,603)	290,487	(2,398,238)	768,528
Operating profit		16,841,942	2,218,969	22,136,510	19,211,765

Financial cost	6.6	(3,815,993)	(5,759,485)	(11,477,850)	(12,539,332)
Other financial results	6.6	(3,454,061)	(4,200,857)	(3,336,196)	(5,489,163)
(Loss) profit before income tax		9,571,888	(7,741,373)	7,322,464	1,183,270

Income tax	7	(8,333,387)	(684,906)	(8,762,427)	(5,697,549)
(Loss) profit for the period		1,238,501	(8,426,279)	(1,439,963)	(4,514,279)

(Loss) profit for the period attributable to:
Equity holders of the parent		108,449	(8,156,746)	(4,483,185)	(7,658,449)
Non-controlling interests		1,130,052	(269,533)	3,043,222	3,144,170
		1,238,501	(8,426,279)	(1,439,963)	(4,514,279)
(Loss) profit per share
Basic (loss) profit attributable to ordinary equity holders of the parent	8	0.0017	(0.1323)	(0.0713)	(0.1242)
Diluted (loss) profit attributable to ordinary equity holders of the parent	8	0.0017	(0.1323)	(0.0713)	(0.1242)

(Loss) profit for the period		1,238,501	(8,426,279)	(1,439,963)	(4,514,279)

Other comprehensive (loss) income		485,703	585,882	(444,254)	616,907
Items that may be subsequently reclassified to profit and loss		485,703	585,882	(444,254)	616,907
Foreign exchange differences on translation of foreign operations from joint ventures		897	(122,814)	897	(21,946)
Foreign exchange differences on translation of foreign operations		484,806	708,696	(445,151)	638,853
Total comprehensive (loss) profit		1,724,204	(7,840,397)	(1,884,217)	(3,897,372)

Total comprehensive (loss) profit attributable to:
Equity holders of the parent		510,976	(7,779,559)	(4,853,354)	(7,377,844)
Non-controlling interests		1,213,228	(60,838)	2,969,137	3,480,472
		1,724,204	(7,840,397)	(1,884,217)	(3,897,372)

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-5

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

For the six-month periods ended of December 31, 2023, and 2022

(Amounts in US$)


	Attributable to the equity holders of the parent
											Equity /
					Stock					Revaluation	(deficit)
			Changes in	Own	options		Cost of		Foreign	of PP&E	attributable
			non-	shares	and share		own		currency	and effect	to owners	Non-
	Issued	Share	controlling	trading	based	Convertible	shares	Retained	translation	of tax rate	of the	controlling	Total
Description	capital	premium	interests	premium	incentives	instruments	held	deficit	reserve	change	parent	Interests	equity
06/30/2022	4,637	158,819,506	(255,893)	(916,202)	3,767,925	175,745	(3,530,926)	(32,682,893)	969,402	1,007,272	127,358,573	30,940,275	158,298,848
Share-based incentives	5	631,778	—	135,361	1,806,100	—	—	—	—	—	2,573,244	—	2,573,244
Business combination	1,640	153,357,564	—	—	1,620,140	—	—	—	—	—	154,979,344	—	154,979,344
Capitalization of convertible notes (Note 5.13)	153	12,211,485	—	—	—	—	—	—	—	—	12,211,638	—	12,211,638
Purchase of own shares	—	—	—	—	—	—	(26,206,394)	—	—	—	(26,206,394)	—	(26,206,394)
Issuance of convertible notes (Note 7.13)	—	—	—	—	—	9,109,516	—	—	—	—	9,109,516	—	9,109,516
Distribution of dividends by subsidiary	—	—	—	—	—	—	—	—	—	—	—	(452,129)	(452,129)
(Loss) profit for the period	—	—	—	—	—	—	—	(7,658,449)	—	—	(7,658,449)	3,144,170	(4,514,279)
Other comprehensive income	—	—	—	—	—	—	—	—	280,605	—	280,605	336,302	616,907
12/31/2022	6,435	325,020,333	(255,893)	(780,841)	7,194,165	9,285,261	(29,737,320)	(40,341,342)	1,250,007	1,007,272	272,648,077	33,968,618	306,616,695

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-6

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

For the six-month periods ended of December 31, 2023, and 2022

(Amounts in US$)


	Attributable to the equity holders of the parent
					Stock					Revaluation	Equity /
			Changes	Own	options		Cost of		Foreign	of PP&E	(deficit)
			in non-	shares	and share		own		currency	and effect	attributable	Non-
	Issued	Share	controlling	trading	based	Convertible	shares	Retained	translation	of tax rate	to owners of	controlling	Total
Description	capital	premium	interests	premium	incentives	instruments	held	deficit	reserve	change	the parent	Interests	equity
06/30/2023	6,493	327,028,559	(255,893)	(780,841)	6,645,442	9,285,261	(30,553,591)	(13,903,017)	1,282,377	(160,702)	298,594,088	31,902,019	330,496,107
Share-based incentives	4	526,017	—	—	7,009,405	—	—	—	—	—	7,535,426	—	7,535,426
Purchase of own shares	—	—	—	—	—	—	(734,388)	—	—	—	(734,388)	—	(734,388)
Distribution of dividends by subsidiary	—	—	—	—	—	—	—	—	—	—	—	(151,612)	(151,612)
(Loss) profit for the period	—	—	—	—	—	—	—	(4,483,185)	—	—	(4,483,185)	3,043,222	(1,439,963)
Other comprehensive loss	—	—	—	—	—	—	—	—	(370,169)	—	(370,169)	(74,085)	(444,254)
12/31/2023	6,497	327,554,576	(255,893)	(780,841)	13,654,847	9,285,261	(31,287,979)	(18,386,202)	912,208	(160,702)	300,541,772	34,719,544	335,261,316

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-7

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the six-month periods ended of December 31, 2023, and 2022

(Amounts in US$)


	Notes	12/31/2023	12/31/2022
OPERATING ACTIVITIES
Loss for the period		(1,439,963)	(4,514,279)

Adjustments to reconcile profit to net cash flows
Income tax	7	8,762,427	5,697,549
Financial results		14,814,046	18,028,495
Depreciation of property, plant and equipment	5.7	2,556,422	2,960,156
Amortization of intangible assets	5.8	5,474,971	5,191,521
Depreciation of leased assets	14	1,711,256	1,837,532
Transactional expenses		—	3,634,992
Share-based incentive and stock options		8,527,214	2,062,345
Share of profit or loss of joint ventures and associates	11	(3,560,967)	(882,288)
Loss of participation in joint ventures and associates	11	—	7,853
Provisions for contingencies		49,090	39,847
Allowance for impairment of trade debtors		296,051	468,992
Allowance for obsolescence		282,836	481,332
Initial recognition and changes in the fair value of biological assets		(338,128)	(351,477)
Changes in the net realizable value of agricultural products after harvest		2,192,558	1,736,959
Gain or loss on sale of equipment and intangible assets		(33,521)	(111,728)

Working capital adjustments
Trade receivables		(38,431,478)	(63,042,799)
Other receivables		3,281,861	(6,589,310)
Income and minimum presumed income taxes payable		8,670,430	(3,869,723)
Inventories and biological assets		13,725,208	(23,455,328)
Trade and other payables		11,867,420	12,216,345
Employee benefits and social security		(1,388,050)	2,185,006
Deferred revenue and advances from customers		(2,698,249)	53,775,013
Income taxes paid		—	(2,772,608)
Interest collected		1,204,931	3,493,607
Inflation effects on working capital adjustments		323,421	658,967
Net cash flows generated by operating activities		35,849,786	8,886,971

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-8

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the six-month periods ended of December 31, 2023, and 2022

(Amounts in US$)


	Notes	12/31/2023	12/31/2022
INVESTMENT ACTIVITIES
Proceeds from sale of property, plant and equipment		45,268	118,914
Net cash received from business combination		—	4,373,265
Investment in financial assets		(16,363,130)	(13,813,944)
Purchase of property, plant and equipment	5.7	(6,070,237)	(3,824,078)
Capitalized development expenditures	5.8	(4,454,893)	(5,926,539)
Purchase of intangible assets	5.8	(219,829)	(148,075)
Net cash flows used by investing activities		(27,062,821)	(19,220,457)

FINANCING ACTIVITIES
Proceeds from borrowings		69,810,628	136,880,982
Repayment of borrowings and financed payments		(79,250,768)	(78,971,568)
Interest payments		(12,168,664)	(9,678,974)
Other financial proceeds or payments, net		(1,288,813)	(3,588,240)
Purchase of own shares		(734,388)	(2,291,365)
Leased assets payments	14	(2,493,617)	(1,553,958)
Cash dividend distributed by subsidiary		(151,612)	(452,129)
Net cash flows (used) generated by financing activities		(26,277,234)	40,344,748

Net (decrease) increase in cash and cash equivalents		(17,490,269)	30,011,262

Inflation effects on cash and cash equivalents		(10,495)	(56,375)

Cash and cash equivalents as of beginning of the period	5.1	48,129,194	33,475,266
Effect of exchange rate changes on cash and equivalents		(6,226,493)	5,119,869
Cash and cash equivalents as of the end of the period	5.1	24,401,937	68,550,022

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-9

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

Index

1.	General information.

2.	Accounting standards and basis of preparation.

3.	New standards, amendments and interpretations issued by the IASB.

4.	Seasonality

5.	Information about components of unaudited interim condensed consolidated statement of financial position.

6.	Information about components of unaudited interim condensed consolidated statement of comprehensive income.

7.	Taxation.

8.	Earnings per share.

9.	Equity information.

10.	Cash flow information.

11.	Joint ventures and associates.

12.	Segment information.

13.	Financial instruments – Risk management.

14.	Leases.

15.	Shareholders and other related parties’ balances and transactions.

16.	Key management personnel compensation.

17.	Share-based payments.

18.	Contingencies, commitments and restrictions on the distribution of profits.

19.	Events occurring after the reporting period.

F-10

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

1. GENERAL INFORMATION

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. To do this, Bioceres’ products create economic incentives for farmers and other stakeholders to adopt environmentally friendly production practices. Bioceres has a unique biotech platform with high impact, patented technologies for seeds and microbial ag inputs, as well as next generation crop nutrition and protection solutions.

Bioceres is a global company with an extensive geographic footprint. The Group’s agricultural inputs are marketed across more than 45 countries, primarily in South America, the United States and Europe.

Unless the context otherwise requires, “we”, “us”, “our”, “Bioceres”, “BIOX”, “the Group”, and “Bioceres Crop Solutions” will refer to Bioceres Crop Solutions Corp. and its subsidiaries.

2. ACCOUNTING STANDARDS AND BASIS OF PREPARATION

Statement of compliance with IFRS as issued by IASB

These unaudited interim condensed consolidated financial statements for the six-month period ended December 31, 2023, have been prepared in accordance with Accounting Standard IAS 34 Interim Financial Reporting.

These unaudited interim condensed consolidated financial statements do not include all notes of the type normally included in an annual financial statement. Accordingly, these unaudited interim condensed consolidated financial statements are to be read in conjunction with the consolidated financial statements for the fiscal year ended June 30, 2023.

Authorization for the issue of the consolidated financial statements

These unaudited interim condensed consolidated financial statements of the Group as of December 31, 2023, June 30, 2023 and for the three and six month periods ended December 31, 2023 and 2022 were authorized by the Board of Directors of Bioceres Crop Solutions Corp. on February 28, 2024.

Basis of measurement

The consolidated financial statements of the Group have been prepared using:

●Going concern basis of accounting, considering the conclusion of the assessment made by the Group’s Management about the ability of the Group and its subsidiaries to continue as a going concern, in accordance with the requirements of paragraph 25 of IAS 1, “Presentation of Financial Statements”.

●Accrual basis of accounting (except for cash flows information). Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there are no cash flows.

Functional currency and presentation currency

a)	Functional currency

Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic market in which the entity operates (i.e., “the functional currency”).

F-11

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

b)	Presentation currency

The consolidated financial statements of the Group are presented in US dollars.

c)	Foreign currency

Transactions entered into by Group entities in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting period. Exchange differences arising from the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising from the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the consolidated statement of profit or loss and other comprehensive income as part of the gain or loss recognized upon such disposal.

Changes in accounting policies

In previous years, the Group presented the sum of revenues from contracts with customers, initial recognition and changes in fair value of biological assets at the point of harvest, and changes in the net realizable value of agricultural products after harvest in a caption “Total” to assist investors to understand the performance of the Group’s comprehensive income for each fiscal year. As of the current period, that caption has been removed from the consolidated statements of comprehensive income to be aligned with comparable companies of the industry.

The accounting policies adopted in the preparation of these unaudited interim condensed consolidated financial statements are consistent with those adopted for the preparation of the consolidated financial statements as of June 30, 2023.

3. NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB

a)The following new standards, amendments and interpretations became applicable for the current reporting period and adopted by the Group.

Amendment to IAS 12 –Deferred tax related to assets and liabilities arising from a single transaction.

International Tax Reform—Pillar Two Model Rules (Amendments to IAS 12)

Amendments to IAS 1 and IFRS Practice Statement 2- Disclosure of Accounting Policies

Amendments to IAS 8-Definition of Accounting Estimates

These new standards and amendments did not have any material impact on the Group.

b)The following new standards are not yet adopted by the Group.

Amendments to IFRS 16- Lease Liability in a Sale and Leaseback. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.

Amendments to IAS1 – Non- current liabilities with covenants. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.

Amendments to IAS 7- Statement of Cash Flows & to IFRS 7- Financial Instruments: Disclosures. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.

Amendments to IAS 21- The Effects of Changes in Foreign Exchange Ratestitled Lack of Exchangeability. The amendments are effective for annual reporting periods beginning on or after 1 January 2025.

F-12

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

Amendment to IAS 7 and IFRS 7 - Supplier Financing. The amendments are effective for annual periods beginning on or after January 1, 2024.

These amendments are not expected to have material impact on the Group.

4. SEASONALITY

Our revenues fluctuate depending on the timing of orders from our distributors and customers and on prevailing market prices, which influence the purchase decisions of growers, the end users of our seed and integrated products, crop protection products and crop nutrition products. Given the cyclicality of crop planting and harvesting, as well as growing seasons, which vary from year to year, our business is highly seasonal. This results in substantial fluctuations in quarterly sales and profitability. Our portfolio is highly oriented to crop planting. Generally, our sales are concentrated in the third and fourth quarters of each calendar year, when demand for our seed and integrated products, crop protection products and crop nutrition products increases as growers begin planting their summer crops in South America, while winter crop season occurs in the Northern hemisphere. With our seed and integrated products business, we contract with growers and seed suppliers based upon our anticipated market demand. Generally, in our seed and integrated products business we stock the seed during the harvest season and ship from inventory throughout the year, with the objective of selling most of the inventory from the current year’s harvest before the next year’s, with our crop protection and our crop nutrition business following a similar cycle to the seed cycle. Milestone, royalty, and license revenues are also likely to fluctuate from period to period given the seasonality of agriculture and time required to progress from one milestone to the next.

Our seed and integrated products, crop protection and crop nutrition businesses are also affected by unpredictable weather conditions such as heavy rains, hail, floods, freezing conditions, windstorms, drought or fire, as well as other hazardous situations beyond our control, which may cause our sales and operating results to fluctuate significantly. In addition, disruptions that cause delays by growers in harvesting or planting can result in the movement of orders to a future quarter, which also causes fluctuations in our quarterly operating results. Finally, some of our customers and distributors order in bulk only one or two times a year, which may further cause our seed product revenues to fluctuate from period to period.

5. INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

5.1. Cash and cash equivalents


	12/31/2023	06/30/2023
Cash at bank and on hand	24,332,260	48,129,194
Mutual funds	69,677	—
	24,401,937	48,129,194

F-13

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

5.2. Other financial assets


	12/31/2023	06/30/2023
Current
Restricted short-term deposits	—	212,703
US Treasury bills	—	9,163,298
Mutual funds	14,736,104	1,596,539
Other investments	2,304,103	1,162,480
	17,040,207	12,135,020

	12/31/2023	06/30/2023
Non-current
Shares of Bioceres S.A.	444,410	444,635
Other investments	333	274
	444,743	444,909

5.3. Trade receivables


	12/31/2023	06/30/2023
Current
Trade debtors	206,838,287	160,269,233
Allowance for impairment of trade debtors	(7,523,261)	(7,425,604)
Shareholders and other related parties (Note 15)	1,223,994	—
Allowance for credit notes to be issued	(3,928,835)	(3,694,019)
Trade debtors - Joint ventures and associates (Note 15)	781,452	865,627
Deferred checks	2,274,646	7,991,237
	199,666,283	158,006,474

The book value is reasonably approximate to the fair value given its short-term nature.

F-14

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

5.4. Other receivables


	12/31/2023	06/30/2023
Current
Taxes	5,490,671	6,113,764
Receivables for PP&E sales	—	156,423
Shareholders and other related parties (Note 15)	3,105,591	3,792,429
Other receivables - Joint ventures and associates (Note 15)	7,500,898	6,104,219
Prepayments to suppliers	3,820,065	10,956,831
Reimbursements over exports	10,558	10,558
Prepaid expenses and other receivables	4,022,045	1,302,221
Miscellaneous	1,131,770	388,553
	25,081,598	28,824,998

	12/31/2023	06/30/2023
Non-current
Taxes	—	873,699
Reimbursements over exports	1,363,902	1,290,227
Loans receivables	230,000	230,000
Miscellaneous	25,740	152,315
	1,619,642	2,546,241

5.5. Inventories


	12/31/2023	06/30/2023
Seeds	7,508,251	1,542,159
Resale products	64,271,825	58,544,931
Manufactured products	21,131,225	25,881,761
Goods in transit	1,408,487	3,620,606
Supplies	17,878,874	24,893,187
Agricultural products	14,121,283	28,436,830
Allowance for obsolescence	(2,581,797)	(2,492,499)
	123,738,148	140,426,975

Net of agricultural products	109,616,865	111,990,145

5.6. Biological assets

Changes in Biological assets:


	Soybean	Corn	Wheat	Barley	Sunflower	Total
Beginning of the period	—	—	87,785	59,057	—	146,842
Initial recognition and changes in the fair value of biological assets at the point of harvest	—	—	231,523	106,605	—	338,128
Costs incurred during the period	581,227	301,686	—	—	55,457	938,370
Decrease due to harvest/disposals	—	—	(319,308)	(165,662)	—	(484,970)
Period ended December 31, 2023	581,227	301,686	—	—	55,457	938,370

F-15

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)


	Soybean	Corn	Wheat	Barley	Sunflower	Total
Beginning of the period	—	—	44,413	12,900	—	57,313
Initial recognition and changes in the fair value of biological assets at the point of harvest	—	—	191,481	159,996	—	351,477
Costs incurred during the period	290,667	263,428	389,282	126,293	27,005	1,096,675
Decrease due to harvest/disposals	—	—	(625,176)	(299,189)	—	(924,365)
Period ended December 31, 2022	290,667	263,428	—	—	27,005	581,100

5.7. Property, plant and equipment

Property, plant and equipment as of December 31, 2023 and June 30, 2023 included the following:


	12/31/2023	06/30/2023
Gross carrying amount	99,485,867	93,634,779
Accumulated depreciation	(28,097,738)	(25,780,944)
Net carrying amount	71,388,129	67,853,835

Net carrying amount for each class of assets is as follows:


	Net carrying	Net carrying
	amount	amount
Class	12/31/2023	06/30/2023
Office equipment	280,108	263,892
Vehicles	2,177,685	2,032,853
Equipment and computer software	190,697	174,399
Fixtures and fittings	2,469,766	2,862,949
Machinery and equipment	13,556,213	14,463,756
Land and buildings	35,745,539	36,144,792
Buildings in progress	16,968,121	11,911,194
Total	71,388,129	67,853,835

1. Gross carrying amount as of December 31, 2023 is as follows:


	Gross carrying amount
	As of the
	beginning			Foreign	As of the
	of the			currency	end of the
Class	period	Additions	Disposals	translation	period
Office equipment	968,088	52,158	—	(3,291)	1,016,955
Vehicles	5,492,319	556,237	(126,068)	(411)	5,922,077
Equipment and computer software	974,509	101,224	—	(7,575)	1,068,158
Fixtures and fittings	7,663,899	10,483	(8,976)	(9,384)	7,656,022
Machinery and equipment	23,513,047	275,297	—	(26,864)	23,761,480
Land and buildings	43,111,723	10,351	—	(29,020)	43,093,054
Buildings in progress (a)	11,911,194	5,112,029	—	(55,102)	16,968,121
Total	93,634,779	6,117,779	(135,044)	(131,647)	99,485,867

(a)	Includes capitalized financial costs of $47,542 corresponding to the period ended December 31, 2023.

F-16

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

2. Accumulated depreciation as of December 31, 2023 is as follows:


	Depreciation
	Accumulated
	as of the			Foreign	Accumulated
	beginning of			currency	as of the end
Class	the period	Disposals	Of the period	translation	of the period
Office equipment	704,196	—	33,828	(1,177)	736,847
Vehicles	3,459,466	(117,055)	416,309	(14,328)	3,744,392
Equipment and computer software	800,110	—	83,364	(6,013)	877,461
Fixtures and fittings	4,800,950	(6,242)	394,798	(3,250)	5,186,256
Machinery and equipment	9,049,291	—	1,185,336	(29,360)	10,205,267
Land and buildings	6,966,931	—	442,787	(62,203)	7,347,515
Total	25,780,944	(123,297)	2,556,422	(116,331)	28,097,738

3. Gross carrying amount as of December 31, 2022 is as follows:


	Gross carrying amount
	As of the		Additions		Foreign	As of the
	beginning		from business		currency	end of the
Class	of the period	Additions	combination	Disposals	translation	period
Office equipment	908,004	305	—	—	724	909,033
Vehicles	5,261,979	84,209	—	(59,744)	(3,948)	5,282,496
Equipment and computer software	925,349	111,226	12,469	—	(32,824)	1,016,220
Fixtures and fittings	7,606,389	34,256	5,379	—	12,143	7,658,167
Machinery and equipment	13,017,830	1,128,712	7,047,496	(7,186)	(14,677)	21,172,175
Land and buildings	40,659,129	—	4,750,136	—	(28,269)	45,380,996
Buildings in progress	3,142,774	2,465,370	1,285,092	—	(17,027)	6,876,209
Total	71,521,454	3,824,078	13,100,572	(66,930)	(83,878)	88,295,296

4. Accumulated depreciation as of December 31, 2022 is as follows:


	Depreciation
	Accumulated
	as of the			Foreign	Accumulated
	beginning of		Of the	currency	as of the end
Class	the period	Disposals	period	translation	of the period
Office equipment	638,466	—	30,827	(466)	668,827
Vehicles	2,596,905	(59,744)	457,562	(1,178)	2,993,545
Equipment and computer software	693,673	—	73,094	(1,549)	765,218
Fixtures and fittings	4,059,470	—	370,828	(355)	4,429,943
Machinery and equipment	7,205,870	—	1,575,862	(9,845)	8,771,887
Land and buildings	6,418,745	—	451,983	473	6,871,201
Total	21,613,129	(59,744)	2,960,156	(12,920)	24,500,621

The depreciation charge is included in Notes 6.3 and 6.4. The Group has no commitments to purchase property, plant and equipment items.

F-17

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

5.8. Intangible assets

Intangible assets as of December 31, 2023 and June 30, 2023 included the following:


	12/31/2023	06/30/2023
Gross carrying amount	206,708,843	202,306,618
Accumulated amortization	(33,965,330)	(28,522,662)
Net carrying amount	172,743,513	173,783,956

Net carrying amount of each class of intangible assets is as follows:


	Net carrying	Net carrying
	amount	amount
Class	12/31/2023 (1)	06/30/2023 (1)
Seed and integrated products
HB4 soy and breeding program	32,554,026	31,679,681
Integrated seed products	2,516,125	2,841,008
Crop nutrition
Microbiological products	50,829,622	49,508,801
Other intangible assets
Trademarks and patents	57,429,133	59,760,753
Software	1,923,055	1,987,690
Customer loyalty	22,491,552	23,006,023
RG/RS/OX Wheat	5,000,000	5,000,000
Total	172,743,513	173,783,956

(1)	Includes $32.2 million as of December 31, 2023 and $27.4 million as of June 30, 2023 of intangible assets not subject to amortization.

1. Gross carrying amount as of December 31, 2023 is as follows:


	Gross carrying amount
	As of the		Foreign	As of the
	beginning of		currency	end of the
Class	the period	Additions	translation	period
Seed and integrated products
HB4 soy and breeding program	34,958,425	1,729,439	—	36,687,864
Integrated seed products	3,219,808	—	(269,869)	2,949,939
Crop nutrition
Microbiological products	55,645,028	2,725,454	(1,661)	58,368,821
Other intangible assets
Trademarks and patents	67,653,234	1,288	—	67,654,522
Software	5,582,411	218,541	(967)	5,799,985
Customer loyalty	30,247,712	—	—	30,247,712
RG/RS/OX Wheat	5,000,000	—	—	5,000,000
Total	202,306,618	4,674,722	(272,497)	206,708,843

F-18

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

2. Accumulated amortization as of December 31, 2023 is as follows:


	Amortization
	Accumulated		Foreign	Accumulated as
	as of beginning		currency	of the end of the
Class	of the period	Of the period	translation	period
Seed and integrated products
HB4 soy and breeding program	3,278,744	855,094	—	4,133,838
Integrated seed products	378,800	86,762	(31,748)	433,814
Crop nutrition
Microbiological products	6,136,227	1,402,972	—	7,539,199
Other intangible assets
Trademarks and patents	7,892,481	2,332,908	—	10,225,389
Software	3,594,721	282,764	(555)	3,876,930
Customer loyalty	7,241,689	514,471	—	7,756,160
Total	28,522,662	5,474,971	(32,303)	33,965,330

3. Gross carrying amount as of December 31, 2022 is as follows:


	Gross carrying amount
	As of the		Additions from
	beginning		business	Foreign currency	As of the end of
Class	of the period	Additions	combination	translation	the period
Seed and integrated products
HB4 soy and breeding program	31,371,088	1,738,631	—	—	33,109,719
Integrated seed products	3,181,155	—	—	8,296	3,189,451
Crop nutrition
Microbiological products	8,855,421	4,187,908	39,613,280	(2,279)	52,654,330
Other intangible assets
Trademarks and patents	12,183,045	49,783	55,420,441	—	67,653,269
Software	5,176,373	98,292	—	(954)	5,273,711
Customer loyalty	28,462,475	—	1,785,237	—	30,247,712
RG/RS/OX Wheat	5,000,000	—	—	—	5,000,000
Total	94,229,557	6,074,614	96,818,958	5,063	197,128,192

F-19

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

4. Accumulated amortization as of December 31, 2022 is as follows:


	Amortization
	Accumulated as		Foreign	Accumulated
	of beginning of		currency	as of the end
Class	the period	Of the period	translation	of the period
Seed and integrated products
HB4 soy and breeding program	1,568,554	799,644	—	2,368,198
Integrated seed products	43,997	22,242	488	66,727
Crop nutrition
Microbiological products	3,063,073	313,970	—	3,377,043
Other intangible assets
Trademarks and patents	3,916,004	2,136,403	—	6,052,407
Software	3,008,388	285,881	(756)	3,293,513
Customer loyalty	5,924,672	1,633,381	—	7,558,053
Total	17,524,688	5,191,521	(268)	22,715,941

The amortization charge is included in Notes 6.3 and 6.4.

5.9. Goodwill


	12/31/2023	06/30/2023

Rizobacter Argentina S.A.	28,080,271	28,080,271
Bioceres Crops S.A.	7,523,322	7,523,322
Pro farm Group, Inc.	76,089,749	76,089,749
Insumos Agroquímicos S.A.	470,090	470,090
	112,163,432	112,163,432

There were no indicators of goodwill impairment.

5.10. Investment properties


	12/31/2023	06/30/2023

Investment properties	3,792,238	3,589,749
	3,792,238	3,589,749

5.11. Trade and other payables


	12/31/2023	06/30/2023

Trade creditors	103,683,392	104,211,238
Shareholders and other related parties (Note 15)	75,271	35,292
Trade creditors - Parent company (Note 15)	161,860	644,191
Trade creditors - Joint ventures and associates (Note 15)	56,385,464	41,402,594
Taxes	3,556,073	3,561,058
Miscellaneous	141,142	953,301
	164,003,202	150,807,674

F-20

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

5.12. Borrowings


	12/31/2023	06/30/2023
Current
Bank borrowings	52,942,957	61,303,952
Corporate bonds	49,749,398	35,547,510
Trust debt securities	7,188,607	7,296,506
Net loans payables- Parents companies and related parties to Parent (Note 15)	3,639,816	3,491,691
	113,520,778	107,639,659
Non-current
Bank borrowings	10,314,800	10,663,266
Corporate bonds	21,202,548	50,007,680
	31,517,348	60,670,946

The carrying value of some borrowings as of December 31, 2023 are measured at amortized cost differ from their fair value. The following fair values measured are based on discounted cash flows (Level 3) due to the use of unobservable inputs, including own credit risk.


	12/31/2023		06/30/2023
	Amortized cost	Fair value	Amortized cost	Fair value
Current
Bank borrowings	52,942,957	49,659,094	61,303,952	57,209,155
Corporate Bonds	49,749,398	49,192,118	35,547,510	34,725,828

Non-current
Bank borrowings	10,314,800	8,698,322	10,663,266	10,374,646
Corporate Bonds	21,202,548	20,670,511	50,007,680	47,014,542

5.13. Secured Notes

Secured Guaranteed Notes

The carrying value of $25.9 million of the Secured Guaranteed Notes as of December 31, 2023 are measured at amortized cost. Its fair value based on discounted cash flows, using a fair interest rate, would amount to $26.9 million.

Secured Convertible Guaranteed Notes

The carrying value of $52.1 million of the Secured Convertible Guaranteed Notes as of December 31, 2023 are measured at amortized cost. Its fair value based on discounted cash flows, using a fair interest rate, would amount to $54.8 million.

Under the terms of the Secured Convertible Guaranteed Notes, the Group is in compliance with covenants.

5.14. Employee benefits and social security


	12/31/2023	06/30/2023
Salaries, accrued incentives, vacations and social security	8,150,518	9,388,639
Key management personnel (Note 15)	68,139	218,068
	8,218,657	9,606,707

F-21

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

5.15. Deferred revenue and advances from customers


	12/31/2023	06/30/2023
Current
Advances from customers	4,466,515	9,216,032
Deferred revenue	17,632,863	15,659,630
	22,099,378	24,875,662
Non-current
Advances from customers	272,334	620,893
Deferred revenue	1,863,506	1,436,912
	2,135,840	2,057,805

6. INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

6.1. Revenue from contracts with customers


	12/31/2023	12/31/2022
Sale of goods and services	255,827,291	220,482,895
Royalties	649,341	909,067
	256,476,632	221,391,962

Transactions of sales of goods and services with joint ventures and with shareholders and other related parties are reported in Note 15.

6.2. Cost of sales


Item	12/31/2023	12/31/2022
Inventories as of the beginning of the period	111,990,145	78,759,610
Business combination	—	11,064,908
Purchases of the period	144,999,639	138,186,645
Production costs	12,981,672	14,596,888
Foreign currency translation	(28,273)	(246,484)
Subtotal	269,943,183	242,361,567
Inventories as of the end of the period (*)	(109,616,865)	(107,544,430)
Cost of sales	160,326,318	134,817,137

(*)Net of agricultural products.

F-22

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

6.3. R&D classified by nature


	Research and	Research and
	development	development
	expenses	expenses
Item	12/31/2023	12/31/2022
Amortization of intangible assets	2,453,158	2,201,938
Analysis and storage	5,302	27,322
Import and export expenses	—	850
Depreciation of property, plant and equipment	312,453	287,180
Freight and haulage	14,278	4,732
Employee benefits and social securities	2,211,907	2,248,105
Maintenance	96,056	303,524
Energy and fuel	5,227	94,870
Supplies and materials	1,182,066	1,078,197
Mobility and travel	89,474	158,193
Share-based incentives	143,749	92,477
Publicity and advertising	—	9,568
Professional fees and outsourced services	994,197	574,614
Professional fees related parties	216,792	102,701
Office supplies	470,376	43,546
Information technology expenses	9,640	19,060
Insurance	19,586	25,738
Depreciation of leased assets	—	33,685
Miscellaneous	57	3,606
Total	8,224,318	7,309,906


	12/31/2023	12/31/2022
R&D capitalized (Note 5.8)	4,454,893	5,926,539
R&D profit and loss	8,224,318	7,309,906
Total	12,679,211	13,236,445

F-23

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

6.4. Expenses classified by nature and function


		Selling,
		general and
	Production	administrative	Total
Item	costs	expenses	12/31/2023
Amortization of intangible assets	60,849	2,960,964	3,021,813
Analysis and storage	570	153,163	153,733
Commissions and royalties	421,677	1,008,251	1,429,928
Import and export expenses	43,902	318,479	362,381
Depreciation of property, plant and equipment	1,308,591	935,378	2,243,969
Depreciation of leased assets	699,044	1,012,212	1,711,256
Impairment of receivables	—	296,051	296,051
Freight and haulage	634,188	6,878,364	7,512,552
Employee benefits and social securities	5,935,502	21,509,102	27,444,604
Maintenance	1,007,395	1,152,332	2,159,727
Energy and fuel	500,658	272,547	773,205
Supplies and materials	367,386	1,691,154	2,058,540
Mobility and travel	94,476	2,148,705	2,243,181
Publicity and advertising	1,300	2,305,251	2,306,551
Contingencies	1,239	47,851	49,090
Share-based incentives	339,904	8,043,561	8,383,465
Professional fees and outsourced services	963,972	3,542,038	4,506,010
Professional fees related parties	—	66,618	66,618
Office supplies and registrations fees	80,236	651,991	732,227
Insurance	81,174	1,102,142	1,183,316
Information technology expenses	27,186	1,924,633	1,951,819
Obsolescence	282,836	—	282,836
Taxes	127,760	7,019,360	7,147,120
Miscellaneous	1,827	57,638	59,465
Total	12,981,672	65,097,785	78,079,457

F-24

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)


		Selling,
		general and
	Production	administrative	Total
Item	costs	expenses	12/31/2022
Amortization of intangible assets	86,842	2,902,741	2,989,583
Analysis and storage	4,460	237,341	241,801
Commissions and royalties	109,703	1,020,272	1,129,975
Import and export expenses	265,121	704,937	970,058
Depreciation of property, plant and equipment	1,666,119	1,006,857	2,672,976
Depreciation of leased assets	230,478	1,573,369	1,803,847
Impairment of receivables	—	468,992	468,992
Freight and haulage	1,201,183	5,002,384	6,203,567
Employee benefits and social securities	7,177,926	20,156,371	27,334,297
Maintenance	722,399	1,446,553	2,168,952
Energy and fuel	753,041	161,850	914,891
Supplies and materials	512,493	627,514	1,140,007
Mobility and travel	39,428	1,837,797	1,877,225
Publicity and advertising	—	3,235,737	3,235,737
Contingencies	—	39,847	39,847
Share-based incentives	—	1,969,868	1,969,868
Professional fees and outsourced services	1,133,009	7,122,701	8,255,710
Professional fees related parties	—	29,818	29,818
Office supplies and registrations fees	23,309	624,246	647,555
Insurance	74,350	1,306,282	1,380,632
Information technology expenses	17,511	1,566,952	1,584,463
Obsolescence	481,332	—	481,332
Taxes	96,233	6,976,043	7,072,276
Miscellaneous	1,951	300,016	301,967
Total	14,596,888	60,318,488	74,915,376

6.5. Other income or expenses, net


	12/31/2023	12/31/2022
Net result from commercialization of agricultural products	(2,960,005)	144,515
Expenses recovery	236,106	232,977
Other income or expenses, net	325,661	391,036
	(2,398,238)	768,528

F-25

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

6.6. Finance results


	12/31/2023	12/31/2022
Financial costs
Interest expenses with the Parents (Note 15)	(194,125)	(299,468)
Interest expenses	(9,994,912)	(10,722,135)
Financial commissions	(1,288,813)	(1,517,729)
	(11,477,850)	(12,539,332)

Other financial results
Exchange differences generated by assets	(12,049,351)	(12,771,727)
Exchange differences generated by liabilities	21,674,845	9,070,404
Changes in fair value of financial assets or liabilities and other financial results	(13,727,825)	(2,068,923)
Net gain of inflation effect on monetary items	766,135	281,083
	(3,336,196)	(5,489,163)

7. TAXATION

Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual earnings.


	12/31/2023	12/31/2022
Current tax expense	(3,845,338)	(6,467,324)
Deferred tax	(4,917,089)	769,775
Total	(8,762,427)	(5,697,549)


	12/31/2023	12/31/2022
Beginning of the period deferred tax	(28,472,383)	(24,994,569)
Additions for business combination	—	(16,704,771)
Charge for the period	(4,917,089)	769,775
Conversion difference	(361,293)	(582,016)
Total net deferred tax	(33,750,765)	(41,511,581)

F-26

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

The tax on the Group’s profit before tax differs from the theoretical amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows:


	12/31/2023	12/31/2022
Earning before income tax-rate	7,322,464	1,183,270
Income tax expense by applying tax rate in force in the respective countries	(5,434,748)	(5,182,386)
Share of profit or loss of subsidiaries, joint ventures and associates	1,219,030	225,376
Stock options charge	(1,489,037)	(298,851)
Non-deductible expenses	(116,220)	(543,505)
Unrecognized deferred tax ¹	—	(995,754)
Tax inflation adjustment	7,460,048	3,132,901
Result of inflation effect on monetary items and other finance results	(11,000,459)	(1,660,369)
Untaxed gains	598,959	33,052
Others	—	(408,013)
Income tax expenses	(8,762,427)	(5,697,549)

1 Corresponds mainly to Pro Farm Group Inc.

8. EARNING PER SHARE

The numerators and denominators used in the calculation of basic EPS and diluted EPS are presented below:


	Three -month period ended		Six-month period ended
	12/31/2023	12/31/2022	12/31/2023	12/31/2022
Numerator
(Loss) profit for the period (basic EPS)	108,449	(8,156,746)	(4,483,185)	(7,658,449)
(Loss) profit for the period (diluted EPS)	108,449	(8,156,746)	(4,483,185)	(7,658,449)
Denominator
Weighted average number of shares (basic EPS)	62,839,961	61,657,343	62,839,961	61,657,343
Weighted average number of shares (diluted EPS)	63,877,692	61,657,343	62,839,961	61,657,343

Basic (loss) profit attributable to ordinary equity holders of the parent	0.0017	(0.1323)	(0.0713)	(0.1242)
Diluted (loss) profit attributable to ordinary equity holders of the parent	0.0017	(0.1323)	(0.0713)	(0.1242)

For the three and six month period ended December 31, 2022 diluted EPS was equal to basic EPS as the effect of potential ordinary shares would be antidilutive.

For the three month period ended December 31, 2022, diluted earnings per share was calculated by adjusting the weighted average number of shares outstanding to assume conversion of all dilutive potential shares. The Group had two categories of dilutive potential shares, share-based incentives and the convertible notes.

The stock options were included in the diluted EPS calculation for the three period ended December 31, 2023 only for the tranches in which the average market price of ordinary shares during the periods was higher than the assumed proceeds per option.

Convertible notes outstanding were not included in the diluted EPS calculations for the three period ended December 31, 2023 because the interest (net of tax and other changes in income or expense) per ordinary share obtainable on conversion exceeds basic earnings per share.

F-27

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

9. EQUITY INFORMATION

Capital issued

As of December 31, 2023, we had (i) 100,000,000 ordinary shares ($0.0001 par value) authorized, (ii) 62,828,025 ordinary shares issued and outstanding, (iii) 1,000,000 preferred shares ($0.0001 par value) authorized, (iv) no preferred shares issued and outstanding, (v) 3,947,634 ordinary shares reserved for our equity compensation plans. Of the total issued shares, we have repurchased 2,258,016 shares of our own.

Holders of the ordinary shares are entitled to one vote for each ordinary share.

10. CASH FLOW INFORMATION

Significant non-cash transactions related to investing and financing activities are as follows:


	12/31/2023	12/31/2022
Investment activities
Net assets acquisition by business combination	—	152,070,313
Investment in-kind in other related parties (Note 15)	—	1,434,802
Capitalization of interest on buildings in progress	47,542	—
	47,542	153,505,115

	12/31/2023	12/31/2022
Financing activities
Capitalization of convertible notes (Note 5.13)	—	12,211,638
Purchase of own shares	—	(23,915,029)
	—	(11,703,391)

11. JOINT VENTURES AND ASSOCIATES


	12/31/2023	06/30/2023
Assets
Synertech Industrias S.A.	39,205,548	36,026,710
Alfalfa Technologies S.R.L.	36,503	36,502
Moolec Science S.A.	3,160,166	3,233,598
	42,402,217	39,296,810


	12/31/2023	06/30/2023
Liabilities
Trigall Genetics S.A.	115,983	622,823
	115,983	622,823

F-28

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

Changes in joint ventures investments and affiliates:


	12/31/2023	12/31/2023
As of the beginning of the period	38,673,987	37,836,144
Share-based incentives	50,383	—
Sale of equity investee - Indrasa Biotecnología S.A.	—	(7,853)
Foreign currency translation	897	(21,946)
Share of profit or loss	3,560,967	882,288
As of the end of the period	42,286,234	38,688,633

Share of profit or loss of joint ventures and affiliates:


	12/31/2023	12/31/2023
Trigall Genetics S.A.	506,840	595,889
Synertech Industrias S.A.	3,178,839	349,012
Moolec Science S.A.	(124,712)	—
Indrasa Biotecnología S.A.	—	(62,613)
	3,560,967	882,288

12. SEGMENT INFORMATION

The tables present information with respect to the Group´s reporting segments:


	Seed and
	integrated		Crop		Crop
Period ended December 31, 2023	products		protection		nutrition		Consolidated
Revenues from contracts with customers
Sale of goods and services	53,777,458		127,029,466		75,020,367		255,827,291
Royalties	649,341		—		—		649,341
Others
Initial recognition and changes in the fair value of biological assets at the point of harvest	77,353		141,457		119,318		338,128
Total	54,504,152		127,170,923		75,139,685		256,814,760

Cost of sales	(36,216,288)		(81,249,196)		(42,860,834)		(160,326,318)
Gross profit per segment	18,287,864		45,921,727		32,278,851		96,488,442
% Gross margin	34	%	36	%	43	%	38	%


	Seed and
	integrated		Crop		Crop
Period ended December 31, 2022	products		protection		nutrition		Consolidated
Revenues from contracts with customers
Sale of goods and services	29,226,197		116,263,527		74,993,171		220,482,895
Royalties	909,067		—		—		909,067
Others
Initial recognition and changes in the fair value of biological assets at the point of harvest	56,530		140,620		154,327		351,477
Total	30,191,794		116,404,147		75,147,498		221,743,439

Cost of sales	(13,606,348)		(79,703,474)		(41,507,315)		(134,817,137)
Gross profit per segment	16,585,446		36,700,673		33,640,183		86,926,302
% Gross margin	55	%	32	%	45	%	39	%

F-29

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

As of the current period, changes in the net realizable value of agricultural products after harvest have been excluded from segment information since those results depend on market fluctuations which are beyond the Group’s operating control. The Group has recast the comparative amounts.

13. FINANCIAL INSTRUMENTS – RISK MANAGEMENT

Financial instruments by category

The following tables show additional information required under IFRS 7 on the financial assets and liabilities recorded as of December 31, 2023, and June 30, 2023.

Financial assets by category


			Mandatorily measured at fair
	Amortized cost		value through profit or loss
Financial asset	12/31/2023	06/30/2023	12/31/2023	06/30/2023
Cash and cash equivalents	24,332,260	48,129,194	69,677	—
Other financial assets	444,743	657,612	17,040,207	11,922,317
Trade receivables	199,666,283	158,006,474	—	—
Other receivables (*)	13,368,459	12,124,724	—	—
Total	237,811,745	218,918,004	17,109,884	11,922,317

(*)	Advances expenses and tax balances are not included.

Financial liabilities by category


			Mandatorily measured at fair
	Amortized cost		value through profit or loss
Financial liability	12/31/2023	06/30/2023	12/31/2023	06/30/2023
Trade and other payables	156,857,878	142,582,166	7,145,324	8,225,508
Borrowings	145,038,126	168,310,605	—	—
Secured notes	77,998,071	75,213,146	—	—
Lease liability	13,600,289	13,889,223	—	—
Consideration for acquisition of assets	6,684,278	4,993,256	—	—
Total	400,178,642	404,988,396	7,145,324	8,225,508

F-30

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

Financial instruments measured at fair value


Measurement at fair value at 12/31/2023	Level 1	Level 2	Level 3

Financial assets at fair value
US Treasury bills	—	—	—
Mutual funds	14,736,104	—	—
Other investments	2,304,103	—	—
Financial liability at fair value
Trade and other payables	—	7,145,324	—

Measurement at fair value at 06/30/2023	Level 1	Level 2	Level 3

Financial assets at fair value
US Treasury bills	9,163,298	—	—
Mutual funds	1,596,539	—	—
Other investments	1,162,480	—	—
Financial liability at fair value
Trade and other payables	—	8,225,508	—

Estimation of fair value

The fair value of marketable securities, mutual funds and US Treasury Bills is calculated using the market approach using quoted prices in active markets for identical assets. The quoted marked price used for financial assets held by the Group is the current bid price. These instruments are included in level 1.

The Group’s financial liabilities, which were not traded in an active market, were determined using valuation techniques that maximize the use of available market information, and thus rely as little as possible on specific estimates of the entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instruments are included in level 2.

If one or more of the significant inputs is not based on observable market data, the instruments are included in level 3.

The Group’s policy is to recognize transfers between different categories of the fair value hierarchy at the time they occur or when there are changes in the circumstances that cause the transfer. There were no transfers between levels of the fair value hierarchy. There were no changes in economic or business circumstances affecting fair value.

Financial instruments not measured at fair value

The financial instruments not measured at fair value include cash and cash equivalents, trade accounts receivable, other accounts receivable, trade payables and other debts, borrowings, financed payments and convertible notes.

The carrying value of financial instruments not measured at fair value does not differ significantly from their fair value, except for borrowings (Note 5.12).

Management estimates that the carrying value of the financial instruments measured at amortized cost approximates their fair value.

F-31

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

Currency risk

Foreign currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rate. Currency on foreign exchange risk arises when the Group enters into transactions denominated in a currency other than its functional currency.

The table below sets forth our net exposure to currency risk as of December 31, 2023:


Net foreign currency position		12/31/2023
Amount expressed in US$		(6,210,949)

Considering only this net currency exposure as of December 31, 2023 if an US Dollar revaluation or depreciation in relation to other foreign currencies with the remaining variables remaining constant, would have a positive or a negative impact on comprehensive income as a result of foreign exchange gains or losses. We estimate that a devaluation or an appreciation of the US Dollar other currencies of 10% during the period ended December 31, 2023 would have resulted in a net pre-tax loss or gain of approximately $0.6 million.

14. LEASES


Right-of-use leased asset	12/31/2023	06/30/2023
Book value at the beginning of the period/year	21,163,192	15,828,032
Additions of the period/year	1,842,539	3,154,950
Additions from business combination	—	3,005,000
Disposals	(558,684)	(1,839,921)
Exchange differences	(129,169)	1,015,131
Book value at the end of the period/year	22,317,878	21,163,192

Depreciation	12/31/2023	06/30/2023
Book value at the beginning of the period/year	7,226,617	3,684,006
Depreciation of the period/year	1,711,256	3,565,894
Disposals	(305,474)	(171,870)
Exchange differences	(18,738)	148,587
Accumulated depreciation at the end of the period/year	8,613,661	7,226,617
Total	13,704,217	13,936,575


Lease liability	12/31/2023	06/30/2023
Book value at the beginning of the period/year	13,889,223	11,751,284
Additions of the period/year	1,842,539	3,154,950
Additions from business combination	—	3,245,000
Interest expenses, exchange differences and inflation effects	362,144	(406,494)
Payments of the period/year	(2,493,617)	(3,855,517)
Total	13,600,289	13,889,223


Lease Liabilities	12/31/2023	06/30/2023
Non-current	9,583,276	10,030,524
Current	4,017,013	3,858,699
Total	13,600,289	13,889,223

F-32

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

The recognized right-of-use assets relate to the following types of assets:


	12/31/2023	06/30/2023
Machinery and equipment	3,655,741	3,655,741
Vehicles	1,940,263	1,475,581
Equipment and computer software	1,025,650	903,306
Land and buildings	15,696,224	15,128,564
	22,317,878	21,163,192

The incremental borrowing rate used was 1.94 % in US$ and 13.05% in reais.

15. SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

During the period ended December 31, 2023, and 2022, the transactions between the Group and related parties, and the related balances owed by and to them, are as follows:


		Value of transactions for the period ended
Party	Transaction type	12/31/2023	12/31/2022
Joint ventures and associates	Sales and services	14,270,782	23,433,292
Joint ventures and associates	Purchases of goods and services	(20,696,699)	(43,850,427)
Key management personnel	Salaries, social security benefits and other benefits	(9,667,629)	(3,263,996)
Key management personnel	Sales and services	—	362,017
Shareholders and other related parties	Sales of goods and services	1,643,269	343,873
Shareholders and other related parties	Purchases of goods and services	(2,178,877)	(305,061)
Shareholders and other related parties	In-kind contributions	—	1,434,802
Parent company and related parties to Parent (Note 6.6)	Interest expenses	(194,125)	(299,468)
Total		(16,823,279)	(22,144,968)


		Amounts receivable from related parties
Party	Transaction type	12/31/2023	06/30/2023
Shareholders and other related parties	Trade debtors	1,223,994	—
Shareholders and other related parties	Other receivables	3,105,591	3,792,429
Joint ventures and associates	Trade debtors	781,452	865,627
Joint ventures and associates	Other receivables	7,730,898	6,334,219
Total		12,841,935	10,992,275


		Amounts payable to related parties
Party	Transaction type	12/31/2023	06/30/2022
Parent company and related parties to Parent	Trade creditors	(161,860)	(644,191)
Parent company and related parties to Parent	Net loans payables	(3,639,816)	(3,491,691)
Key management personnel	Salaries, social security benefits and other benefits	(68,139)	(218,068)
Shareholders and other related parties	Trade and other payables	(75,271)	(35,292)
Joint ventures and associates	Trade creditors	(56,385,464)	(41,402,594)
Total		(60,330,550)	(45,791,836)

F-33

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

16. KEY MANAGEMENT PERSONNEL COMPENSATION

The compensation of directors and other members of key management personnel, including social contributions and other benefits, were as follows for the period ended December 31, 2023, and 2022.


	12/31/2023	12/31/2022

Salaries, social security and other benefits	1,140,415	1,201,651
Share-based incentives	8,527,214	2,062,345
Total	9,667,629	3,263,996

17. SHARE-BASED PAYMENT

Pursuant to the 2023 Omnibus Equity Incentive Plan approved on May 12, 2023, in August 2023 the Board has granted the following stock options plan to certain directors, executives and management of the Group.

Past Share Option plan: immediately vested options with a strike price between $11.93 and $13.24.

Base Share Option plan: to vest and become exercisable in equal installments on June 30, 2023, June 30, 2024, and June 30, 2025, with a strike price between $10.47 and $10.79.

Performance Share Option plan: to vest and become exercisable if the Group’s fiscal year 2025 EBITDA reaches at least US$120 million, at 0% of the award, and linearly thereafter up to 100% of the awarded options when reaching at least US$150 million. These options have also a strike price of between $10.47 and $10.79.

The fair value of the stock options at the grant date was estimated using the “Black-Scholes” model considering the terms and conditions under which the stock options were granted and adjusted to consider the possible dilutive effect of the future exercise of options. As of December 31, 2023, the expenses associated with share-based incentive plans are included in results within “Share-based incentives” along with the associated increase in net worth.

18. CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS

There were no other significant changes to the contingencies, commitments and restrictions on the distribution of profits from the disclosure made in the Consolidated financial statement as of June 30, 2023.

19. EVENTS OCCURRING AFTER THE REPORTING PERIOD

Subsequent to December 31, 2023, there have been no other situations or circumstances that may require significant adjustments or further disclosure in these consolidated financial statements that were not mentioned above.

F-34

EX-101.SCH 3 biox-20231231.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Calc2 link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details) link:presentationLink link:calculationLink link:definitionLink 40503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details) link:presentationLink link:calculationLink link:definitionLink 40504 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details) link:presentationLink link:calculationLink link:definitionLink 40517 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details) link:presentationLink link:calculationLink link:definitionLink 40521 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details) link:presentationLink link:calculationLink link:definitionLink 40522 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details) link:presentationLink link:calculationLink link:definitionLink 40604 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details) link:presentationLink link:calculationLink link:definitionLink 40605 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details) link:presentationLink link:calculationLink link:definitionLink 40606 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - TAXATION - Taxes on income (Details) link:presentationLink link:calculationLink link:definitionLink 40703 - Disclosure - TAXATION - Reconciliation of the statutory tax rate (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - CASH FLOW INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - SEGMENT INFORMATION - Group's reporting segments (Details) link:presentationLink link:calculationLink link:definitionLink 41402 - Disclosure - LEASES - Lease liability (Details) link:presentationLink link:calculationLink link:definitionLink 41501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 41601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY link:presentationLink link:calculationLink link:definitionLink 40505 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 40506 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details) link:presentationLink link:calculationLink link:definitionLink 40507 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details) link:presentationLink link:calculationLink link:definitionLink 40508 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - net carrying amount (Details) link:presentationLink link:calculationLink link:definitionLink 40509 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - gross carrying amounts (Details) link:presentationLink link:calculationLink link:definitionLink 40510 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - accumulated depreciation (Details) link:presentationLink link:calculationLink link:definitionLink 40511 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details) link:presentationLink link:calculationLink link:definitionLink 40512 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, net carrying amount (Details) link:presentationLink link:calculationLink link:definitionLink 40513 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, gross carrying amount (Details) link:presentationLink link:calculationLink link:definitionLink 40514 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, accumulated amortization (Details) link:presentationLink link:calculationLink link:definitionLink 40515 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 40518 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 40519 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details) link:presentationLink link:calculationLink link:definitionLink 40520 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - EQUITY INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - JOINT VENTURES AND ASSOCIATES (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details) link:presentationLink link:calculationLink link:definitionLink 41302 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details) link:presentationLink link:calculationLink link:definitionLink 41303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details) link:presentationLink link:calculationLink link:definitionLink 41304 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - LEASES - Right-of-use leased asset (Details) link:presentationLink link:calculationLink link:definitionLink 41403 - Disclosure - LEASES - Right-of-use asset by type (Details) link:presentationLink link:calculationLink link:definitionLink 41502 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 41503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details) link:presentationLink link:calculationLink link:definitionLink 41701 - Disclosure - SHARE-BASED PAYMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - GENERAL INFORMATION link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PREPARATION link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - SEASONALITY link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - TAXATION link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - EARNING PER SHARE link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - EQUITY INFORMATION link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - CASH FLOW INFORMATION link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - JOINT VENTURES AND ASSOCIATES link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 11501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 11601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION link:presentationLink link:calculationLink link:definitionLink 11701 - Disclosure - SHARE-BASED PAYMENT link:presentationLink link:calculationLink link:definitionLink 11801 - Disclosure - CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS link:presentationLink link:calculationLink link:definitionLink 11901 - Disclosure - EVENTS OCCURRING AFTER THE REPORTING PERIOD link:presentationLink link:calculationLink link:definitionLink 20102 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Policies) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - TAXATION (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - EARNING PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - CASH FLOW INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - JOINT VENTURES AND ASSOCIATES (Tables) link:presentationLink link:calculationLink link:definitionLink 31203 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 31303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 31403 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 31503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 31603 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - GENERAL INFORMATION - (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - SEASONALITY (Details) link:presentationLink link:calculationLink link:definitionLink 40516 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - TAXATION - Movement on the deferred income tax (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - EARNING PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details) link:presentationLink link:calculationLink link:definitionLink 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 biox-20231231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 5 biox-20231231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 6 biox-20231231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information [Abstract] Document Type Entity Registrant Name Entity Central Index Key Document Period End Date Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION ASSETS. ASSETS CURRENT ASSETS Current Cash and cash equivalents Cash and cash equivalents Cash and cash equivalents Other current financial assets Other financial assets Other financial assets Trade and other current receivables Trade receivables Trade receivables Other current receivables Other receivables Other receivables Current tax assets Income and minimum presumed recoverable income taxes Current inventories Inventories Biological assets End of period Beginning of the period Biological assets Total current assets Total current assets NON-CURRENT ASSETS.. NON-CURRENT ASSETS Non-current Other non-current financial assets Other financial assets Other financial assets Other non-current receivables Other receivables Other receivables Current tax assets, non-current Income and minimum presumed recoverable income taxes Deferred tax assets Deferred tax assets The amount of investments accounted for using the equity method, asset position. Investments Accounted For Using Equity Method, Assets Investments in joint ventures and associates Assets in joint ventures and associates Investment property Investment properties Property, plant and equipment As of the beginning of period As of the end of period As of the end of period As of the beginning of period Property, plant and equipment Intangible assets Balance at end of the period Balance at beginning of the period Balance at end of the period Balance at beginning of the period Intangible assets Goodwill Goodwill Right-of-use assets Book value at the end of the period/year Book value at the beginning of the period/year Right of use asset Non-current assets Total non-current assets Assets Total assets LIABILITIES. LIABILITIES CURRENT LIABILITIES. Current CURRENT LIABILITIES Trade and other current payables Trade and other payables Trade and other payable Current borrowings Borrowings Employee Benefits and Social Security, Current Employee benefits and social security Employee benefits and social security Current deferred income including current contract liabilities Deferred revenue and advances from customers Deferred revenue and advances from customers Current tax liabilities Income tax payable The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as current. Consideration for Acquisition of Assets, Current Consideration for acquisition Current lease liabilities Lease liabilities Current Current liabilities Total current liabilities NON-CURRENT LIABILITIES. Non-current NON-CURRENT LIABILITIES Non-current portion of non-current borrowings Borrowings Non-current contract liabilities Deferred revenue and advances from customers Deferred revenue and advances from customers The amount of investments accounted for using the equity method, liability position. Investments accounted for using equity method, liability Joint ventures and associates Liabilities in joint ventures and associates Deferred tax liabilities Deferred tax liabilities Non-current provisions Provisions The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as non-current. Consideration for Acquisition of Assets, Non Current Consideration for acquisition Amount of secured debt, non-current. Secured Debt, Non-Current Secured notes Non-current lease liabilities Lease liabilities Non-current Non-current liabilities Total non-current liabilities Liabilities Total liabilities EQUITY. EQUITY Equity attributable to owners of parent Equity attributable to owners of the parent Non-controlling interests. Non-controlling interest Equity Balance Balance Total equity Equity and liabilities Total equity and liabilities UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Revenue from contracts with customers Revenues from contracts with customers Sale of goods and services Gains (losses) on fair value adjustment, biological assets Initial recognition and changes in the fair value of biological assets at the point of harvest Initial recognition and changes in the fair value of biological assets at the point of harvest Cost of sales Cost of sales Cost of sales Change in the net realizable value of agricultural. Change In The Net Realizable Value Of Agricultural Changes in the net realizable value of agricultural products after harvest Research and development expense Research and development expenses Total Selling, general and administrative expense Selling, general and administrative expenses Share of profit (loss) of associates and joint ventures accounted for using equity method Share of profit or loss of joint ventures and associates Share of profit or loss of joint ventures and associates Share of profit or loss Other operating income (expense) Other income or expenses, net Total Profit (loss) from operating activities Operating profit Finance income (cost) Financial cost Other finance income (cost) Other financial results Other financial results Profit (loss) before tax (Loss) profit before income tax Tax expense (income), continuing operations Income tax Income tax expenses Result for the year Loss for the period (Loss) profit for the period (Loss) profit for the period (Loss) profit for the period attributable to: Profit (loss), attributable to owners of parent Equity holders of the parent Profit (loss), attributable to non-controlling interests Non-controlling interests EARNING PER SHARE (Loss) profit per share Basic earnings (loss) per share Basic (loss) profit attributable to ordinary equity holders of the parent Diluted earnings (loss) per share Diluted (loss) profit attributable to ordinary equity holders of the parent Other comprehensive income Other comprehensive (loss) income Other comprehensive income (loss) Other comprehensive income that will be reclassified to profit or loss, net of tax Items that may be subsequently reclassified to profit and loss Gains (Losses) on Exchange Differences on Translation From Joint Venture, net of tax Foreign exchange differences on translation of foreign operations from joint ventures Gains (losses) on exchange differences on translation, net of tax Foreign exchange differences on translation of foreign operations Comprehensive income Total comprehensive (loss) profit Total comprehensive (loss) profit attributable to: Comprehensive income, attributable to owners of parent Equity holders of the parent Comprehensive income, attributable to non-controlling interests Non-controlling interests UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Statement of changes in equity [table] Components of equity [axis] Equity [member] Equity / (deficit) attributable to owners of the parent Issued capital Share premium The member stands for the changes in non-controlling interest. Changes in non-controlling interest The member stands for the own shares trading premium. Own shares trading premium This member stands for Stock Options And Share Based Incentives. Stock options and share based incentives Convertible instruments Cost of own shares held Retained deficit Foreign currency translation reserve This member stands for revaluation of PP&E and effect of tax rate change. Revaluation of PP&E and effect of tax rate change Non-controlling Interests Statement of changes in equity [line items] Statement of changes in equity Increase (decrease) through share-based payment transactions, equity Share-based incentives The increase (decrease) in equity resulting from business combination transactions. Increase (Decrease) Through Business Combination Transactions, Equity Business combination The increase (decrease) in equity resulting from capitalization of convertible notes Increase (Decrease) Through Capitalization of Convertible Notes, Equity Capitalization of convertible notes Increase (decrease) through treasury share transactions, equity Purchase of own shares Issue of convertible instruments Issuance of convertible notes Dividends recognised as distributions to owners Distribution of dividends by subsidiary UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS OPERATING ACTIVITIES Adjustments to reconcile loss to net cash flows Adjustments to reconcile profit to net cash flows Adjustments for income tax expense Income tax Adjustments for finance costs Financial results Adjustments for depreciation expense Depreciation of property, plant and equipment Adjustments for amortisation expense Amortization of intangible assets Depreciation, right-of-use assets Depreciation of leased assets Depreciation of the period/year Adjustments for transaction expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for Transaction Expenses Transactional expenses Adjustments for share-based payments Share-based incentive and stock options Adjustments for gain (loss) of participation in joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments For Gain (Loss) of Participation In Joint Ventures and Associates Loss of participation in joint ventures and associates Adjustments for provisions Provisions for contingencies Impairment loss recognised in profit or loss, trade receivables Allowance for impairment of trade debtors Adjustments for obsolescence to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for Obsolescence Allowance for obsolescence Obsolescence Gains (losses) on fair value adjustment attributable to price changes, biological assets Initial recognition and changes in the fair value of biological assets Gains (losses) on change in fair value less costs to sell of biological assets for current period Changes in the net realizable value of agricultural products after harvest Adjustments for losses (gains) on disposal of non-current assets Gain or loss on sale of equipment and intangible assets No definition available. Working capital adjustments Adjustments for decrease (increase) in trade accounts receivable Trade receivables Adjustments for decrease (increase) in other operating receivables Other receivables Adjustments for decrease (increase) in income and minimum presumed income taxes to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for Decrease (Increase) in Income and Minimum Presumed Income Taxes Income and minimum presumed income taxes payable Adjustments for decrease (increase) in inventories Inventories and biological assets Adjustments for increase (decrease) in trade and other payables Trade and other payables Adjustments for decrease (increase) in employee benefits and social security to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for Decrease (Increase) in Employee Benefits and Social Security Employee benefits and social security Adjustments for decrease (increase) in deferred revenue and advances from customers to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for Decrease (Increase) in Deferred Revenue and Advances from Customers Deferred revenue and advances from customers Adjustments for decrease (increase) in income and minimum presumed income taxes paid/payable to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments For Decrease Increase In Income And Minimum Presumed Income Taxes Payable Income taxes paid Finance income received, classified as operating activities Interest collected Adjustments for decrease (increase) in Inflation effects on working capital adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for Decrease (Increase) in Inflation Effects on Working Capital Adjustments Inflation effects on working capital adjustments Cash flows from (used in) operating activities Net cash flows generated by operating activities INVESTMENT ACTIVITIES Proceeds from sales of property, plant and equipment, classified as investing activities Proceeds from sale of property, plant and equipment Amount of aggregate cash flows from obtaining control of subsidiaries or other businesses, classified as investing activities. Cash Flows From Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities Net cash received from business combination The cash inflow (outflow) generated from financial assets that the entity classifies as investing activities. Investment in financial assets Purchase of property, plant and equipment, classified as investing activities Purchase of property, plant and equipment Payments for development project expenditure Capitalized development expenditures Purchase of intangible assets, classified as investing activities Purchase of intangible assets Cash flows from (used in) investing activities Net cash flows used by investing activities FINANCING ACTIVITIES Proceeds from borrowings, classified as financing activities Proceeds from borrowings Repayments of borrowings, classified as financing activities Repayment of borrowings and financed payments Interest paid, classified as financing activities Interest payments Other inflows (outflows) of cash, classified as financing activities Other financial proceeds or payments, net Payments to acquire or redeem entity's shares Purchase of own shares Payments of lease liabilities, classified as financing activities Leased assets payments Dividends paid, classified as financing activities Cash dividend distributed by subsidiary Cash flows from (used in) financing activities Net cash flows (used) generated by financing activities Increase (decrease) in cash and cash equivalents before effect of exchange rate changes Net (decrease) increase in cash and cash equivalents The effect of inflation effects on cash and cash equivalents. Inflation Effects on Cash and Cash Equivalents Inflation effects on cash and cash equivalents Cash and cash equivalents if different from statement of financial position Cash and cash equivalents as of the end of the period Cash and cash equivalents as of beginning of the period Effect of exchange rate changes on cash and cash equivalents Effect of exchange rate changes on cash and equivalents No Definition Available GENERAL INFORMATION Disclosure of general information about financial statements [text block] GENERAL INFORMATION No definition available. ACCOUNTING STANDARDS AND BASIS OF PREPARATION The entire disclosure on accounting standards and basis of presentation. Disclosure Of Accounting Standards And Basis Of Presentation [Text Block] ACCOUNTING STANDARDS AND BASIS OF PREPARATION n/a NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB Disclosure of expected impact of initial application of new standards or interpretations [text block] NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB No definition availability. SEASONALITY The entire disclosure of the seasonality of the entity's business. Disclosure of Seasonality [Text Block] SEASONALITY n/a INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION The disclosure of components of Consolidated Statements of Financial Position. Disclosure Of Components Of Consolidated Statements Of Financial Position INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME The entire disclosure of information about components of consolidated statement of comprehensive income. Disclosure of Information About Components of Consolidated Statements of Comprehensive Income [Text Block] INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME TAXATION Disclosure of income tax [text block] TAXATION Disclosure of earnings per share [text block] EARNING PER SHARE EQUITY INFORMATION Disclosure of share capital, reserves and other equity interest [text block] EQUITY INFORMATION It represents the information pertaining to non cash transactions in cash flow. CASH FLOW INFORMATION Disclosure of cash flow statement [text block] CASH FLOW INFORMATION JOINT VENTURES AND ASSOCIATES The entire disclosure on investments in joint ventures and associates. Investments In Joint Ventures And Associates [Text Block] JOINT VENTURES AND ASSOCIATES SEGMENT INFORMATION Disclosure of entity's operating segments [text block] SEGMENT INFORMATION FINANCIAL INSTRUMENTS - RISK MANAGEMENT Disclosure of financial risk management [text block] FINANCIAL INSTRUMENTS - RISK MANAGEMENT LEASES Disclosure of leases [text block] LEASES SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS Disclosure of related party [text block] SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS No definition available. KEY MANAGEMENT PERSONNEL COMPENSATION Disclosure of information about key management personnel [text block] KEY MANAGEMENT PERSONNEL COMPENSATION EX-101.PRE 7 biox-20231231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 8 biox-20231231xex99d1001.jpg GRAPHIC begin 644 biox-20231231xex99d1001.jpg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biox-20231231xex99d1002.jpg GRAPHIC begin 644 biox-20231231xex99d1002.jpg M_]C_X 02D9)1@ ! @ 0 ! #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" 4 -4# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#])OBM\4_# MGP7\ ZMXP\57PL-&TV+?(^,O(Q.$C1?XG9B !ZGTYK\]_'?[0GQMMO%>A?%6 M/5VTO7=1E1/#GP/M[:6\N;_1V.7N+I8@3%(W#B1E&-N!C[I^M/VRO T/BCP/ MHNOZG&E[X;\$WLWBO4]-E;"7HM;.=X8F'\2F;RP1Z$U\7-JUYHNCZC/K&IWK MZIJ TV7Q1?6=^-.OO$NO:E#]JATUK[K:Z?:6VUG"$<<=Q772BK7,I-W/T,^ M_P <_#_[0?P[M?%?A_SK<%VMK[3;M=MQ8728\R"5>S*2/J"#WKY?T+]MCXRZ ME\)]8^+ ^&WA:\\ :/=W$5XD&M2PWYBAE\N1T5D*Y'7&>?2G?\$O= O(]%^+ M'B:*QLM.\,ZSKR1Z5%I;SO9R^0C)++ TY,CHS,HWNWN+D3EK8-:;3 RLP7=D=,]ZJ-./-)6OL) MR=D?I_X?^,MYXJ^*?A/3-/N/#T?AG7O"J>(([2ZNW37-SL"A6WQM\D*0"V<[ MLCMSL:'^T;\,/$OCF7P;I7CS0K_Q/&[1G3(+U&E+K]Y5YPS#!R 21@U\DZO8 M>-?$7[17A**\LQIGCZ^^!EU#+%;H(DM]2*_AK\*/%W[2'AWXWZ M)+J?B#Q/K\MWIUB=.DENM\<:'I5EJ]M)>:?<7%Z@2[A0!F>)LX< ,O3/48JG MXL_:7^%?@5=$/B#Q[H>D?VU;QW>GBZNU0SP. 4E ZA"",,<#WKX:\!?"W0;7 MX@?L?^'7FG\;^%6/B>[@EUS1&LU9& DC!MI2VU5<;DW'D;2.U5/BK:#X?_M) M_&RQ\<>,]+^'>E>)K:V32;C6?!_]L0ZCIHMS']GM9 P\HI]WRE') /\ "*%2 MC>U_ZO8.9GZ _$/XZ_#WX3Z=IU]XN\8:1H-KJ(S9R7=RH^T# .Z,#)9<$'(X MY'-=5X=\1Z5XNT.RUG1-1MM6TF]C$MM>VZL.#7YS^)=&\-_"6#X-W MK?$+5/!NNZ9X+:RTWQ7XP\+>=HNI6;2LXLIX'8O;W"JW8YVX&3D _5?[#&K' M7/V1_#KPUXK\5:Y;>!!KEBU['IGB&06US'L8),FQL%BCG;P M.>".#7C/[/GQR\'?LP_#/5/AS\1M4/ASQ3X9U/4!'87,+^;JL$ES)-!-: ^ M>)%D4 )DAL@@5;34;WXG_M.?L^^(/%?A :#J-UX4UN];1[X"X:P7*J\T.X+O1>KC) ^4&OE MS1_'G@'X/ZE^T)H'Q92&#Q'X@UV\OK>VOK1I9->TR6"-+2*V^4^<% :+RUSM M;L,UR/PUUFR^!_Q/_9_;XN7<6C7EC\,+BVDN=60L+*8W,6Q9'P?*81_N]Q(Y MRN><%>S7]=0YC[P\'>-=!^(7AVTU[PUJ]IKFC78+07MC*)(WP<'!'<$$$=0: M\1N_C7\3_B!\0?&^B?"_P]X6DTWP9>+IM_/XHOIXI[ZZ,2RLD*1*?+0!U D? M(8YP, U5_8N6#44^+'B30[5[3P/X@\87%_X?'E&*.XA\F));B)"!B.25)&' MSR:\[^*VO?!S5/B9XMN_&VJ:S\!/B5I<[6]MX@T[4)+.76[15!@N4VJ8KI3G M'ELK.NW:>U)12DU8;>ESZ!T+]HCP[#\(M)\=>.@WPVCNV-O/I_B)O)F@N5=D M:)00#)DJ2I4?,N&Q7/?&[]HRVT3]GF[^(WPXU?2?$42WME;0W2MY]N?-NXH9 M%(5@0P60\'!!QD5X'X9^(&M1>(?@#\4OC="]GHD>CZQ8?VO?V1A@M+YYT%I> M7$>,6[3VR'!( !8CC--=!O]4UW3K?5K2:_T+R_ M[4MTD!>SWQ^8GF#^'*?,,]J\B\6_MH?#'PIXY\!>'F\0Z?>1>+8WGBU&&[7R M;:+83!(WE:-:VFH6ES?W:$10RRV16 M%';'REVX7/>I5-;O^M+@Y'V#X9^)J22^/[GQ#K/AFVTCPWJ3V_VFQOBQM(5B M1S]M+@+%*-V2H)&"O/-3> OCO\/?BA8ZG>>%/%^E:Y;Z8GF7K6MP";=,$[W4 M\A2 2&Q@XX-?&/CC1;N]TOXU7'=,^,.G:KXAL+>!I6N=+BAMFG_=@ M$R*IV.5 .0A]*[OQ/XR\,?&7X_6/B'X87$&M:7HG@C6K?Q)K>EQG[,\*[ M3J5W_(1P3MYV@YQVJ?7/VA_AGX:\#M5\<:+8>)Y'2(:;/=JLBN_W$;LK- MV5B">PKY4T_0+33?V3/V2I+338;2Y3Q1X;F9X;<*ZO(KF5R0,@L2=Q[Y.:YG MXL>*_#?@G4OBCIVBZA9ZM<:MXE>YU;X/^-]",EWK-T\B#SM/GB/F%)-JO&Q# MJN/X0#35--V0.5&&&5E/!!!((->.^,OV./A/X_BD@USPT;NREU==SM(Q'%$@Z*JC@"K:6T2-N6)%;U"@&BBH&.V+OW[1NQC=CG%,6VA2=YUB M19G&&D"C<1Z$T44 $EM#-)'))$CR1G*.R@E?H>U$]M#=)LFB29,YVR*&&?7F MBB@!Y12RL5!9>AQR*9-;0W.SS8DEV'[A\+7>G"W)4P/$]S$Y M+*5R3E1WQ[445<>HF>L(BQJ%4!548 P *CGM(+HH9H8YBAW(9$#;3ZC/2BB MH&/FACN(FCE198V&&1QD$>XH$,:Q+&(U$:@ (!P .G%%% "26T4LD M2CLH)7/7![4DEK#-&(Y(D>,$$*R@@$=#BBB@!ZHJDD DY.!UID%K#:QF.&& M.%"22L:A02>IP*** '^6FU5VKA>@QTIC6L+SI.T,;3(,+(5!91Z ]J** ):* %** /_]D! end XML 10 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1

Document and Entity Information
6 Months Ended

Dec. 31, 2023

Document and Entity Information [Abstract]

Document Type 6-K

Entity Registrant Name Bioceres Crop Solutions Corp.

Entity Central Index Key 0001769484

Document Period End Date Dec. 31, 2023

Current Fiscal Year End Date --06-30

Document Fiscal Year Focus 2024

Document Fiscal Period Focus Q2

Amendment Flag false

X

- References
No definition available.
+ Details

Name: biox_DocumentAndEntityInformationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

XML 11 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($)

Dec. 31, 2023

Jun. 30, 2023

CURRENT ASSETS

Cash and cash equivalents $ 24,401,937 $ 48,129,194

Other financial assets 17,040,207 12,135,020

Trade receivables 199,666,283 158,006,474

Other receivables 25,081,598 28,824,998

Income and minimum presumed recoverable income taxes 1,120,881 9,444,898

Inventories 123,738,148 140,426,975

Biological assets 938,370 146,842

Total current assets 391,987,424 397,114,401

NON-CURRENT ASSETS

Other financial assets 444,743 444,909

Other receivables 1,619,642 2,546,241

Income and minimum presumed recoverable income taxes 3,794 16,286

Deferred tax assets 9,273,827 7,312,964

Investments in joint ventures and associates 42,402,217 39,296,810

Investment properties 3,792,238 3,589,749

Property, plant and equipment 71,388,129 67,853,835

Intangible assets 172,743,513 173,783,956

Goodwill 112,163,432 112,163,432

Right of use asset 13,704,217 13,936,575

Total non-current assets 427,535,752 420,944,757

Total assets 819,523,176 818,059,158

CURRENT LIABILITIES

Trade and other payables 164,003,202 150,807,674

Borrowings 113,520,778 107,639,659

Employee benefits and social security 8,218,657 9,606,707

Deferred revenue and advances from customers 22,099,378 24,875,662

Income tax payable 864,954 509,034

Consideration for acquisition 4,082,708 1,415,099

Lease liabilities 4,017,013 3,858,699

Total current liabilities 316,806,690 298,712,534

NON-CURRENT LIABILITIES

Borrowings 31,517,348 60,670,946

Deferred revenue and advances from customers 2,135,840 2,057,805

Joint ventures and associates 115,983 622,823

Deferred tax liabilities 43,024,592 35,785,347

Provisions 478,490 891,769

Consideration for acquisition 2,601,570 3,578,157

Secured notes 77,998,071 75,213,146

Lease liabilities 9,583,276 10,030,524

Total non-current liabilities 167,455,170 188,850,517

Total liabilities 484,261,860 487,563,051

EQUITY

Equity attributable to owners of the parent 300,541,772 298,594,088

Non-controlling interest 34,719,544 31,902,019

Total equity 335,261,316 330,496,107

Total equity and liabilities $ 819,523,176 $ 818,059,158

X

- Definition
The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as current.
+ References
No definition available.
+ Details

Name: biox_ConsiderationForAcquisitionOfAssetsCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as non-current.
+ References
No definition available.
+ Details

Name: biox_ConsiderationForAcquisitionOfAssetsNonCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of investments accounted for using the equity method, asset position.
+ References
No definition available.
+ Details

Name: biox_InvestmentsAccountedForUsingEquityMethodAssets

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of investments accounted for using the equity method, liability position.
+ References
No definition available.
+ Details

Name: biox_InvestmentsAccountedForUsingEquityMethodLiability

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of secured debt, non-current.
+ References
No definition available.
+ Details

Name: biox_SecuredDebtNonCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Assets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of living animals or plants recognised as assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 43
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_43&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph f
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_BiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B13
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CashAndCashEquivalents

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentAssetsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current lease liabilities. [Refer: Lease liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentLeaseLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 69
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentProvisionsForEmployeeBenefits

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The excess of amount paid for current tax in respect of current and prior periods over the amount due for those periods. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph n
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_n&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentTaxAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The non-current amount of current tax assets. [Refer: Current tax assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph n
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_n&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentTaxAssetsNoncurrent

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current tax for current and prior periods to the extent unpaid. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph n
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_n&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentTaxLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph g
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph o
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 56
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DeferredTaxAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph g
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph o
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 56
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DeferredTaxLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of residual interest in the assets of the entity after deducting all its liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 32
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Equity

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_EquityAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_EquityAndLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph r
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_r&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_EquityAttributableToOwnersOfParent

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 36
-IssueDate 2023-01-01
-Paragraph 134
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 36
-IssueDate 2023-01-01
-Paragraph 135
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_a&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B67
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Goodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current inventories. [Refer: Inventories]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 2
-IssueDate 2023-01-01
-Paragraph 36
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 68
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Inventories

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 76
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InvestmentProperty

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Liabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The non-current portion of non-current borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_LongtermBorrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph 12
-Subparagraph f
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_f&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 10
-IssueDate 2023-01-01
-Paragraph 22
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2023-en-r&anchor=para_22&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph q
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_q&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncontrollingInterests

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of assets that do not meet the definition of current assets. [Refer: Current assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentAssetsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of non-current contract liabilities. [Refer: Contract liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 105
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_105&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentContractLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of non-current lease liabilities. [Refer: Lease liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentLeaseLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause iv
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 69
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherCurrentFinancialAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current other receivables. [Refer: Other receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherCurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of non-current provisions other than provisions for employee benefits. [Refer: Non-current provisions]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherLongtermProvisions

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherNoncurrentFinancialAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of non-current other receivables. [Refer: Other receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherNoncurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph j
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermBorrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph k
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentPayables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_h&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 12 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
3 Months Ended 6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Revenues from contracts with customers $ 140,293,827 $ 94,548,714 $ 256,476,632 $ 221,391,962

Initial recognition and changes in the fair value of biological assets at the point of harvest (72,785) (138,529) 338,128 351,477

Cost of sales (88,710,537) (59,141,259) (160,326,318) (134,817,137)

Changes in the net realizable value of agricultural products after harvest (746,242) (1,509,023) (2,192,558) (1,736,959)

Research and development expenses (3,643,077) (3,457,892) (8,224,318) (7,309,906)

Selling, general and administrative expenses (31,164,937) (28,413,577) (65,097,785) (60,318,488)

Share of profit or loss of joint ventures and associates 2,052,296 40,048 3,560,967 882,288

Other income or expenses, net (1,166,603) 290,487 (2,398,238) 768,528

Operating profit 16,841,942 2,218,969 22,136,510 19,211,765

Financial cost (3,815,993) (5,759,485) (11,477,850) (12,539,332)

Other financial results (3,454,061) (4,200,857) (3,336,196) (5,489,163)

(Loss) profit before income tax 9,571,888 (7,741,373) 7,322,464 1,183,270

Income tax (8,333,387) (684,906) (8,762,427) (5,697,549)

(Loss) profit for the period 1,238,501 (8,426,279) (1,439,963) (4,514,279)

(Loss) profit for the period attributable to:

Equity holders of the parent 108,449 (8,156,746) (4,483,185) (7,658,449)

Non-controlling interests 1,130,052 (269,533) 3,043,222 3,144,170

(Loss) profit for the period $ 1,238,501 $ (8,426,279) $ (1,439,963) $ (4,514,279)

(Loss) profit per share

Basic (loss) profit attributable to ordinary equity holders of the parent $ 0.0017 $ (0.1323) $ (0.0713) $ (0.1242)

Diluted (loss) profit attributable to ordinary equity holders of the parent $ 0.0017 $ (0.1323) $ (0.0713) $ (0.1242)

(Loss) profit for the period $ 1,238,501 $ (8,426,279) $ (1,439,963) $ (4,514,279)

Other comprehensive (loss) income 485,703 585,882 (444,254) 616,907

Items that may be subsequently reclassified to profit and loss 485,703 585,882 (444,254) 616,907

Foreign exchange differences on translation of foreign operations from joint ventures 897 (122,814) 897 (21,946)

Foreign exchange differences on translation of foreign operations 484,806 708,696 (445,151) 638,853

Total comprehensive (loss) profit 1,724,204 (7,840,397) (1,884,217) (3,897,372)

Total comprehensive (loss) profit attributable to:

Equity holders of the parent 510,976 (7,779,559) (4,853,354) (7,377,844)

Non-controlling interests 1,213,228 (60,838) 2,969,137 3,480,472

Total comprehensive (loss) profit $ 1,724,204 $ (7,840,397) $ (1,884,217) $ (3,897,372)

X

- Definition
Change in the net realizable value of agricultural.
+ References
No definition available.
+ Details

Name: biox_ChangeInNetRealizableValueOfAgricultural

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 67
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_BasicEarningsLossPerShare

Namespace Prefix: ifrs-full_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 32
-Subparagraph a
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81A
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause ix
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ComprehensiveIncome

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_ComprehensiveIncomeAttributableToAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81B
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_b_i&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81B
-Subparagraph b
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_b_ii&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 99
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CostOfSales

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 67
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DilutedEarningsLossPerShare

Namespace Prefix: ifrs-full_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_EarningsPerShareAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of income or cost associated with interest and other financing activities of the entity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinanceIncomeCost

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 91
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_IncomeStatementAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 26
-IssueDate 2023-01-01
-Paragraph 35
-Subparagraph b
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 79
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B13
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncomeTaxExpenseContinuingOperations

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81A
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 91
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherComprehensiveIncome

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of other comprehensive income, net of tax, related to exchange differences on translation of the financial statements of a parent company or a stand-alone entity to a different presentation currency. [Refer: Other comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 91
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph IG6
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82A
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82A&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherFinanceIncomeCost

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherOperatingIncomeExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 18
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 32
-Subparagraph a
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 17
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard
-URIDate 2023-03-23

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81A
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard
-URIDate 2023-03-23

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLoss

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_ProfitLossAttributableToAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph 12
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81B
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLossAttributableToNoncontrollingInterests

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81B
-Subparagraph a
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLossAttributableToOwnersOfParent

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The profit (loss) before tax expense or income. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 5
-IssueDate 2023-01-01
-Paragraph 33
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 102
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLossBeforeTax

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 32
-IssueDate 2023-01-01
-Paragraph IE33
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLossFromOperatingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 126
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ResearchAndDevelopmentExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 114
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_113_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RevenueFromContractsWithCustomers

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of expense relating to selling, general and administrative activities of the entity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_SellingGeneralAndAdministrativeExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 13 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)

Equity / (deficit) attributable to owners of the parent

Issued capital

Share premium

Changes in non-controlling interest

Own shares trading premium

Stock options and share based incentives

Convertible instruments

Cost of own shares held

Retained deficit

Foreign currency translation reserve

Revaluation of PP&E and effect of tax rate change

Non-controlling Interests

Total

Balance at Jun. 30, 2022 $ 127,358,573 $ 4,637 $ 158,819,506 $ (255,893) $ (916,202) $ 3,767,925 $ 175,745 $ (3,530,926) $ (32,682,893) $ 969,402 $ 1,007,272 $ 30,940,275 $ 158,298,848

Share-based incentives 2,573,244 5 631,778 135,361 1,806,100 2,573,244

Business combination 154,979,344 1,640 153,357,564 1,620,140 154,979,344

Capitalization of convertible notes 12,211,638 153 12,211,485 12,211,638

Purchase of own shares (26,206,394) (26,206,394) (26,206,394)

Issuance of convertible notes 9,109,516 9,109,516 9,109,516

Distribution of dividends by subsidiary (452,129) (452,129)

(Loss) profit for the period (7,658,449) (7,658,449) 3,144,170 (4,514,279)

Other comprehensive income (loss) 280,605 280,605 336,302 616,907

Balance at Dec. 31, 2022 272,648,077 6,435 325,020,333 (255,893) (780,841) 7,194,165 9,285,261 (29,737,320) (40,341,342) 1,250,007 1,007,272 33,968,618 306,616,695

Balance at Jun. 30, 2023 298,594,088 6,493 327,028,559 (255,893) (780,841) 6,645,442 9,285,261 (30,553,591) (13,903,017) 1,282,377 (160,702) 31,902,019 330,496,107

Share-based incentives 7,535,426 4 526,017 7,009,405 7,535,426

Purchase of own shares (734,388) (734,388) (734,388)

Distribution of dividends by subsidiary (151,612) (151,612)

(Loss) profit for the period (4,483,185) (4,483,185) 3,043,222 (1,439,963)

Other comprehensive income (loss) (370,169) (370,169) (74,085) (444,254)

Balance at Dec. 31, 2023 $ 300,541,772 $ 6,497 $ 327,554,576 $ (255,893) $ (780,841) $ 13,654,847 $ 9,285,261 $ (31,287,979) $ (18,386,202) $ 912,208 $ (160,702) $ 34,719,544 $ 335,261,316

X

- Definition
The increase (decrease) in equity resulting from business combination transactions.
+ References
No definition available.
+ Details

Name: biox_IncreaseDecreaseThroughBusinessCombinationTransactionsEquity

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) in equity resulting from capitalization of convertible notes
+ References
No definition available.
+ Details

Name: biox_IncreaseDecreaseThroughCapitalizationOfConvertibleNotesEquity

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of dividends recognised as distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 107
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_107&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DividendsPaid

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of residual interest in the assets of the entity after deducting all its liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 32
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Equity

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The change in equity resulting from the issuing of convertible instruments.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IssueOfConvertibleInstruments

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81A
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 91
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherComprehensiveIncome

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 18
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 32
-Subparagraph a
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 17
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard
-URIDate 2023-03-23

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81A
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard
-URIDate 2023-03-23

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLoss

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 14 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

Jun. 30, 2023

OPERATING ACTIVITIES

Loss for the period $ 1,238,501 $ (8,426,279) $ (1,439,963) $ (4,514,279)

Adjustments to reconcile profit to net cash flows

Income tax 8,762,427 5,697,549

Financial results 14,814,046 18,028,495

Depreciation of property, plant and equipment 2,556,422 2,960,156

Amortization of intangible assets 5,474,971 5,191,521

Depreciation of leased assets 1,711,256 1,837,532

Transactional expenses 3,634,992

Share-based incentive and stock options 8,527,214 2,062,345

Share of profit or loss of joint ventures and associates (2,052,296) (40,048) (3,560,967) (882,288)

Loss of participation in joint ventures and associates 7,853

Provisions for contingencies 49,090 39,847

Allowance for impairment of trade debtors 296,051 468,992

Allowance for obsolescence 282,836 481,332

Initial recognition and changes in the fair value of biological assets (338,128) (351,477)

Changes in the net realizable value of agricultural products after harvest 2,192,558 1,736,959

Gain or loss on sale of equipment and intangible assets (33,521) (111,728)

Working capital adjustments

Trade receivables (38,431,478) (63,042,799)

Other receivables 3,281,861 (6,589,310)

Income and minimum presumed income taxes payable 8,670,430 (3,869,723)

Inventories and biological assets 13,725,208 (23,455,328)

Trade and other payables 11,867,420 12,216,345

Employee benefits and social security (1,388,050) 2,185,006

Deferred revenue and advances from customers (2,698,249) 53,775,013

Income taxes paid (2,772,608)

Interest collected 1,204,931 3,493,607

Inflation effects on working capital adjustments 323,421 658,967

Net cash flows generated by operating activities 35,849,786 8,886,971

INVESTMENT ACTIVITIES

Proceeds from sale of property, plant and equipment 45,268 118,914

Net cash received from business combination 4,373,265

Investment in financial assets (16,363,130) (13,813,944)

Purchase of property, plant and equipment (6,070,237) (3,824,078)

Capitalized development expenditures (4,454,893) (5,926,539)

Purchase of intangible assets (219,829) (148,075)

Net cash flows used by investing activities (27,062,821) (19,220,457)

FINANCING ACTIVITIES

Proceeds from borrowings 69,810,628 136,880,982

Repayment of borrowings and financed payments (79,250,768) (78,971,568)

Interest payments (12,168,664) (9,678,974)

Other financial proceeds or payments, net (1,288,813) (3,588,240)

Purchase of own shares (734,388) (2,291,365)

Leased assets payments (2,493,617) (1,553,958)

Cash dividend distributed by subsidiary (151,612) (452,129)

Net cash flows (used) generated by financing activities (26,277,234) 40,344,748

Net (decrease) increase in cash and cash equivalents (17,490,269) 30,011,262

Inflation effects on cash and cash equivalents (10,495) (56,375)

Cash and cash equivalents as of beginning of the period 48,129,194 33,475,266 $ 33,475,266

Effect of exchange rate changes on cash and equivalents (6,226,493) 5,119,869

Cash and cash equivalents as of the end of the period $ 24,401,937 $ 68,550,022 $ 24,401,937 $ 68,550,022 $ 48,129,194

X

- Definition
Adjustments for decrease (increase) in deferred revenue and advances from customers to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForDecreaseIncreaseInDeferredRevenueAndAdvancesFromCustomers

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in employee benefits and social security to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForDecreaseIncreaseInEmployeeBenefitsAndSocialSecurity

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in income and minimum presumed income taxes to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxes

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in income and minimum presumed income taxes paid/payable to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxesPayable

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in Inflation effects on working capital adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForDecreaseIncreaseInInflationEffectsOnWorkingCapitalAdjustments

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for gain (loss) of participation in joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForGainLossOfParticipationInJointVenturesAndAssociates

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Adjustments for obsolescence to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForObsolescence

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for transaction expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForTransactionExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of aggregate cash flows from obtaining control of subsidiaries or other businesses, classified as investing activities.
+ References
No definition available.
+ Details

Name: biox_CashFlowsFromObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The effect of inflation effects on cash and cash equivalents.
+ References
No definition available.
+ Details

Name: biox_InflationEffectsOnCashAndCashEquivalents

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow (outflow) generated from financial assets that the entity classifies as investing activities.
+ References
No definition available.
+ Details

Name: biox_ProceedsFromFinancialAssets

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: biox_WorkingCapitalAdjustmentsOperatingActivitiesAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForAmortisationExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForDecreaseIncreaseInInventories

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForDepreciationExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for finance costs to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance costs; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForFinanceCosts

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 35
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForIncomeTaxExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for losses (gains) on disposal of non-current assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Non-current assets; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 14
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_14&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForProvisions

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_AdjustmentsForReconcileProfitLossAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForSharebasedPayments

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 10
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CashFlowsFromUsedInFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 10
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CashFlowsFromUsedInInvestingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 10
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CashFlowsFromUsedInOperatingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DepreciationRightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow for dividends paid by the entity, classified as financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 31
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DividendsPaidClassifiedAsFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 25
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 28
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from finance income received, classified as operating activities. [Refer: Finance income]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 31
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinanceIncomeReceivedClassifiedAsOperatingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The gains (losses) arising during the current period on the change in fair value less costs to sell of biological assets. [Refer: Biological assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 40
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_40&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The gains (losses) arising from changes in fair value less costs to sell of biological assets due to price changes in the market. [Refer: Biological assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 51
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_51&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Section Example 1 XYZ Dairy Ltd
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS41_IE_ex1_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for interest paid, classified as financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 31
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InterestPaidClassifiedAsFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 21
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for expenditure related to development projects.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 16
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PaymentsForDevelopmentProjectExpenditure

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 17
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire or redeem entity's shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 17
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PaymentsToAcquireOrRedeemEntitysShares

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from borrowings obtained. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 17
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 16
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 18
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 32
-Subparagraph a
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 17
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard
-URIDate 2023-03-23

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81A
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard
-URIDate 2023-03-23

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLoss

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 16
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 16
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 17
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 15 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1

GENERAL INFORMATION
6 Months Ended

Dec. 31, 2023

GENERAL INFORMATION

GENERAL INFORMATION
1. GENERAL INFORMATION
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. To do this, Bioceres’ products create economic incentives for farmers and other stakeholders to adopt environmentally friendly production practices. Bioceres has a unique biotech platform with high impact, patented technologies for seeds and microbial ag inputs, as well as next generation crop nutrition and protection solutions.
Bioceres is a global company with an extensive geographic footprint. The Group’s agricultural inputs are marketed across more than 45 countries, primarily in South America, the United States and Europe.
Unless the context otherwise requires, “we”, “us”, “our”, “Bioceres”, “BIOX”, “the Group”, and “Bioceres Crop Solutions” will refer to Bioceres Crop Solutions Corp. and its subsidiaries.

X

- Definition
No Definition Available
+ References
No definition available.
+ Details

Name: biox_GeneralInformationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for general information about financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 51
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_51&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 16 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1

ACCOUNTING STANDARDS AND BASIS OF PREPARATION
6 Months Ended

Dec. 31, 2023

ACCOUNTING STANDARDS AND BASIS OF PREPARATION

ACCOUNTING STANDARDS AND BASIS OF PREPARATION
2. ACCOUNTING STANDARDS AND BASIS OF PREPARATION
Statement of compliance with IFRS as issued by IASB
These unaudited interim condensed consolidated financial statements for the six-month period ended December 31, 2023, have been prepared in accordance with Accounting Standard IAS 34 Interim Financial Reporting.
These unaudited interim condensed consolidated financial statements do not include all notes of the type normally included in an annual financial statement. Accordingly, these unaudited interim condensed consolidated financial statements are to be read in conjunction with the consolidated financial statements for the fiscal year ended June 30, 2023.
Authorization for the issue of the consolidated financial statements
These unaudited interim condensed consolidated financial statements of the Group as of December 31, 2023, June 30, 2023 and for the three and six month periods ended December 31, 2023 and 2022 were authorized by the Board of Directors of Bioceres Crop Solutions Corp. on February 28, 2024.
Basis of measurement
The consolidated financial statements of the Group have been prepared using:
●Going concern basis of accounting, considering the conclusion of the assessment made by the Group’s Management about the ability of the Group and its subsidiaries to continue as a going concern, in accordance with the requirements of paragraph 25 of IAS 1, “Presentation of Financial Statements”.
●Accrual basis of accounting (except for cash flows information). Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there are no cash flows.
Functional currency and presentation currency
a)
Functional currency
Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic market in which the entity operates (i.e., “the functional currency”).
b)
Presentation currency
The consolidated financial statements of the Group are presented in US dollars.
c)
Foreign currency
Transactions entered into by Group entities in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting period. Exchange differences arising from the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising from the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the consolidated statement of profit or loss and other comprehensive income as part of the gain or loss recognized upon such disposal.
Changes in accounting policies
In previous years, the Group presented the sum of revenues from contracts with customers, initial recognition and changes in fair value of biological assets at the point of harvest, and changes in the net realizable value of agricultural products after harvest in a caption “Total” to assist investors to understand the performance of the Group’s comprehensive income for each fiscal year. As of the current period, that caption has been removed from the consolidated statements of comprehensive income to be aligned with comparable companies of the industry.
The accounting policies adopted in the preparation of these unaudited interim condensed consolidated financial statements are consistent with those adopted for the preparation of the consolidated financial statements as of June 30, 2023.

X

- References
No definition available.
+ Details

Name: biox_AccountingStandardsAndBasisOfPreparationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure on accounting standards and basis of presentation.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1

NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB
6 Months Ended

Dec. 31, 2023

NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB

NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB
3. NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB
a)The following new standards, amendments and interpretations became applicable for the current reporting period and adopted by the Group.
- Amendment to IAS 12 –Deferred tax related to assets and liabilities arising from a single transaction.
- International Tax Reform—Pillar Two Model Rules (Amendments to IAS 12)
- Amendments to IAS 1 and IFRS Practice Statement 2- Disclosure of Accounting Policies
- Amendments to IAS 8-Definition of Accounting Estimates
These new standards and amendments did not have any material impact on the Group.
b)The following new standards are not yet adopted by the Group.
- Amendments to IFRS 16- Lease Liability in a Sale and Leaseback. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.
- Amendments to IAS1 – Non- current liabilities with covenants. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.
- Amendments to IAS 7- Statement of Cash Flows & to IFRS 7- Financial Instruments: Disclosures. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.
- Amendments to IAS 21- The Effects of Changes in Foreign Exchange Ratestitled Lack of Exchangeability. The amendments are effective for annual reporting periods beginning on or after 1 January 2025.
- Amendment to IAS 7 and IFRS 7 - Supplier Financing. The amendments are effective for annual periods beginning on or after January 1, 2024.
These amendments are not expected to have material impact on the Group.

X

- Definition
n/a
+ References
No definition available.
+ Details

Name: biox_NewStandardsAmendmentsAndInterpretationsIssuedByIasbAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 8
-IssueDate 2023-01-01
-Paragraph 30
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_30_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1

SEASONALITY
6 Months Ended

Dec. 31, 2023

SEASONALITY

SEASONALITY
4. SEASONALITY
Our revenues fluctuate depending on the timing of orders from our distributors and customers and on prevailing market prices, which influence the purchase decisions of growers, the end users of our seed and integrated products, crop protection products and crop nutrition products. Given the cyclicality of crop planting and harvesting, as well as growing seasons, which vary from year to year, our business is highly seasonal. This results in substantial fluctuations in quarterly sales and profitability. Our portfolio is highly oriented to crop planting. Generally, our sales are concentrated in the third and fourth quarters of each calendar year, when demand for our seed and integrated products, crop protection products and crop nutrition products increases as growers begin planting their summer crops in South America, while winter crop season occurs in the Northern hemisphere. With our seed and integrated products business, we contract with growers and seed suppliers based upon our anticipated market demand. Generally, in our seed and integrated products business we stock the seed during the harvest season and ship from inventory throughout the year, with the objective of selling most of the inventory from the current year’s harvest before the next year’s, with our crop protection and our crop nutrition business following a similar cycle to the seed cycle. Milestone, royalty, and license revenues are also likely to fluctuate from period to period given the seasonality of agriculture and time required to progress from one milestone to the next.

Our seed and integrated products, crop protection and crop nutrition businesses are also affected by unpredictable weather conditions such as heavy rains, hail, floods, freezing conditions, windstorms, drought or fire, as well as other hazardous situations beyond our control, which may cause our sales and operating results to fluctuate significantly. In addition, disruptions that cause delays by growers in harvesting or planting can result in the movement of orders to a future quarter, which also causes fluctuations in our quarterly operating results. Finally, some of our customers and distributors order in bulk only one or two times a year, which may further cause our seed product revenues to fluctuate from period to period.

X

- Definition
No definition availability.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfSeasonalityAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure of the seasonality of the entity's business.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfSeasonalityTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
6 Months Ended

Dec. 31, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
5. INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
5.1. Cash and cash equivalents


12/31/2023

06/30/2023
Cash at bank and on hand

24,332,260

48,129,194
Mutual funds

69,677

—

24,401,937

48,129,194

5.2. Other financial assets


12/31/2023

06/30/2023
Current


Restricted short-term deposits

—

212,703
US Treasury bills

—

9,163,298
Mutual funds

14,736,104

1,596,539
Other investments

2,304,103

1,162,480

17,040,207

12,135,020


12/31/2023

06/30/2023
Non-current




Shares of Bioceres S.A.

444,410

444,635
Other investments

333

274

444,743

444,909

5.3. Trade receivables


12/31/2023

06/30/2023
Current

Trade debtors

206,838,287

160,269,233
Allowance for impairment of trade debtors

(7,523,261)

(7,425,604)
Shareholders and other related parties (Note 15)

1,223,994

—
Allowance for credit notes to be issued

(3,928,835)

(3,694,019)
Trade debtors - Joint ventures and associates (Note 15)

781,452

865,627
Deferred checks

2,274,646

7,991,237

199,666,283

158,006,474

The book value is reasonably approximate to the fair value given its short-term nature.

5.4. Other receivables


12/31/2023

06/30/2023
Current




Taxes

5,490,671

6,113,764
Receivables for PP&E sales

—

156,423
Shareholders and other related parties (Note 15)

3,105,591

3,792,429
Other receivables - Joint ventures and associates (Note 15)

7,500,898

6,104,219
Prepayments to suppliers

3,820,065

10,956,831
Reimbursements over exports

10,558

10,558
Prepaid expenses and other receivables

4,022,045

1,302,221
Miscellaneous

1,131,770

388,553

25,081,598

28,824,998


12/31/2023

06/30/2023
Non-current

Taxes

—

873,699
Reimbursements over exports

1,363,902

1,290,227
Loans receivables

230,000

230,000
Miscellaneous

25,740

152,315

1,619,642

2,546,241

5.5. Inventories


12/31/2023

06/30/2023
Seeds

7,508,251

1,542,159
Resale products

64,271,825

58,544,931
Manufactured products

21,131,225

25,881,761
Goods in transit

1,408,487

3,620,606
Supplies

17,878,874

24,893,187
Agricultural products

14,121,283

28,436,830
Allowance for obsolescence

(2,581,797)

(2,492,499)

123,738,148

140,426,975

Net of agricultural products

109,616,865

111,990,145

5.6. Biological assets
Changes in Biological assets:


Soybean

Corn

Wheat

Barley

Sunflower

Total
Beginning of the period

—

—

87,785

59,057

—

146,842
Initial recognition and changes in the fair value of biological assets at the point of harvest

—

—

231,523

106,605

—

338,128
Costs incurred during the period

581,227

301,686

—

—

55,457

938,370
Decrease due to harvest/disposals

—

—

(319,308)

(165,662)

—

(484,970)
Period ended December 31, 2023

581,227

301,686

—

—

55,457

938,370


Soybean

Corn

Wheat

Barley

Sunflower

Total
Beginning of the period

—

—

44,413

12,900

—

57,313
Initial recognition and changes in the fair value of biological assets at the point of harvest

—

—

191,481

159,996

—

351,477
Costs incurred during the period

290,667

263,428

389,282

126,293

27,005

1,096,675
Decrease due to harvest/disposals

—

—

(625,176)

(299,189)

—

(924,365)
Period ended December 31, 2022

290,667

263,428

—

—

27,005

581,100

5.7. Property, plant and equipment
Property, plant and equipment as of December 31, 2023 and June 30, 2023 included the following:


12/31/2023

06/30/2023
Gross carrying amount

99,485,867

93,634,779
Accumulated depreciation

(28,097,738)

(25,780,944)
Net carrying amount

71,388,129

67,853,835

Net carrying amount for each class of assets is as follows:

Net carrying

Net carrying

amount

amount
Class

12/31/2023

06/30/2023
Office equipment

280,108

263,892
Vehicles

2,177,685

2,032,853
Equipment and computer software

190,697

174,399
Fixtures and fittings

2,469,766

2,862,949
Machinery and equipment

13,556,213

14,463,756
Land and buildings

35,745,539

36,144,792
Buildings in progress

16,968,121

11,911,194
Total

71,388,129

67,853,835

1. Gross carrying amount as of December 31, 2023 is as follows:

Gross carrying amount

As of the

beginning

Foreign

As of the

of the

currency

end of the
Class

period

Additions

Disposals

translation

period
Office equipment

968,088

52,158

—

(3,291)

1,016,955
Vehicles

5,492,319

556,237

(126,068)

(411)

5,922,077
Equipment and computer software

974,509

101,224

—

(7,575)

1,068,158
Fixtures and fittings

7,663,899

10,483

(8,976)

(9,384)

7,656,022
Machinery and equipment

23,513,047

275,297

—

(26,864)

23,761,480
Land and buildings

43,111,723

10,351

—

(29,020)

43,093,054
Buildings in progress (a)

11,911,194

5,112,029

—

(55,102)

16,968,121
Total

93,634,779

6,117,779

(135,044)

(131,647)

99,485,867
(a)
Includes capitalized financial costs of $47,542 corresponding to the period ended December 31, 2023.
2. Accumulated depreciation as of December 31, 2023 is as follows:

Depreciation

Accumulated

as of the

Foreign

Accumulated

beginning of

currency

as of the end
Class

the period

Disposals

Of the period

translation

of the period
Office equipment

704,196

—

33,828

(1,177)

736,847
Vehicles

3,459,466

(117,055)

416,309

(14,328)

3,744,392
Equipment and computer software

800,110

—

83,364

(6,013)

877,461
Fixtures and fittings

4,800,950

(6,242)

394,798

(3,250)

5,186,256
Machinery and equipment

9,049,291

—

1,185,336

(29,360)

10,205,267
Land and buildings

6,966,931

—

442,787

(62,203)

7,347,515
Total

25,780,944

(123,297)

2,556,422

(116,331)

28,097,738

3. Gross carrying amount as of December 31, 2022 is as follows:

Gross carrying amount

As of the

Additions

Foreign

As of the

beginning

from business

currency

end of the
Class

of the period

Additions

combination

Disposals

translation

period
Office equipment

908,004

305

—

—

724

909,033
Vehicles

5,261,979

84,209

—

(59,744)

(3,948)

5,282,496
Equipment and computer software

925,349

111,226

12,469

—

(32,824)

1,016,220
Fixtures and fittings

7,606,389

34,256

5,379

—

12,143

7,658,167
Machinery and equipment

13,017,830

1,128,712

7,047,496

(7,186)

(14,677)

21,172,175
Land and buildings

40,659,129

—

4,750,136

—

(28,269)

45,380,996
Buildings in progress

3,142,774

2,465,370

1,285,092

—

(17,027)

6,876,209
Total

71,521,454

3,824,078

13,100,572

(66,930)

(83,878)

88,295,296

4. Accumulated depreciation as of December 31, 2022 is as follows:

Depreciation

Accumulated

as of the

Foreign

Accumulated

beginning of

Of the

currency

as of the end
Class

the period

Disposals

period

translation

of the period
Office equipment

638,466

—

30,827

(466)

668,827
Vehicles

2,596,905

(59,744)

457,562

(1,178)

2,993,545
Equipment and computer software

693,673

—

73,094

(1,549)

765,218
Fixtures and fittings

4,059,470

—

370,828

(355)

4,429,943
Machinery and equipment

7,205,870

—

1,575,862

(9,845)

8,771,887
Land and buildings

6,418,745

—

451,983

473

6,871,201
Total

21,613,129

(59,744)

2,960,156

(12,920)

24,500,621

The depreciation charge is included in Notes 6.3 and 6.4. The Group has no commitments to purchase property, plant and equipment items.
5.8. Intangible assets
Intangible assets as of December 31, 2023 and June 30, 2023 included the following:


12/31/2023

06/30/2023
Gross carrying amount

206,708,843

202,306,618
Accumulated amortization

(33,965,330)

(28,522,662)
Net carrying amount

172,743,513

173,783,956

Net carrying amount of each class of intangible assets is as follows:

Net carrying

Net carrying

amount

amount
Class

12/31/2023 (1)

06/30/2023 (1)
Seed and integrated products

HB4 soy and breeding program

32,554,026

31,679,681
Integrated seed products

2,516,125

2,841,008
Crop nutrition

Microbiological products

50,829,622

49,508,801
Other intangible assets

Trademarks and patents

57,429,133

59,760,753
Software

1,923,055

1,987,690
Customer loyalty

22,491,552

23,006,023
RG/RS/OX Wheat

5,000,000

5,000,000
Total

172,743,513

173,783,956
(1) Includes $32.2 million as of December 31, 2023 and $27.4 million as of June 30, 2023 of intangible assets not subject to amortization.
1. Gross carrying amount as of December 31, 2023 is as follows:

Gross carrying amount

As of the

Foreign

As of the

beginning of

currency

end of the
Class

the period

Additions

translation

period
Seed and integrated products

HB4 soy and breeding program

34,958,425

1,729,439

—

36,687,864
Integrated seed products

3,219,808

—

(269,869)

2,949,939
Crop nutrition

Microbiological products

55,645,028

2,725,454

(1,661)

58,368,821
Other intangible assets

Trademarks and patents

67,653,234

1,288

—

67,654,522
Software

5,582,411

218,541

(967)

5,799,985
Customer loyalty

30,247,712

—

—

30,247,712
RG/RS/OX Wheat

5,000,000

—

—

5,000,000
Total

202,306,618

4,674,722

(272,497)

206,708,843

2. Accumulated amortization as of December 31, 2023 is as follows:

Amortization

Accumulated

Foreign

Accumulated as

as of beginning

currency

of the end of the
Class

of the period

Of the period

translation

period
Seed and integrated products








HB4 soy and breeding program

3,278,744

855,094

—

4,133,838
Integrated seed products

378,800

86,762

(31,748)

433,814
Crop nutrition

Microbiological products

6,136,227

1,402,972

—

7,539,199
Other intangible assets

Trademarks and patents

7,892,481

2,332,908

—

10,225,389
Software

3,594,721

282,764

(555)

3,876,930
Customer loyalty

7,241,689

514,471

—

7,756,160
Total

28,522,662

5,474,971

(32,303)

33,965,330

3. Gross carrying amount as of December 31, 2022 is as follows:

Gross carrying amount

As of the

Additions from

beginning

business

Foreign currency

As of the end of
Class

of the period

Additions

combination

translation

the period
Seed and integrated products






HB4 soy and breeding program

31,371,088

1,738,631

—

—

33,109,719
Integrated seed products

3,181,155

—

—

8,296

3,189,451
Crop nutrition

Microbiological products

8,855,421

4,187,908

39,613,280

(2,279)

52,654,330
Other intangible assets

Trademarks and patents

12,183,045

49,783

55,420,441

—

67,653,269
Software

5,176,373

98,292

—

(954)

5,273,711
Customer loyalty

28,462,475

—

1,785,237

—

30,247,712
RG/RS/OX Wheat

5,000,000

—

—

—

5,000,000
Total

94,229,557

6,074,614

96,818,958

5,063

197,128,192

4. Accumulated amortization as of December 31, 2022 is as follows:

Amortization

Accumulated as



Foreign

Accumulated

of beginning of

currency

as of the end
Class

the period

Of the period

translation

of the period
Seed and integrated products

HB4 soy and breeding program

1,568,554

799,644

—

2,368,198
Integrated seed products

43,997

22,242

488

66,727
Crop nutrition

Microbiological products

3,063,073

313,970

—

3,377,043
Other intangible assets

Trademarks and patents

3,916,004

2,136,403

—

6,052,407
Software

3,008,388

285,881

(756)

3,293,513
Customer loyalty

5,924,672

1,633,381

—

7,558,053
Total

17,524,688

5,191,521

(268)

22,715,941

The amortization charge is included in Notes 6.3 and 6.4.
5.9. Goodwill


12/31/2023

06/30/2023

Rizobacter Argentina S.A.

28,080,271

28,080,271
Bioceres Crops S.A.

7,523,322

7,523,322
Pro farm Group, Inc.

76,089,749

76,089,749
Insumos Agroquímicos S.A.

470,090

470,090

112,163,432

112,163,432

There were no indicators of goodwill impairment.

5.10. Investment properties


12/31/2023

06/30/2023

Investment properties

3,792,238

3,589,749

3,792,238

3,589,749

5.11. Trade and other payables


12/31/2023

06/30/2023

Trade creditors

103,683,392

104,211,238
Shareholders and other related parties (Note 15)

75,271

35,292
Trade creditors - Parent company (Note 15)

161,860

644,191
Trade creditors - Joint ventures and associates (Note 15)

56,385,464

41,402,594
Taxes

3,556,073

3,561,058
Miscellaneous

141,142

953,301

164,003,202

150,807,674

5.12. Borrowings


12/31/2023

06/30/2023
Current

Bank borrowings

52,942,957

61,303,952
Corporate bonds

49,749,398

35,547,510
Trust debt securities

7,188,607

7,296,506
Net loans payables- Parents companies and related parties to Parent (Note 15)

3,639,816

3,491,691

113,520,778

107,639,659
Non-current

Bank borrowings

10,314,800

10,663,266
Corporate bonds

21,202,548

50,007,680

31,517,348

60,670,946

The carrying value of some borrowings as of December 31, 2023 are measured at amortized cost differ from their fair value. The following fair values measured are based on discounted cash flows (Level 3) due to the use of unobservable inputs, including own credit risk.

12/31/2023

06/30/2023


Amortized cost

Fair value

Amortized cost

Fair value
Current

Bank borrowings

52,942,957

49,659,094

61,303,952

57,209,155
Corporate Bonds

49,749,398

49,192,118

35,547,510

34,725,828

Non-current

Bank borrowings

10,314,800

8,698,322

10,663,266

10,374,646
Corporate Bonds

21,202,548

20,670,511

50,007,680

47,014,542

5.13. Secured Notes
Secured Guaranteed Notes
The carrying value of $25.9 million of the Secured Guaranteed Notes as of December 31, 2023 are measured at amortized cost. Its fair value based on discounted cash flows, using a fair interest rate, would amount to $26.9 million.
Secured Convertible Guaranteed Notes
The carrying value of $52.1 million of the Secured Convertible Guaranteed Notes as of December 31, 2023 are measured at amortized cost. Its fair value based on discounted cash flows, using a fair interest rate, would amount to $54.8 million.
Under the terms of the Secured Convertible Guaranteed Notes, the Group is in compliance with covenants.
5.14. Employee benefits and social security


12/31/2023

06/30/2023
Salaries, accrued incentives, vacations and social security

8,150,518

9,388,639
Key management personnel (Note 15)

68,139

218,068

8,218,657

9,606,707

5.15. Deferred revenue and advances from customers


12/31/2023

06/30/2023
Current




Advances from customers

4,466,515

9,216,032
Deferred revenue

17,632,863

15,659,630

22,099,378

24,875,662
Non-current

Advances from customers

272,334

620,893
Deferred revenue

1,863,506

1,436,912

2,135,840

2,057,805

X

- Definition
n/a
+ References
No definition available.
+ Details

Name: biox_ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of components of Consolidated Statements of Financial Position.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
6 Months Ended

Dec. 31, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
6. INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
6.1. Revenue from contracts with customers


12/31/2023

12/31/2022
Sale of goods and services

255,827,291

220,482,895
Royalties

649,341

909,067

256,476,632

221,391,962

Transactions of sales of goods and services with joint ventures and with shareholders and other related parties are reported in Note 15.
6.2. Cost of sales

Item

12/31/2023

12/31/2022
Inventories as of the beginning of the period

111,990,145

78,759,610
Business combination

—

11,064,908
Purchases of the period

144,999,639

138,186,645
Production costs

12,981,672

14,596,888
Foreign currency translation

(28,273)

(246,484)
Subtotal

269,943,183

242,361,567
Inventories as of the end of the period (*)

(109,616,865)

(107,544,430)
Cost of sales

160,326,318

134,817,137
(*)Net of agricultural products.

6.3. R&D classified by nature


Research and

Research and

development

development

expenses

expenses
Item

12/31/2023

12/31/2022
Amortization of intangible assets

2,453,158

2,201,938
Analysis and storage

5,302

27,322
Import and export expenses

—

850
Depreciation of property, plant and equipment

312,453

287,180
Freight and haulage

14,278

4,732
Employee benefits and social securities

2,211,907

2,248,105
Maintenance

96,056

303,524
Energy and fuel

5,227

94,870
Supplies and materials

1,182,066

1,078,197
Mobility and travel

89,474

158,193
Share-based incentives

143,749

92,477
Publicity and advertising

—

9,568
Professional fees and outsourced services

994,197

574,614
Professional fees related parties

216,792

102,701
Office supplies

470,376

43,546
Information technology expenses

9,640

19,060
Insurance

19,586

25,738
Depreciation of leased assets

—

33,685
Miscellaneous

57

3,606
Total

8,224,318

7,309,906


12/31/2023

12/31/2022
R&D capitalized (Note 5.8)

4,454,893

5,926,539
R&D profit and loss

8,224,318

7,309,906
Total

12,679,211

13,236,445

6.4. Expenses classified by nature and function




Selling,


general and

Production

administrative

Total
Item

costs

expenses

12/31/2023
Amortization of intangible assets

60,849

2,960,964

3,021,813
Analysis and storage

570

153,163

153,733
Commissions and royalties

421,677

1,008,251

1,429,928
Import and export expenses

43,902

318,479

362,381
Depreciation of property, plant and equipment

1,308,591

935,378

2,243,969
Depreciation of leased assets

699,044

1,012,212

1,711,256
Impairment of receivables

—

296,051

296,051
Freight and haulage

634,188

6,878,364

7,512,552
Employee benefits and social securities

5,935,502

21,509,102

27,444,604
Maintenance

1,007,395

1,152,332

2,159,727
Energy and fuel

500,658

272,547

773,205
Supplies and materials

367,386

1,691,154

2,058,540
Mobility and travel

94,476

2,148,705

2,243,181
Publicity and advertising

1,300

2,305,251

2,306,551
Contingencies

1,239

47,851

49,090
Share-based incentives

339,904

8,043,561

8,383,465
Professional fees and outsourced services

963,972

3,542,038

4,506,010
Professional fees related parties

—

66,618

66,618
Office supplies and registrations fees

80,236

651,991

732,227
Insurance

81,174

1,102,142

1,183,316
Information technology expenses

27,186

1,924,633

1,951,819
Obsolescence

282,836

—

282,836
Taxes

127,760

7,019,360

7,147,120
Miscellaneous

1,827

57,638

59,465
Total

12,981,672

65,097,785

78,079,457




Selling,


general and

Production

administrative

Total
Item

costs

expenses

12/31/2022
Amortization of intangible assets

86,842

2,902,741

2,989,583
Analysis and storage

4,460

237,341

241,801
Commissions and royalties

109,703

1,020,272

1,129,975
Import and export expenses

265,121

704,937

970,058
Depreciation of property, plant and equipment

1,666,119

1,006,857

2,672,976
Depreciation of leased assets

230,478

1,573,369

1,803,847
Impairment of receivables

—

468,992

468,992
Freight and haulage

1,201,183

5,002,384

6,203,567
Employee benefits and social securities

7,177,926

20,156,371

27,334,297
Maintenance

722,399

1,446,553

2,168,952
Energy and fuel

753,041

161,850

914,891
Supplies and materials

512,493

627,514

1,140,007
Mobility and travel

39,428

1,837,797

1,877,225
Publicity and advertising

—

3,235,737

3,235,737
Contingencies

—

39,847

39,847
Share-based incentives

—

1,969,868

1,969,868
Professional fees and outsourced services

1,133,009

7,122,701

8,255,710
Professional fees related parties

—

29,818

29,818
Office supplies and registrations fees

23,309

624,246

647,555
Insurance

74,350

1,306,282

1,380,632
Information technology expenses

17,511

1,566,952

1,584,463
Obsolescence

481,332

—

481,332
Taxes

96,233

6,976,043

7,072,276
Miscellaneous

1,951

300,016

301,967
Total

14,596,888

60,318,488

74,915,376

6.5. Other income or expenses, net


12/31/2023

12/31/2022
Net result from commercialization of agricultural products

(2,960,005)

144,515
Expenses recovery

236,106

232,977
Other income or expenses, net

325,661

391,036

(2,398,238)

768,528

6.6. Finance results


12/31/2023

12/31/2022
Financial costs

Interest expenses with the Parents (Note 15)

(194,125)

(299,468)
Interest expenses

(9,994,912)

(10,722,135)
Financial commissions

(1,288,813)

(1,517,729)

(11,477,850)

(12,539,332)

Other financial results


Exchange differences generated by assets

(12,049,351)

(12,771,727)
Exchange differences generated by liabilities

21,674,845

9,070,404
Changes in fair value of financial assets or liabilities and other financial results

(13,727,825)

(2,068,923)
Net gain of inflation effect on monetary items

766,135

281,083

(3,336,196)

(5,489,163)

X

- Definition
The entire disclosure of information about components of consolidated statement of comprehensive income.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_StatementOfComprehensiveIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1

TAXATION
6 Months Ended

Dec. 31, 2023

TAXATION

TAXATION
7. TAXATION
Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual earnings.


12/31/2023

12/31/2022
Current tax expense

(3,845,338)

(6,467,324)
Deferred tax

(4,917,089)

769,775
Total

(8,762,427)

(5,697,549)


12/31/2023

12/31/2022
Beginning of the period deferred tax

(28,472,383)

(24,994,569)
Additions for business combination

—

(16,704,771)
Charge for the period

(4,917,089)

769,775
Conversion difference

(361,293)

(582,016)
Total net deferred tax

(33,750,765)

(41,511,581)

The tax on the Group’s profit before tax differs from the theoretical amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows:


12/31/2023

12/31/2022
Earning before income tax-rate

7,322,464

1,183,270
Income tax expense by applying tax rate in force in the respective countries

(5,434,748)

(5,182,386)
Share of profit or loss of subsidiaries, joint ventures and associates

1,219,030

225,376
Stock options charge

(1,489,037)

(298,851)
Non-deductible expenses

(116,220)

(543,505)
Unrecognized deferred tax ¹

—

(995,754)
Tax inflation adjustment

7,460,048

3,132,901
Result of inflation effect on monetary items and other finance results

(11,000,459)

(1,660,369)
Untaxed gains

598,959

33,052
Others

—

(408,013)
Income tax expenses

(8,762,427)

(5,697,549)
1 Corresponds mainly to Pro Farm Group Inc.

X

- Definition
The entire disclosure for income taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfIncomeTaxExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1

EARNING PER SHARE
6 Months Ended

Dec. 31, 2023

EARNING PER SHARE

EARNING PER SHARE
8. EARNING PER SHARE
The numerators and denominators used in the calculation of basic EPS and diluted EPS are presented below:

Three -month period ended

Six-month period ended


12/31/2023

12/31/2022

12/31/2023

12/31/2022
Numerator



(Loss) profit for the period (basic EPS)

108,449

(8,156,746)

(4,483,185)

(7,658,449)
(Loss) profit for the period (diluted EPS)

108,449

(8,156,746)

(4,483,185)

(7,658,449)
Denominator

Weighted average number of shares (basic EPS)

62,839,961

61,657,343

62,839,961

61,657,343
Weighted average number of shares (diluted EPS)

63,877,692

61,657,343

62,839,961

61,657,343

Basic (loss) profit attributable to ordinary equity holders of the parent

0.0017

(0.1323)

(0.0713)

(0.1242)
Diluted (loss) profit attributable to ordinary equity holders of the parent

0.0017

(0.1323)

(0.0713)

(0.1242)

For the three and six month period ended December 31, 2022 diluted EPS was equal to basic EPS as the effect of potential ordinary shares would be antidilutive.
For the three month period ended December 31, 2022, diluted earnings per share was calculated by adjusting the weighted average number of shares outstanding to assume conversion of all dilutive potential shares. The Group had two categories of dilutive potential shares, share-based incentives and the convertible notes.
The stock options were included in the diluted EPS calculation for the three period ended December 31, 2023 only for the tranches in which the average market price of ordinary shares during the periods was higher than the assumed proceeds per option.
Convertible notes outstanding were not included in the diluted EPS calculations for the three period ended December 31, 2023 because the interest (net of tax and other changes in income or expense) per ordinary share obtainable on conversion exceeds basic earnings per share.

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfEarningsPerShareExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_EarningsPerShareAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1

EQUITY INFORMATION
6 Months Ended

Dec. 31, 2023

EQUITY INFORMATION

EQUITY INFORMATION
9. EQUITY INFORMATION
Capital issued
As of December 31, 2023, we had (i) 100,000,000 ordinary shares ($0.0001 par value) authorized, (ii) 62,828,025 ordinary shares issued and outstanding, (iii) 1,000,000 preferred shares ($0.0001 par value) authorized, (iv) no preferred shares issued and outstanding, (v) 3,947,634 ordinary shares reserved for our equity compensation plans. Of the total issued shares, we have repurchased 2,258,016 shares of our own.
Holders of the ordinary shares are entitled to one vote for each ordinary share.

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfClassesOfShareCapitalAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for share capital, reserves and other equity interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 79
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1

CASH FLOW INFORMATION
6 Months Ended

Dec. 31, 2023

CASH FLOW INFORMATION

CASH FLOW INFORMATION
10. CASH FLOW INFORMATION
Significant non-cash transactions related to investing and financing activities are as follows:


12/31/2023

12/31/2022
Investment activities

Net assets acquisition by business combination

—

152,070,313
Investment in-kind in other related parties (Note 15)

—

1,434,802
Capitalization of interest on buildings in progress

47,542

—

47,542

153,505,115

12/31/2023

12/31/2022
Financing activities




Capitalization of convertible notes (Note 5.13)

—

12,211,638
Purchase of own shares

—

(23,915,029)

—

(11,703,391)

X

- Definition
It represents the information pertaining to non cash transactions in cash flow.
+ References
No definition available.
+ Details

Name: biox_StatementOfNonCashTransactionsCashFlowsAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for a statement of cash flows.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Section Presentation of a statement of cash flows
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfCashFlowStatementExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1

JOINT VENTURES AND ASSOCIATES
6 Months Ended

Dec. 31, 2023

JOINT VENTURES AND ASSOCIATES

JOINT VENTURES AND ASSOCIATES
11. JOINT VENTURES AND ASSOCIATES


12/31/2023

06/30/2023
Assets




Synertech Industrias S.A.

39,205,548

36,026,710
Alfalfa Technologies S.R.L.

36,503

36,502
Moolec Science S.A.

3,160,166

3,233,598

42,402,217

39,296,810


12/31/2023

06/30/2023
Liabilities




Trigall Genetics S.A.

115,983

622,823

115,983

622,823

Changes in joint ventures investments and affiliates:


12/31/2023

12/31/2023
As of the beginning of the period

38,673,987

37,836,144
Share-based incentives

50,383

—
Sale of equity investee - Indrasa Biotecnología S.A.

—

(7,853)
Foreign currency translation

897

(21,946)
Share of profit or loss

3,560,967

882,288
As of the end of the period

42,286,234

38,688,633

Share of profit or loss of joint ventures and affiliates:


12/31/2023

12/31/2023
Trigall Genetics S.A.

506,840

595,889
Synertech Industrias S.A.

3,178,839

349,012
Moolec Science S.A.

(124,712)

—
Indrasa Biotecnología S.A.

—

(62,613)

3,560,967

882,288

X

- Definition
The entire disclosure on investments in joint ventures and associates.
+ References
No definition available.
+ Details

Name: biox_InvestmentsInJointVenturesAndAssociatesTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_InvestmentsAccountedForUsingEquityMethodAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1

SEGMENT INFORMATION
6 Months Ended

Dec. 31, 2023

SEGMENT INFORMATION

SEGMENT INFORMATION
12. SEGMENT INFORMATION
The tables present information with respect to the Group´s reporting segments:


Seed and






integrated

Crop

Crop

Period ended December 31, 2023

products

protection

nutrition

Consolidated

Revenues from contracts with customers

Sale of goods and services

53,777,458

127,029,466

75,020,367

255,827,291

Royalties

649,341

—

—

649,341

Others

Initial recognition and changes in the fair value of biological assets at the point of harvest

77,353

141,457

119,318

338,128

Total

54,504,152

127,170,923

75,139,685

256,814,760

Cost of sales

(36,216,288)

(81,249,196)

(42,860,834)

(160,326,318)

Gross profit per segment

18,287,864

45,921,727

32,278,851

96,488,442

% Gross margin

34
%
36
%
43
%
38
%


Seed and






integrated

Crop

Crop

Period ended December 31, 2022

products

protection

nutrition

Consolidated

Revenues from contracts with customers

Sale of goods and services

29,226,197

116,263,527

74,993,171

220,482,895

Royalties

909,067

—

—

909,067

Others

Initial recognition and changes in the fair value of biological assets at the point of harvest

56,530

140,620

154,327

351,477

Total

30,191,794

116,404,147

75,147,498

221,743,439

Cost of sales

(13,606,348)

(79,703,474)

(41,507,315)

(134,817,137)

Gross profit per segment

16,585,446

36,700,673

33,640,183

86,926,302

% Gross margin

55
%
32
%
45
%
39
%

As of the current period, changes in the net realizable value of agricultural products after harvest have been excluded from segment information since those results depend on market fluctuations which are beyond the Group’s operating control. The Group has recast the comparative amounts.

X

- Definition
The entire disclosure for operating segments.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfOperatingSegmentsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 27 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1

FINANCIAL INSTRUMENTS - RISK MANAGEMENT
6 Months Ended

Dec. 31, 2023

FINANCIAL INSTRUMENTS - RISK MANAGEMENT

FINANCIAL INSTRUMENTS - RISK MANAGEMENT
13. FINANCIAL INSTRUMENTS – RISK MANAGEMENT
Financial instruments by category
The following tables show additional information required under IFRS 7 on the financial assets and liabilities recorded as of December 31, 2023, and June 30, 2023.

Financial assets by category

Mandatorily measured at fair

Amortized cost

value through profit or loss
Financial asset

12/31/2023

06/30/2023

12/31/2023

06/30/2023
Cash and cash equivalents

24,332,260

48,129,194

69,677

—
Other financial assets

444,743

657,612

17,040,207

11,922,317
Trade receivables

199,666,283

158,006,474

—

—
Other receivables (*)

13,368,459

12,124,724

—

—
Total

237,811,745

218,918,004

17,109,884

11,922,317
(*)
Advances expenses and tax balances are not included.
Financial liabilities by category

Mandatorily measured at fair

Amortized cost

value through profit or loss
Financial liability

12/31/2023

06/30/2023

12/31/2023

06/30/2023
Trade and other payables

156,857,878

142,582,166

7,145,324

8,225,508
Borrowings

145,038,126

168,310,605

—

—
Secured notes

77,998,071

75,213,146

—

—
Lease liability

13,600,289

13,889,223

—

—
Consideration for acquisition of assets

6,684,278

4,993,256

—

—
Total

400,178,642

404,988,396

7,145,324

8,225,508

Financial instruments measured at fair value

Measurement at fair value at 12/31/2023

Level 1

Level 2

Level 3

Financial assets at fair value

US Treasury bills

—

—

—
Mutual funds

14,736,104

—

—
Other investments

2,304,103

—

—
Financial liability at fair value






Trade and other payables

—

7,145,324

—

Measurement at fair value at 06/30/2023

Level 1

Level 2

Level 3

Financial assets at fair value

US Treasury bills

9,163,298

—

—
Mutual funds

1,596,539

—

—
Other investments

1,162,480

—

—
Financial liability at fair value

Trade and other payables

—

8,225,508

—

Estimation of fair value
The fair value of marketable securities, mutual funds and US Treasury Bills is calculated using the market approach using quoted prices in active markets for identical assets. The quoted marked price used for financial assets held by the Group is the current bid price. These instruments are included in level 1.
The Group’s financial liabilities, which were not traded in an active market, were determined using valuation techniques that maximize the use of available market information, and thus rely as little as possible on specific estimates of the entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instruments are included in level 2.
If one or more of the significant inputs is not based on observable market data, the instruments are included in level 3.
The Group’s policy is to recognize transfers between different categories of the fair value hierarchy at the time they occur or when there are changes in the circumstances that cause the transfer. There were no transfers between levels of the fair value hierarchy. There were no changes in economic or business circumstances affecting fair value.
Financial instruments not measured at fair value
The financial instruments not measured at fair value include cash and cash equivalents, trade accounts receivable, other accounts receivable, trade payables and other debts, borrowings, financed payments and convertible notes.
The carrying value of financial instruments not measured at fair value does not differ significantly from their fair value, except for borrowings (Note 5.12).
Management estimates that the carrying value of the financial instruments measured at amortized cost approximates their fair value.
Currency risk
Foreign currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rate. Currency on foreign exchange risk arises when the Group enters into transactions denominated in a currency other than its functional currency.
The table below sets forth our net exposure to currency risk as of December 31, 2023:

Net foreign currency position

12/31/2023
Amount expressed in US$

(6,210,949)

Considering only this net currency exposure as of December 31, 2023 if an US Dollar revaluation or depreciation in relation to other foreign currencies with the remaining variables remaining constant, would have a positive or a negative impact on comprehensive income as a result of foreign exchange gains or losses. We estimate that a devaluation or an appreciation of the US Dollar other currencies of 10% during the period ended December 31, 2023 would have resulted in a net pre-tax loss or gain of approximately $0.6 million.

X

- Definition
The disclosure of the entity's financial risk management practices and policies.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfFinancialRiskManagementExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 28 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1

LEASES
6 Months Ended

Dec. 31, 2023

LEASES

LEASES
14. LEASES

Right-of-use leased asset

12/31/2023

06/30/2023
Book value at the beginning of the period/year

21,163,192

15,828,032
Additions of the period/year

1,842,539

3,154,950
Additions from business combination

—

3,005,000
Disposals

(558,684)

(1,839,921)
Exchange differences

(129,169)

1,015,131
Book value at the end of the period/year

22,317,878

21,163,192

Depreciation

12/31/2023

06/30/2023
Book value at the beginning of the period/year

7,226,617

3,684,006
Depreciation of the period/year

1,711,256

3,565,894
Disposals

(305,474)

(171,870)
Exchange differences

(18,738)

148,587
Accumulated depreciation at the end of the period/year

8,613,661

7,226,617
Total

13,704,217

13,936,575

Lease liability

12/31/2023

06/30/2023
Book value at the beginning of the period/year

13,889,223

11,751,284
Additions of the period/year

1,842,539

3,154,950
Additions from business combination

—

3,245,000
Interest expenses, exchange differences and inflation effects

362,144

(406,494)
Payments of the period/year

(2,493,617)

(3,855,517)
Total

13,600,289

13,889,223

Lease Liabilities

12/31/2023

06/30/2023
Non-current

9,583,276

10,030,524
Current

4,017,013

3,858,699
Total

13,600,289

13,889,223

The recognized right-of-use assets relate to the following types of assets:


12/31/2023

06/30/2023
Machinery and equipment

3,655,741

3,655,741
Vehicles

1,940,263

1,475,581
Equipment and computer software

1,025,650

903,306
Land and buildings

15,696,224

15,128,564

22,317,878

21,163,192

The incremental borrowing rate used was 1.94 % in US$ and 13.05% in reais.

X

- Definition
The entire disclosure for leases.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Section Presentation
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfLeasesExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_PresentationOfLeasesForLesseeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS
6 Months Ended

Dec. 31, 2023

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS
15. SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS
During the period ended December 31, 2023, and 2022, the transactions between the Group and related parties, and the related balances owed by and to them, are as follows:

Value of transactions for the period ended
Party

Transaction type

12/31/2023

12/31/2022
Joint ventures and associates

Sales and services

14,270,782

23,433,292
Joint ventures and associates

Purchases of goods and services

(20,696,699)

(43,850,427)
Key management personnel

Salaries, social security benefits and other benefits

(9,667,629)

(3,263,996)
Key management personnel

Sales and services

—

362,017
Shareholders and other related parties

Sales of goods and services

1,643,269

343,873
Shareholders and other related parties

Purchases of goods and services

(2,178,877)

(305,061)
Shareholders and other related parties

In-kind contributions

—

1,434,802
Parent company and related parties to Parent (Note 6.6)

Interest expenses

(194,125)

(299,468)
Total

(16,823,279)

(22,144,968)

Amounts receivable from related parties
Party

Transaction type

12/31/2023

06/30/2023
Shareholders and other related parties

Trade debtors

1,223,994

—
Shareholders and other related parties

Other receivables

3,105,591

3,792,429
Joint ventures and associates

Trade debtors

781,452

865,627
Joint ventures and associates

Other receivables

7,730,898

6,334,219
Total

12,841,935

10,992,275

Amounts payable to related parties
Party

Transaction type

12/31/2023

06/30/2022
Parent company and related parties to Parent

Trade creditors

(161,860)

(644,191)
Parent company and related parties to Parent

Net loans payables

(3,639,816)

(3,491,691)
Key management personnel

Salaries, social security benefits and other benefits

(68,139)

(218,068)
Shareholders and other related parties

Trade and other payables

(75,271)

(35,292)
Joint ventures and associates

Trade creditors

(56,385,464)

(41,402,594)
Total

(60,330,550)

(45,791,836)

X

- Definition
The entire disclosure for related parties.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Section Disclosures
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfRelatedPartyExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 30 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1

KEY MANAGEMENT PERSONNEL COMPENSATION
6 Months Ended

Dec. 31, 2023

KEY MANAGEMENT PERSONNEL COMPENSATION

KEY MANAGEMENT PERSONNEL COMPENSATION
16. KEY MANAGEMENT PERSONNEL COMPENSATION
The compensation of directors and other members of key management personnel, including social contributions and other benefits, were as follows for the period ended December 31, 2023, and 2022.


12/31/2023

12/31/2022

Salaries, social security and other benefits

1,140,415

1,201,651
Share-based incentives

8,527,214

2,062,345
Total

9,667,629

3,263,996

X

- References
No definition available.
+ Details

Name: biox_KeyManagementPersonnelCompensationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1

SHARE-BASED PAYMENT
6 Months Ended

Dec. 31, 2023

SHARE-BASED PAYMENT

SHARE-BASED PAYMENT
17. SHARE-BASED PAYMENT
Pursuant to the 2023 Omnibus Equity Incentive Plan approved on May 12, 2023, in August 2023 the Board has granted the following stock options plan to certain directors, executives and management of the Group.
- Past Share Option plan: immediately vested options with a strike price between $11.93 and $13.24.
- Base Share Option plan: to vest and become exercisable in equal installments on June 30, 2023, June 30, 2024, and June 30, 2025, with a strike price between $10.47 and $10.79.
- Performance Share Option plan: to vest and become exercisable if the Group’s fiscal year 2025 EBITDA reaches at least US$120 million, at 0% of the award, and linearly thereafter up to 100% of the awarded options when reaching at least US$150 million. These options have also a strike price of between $10.47 and $10.79.
The fair value of the stock options at the grant date was estimated using the “Black-Scholes” model considering the terms and conditions under which the stock options were granted and adjusted to consider the possible dilutive effect of the future exercise of options. As of December 31, 2023, the expenses associated with share-based incentive plans are included in results within “Share-based incentives” along with the associated increase in net worth.

X

- Definition
The entire disclosure for share-based payment arrangements.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 44
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_44&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1

CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS
6 Months Ended

Dec. 31, 2023

CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS

CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS
18. CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS
There were no other significant changes to the contingencies, commitments and restrictions on the distribution of profits from the disclosure made in the Consolidated financial statement as of June 30, 2023.

X

- References
No definition available.
+ Details

Name: biox_ContingenciesCommitmentsAndRestrictionsOnDistributionOfProfitsAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of commitments.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfCommitmentsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1

EVENTS OCCURRING AFTER THE REPORTING PERIOD
6 Months Ended

Dec. 31, 2023

EVENTS OCCURRING AFTER THE REPORTING PERIOD

EVENTS OCCURRING AFTER THE REPORTING PERIOD
19. EVENTS OCCURRING AFTER THE REPORTING PERIOD
Subsequent to December 31, 2023, there have been no other situations or circumstances that may require significant adjustments or further disclosure in these consolidated financial statements that were not mentioned above.

X

- Definition
The entire disclosure for events after the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 10
-IssueDate 2023-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1

ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Policies)
6 Months Ended

Dec. 31, 2023

ACCOUNTING STANDARDS AND BASIS OF PREPARATION

Basis of measurement
Basis of measurement
The consolidated financial statements of the Group have been prepared using:
●Going concern basis of accounting, considering the conclusion of the assessment made by the Group’s Management about the ability of the Group and its subsidiaries to continue as a going concern, in accordance with the requirements of paragraph 25 of IAS 1, “Presentation of Financial Statements”.
●Accrual basis of accounting (except for cash flows information). Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there are no cash flows.

Functional currency
a)
Functional currency
Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic market in which the entity operates (i.e., “the functional currency”).

Presentation currency
b)
Presentation currency
The consolidated financial statements of the Group are presented in US dollars.

Foreign currency
c)
Foreign currency
Transactions entered into by Group entities in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting period. Exchange differences arising from the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising from the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the consolidated statement of profit or loss and other comprehensive income as part of the gain or loss recognized upon such disposal.

Changes in accounting policies
Changes in accounting policies
In previous years, the Group presented the sum of revenues from contracts with customers, initial recognition and changes in fair value of biological assets at the point of harvest, and changes in the net realizable value of agricultural products after harvest in a caption “Total” to assist investors to understand the performance of the Group’s comprehensive income for each fiscal year. As of the current period, that caption has been removed from the consolidated statements of comprehensive income to be aligned with comparable companies of the industry.
The accounting policies adopted in the preparation of these unaudited interim condensed consolidated financial statements are consistent with those adopted for the preparation of the consolidated financial statements as of June 30, 2023.

X

- References
No definition available.
+ Details

Name: biox_AccountingStandardsAndBasisOfPreparationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The description of the entity's accounting policy for the basis of measurement, preparation, and presentation of the financial statements.
+ References
No definition available.
+ Details

Name: biox_DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The description of the entity's changes in accounting policies.
+ References
No definition available.
+ Details

Name: biox_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The description of the entity's accounting policy for the currency used in presenting financial statements to regulatory agencies.
+ References
No definition available.
+ Details

Name: biox_DescriptionOfAccountingPolicyForPresentationCurrencyTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The description of the entity's material accounting policy information for foreign currency translation.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 117
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The description of the entity's material accounting policy information for the currency of the primary economic environment in which the entity operates.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 117
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables)
6 Months Ended

Dec. 31, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Schedule of cash and cash equivalents


12/31/2023

06/30/2023
Cash at bank and on hand

24,332,260

48,129,194
Mutual funds

69,677

—

24,401,937

48,129,194

Schedule of other financial assets


12/31/2023

06/30/2023
Current


Restricted short-term deposits

—

212,703
US Treasury bills

—

9,163,298
Mutual funds

14,736,104

1,596,539
Other investments

2,304,103

1,162,480

17,040,207

12,135,020


12/31/2023

06/30/2023
Non-current




Shares of Bioceres S.A.

444,410

444,635
Other investments

333

274

444,743

444,909

Schedule of trade receivables


12/31/2023

06/30/2023
Current

Trade debtors

206,838,287

160,269,233
Allowance for impairment of trade debtors

(7,523,261)

(7,425,604)
Shareholders and other related parties (Note 15)

1,223,994

—
Allowance for credit notes to be issued

(3,928,835)

(3,694,019)
Trade debtors - Joint ventures and associates (Note 15)

781,452

865,627
Deferred checks

2,274,646

7,991,237

199,666,283

158,006,474

Schedule of other receivables


12/31/2023

06/30/2023
Current




Taxes

5,490,671

6,113,764
Receivables for PP&E sales

—

156,423
Shareholders and other related parties (Note 15)

3,105,591

3,792,429
Other receivables - Joint ventures and associates (Note 15)

7,500,898

6,104,219
Prepayments to suppliers

3,820,065

10,956,831
Reimbursements over exports

10,558

10,558
Prepaid expenses and other receivables

4,022,045

1,302,221
Miscellaneous

1,131,770

388,553

25,081,598

28,824,998


12/31/2023

06/30/2023
Non-current

Taxes

—

873,699
Reimbursements over exports

1,363,902

1,290,227
Loans receivables

230,000

230,000
Miscellaneous

25,740

152,315

1,619,642

2,546,241

Schedule of inventories


12/31/2023

06/30/2023
Seeds

7,508,251

1,542,159
Resale products

64,271,825

58,544,931
Manufactured products

21,131,225

25,881,761
Goods in transit

1,408,487

3,620,606
Supplies

17,878,874

24,893,187
Agricultural products

14,121,283

28,436,830
Allowance for obsolescence

(2,581,797)

(2,492,499)

123,738,148

140,426,975

Net of agricultural products

109,616,865

111,990,145

Schedule of changes in biological assets


Soybean

Corn

Wheat

Barley

Sunflower

Total
Beginning of the period

—

—

87,785

59,057

—

146,842
Initial recognition and changes in the fair value of biological assets at the point of harvest

—

—

231,523

106,605

—

338,128
Costs incurred during the period

581,227

301,686

—

—

55,457

938,370
Decrease due to harvest/disposals

—

—

(319,308)

(165,662)

—

(484,970)
Period ended December 31, 2023

581,227

301,686

—

—

55,457

938,370


Soybean

Corn

Wheat

Barley

Sunflower

Total
Beginning of the period

—

—

44,413

12,900

—

57,313
Initial recognition and changes in the fair value of biological assets at the point of harvest

—

—

191,481

159,996

—

351,477
Costs incurred during the period

290,667

263,428

389,282

126,293

27,005

1,096,675
Decrease due to harvest/disposals

—

—

(625,176)

(299,189)

—

(924,365)
Period ended December 31, 2022

290,667

263,428

—

—

27,005

581,100

Schedule of property plant and equipment


12/31/2023

06/30/2023
Gross carrying amount

99,485,867

93,634,779
Accumulated depreciation

(28,097,738)

(25,780,944)
Net carrying amount

71,388,129

67,853,835

Schedule of net carrying amount

Net carrying

Net carrying

amount

amount
Class

12/31/2023

06/30/2023
Office equipment

280,108

263,892
Vehicles

2,177,685

2,032,853
Equipment and computer software

190,697

174,399
Fixtures and fittings

2,469,766

2,862,949
Machinery and equipment

13,556,213

14,463,756
Land and buildings

35,745,539

36,144,792
Buildings in progress

16,968,121

11,911,194
Total

71,388,129

67,853,835

Schedule of gross carrying amount
1. Gross carrying amount as of December 31, 2023 is as follows:

Gross carrying amount

As of the

beginning

Foreign

As of the

of the

currency

end of the
Class

period

Additions

Disposals

translation

period
Office equipment

968,088

52,158

—

(3,291)

1,016,955
Vehicles

5,492,319

556,237

(126,068)

(411)

5,922,077
Equipment and computer software

974,509

101,224

—

(7,575)

1,068,158
Fixtures and fittings

7,663,899

10,483

(8,976)

(9,384)

7,656,022
Machinery and equipment

23,513,047

275,297

—

(26,864)

23,761,480
Land and buildings

43,111,723

10,351

—

(29,020)

43,093,054
Buildings in progress (a)

11,911,194

5,112,029

—

(55,102)

16,968,121
Total

93,634,779

6,117,779

(135,044)

(131,647)

99,485,867
(a)
Includes capitalized financial costs of $47,542 corresponding to the period ended December 31, 2023.
3. Gross carrying amount as of December 31, 2022 is as follows:

Gross carrying amount

As of the

Additions

Foreign

As of the

beginning

from business

currency

end of the
Class

of the period

Additions

combination

Disposals

translation

period
Office equipment

908,004

305

—

—

724

909,033
Vehicles

5,261,979

84,209

—

(59,744)

(3,948)

5,282,496
Equipment and computer software

925,349

111,226

12,469

—

(32,824)

1,016,220
Fixtures and fittings

7,606,389

34,256

5,379

—

12,143

7,658,167
Machinery and equipment

13,017,830

1,128,712

7,047,496

(7,186)

(14,677)

21,172,175
Land and buildings

40,659,129

—

4,750,136

—

(28,269)

45,380,996
Buildings in progress

3,142,774

2,465,370

1,285,092

—

(17,027)

6,876,209
Total

71,521,454

3,824,078

13,100,572

(66,930)

(83,878)

88,295,296

Schedule of accumulated depreciation
2. Accumulated depreciation as of December 31, 2023 is as follows:

Depreciation

Accumulated

as of the

Foreign

Accumulated

beginning of

currency

as of the end
Class

the period

Disposals

Of the period

translation

of the period
Office equipment

704,196

—

33,828

(1,177)

736,847
Vehicles

3,459,466

(117,055)

416,309

(14,328)

3,744,392
Equipment and computer software

800,110

—

83,364

(6,013)

877,461
Fixtures and fittings

4,800,950

(6,242)

394,798

(3,250)

5,186,256
Machinery and equipment

9,049,291

—

1,185,336

(29,360)

10,205,267
Land and buildings

6,966,931

—

442,787

(62,203)

7,347,515
Total

25,780,944

(123,297)

2,556,422

(116,331)

28,097,738
4. Accumulated depreciation as of December 31, 2022 is as follows:

Depreciation

Accumulated

as of the

Foreign

Accumulated

beginning of

Of the

currency

as of the end
Class

the period

Disposals

period

translation

of the period
Office equipment

638,466

—

30,827

(466)

668,827
Vehicles

2,596,905

(59,744)

457,562

(1,178)

2,993,545
Equipment and computer software

693,673

—

73,094

(1,549)

765,218
Fixtures and fittings

4,059,470

—

370,828

(355)

4,429,943
Machinery and equipment

7,205,870

—

1,575,862

(9,845)

8,771,887
Land and buildings

6,418,745

—

451,983

473

6,871,201
Total

21,613,129

(59,744)

2,960,156

(12,920)

24,500,621

Schedule of intangible assets


12/31/2023

06/30/2023
Gross carrying amount

206,708,843

202,306,618
Accumulated amortization

(33,965,330)

(28,522,662)
Net carrying amount

172,743,513

173,783,956

Schedule of net carrying amount of intangibles

Net carrying

Net carrying

amount

amount
Class

12/31/2023 (1)

06/30/2023 (1)
Seed and integrated products

HB4 soy and breeding program

32,554,026

31,679,681
Integrated seed products

2,516,125

2,841,008
Crop nutrition

Microbiological products

50,829,622

49,508,801
Other intangible assets

Trademarks and patents

57,429,133

59,760,753
Software

1,923,055

1,987,690
Customer loyalty

22,491,552

23,006,023
RG/RS/OX Wheat

5,000,000

5,000,000
Total

172,743,513

173,783,956
(1) Includes $32.2 million as of December 31, 2023 and $27.4 million as of June 30, 2023 of intangible assets not subject to amortization.

Schedule of gross carrying amounts of intangibles
1. Gross carrying amount as of December 31, 2023 is as follows:

Gross carrying amount

As of the

Foreign

As of the

beginning of

currency

end of the
Class

the period

Additions

translation

period
Seed and integrated products

HB4 soy and breeding program

34,958,425

1,729,439

—

36,687,864
Integrated seed products

3,219,808

—

(269,869)

2,949,939
Crop nutrition

Microbiological products

55,645,028

2,725,454

(1,661)

58,368,821
Other intangible assets

Trademarks and patents

67,653,234

1,288

—

67,654,522
Software

5,582,411

218,541

(967)

5,799,985
Customer loyalty

30,247,712

—

—

30,247,712
RG/RS/OX Wheat

5,000,000

—

—

5,000,000
Total

202,306,618

4,674,722

(272,497)

206,708,843
3. Gross carrying amount as of December 31, 2022 is as follows:

Gross carrying amount

As of the

Additions from

beginning

business

Foreign currency

As of the end of
Class

of the period

Additions

combination

translation

the period
Seed and integrated products






HB4 soy and breeding program

31,371,088

1,738,631

—

—

33,109,719
Integrated seed products

3,181,155

—

—

8,296

3,189,451
Crop nutrition

Microbiological products

8,855,421

4,187,908

39,613,280

(2,279)

52,654,330
Other intangible assets

Trademarks and patents

12,183,045

49,783

55,420,441

—

67,653,269
Software

5,176,373

98,292

—

(954)

5,273,711
Customer loyalty

28,462,475

—

1,785,237

—

30,247,712
RG/RS/OX Wheat

5,000,000

—

—

—

5,000,000
Total

94,229,557

6,074,614

96,818,958

5,063

197,128,192

Schedule of accumulated amortization of intangibles
2. Accumulated amortization as of December 31, 2023 is as follows:

Amortization

Accumulated

Foreign

Accumulated as

as of beginning

currency

of the end of the
Class

of the period

Of the period

translation

period
Seed and integrated products








HB4 soy and breeding program

3,278,744

855,094

—

4,133,838
Integrated seed products

378,800

86,762

(31,748)

433,814
Crop nutrition

Microbiological products

6,136,227

1,402,972

—

7,539,199
Other intangible assets

Trademarks and patents

7,892,481

2,332,908

—

10,225,389
Software

3,594,721

282,764

(555)

3,876,930
Customer loyalty

7,241,689

514,471

—

7,756,160
Total

28,522,662

5,474,971

(32,303)

33,965,330
4. Accumulated amortization as of December 31, 2022 is as follows:

Amortization

Accumulated as



Foreign

Accumulated

of beginning of

currency

as of the end
Class

the period

Of the period

translation

of the period
Seed and integrated products

HB4 soy and breeding program

1,568,554

799,644

—

2,368,198
Integrated seed products

43,997

22,242

488

66,727
Crop nutrition

Microbiological products

3,063,073

313,970

—

3,377,043
Other intangible assets

Trademarks and patents

3,916,004

2,136,403

—

6,052,407
Software

3,008,388

285,881

(756)

3,293,513
Customer loyalty

5,924,672

1,633,381

—

7,558,053
Total

17,524,688

5,191,521

(268)

22,715,941

Schedule of carrying amount of goodwill


12/31/2023

06/30/2023

Rizobacter Argentina S.A.

28,080,271

28,080,271
Bioceres Crops S.A.

7,523,322

7,523,322
Pro farm Group, Inc.

76,089,749

76,089,749
Insumos Agroquímicos S.A.

470,090

470,090

112,163,432

112,163,432

Schedule of investment properties


12/31/2023

06/30/2023

Investment properties

3,792,238

3,589,749

3,792,238

3,589,749

Schedule of trade and other payable


12/31/2023

06/30/2023

Trade creditors

103,683,392

104,211,238
Shareholders and other related parties (Note 15)

75,271

35,292
Trade creditors - Parent company (Note 15)

161,860

644,191
Trade creditors - Joint ventures and associates (Note 15)

56,385,464

41,402,594
Taxes

3,556,073

3,561,058
Miscellaneous

141,142

953,301

164,003,202

150,807,674

Schedule of borrowings


12/31/2023

06/30/2023
Current

Bank borrowings

52,942,957

61,303,952
Corporate bonds

49,749,398

35,547,510
Trust debt securities

7,188,607

7,296,506
Net loans payables- Parents companies and related parties to Parent (Note 15)

3,639,816

3,491,691

113,520,778

107,639,659
Non-current

Bank borrowings

10,314,800

10,663,266
Corporate bonds

21,202,548

50,007,680

31,517,348

60,670,946

Schedule of carrying value of borrowings

12/31/2023

06/30/2023


Amortized cost

Fair value

Amortized cost

Fair value
Current

Bank borrowings

52,942,957

49,659,094

61,303,952

57,209,155
Corporate Bonds

49,749,398

49,192,118

35,547,510

34,725,828

Non-current

Bank borrowings

10,314,800

8,698,322

10,663,266

10,374,646
Corporate Bonds

21,202,548

20,670,511

50,007,680

47,014,542

Schedule of employee benefits and social security


12/31/2023

06/30/2023
Salaries, accrued incentives, vacations and social security

8,150,518

9,388,639
Key management personnel (Note 15)

68,139

218,068

8,218,657

9,606,707

Schedule of deferred revenue and advances from customers


12/31/2023

06/30/2023
Current




Advances from customers

4,466,515

9,216,032
Deferred revenue

17,632,863

15,659,630

22,099,378

24,875,662
Non-current

Advances from customers

272,334

620,893
Deferred revenue

1,863,506

1,436,912

2,135,840

2,057,805

X

- Definition
n/a
+ References
No definition available.
+ Details

Name: biox_ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
he disclosure of detailed information about accumulated amortization of intangible assets.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfAccumulatedAmortizationOfIntangibleAssets.TextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The tabular disclosure of salaries and social security payables.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about carrying value of borrowings.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfCarryingValueOfBorrowingsExplanatory

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of depreciation.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfDepreciationExpenseTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about gross carrying amount of intangible assets.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfGrossCarryingAmountOfIntangibleAssetsTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of gross carrying amount of each asset class.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfGrossCarryingAmountTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about other intangible assets.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfNetCarryingAmountOfOtherIntangibleAssetsTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of net carrying amount of each asset class.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfNetCarryingAmountTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of other financial assets.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfOtherFinancialAssetsExplanatory

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about other receivables.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfOtherReceivablesTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Definition: Tabular disclosure of components of trade and other payables.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The tabular disclosure of current and non-current trade receivables.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfTradeReceivablesTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
No definition available.
+ Details

Name: biox_IfrsScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 7
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for investment property.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS40_g74-79_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfInvestmentPropertyExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of performance obligations in contracts with customers. [Refer: Performance obligations [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 119
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_119&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfPerformanceObligationsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of the reconciliation of changes in biological assets. [Refer: Biological assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of the reconciliation of changes in goodwill. [Refer: Goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B67
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables)
6 Months Ended

Dec. 31, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Schedule of revenue from contracts with customers


12/31/2023

12/31/2022
Sale of goods and services

255,827,291

220,482,895
Royalties

649,341

909,067

256,476,632

221,391,962

Schedule of cost of sales

Item

12/31/2023

12/31/2022
Inventories as of the beginning of the period

111,990,145

78,759,610
Business combination

—

11,064,908
Purchases of the period

144,999,639

138,186,645
Production costs

12,981,672

14,596,888
Foreign currency translation

(28,273)

(246,484)
Subtotal

269,943,183

242,361,567
Inventories as of the end of the period (*)

(109,616,865)

(107,544,430)
Cost of sales

160,326,318

134,817,137
(*)Net of agricultural products.

Schedule of R&D classified by nature


Research and

Research and

development

development

expenses

expenses
Item

12/31/2023

12/31/2022
Amortization of intangible assets

2,453,158

2,201,938
Analysis and storage

5,302

27,322
Import and export expenses

—

850
Depreciation of property, plant and equipment

312,453

287,180
Freight and haulage

14,278

4,732
Employee benefits and social securities

2,211,907

2,248,105
Maintenance

96,056

303,524
Energy and fuel

5,227

94,870
Supplies and materials

1,182,066

1,078,197
Mobility and travel

89,474

158,193
Share-based incentives

143,749

92,477
Publicity and advertising

—

9,568
Professional fees and outsourced services

994,197

574,614
Professional fees related parties

216,792

102,701
Office supplies

470,376

43,546
Information technology expenses

9,640

19,060
Insurance

19,586

25,738
Depreciation of leased assets

—

33,685
Miscellaneous

57

3,606
Total

8,224,318

7,309,906


12/31/2023

12/31/2022
R&D capitalized (Note 5.8)

4,454,893

5,926,539
R&D profit and loss

8,224,318

7,309,906
Total

12,679,211

13,236,445

Schedule of expenses classified by nature and function




Selling,


general and

Production

administrative

Total
Item

costs

expenses

12/31/2023
Amortization of intangible assets

60,849

2,960,964

3,021,813
Analysis and storage

570

153,163

153,733
Commissions and royalties

421,677

1,008,251

1,429,928
Import and export expenses

43,902

318,479

362,381
Depreciation of property, plant and equipment

1,308,591

935,378

2,243,969
Depreciation of leased assets

699,044

1,012,212

1,711,256
Impairment of receivables

—

296,051

296,051
Freight and haulage

634,188

6,878,364

7,512,552
Employee benefits and social securities

5,935,502

21,509,102

27,444,604
Maintenance

1,007,395

1,152,332

2,159,727
Energy and fuel

500,658

272,547

773,205
Supplies and materials

367,386

1,691,154

2,058,540
Mobility and travel

94,476

2,148,705

2,243,181
Publicity and advertising

1,300

2,305,251

2,306,551
Contingencies

1,239

47,851

49,090
Share-based incentives

339,904

8,043,561

8,383,465
Professional fees and outsourced services

963,972

3,542,038

4,506,010
Professional fees related parties

—

66,618

66,618
Office supplies and registrations fees

80,236

651,991

732,227
Insurance

81,174

1,102,142

1,183,316
Information technology expenses

27,186

1,924,633

1,951,819
Obsolescence

282,836

—

282,836
Taxes

127,760

7,019,360

7,147,120
Miscellaneous

1,827

57,638

59,465
Total

12,981,672

65,097,785

78,079,457




Selling,


general and

Production

administrative

Total
Item

costs

expenses

12/31/2022
Amortization of intangible assets

86,842

2,902,741

2,989,583
Analysis and storage

4,460

237,341

241,801
Commissions and royalties

109,703

1,020,272

1,129,975
Import and export expenses

265,121

704,937

970,058
Depreciation of property, plant and equipment

1,666,119

1,006,857

2,672,976
Depreciation of leased assets

230,478

1,573,369

1,803,847
Impairment of receivables

—

468,992

468,992
Freight and haulage

1,201,183

5,002,384

6,203,567
Employee benefits and social securities

7,177,926

20,156,371

27,334,297
Maintenance

722,399

1,446,553

2,168,952
Energy and fuel

753,041

161,850

914,891
Supplies and materials

512,493

627,514

1,140,007
Mobility and travel

39,428

1,837,797

1,877,225
Publicity and advertising

—

3,235,737

3,235,737
Contingencies

—

39,847

39,847
Share-based incentives

—

1,969,868

1,969,868
Professional fees and outsourced services

1,133,009

7,122,701

8,255,710
Professional fees related parties

—

29,818

29,818
Office supplies and registrations fees

23,309

624,246

647,555
Insurance

74,350

1,306,282

1,380,632
Information technology expenses

17,511

1,566,952

1,584,463
Obsolescence

481,332

—

481,332
Taxes

96,233

6,976,043

7,072,276
Miscellaneous

1,951

300,016

301,967
Total

14,596,888

60,318,488

74,915,376

Schedule of other income or expenses, net


12/31/2023

12/31/2022
Net result from commercialization of agricultural products

(2,960,005)

144,515
Expenses recovery

236,106

232,977
Other income or expenses, net

325,661

391,036

(2,398,238)

768,528

Schedule of net financial cost


12/31/2023

12/31/2022
Financial costs

Interest expenses with the Parents (Note 15)

(194,125)

(299,468)
Interest expenses

(9,994,912)

(10,722,135)
Financial commissions

(1,288,813)

(1,517,729)

(11,477,850)

(12,539,332)

Other financial results


Exchange differences generated by assets

(12,049,351)

(12,771,727)
Exchange differences generated by liabilities

21,674,845

9,070,404
Changes in fair value of financial assets or liabilities and other financial results

(13,727,825)

(2,068,923)
Net gain of inflation effect on monetary items

766,135

281,083

(3,336,196)

(5,489,163)

X

- Definition
The disclosure of the cost of sales. [Refer: Cost of sales]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfCostOfSalesExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of the disaggregation of revenue from contracts with customers. [Refer: Revenue from contracts with customers]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 114
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of expenses by nature. [Refer: Expenses, by nature]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfExpensesByNatureExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of finance income (cost). [Refer: Finance income (cost)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of other operating income or expense. [Refer: Other operating income (expense)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of research and development expense. [Refer: Research and development expense]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_StatementOfComprehensiveIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 37 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1

TAXATION (Tables)
6 Months Ended

Dec. 31, 2023

TAXATION

Schedule of current tax


12/31/2023

12/31/2022
Current tax expense

(3,845,338)

(6,467,324)
Deferred tax

(4,917,089)

769,775
Total

(8,762,427)

(5,697,549)

Schedule of net deferred tax


12/31/2023

12/31/2022
Beginning of the period deferred tax

(28,472,383)

(24,994,569)
Additions for business combination

—

(16,704,771)
Charge for the period

(4,917,089)

769,775
Conversion difference

(361,293)

(582,016)
Total net deferred tax

(33,750,765)

(41,511,581)

Schedule of reconciliation of the statutory tax rate to the effective tax rate


12/31/2023

12/31/2022
Earning before income tax-rate

7,322,464

1,183,270
Income tax expense by applying tax rate in force in the respective countries

(5,434,748)

(5,182,386)
Share of profit or loss of subsidiaries, joint ventures and associates

1,219,030

225,376
Stock options charge

(1,489,037)

(298,851)
Non-deductible expenses

(116,220)

(543,505)
Unrecognized deferred tax ¹

—

(995,754)
Tax inflation adjustment

7,460,048

3,132,901
Result of inflation effect on monetary items and other finance results

(11,000,459)

(1,660,369)
Untaxed gains

598,959

33,052
Others

—

(408,013)
Income tax expenses

(8,762,427)

(5,697,549)
1 Corresponds mainly to Pro Farm Group Inc.

X

- Definition
Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.
+ References
No definition available.
+ Details

Name: biox_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.
+ References
No definition available.
+ Details

Name: biox_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfDeferredTaxesExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 38 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1

EARNING PER SHARE (Tables)
6 Months Ended

Dec. 31, 2023

EARNING PER SHARE

Schedule of earnings per share

Three -month period ended

Six-month period ended


12/31/2023

12/31/2022

12/31/2023

12/31/2022
Numerator



(Loss) profit for the period (basic EPS)

108,449

(8,156,746)

(4,483,185)

(7,658,449)
(Loss) profit for the period (diluted EPS)

108,449

(8,156,746)

(4,483,185)

(7,658,449)
Denominator

Weighted average number of shares (basic EPS)

62,839,961

61,657,343

62,839,961

61,657,343
Weighted average number of shares (diluted EPS)

63,877,692

61,657,343

62,839,961

61,657,343

Basic (loss) profit attributable to ordinary equity holders of the parent

0.0017

(0.1323)

(0.0713)

(0.1242)
Diluted (loss) profit attributable to ordinary equity holders of the parent

0.0017

(0.1323)

(0.0713)

(0.1242)

X

- References
No definition available.
+ Details

Name: ifrs-full_EarningsPerShareAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_EarningsPerShareExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1

CASH FLOW INFORMATION (Tables)
6 Months Ended

Dec. 31, 2023

CASH FLOW INFORMATION

Schedule of significant non-cash transactions related to investing and financing activities


12/31/2023

12/31/2022
Investment activities

Net assets acquisition by business combination

—

152,070,313
Investment in-kind in other related parties (Note 15)

—

1,434,802
Capitalization of interest on buildings in progress

47,542

—

47,542

153,505,115

12/31/2023

12/31/2022
Financing activities




Capitalization of convertible notes (Note 5.13)

—

12,211,638
Purchase of own shares

—

(23,915,029)

—

(11,703,391)

X

- Definition
The tabular disclosure of significant non-cash transactions related to investing and financing activities.
+ References
No definition available.
+ Details

Name: biox_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
It represents the information pertaining to non cash transactions in cash flow.
+ References
No definition available.
+ Details

Name: biox_StatementOfNonCashTransactionsCashFlowsAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 40 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1

JOINT VENTURES AND ASSOCIATES (Tables)
6 Months Ended

Dec. 31, 2023

JOINT VENTURES AND ASSOCIATES

Schedule of investments in joint ventures and associates


12/31/2023

06/30/2023
Assets




Synertech Industrias S.A.

39,205,548

36,026,710
Alfalfa Technologies S.R.L.

36,503

36,502
Moolec Science S.A.

3,160,166

3,233,598

42,402,217

39,296,810


12/31/2023

06/30/2023
Liabilities




Trigall Genetics S.A.

115,983

622,823

115,983

622,823

Schedule of changes in joint ventures


12/31/2023

12/31/2023
As of the beginning of the period

38,673,987

37,836,144
Share-based incentives

50,383

—
Sale of equity investee - Indrasa Biotecnología S.A.

—

(7,853)
Foreign currency translation

897

(21,946)
Share of profit or loss

3,560,967

882,288
As of the end of the period

42,286,234

38,688,633

Schedule of share of profit or loss of joint ventures and associates


12/31/2023

12/31/2023
Trigall Genetics S.A.

506,840

595,889
Synertech Industrias S.A.

3,178,839

349,012
Moolec Science S.A.

(124,712)

—
Indrasa Biotecnología S.A.

—

(62,613)

3,560,967

882,288

X

- Definition
The disclosure of investments in joint ventures and affiliates.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Information pertains to disclosure of investments in associates and joint ventures.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of share of profit / (loss) joint ventures and affiliates.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_InvestmentsAccountedForUsingEquityMethodAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 41 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1

SEGMENT INFORMATION (Tables)
6 Months Ended

Dec. 31, 2023

SEGMENT INFORMATION

Schedule of operating results group's reporting segments


Seed and






integrated

Crop

Crop

Period ended December 31, 2023

products

protection

nutrition

Consolidated

Revenues from contracts with customers

Sale of goods and services

53,777,458

127,029,466

75,020,367

255,827,291

Royalties

649,341

—

—

649,341

Others

Initial recognition and changes in the fair value of biological assets at the point of harvest

77,353

141,457

119,318

338,128

Total

54,504,152

127,170,923

75,139,685

256,814,760

Cost of sales

(36,216,288)

(81,249,196)

(42,860,834)

(160,326,318)

Gross profit per segment

18,287,864

45,921,727

32,278,851

96,488,442

% Gross margin

34
%
36
%
43
%
38
%


Seed and






integrated

Crop

Crop

Period ended December 31, 2022

products

protection

nutrition

Consolidated

Revenues from contracts with customers

Sale of goods and services

29,226,197

116,263,527

74,993,171

220,482,895

Royalties

909,067

—

—

909,067

Others

Initial recognition and changes in the fair value of biological assets at the point of harvest

56,530

140,620

154,327

351,477

Total

30,191,794

116,404,147

75,147,498

221,743,439

Cost of sales

(13,606,348)

(79,703,474)

(41,507,315)

(134,817,137)

Gross profit per segment

16,585,446

36,700,673

33,640,183

86,926,302

% Gross margin

55
%
32
%
45
%
39
%

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfOperatingSegmentsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of operating segments. [Refer: Operating segments [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfOperatingSegmentsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1

FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables)
6 Months Ended

Dec. 31, 2023

FINANCIAL INSTRUMENTS - RISK MANAGEMENT

Schedule of financial assets by category

Mandatorily measured at fair

Amortized cost

value through profit or loss
Financial asset

12/31/2023

06/30/2023

12/31/2023

06/30/2023
Cash and cash equivalents

24,332,260

48,129,194

69,677

—
Other financial assets

444,743

657,612

17,040,207

11,922,317
Trade receivables

199,666,283

158,006,474

—

—
Other receivables (*)

13,368,459

12,124,724

—

—
Total

237,811,745

218,918,004

17,109,884

11,922,317
(*)
Advances expenses and tax balances are not included.

Schedule financial liabilities by category

Mandatorily measured at fair

Amortized cost

value through profit or loss
Financial liability

12/31/2023

06/30/2023

12/31/2023

06/30/2023
Trade and other payables

156,857,878

142,582,166

7,145,324

8,225,508
Borrowings

145,038,126

168,310,605

—

—
Secured notes

77,998,071

75,213,146

—

—
Lease liability

13,600,289

13,889,223

—

—
Consideration for acquisition of assets

6,684,278

4,993,256

—

—
Total

400,178,642

404,988,396

7,145,324

8,225,508

Schedule of fair value by hierarchy

Measurement at fair value at 12/31/2023

Level 1

Level 2

Level 3

Financial assets at fair value

US Treasury bills

—

—

—
Mutual funds

14,736,104

—

—
Other investments

2,304,103

—

—
Financial liability at fair value






Trade and other payables

—

7,145,324

—

Measurement at fair value at 06/30/2023

Level 1

Level 2

Level 3

Financial assets at fair value

US Treasury bills

9,163,298

—

—
Mutual funds

1,596,539

—

—
Other investments

1,162,480

—

—
Financial liability at fair value

Trade and other payables

—

8,225,508

—

Schedule of net exposure

Net foreign currency position

12/31/2023
Amount expressed in US$

(6,210,949)

X

- Definition
The disclosure of the fair value of financial instruments. [Refer: Financial instruments, class [member]; At fair value [member]]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of financial assets. [Refer: Financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 7
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfFinancialAssetsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of financial liabilities. [Refer: Financial liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 7
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of information that enables users of financial statements to evaluate the nature and extent of risks arising from financial instruments to which the entity is exposed. [Refer: Financial instruments, class [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 31
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 43 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1

LEASES (Tables)
6 Months Ended

Dec. 31, 2023

LEASES

Schedule of right of use leased assets and lease liability from beginning of year to end of year

Right-of-use leased asset

12/31/2023

06/30/2023
Book value at the beginning of the period/year

21,163,192

15,828,032
Additions of the period/year

1,842,539

3,154,950
Additions from business combination

—

3,005,000
Disposals

(558,684)

(1,839,921)
Exchange differences

(129,169)

1,015,131
Book value at the end of the period/year

22,317,878

21,163,192

Depreciation

12/31/2023

06/30/2023
Book value at the beginning of the period/year

7,226,617

3,684,006
Depreciation of the period/year

1,711,256

3,565,894
Disposals

(305,474)

(171,870)
Exchange differences

(18,738)

148,587
Accumulated depreciation at the end of the period/year

8,613,661

7,226,617
Total

13,704,217

13,936,575

Lease liability

12/31/2023

06/30/2023
Book value at the beginning of the period/year

13,889,223

11,751,284
Additions of the period/year

1,842,539

3,154,950
Additions from business combination

—

3,245,000
Interest expenses, exchange differences and inflation effects

362,144

(406,494)
Payments of the period/year

(2,493,617)

(3,855,517)
Total

13,600,289

13,889,223

Lease Liabilities

12/31/2023

06/30/2023
Non-current

9,583,276

10,030,524
Current

4,017,013

3,858,699
Total

13,600,289

13,889,223

Schedule of right-of-use leased assets


12/31/2023

06/30/2023
Machinery and equipment

3,655,741

3,655,741
Vehicles

1,940,263

1,475,581
Equipment and computer software

1,025,650

903,306
Land and buildings

15,696,224

15,128,564

22,317,878

21,163,192

X

- Definition
The tabular disclosure of roll forward of right of use leased assets and lease liability
+ References
No definition available.
+ Details

Name: biox_Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of right-of-use leased assets.
+ References
No definition available.
+ Details

Name: biox_RightOfUseLeasedAssetsTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_PresentationOfLeasesForLesseeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 44 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables)
6 Months Ended

Dec. 31, 2023

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Schedule of transactions between the group and related parties, and the related balances owed

Value of transactions for the period ended
Party

Transaction type

12/31/2023

12/31/2022
Joint ventures and associates

Sales and services

14,270,782

23,433,292
Joint ventures and associates

Purchases of goods and services

(20,696,699)

(43,850,427)
Key management personnel

Salaries, social security benefits and other benefits

(9,667,629)

(3,263,996)
Key management personnel

Sales and services

—

362,017
Shareholders and other related parties

Sales of goods and services

1,643,269

343,873
Shareholders and other related parties

Purchases of goods and services

(2,178,877)

(305,061)
Shareholders and other related parties

In-kind contributions

—

1,434,802
Parent company and related parties to Parent (Note 6.6)

Interest expenses

(194,125)

(299,468)
Total

(16,823,279)

(22,144,968)

Amounts receivable from related parties
Party

Transaction type

12/31/2023

06/30/2023
Shareholders and other related parties

Trade debtors

1,223,994

—
Shareholders and other related parties

Other receivables

3,105,591

3,792,429
Joint ventures and associates

Trade debtors

781,452

865,627
Joint ventures and associates

Other receivables

7,730,898

6,334,219
Total

12,841,935

10,992,275

Amounts payable to related parties
Party

Transaction type

12/31/2023

06/30/2022
Parent company and related parties to Parent

Trade creditors

(161,860)

(644,191)
Parent company and related parties to Parent

Net loans payables

(3,639,816)

(3,491,691)
Key management personnel

Salaries, social security benefits and other benefits

(68,139)

(218,068)
Shareholders and other related parties

Trade and other payables

(75,271)

(35,292)
Joint ventures and associates

Trade creditors

(56,385,464)

(41,402,594)
Total

(60,330,550)

(45,791,836)

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 18
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1

KEY MANAGEMENT PERSONNEL COMPENSATION (Tables)
6 Months Ended

Dec. 31, 2023

KEY MANAGEMENT PERSONNEL COMPENSATION

Schedule of compensation of directors and other members of key management personnel


12/31/2023

12/31/2022

Salaries, social security and other benefits

1,140,415

1,201,651
Share-based incentives

8,527,214

2,062,345
Total

9,667,629

3,263,996

X

- Definition
The tabular disclosure of compensation of directors and other members of key management personnel.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: biox_KeyManagementPersonnelCompensationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 46 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1

GENERAL INFORMATION - (Details)

Dec. 31, 2023

country

Business information

Number of countries where Group's agricultural inputs are marketed 45

X

- References
No definition available.
+ Details

Name: biox_BusinessInformationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The minimum number of countries where the entity has marketed agricultural inputs.
+ References
No definition available.
+ Details

Name: biox_MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs

Namespace Prefix: biox_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

XML 47 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1

SEASONALITY (Details)

Dec. 31, 2023

item

SEASONALITY

Some customers and distributers order per year, minimum 1

Some customers and distributers order per year, maximum 2

X

- Definition
The maximum number of bulk orders per year of some customers and distributors of the entity.
+ References
No definition available.
+ Details

Name: biox_CustomersAndDistributorBulkOrdersPerYearMaximum

Namespace Prefix: biox_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
The minimum number of bulk orders per year of some customers and distributors of the entity.
+ References
No definition available.
+ Details

Name: biox_CustomersAndDistributorBulkOrdersPerYearMinimum

Namespace Prefix: biox_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
No definition availability.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfSeasonalityAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 48 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Cash at bank and on hand $ 24,332,260 $ 48,129,194

Mutual funds 69,677

Cash and cash equivalents $ 24,401,937 $ 48,129,194

X

- Definition
n/a
+ References
No definition available.
+ Details

Name: biox_ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of an investment program funded by shareholders that trades in diversified holdings and is professionally managed.
+ References
No definition available.
+ Details

Name: biox_MutualFundsAtCarryingValue

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of cash on hand and demand deposits. [Refer: Cash on hand]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Cash

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B13
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CashAndCashEquivalents

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 49 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Current

Restricted short-term deposits $ 212,703

US Treasury bills 9,163,298

Mutual funds $ 14,736,104 1,596,539

Other investments 2,304,103 1,162,480

Other financial assets 17,040,207 12,135,020

Non-current

Shares of Bioceres S.A. 444,410 444,635

Other investments 333 274

Other financial assets $ 444,743 $ 444,909

X

- Definition
The amount of non-current other marketable securities classified as non-current.
+ References
No definition available.
+ Details

Name: biox_OtherMarketableSecuritiesClassifiedAsNonCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of short-term investments held by the entity that are not classified as cash equivalents.
+ References
No definition available.
+ Details

Name: biox_ShortTermInvestmentsNotClassifiedAsCashEquivalents

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentAssetsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentAssetsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of non-current financial assets available-for-sale. [Refer: Financial assets available-for-sale; Non-current financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Note Expired 2023-01-01
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 8
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_d&doctype=Standard&book=b
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentFinancialAssetsAvailableforsale

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherCurrentFinancialAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherNoncurrentFinancialAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
A classification of cash equivalents representing short-term investments. [Refer: Cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 50 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Components of Consolidated Statement of Financial Position

Trade debtors $ 206,838,287 $ 160,269,233

Allowance for impairment of trade debtors (7,523,261) (7,425,604)

Allowance for credit notes to be issued (3,928,835) (3,694,019)

Deferred checks 2,274,646 7,991,237

Trade receivables 199,666,283 158,006,474

Shareholders and other related parties

Components of Consolidated Statement of Financial Position

Shareholders and other related parties (Note 15) 1,223,994

Joint ventures and associates

Components of Consolidated Statement of Financial Position

Trade debtors $ 781,452 $ 865,627

X

- Definition
The amount of allowance for return of goods.
+ References
No definition available.
+ Details

Name: biox_AllowanceForReturnOfGoods

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of trade receivables due from related parties.
+ References
No definition available.
+ Details

Name: biox_TradeReceivablesFromRelatedParties

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of an allowance account used to record impairments to financial assets due to credit losses. [Refer: Financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Note Expired 2023-01-01
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 16
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current trade receivables. [Refer: Trade receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 68
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentTradeReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount receivable by the entity that it does not separately disclose in the same statement or note.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_h&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_JointVenturesAndAssociatesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 51 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Current

Taxes $ 5,490,671 $ 6,113,764

Prepayments to suppliers 3,820,065 10,956,831

Reimbursements over exports 10,558 10,558

Prepaid expenses and other receivables 4,022,045 1,302,221

Miscellaneous 1,131,770 388,553

Other receivables 25,081,598 28,824,998

Non-current

Taxes 873,699

Reimbursements over exports 1,363,902 1,290,227

Loan receivables 230,000 230,000

Miscellaneous 25,740 152,315

Other receivables 1,619,642 2,546,241

Receivables for PP&E sales

Current

Other receivables 156,423

Shareholders and other related parties

Current

Other receivables 3,105,591 3,792,429

Joint ventures and associates

Current

Other receivables $ 7,500,898 $ 6,104,219

X

- Definition
Represents the amount of non-current receivables from advances to suppliers.
+ References
No definition available.
+ Details

Name: biox_AdvancesToSuppliersNonCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the non current amount of loan receivable.
+ References
No definition available.
+ Details

Name: biox_LoanReceivableNonCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the amount of other current receivables, other.
+ References
No definition available.
+ Details

Name: biox_OtherCurrentReceivablesOther

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents other non-current receivables.
+ References
No definition available.
+ Details

Name: biox_OtherNonCurrentReceivablesOther

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the amount of expenditure that is to be reimbursed.
+ References
No definition available.
+ Details

Name: biox_ReceivablesFromReimbursementOfExpenditureCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the amount of current tax credit receivables.
+ References
No definition available.
+ Details

Name: biox_ReceivablesFromTaxCreditsCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the amount of non-current tax credit receivables.
+ References
No definition available.
+ Details

Name: biox_ReceivablesFromTaxCreditsNonCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current advances made to suppliers before goods or services are received.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentAdvancesToSuppliers

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentAssetsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentPrepaidExpenses

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentAssetsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current other receivables. [Refer: Other receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherCurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of non-current other receivables. [Refer: Other receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherNoncurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_ReceivablesForPpESalesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_JointVenturesAndAssociatesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 52 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Inventory

Goods in transit $ 1,408,487 $ 3,620,606

Supplies 17,878,874 24,893,187

Agricultural products 14,121,283 28,436,830

Inventories 123,738,148 140,426,975

Net of agricultural products 109,616,865 111,990,145

Seeds

Inventory

Inventories 7,508,251 1,542,159

Resale products

Inventory

Inventories 64,271,825 58,544,931

Manufactured products

Inventory

Inventories 21,131,225 25,881,761

Allowance for obsolescence

Inventory

Inventories $ (2,581,797) $ (2,492,499)

X

- Definition
The amount of current inventories excluding agricultural produce.
+ References
No definition available.
+ Details

Name: biox_InventoriesExcludingAgriculturalProduce

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
A classification of current inventory representing the amount of harvested produce of the entity's biological assets. [Refer: Biological assets; Inventories]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 2
-IssueDate 2023-01-01
-Paragraph 37
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentAgriculturalProduce

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
A classification of current inventory representing the amount of inventories in transit. [Refer: Inventories]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 2
-IssueDate 2023-01-01
-Paragraph 37
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentInventoriesInTransit

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
A classification of current inventory representing the amount of materials and supplies to be consumed in a production process or while rendering services. [Refer: Inventories]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 2
-IssueDate 2023-01-01
-Paragraph 37
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentMaterialsAndSuppliesToBeConsumedInProductionProcessOrRenderingServices

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current inventories. [Refer: Inventories]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 2
-IssueDate 2023-01-01
-Paragraph 36
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 68
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Inventories

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_SeedsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_MicrobiologicalResaleProductsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_MicrobiologicalProductsProducedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 53 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details) - USD ($)
3 Months Ended 6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

Biological assets

Beginning of the period $ 146,842 $ 57,313

Initial recognition and changes in the fair value of biological assets at the point of harvest $ (72,785) $ (138,529) 338,128 351,477

Cost incurred during the period 938,370 1,096,675

Decrease due to harvest/disposals (484,970) (924,365)

End of period 938,370 581,100 938,370 581,100

Soybean

Biological assets

Beginning of the period 0 0

Cost incurred during the period 581,227 290,667

End of period 581,227 290,667 581,227 290,667

Corn

Biological assets

Beginning of the period 0 0

Cost incurred during the period 301,686 263,428

End of period 301,686 263,428 301,686 263,428

Wheat

Biological assets

Beginning of the period 87,785 44,413

Initial recognition and changes in the fair value of biological assets at the point of harvest 231,523 191,481

Cost incurred during the period 389,282

Decrease due to harvest/disposals (319,308) (625,176)

Barley

Biological assets

Beginning of the period 59,057 12,900

Initial recognition and changes in the fair value of biological assets at the point of harvest 106,605 159,996

Cost incurred during the period 126,293

Decrease due to harvest/disposals (165,662) (299,189)

Sunflower

Biological assets

Beginning of the period 0 0

Cost incurred during the period 55,457 27,005

End of period $ 55,457 $ 27,005 $ 55,457 $ 27,005

X

- Definition
The decrease in biological assets due to the detachment of produce from the assets or the cessation of the assets' life processes and disposals.
+ References
No definition available.
+ Details

Name: biox_DecreaseDueToHarvestAndDisposalsBiologicalAssets

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of additions to biological assets, other than those acquired through business combinations. [Refer: Business combinations [member]; Biological assets]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of living animals or plants recognised as assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 43
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_43&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph f
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_BiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_BiologicalAssetsSoybeanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_BiologicalAssetsCornMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_BiologicalAssetsWheatMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_BiologicalAssetsBarleyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_SunflowerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 54 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Dec. 31, 2022

Jun. 30, 2022

Property, plant and equipment

Property, plant and equipment $ 71,388,129 $ 67,853,835

Gross carrying amount

Property, plant and equipment

Property, plant and equipment 99,485,867 93,634,779 $ 88,295,296 $ 71,521,454

Accumulated depreciation

Property, plant and equipment

Property, plant and equipment $ (28,097,738) $ (25,780,944) $ (24,500,621) $ (21,613,129)

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 55 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - net carrying amount (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Property, plant and equipment

Property, plant and equipment $ 71,388,129 $ 67,853,835

Office equipment

Property, plant and equipment

Property, plant and equipment 280,108 263,892

Vehicles

Property, plant and equipment

Property, plant and equipment 2,177,685 2,032,853

Equipment and computer software

Property, plant and equipment

Property, plant and equipment 190,697 174,399

Fixture and fittings

Property, plant and equipment

Property, plant and equipment 2,469,766 2,862,949

Machinery and equipment

Property, plant and equipment

Property, plant and equipment 13,556,213 14,463,756

Land and buildings

Property, plant and equipment

Property, plant and equipment 35,745,539 36,144,792

Buildings in progress

Property, plant and equipment

Property, plant and equipment $ 16,968,121 $ 11,911,194

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 56 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - gross carrying amounts (Details) - USD ($)
6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Property, plant and equipment

As of the beginning of period $ 67,853,835

Additions from business combination $ 13,100,572

As of the end of period 71,388,129

Capitalized financial costs 47,542

Office equipment

Property, plant and equipment

As of the beginning of period 263,892

As of the end of period 280,108

Vehicles

Property, plant and equipment

As of the beginning of period 2,032,853

As of the end of period 2,177,685

Equipment and computer software

Property, plant and equipment

As of the beginning of period 174,399

Additions from business combination 12,469

As of the end of period 190,697

Fixture and fittings

Property, plant and equipment

As of the beginning of period 2,862,949

Additions from business combination 5,379

As of the end of period 2,469,766

Machinery and equipment

Property, plant and equipment

As of the beginning of period 14,463,756

Additions from business combination 7,047,496

As of the end of period 13,556,213

Land and buildings

Property, plant and equipment

As of the beginning of period 36,144,792

Additions from business combination 4,750,136

As of the end of period 35,745,539

Buildings in progress

Property, plant and equipment

As of the beginning of period 11,911,194

Additions from business combination 1,285,092

As of the end of period 16,968,121

Gross carrying amount

Property, plant and equipment

As of the beginning of period 93,634,779 71,521,454

Additions 6,117,779 3,824,078

Disposals (135,044) (66,930)

Foreign currency translation (131,647) (83,878)

As of the end of period 99,485,867 88,295,296

Gross carrying amount | Office equipment

Property, plant and equipment

As of the beginning of period 968,088 908,004

Additions 52,158 305

Foreign currency translation (3,291) 724

As of the end of period 1,016,955 909,033

Gross carrying amount | Vehicles

Property, plant and equipment

As of the beginning of period 5,492,319 5,261,979

Additions 556,237 84,209

Disposals (126,068) (59,744)

Foreign currency translation (411) (3,948)

As of the end of period 5,922,077 5,282,496

Gross carrying amount | Equipment and computer software

Property, plant and equipment

As of the beginning of period 974,509 925,349

Additions 101,224 111,226

Foreign currency translation (7,575) (32,824)

As of the end of period 1,068,158 1,016,220

Gross carrying amount | Fixture and fittings

Property, plant and equipment

As of the beginning of period 7,663,899 7,606,389

Additions 10,483 34,256

Disposals (8,976)

Foreign currency translation (9,384) 12,143

As of the end of period 7,656,022 7,658,167

Gross carrying amount | Machinery and equipment

Property, plant and equipment

As of the beginning of period 23,513,047 13,017,830

Additions 275,297 1,128,712

Disposals (7,186)

Foreign currency translation (26,864) (14,677)

As of the end of period 23,761,480 21,172,175

Gross carrying amount | Land and buildings

Property, plant and equipment

As of the beginning of period 43,111,723 40,659,129

Additions 10,351

Foreign currency translation (29,020) (28,269)

As of the end of period 43,093,054 45,380,996

Gross carrying amount | Buildings in progress

Property, plant and equipment

As of the beginning of period 11,911,194 3,142,774

Additions 5,112,029 2,465,370

Foreign currency translation (55,102) (17,027)

As of the end of period $ 16,968,121 $ 6,876,209

X

- Definition
The increase in investment property resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Investment property]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 76
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph d
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AcquisitionsThroughBusinessCombinationsInvestmentProperty

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisposalsPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_viii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InterestCostsCapitalised

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 57 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - accumulated depreciation (Details) - USD ($)
6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Jun. 30, 2023

Jun. 30, 2022

Property, plant and equipment

As of the beginning of period $ (71,388,129) $ (67,853,835)

As of the end of period (71,388,129)

Office equipment

Property, plant and equipment

As of the beginning of period (280,108) (263,892)

As of the end of period (280,108)

Vehicles

Property, plant and equipment

As of the beginning of period (2,177,685) (2,032,853)

As of the end of period (2,177,685)

Equipment and computer software

Property, plant and equipment

As of the beginning of period (190,697) (174,399)

As of the end of period (190,697)

Fixture and fittings

Property, plant and equipment

As of the beginning of period (2,469,766) (2,862,949)

As of the end of period (2,469,766)

Machinery and equipment

Property, plant and equipment

As of the beginning of period (13,556,213) (14,463,756)

As of the end of period (13,556,213)

Land and buildings

Property, plant and equipment

As of the beginning of period (35,745,539) (36,144,792)

As of the end of period (35,745,539)

Accumulated depreciation

Property, plant and equipment

As of the beginning of period 28,097,738 $ 24,500,621 25,780,944 $ 21,613,129

Disposals (123,297) (59,744)

Depreciation of the period 2,556,422 2,960,156

Foreign currency translation (116,331) (12,920)

As of the end of period 28,097,738 24,500,621

Accumulated depreciation | Office equipment

Property, plant and equipment

As of the beginning of period 736,847 668,827 704,196 638,466

Depreciation of the period 33,828 30,827

Foreign currency translation (1,177) (466)

As of the end of period 736,847 668,827

Accumulated depreciation | Vehicles

Property, plant and equipment

As of the beginning of period 3,744,392 2,993,545 3,459,466 2,596,905

Disposals (117,055) (59,744)

Depreciation of the period 416,309 457,562

Foreign currency translation (14,328) (1,178)

As of the end of period 3,744,392 2,993,545

Accumulated depreciation | Equipment and computer software

Property, plant and equipment

As of the beginning of period 877,461 765,218 800,110 693,673

Depreciation of the period 83,364 73,094

Foreign currency translation (6,013) (1,549)

As of the end of period 877,461 765,218

Accumulated depreciation | Fixture and fittings

Property, plant and equipment

As of the beginning of period 5,186,256 4,429,943 4,800,950 4,059,470

Disposals (6,242)

Depreciation of the period 394,798 370,828

Foreign currency translation (3,250) (355)

As of the end of period 5,186,256 4,429,943

Accumulated depreciation | Machinery and equipment

Property, plant and equipment

As of the beginning of period 10,205,267 8,771,887 9,049,291 7,205,870

Depreciation of the period 1,185,336 1,575,862

Foreign currency translation (29,360) (9,845)

As of the end of period 10,205,267 8,771,887

Accumulated depreciation | Land and buildings

Property, plant and equipment

As of the beginning of period 7,347,515 6,871,201 $ 6,966,931 $ 6,418,745

Depreciation of the period 442,787 451,983

Foreign currency translation (62,203) 473

As of the end of period $ 7,347,515 $ 6,871,201

X

- Definition
The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisposalsPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_viii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 58 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Dec. 31, 2022

Jun. 30, 2022

Intangible assets

Intangible assets $ 172,743,513 $ 173,783,956

Gross carrying amount

Intangible assets

Intangible assets 206,708,843 202,306,618 $ 197,128,192 $ 94,229,557

Accumulated depreciation

Intangible assets

Intangible assets $ (33,965,330) $ (28,522,662) $ (22,715,941) $ (17,524,688)

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfIntangibleAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 59 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, net carrying amount (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Intangible assets

Intangible assets $ 172,743,513 $ 173,783,956

Intangible assets not subject to amortization 32,200,000 27,400,000

HB4 and breeding program

Intangible assets

Intangible assets 32,554,026 31,679,681

Integrated seed products

Intangible assets

Intangible assets 2,516,125 2,841,008

Microbiology product

Intangible assets

Intangible assets 50,829,622 49,508,801

Trademarks and patents

Intangible assets

Intangible assets 57,429,133 59,760,753

Software

Intangible assets

Intangible assets 1,923,055 1,987,690

Customer loyalty

Intangible assets

Intangible assets 22,491,552 23,006,023

RG/RS/OX Wheat

Intangible assets

Intangible assets $ 5,000,000 $ 5,000,000

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfIntangibleAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 122
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_122_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 36
-IssueDate 2023-01-01
-Paragraph 134
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_b&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 36
-IssueDate 2023-01-01
-Paragraph 135
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_SoybeanHb4Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_EcoseedIntegratedProductsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_MicrobiologyProductMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_RgRsOxWheatMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 60 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, gross carrying amount (Details) - USD ($)
6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Intangible assets

Balance at beginning of the period $ 173,783,956

Balance at end of the period 172,743,513

Gross carrying amount

Intangible assets

Balance at beginning of the period 202,306,618 $ 94,229,557

Additions 4,674,722 6,074,614

Additions from business combination 96,818,958

Foreign currency translation (272,497) 5,063

Balance at end of the period 206,708,843 197,128,192

HB4 and breeding program

Intangible assets

Balance at beginning of the period 31,679,681

Balance at end of the period 32,554,026

HB4 and breeding program | Gross carrying amount

Intangible assets

Balance at beginning of the period 34,958,425 31,371,088

Additions 1,729,439 1,738,631

Balance at end of the period 36,687,864 33,109,719

Integrated seed products

Intangible assets

Balance at beginning of the period 2,841,008

Balance at end of the period 2,516,125

Integrated seed products | Gross carrying amount

Intangible assets

Balance at beginning of the period 3,219,808 3,181,155

Foreign currency translation (269,869) 8,296

Balance at end of the period 2,949,939 3,189,451

Microbiology product

Intangible assets

Balance at beginning of the period 49,508,801

Balance at end of the period 50,829,622

Microbiology product | Gross carrying amount

Intangible assets

Balance at beginning of the period 55,645,028 8,855,421

Additions 2,725,454 4,187,908

Additions from business combination 39,613,280

Foreign currency translation (1,661) (2,279)

Balance at end of the period 58,368,821 52,654,330

Trademarks and patents

Intangible assets

Balance at beginning of the period 59,760,753

Balance at end of the period 57,429,133

Trademarks and patents | Gross carrying amount

Intangible assets

Balance at beginning of the period 67,653,234 12,183,045

Additions 1,288 49,783

Additions from business combination 55,420,441

Balance at end of the period 67,654,522 67,653,269

Software

Intangible assets

Balance at beginning of the period 1,987,690

Balance at end of the period 1,923,055

Software | Gross carrying amount

Intangible assets

Balance at beginning of the period 5,582,411 5,176,373

Additions 218,541 98,292

Foreign currency translation (967) (954)

Balance at end of the period 5,799,985 5,273,711

Customer loyalty

Intangible assets

Balance at beginning of the period 23,006,023

Balance at end of the period 22,491,552

Customer loyalty | Gross carrying amount

Intangible assets

Balance at beginning of the period 30,247,712 28,462,475

Additions from business combination 1,785,237

Balance at end of the period 30,247,712 30,247,712

RG/RS/OX Wheat

Intangible assets

Balance at beginning of the period 5,000,000

Balance at end of the period 5,000,000

RG/RS/OX Wheat | Gross carrying amount

Intangible assets

Balance at beginning of the period 5,000,000 5,000,000

Balance at end of the period $ 5,000,000 $ 5,000,000

X

- Definition
The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfIntangibleAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_SoybeanHb4Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_EcoseedIntegratedProductsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_MicrobiologyProductMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_RgRsOxWheatMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 61 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, accumulated amortization (Details) - USD ($)
6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Intangible assets

Balance at beginning of the period $ (173,783,956)

Balance at end of the period (172,743,513)

Accumulated depreciation

Intangible assets

Balance at beginning of the period 28,522,662 $ 17,524,688

Amortization of the period 5,474,971 5,191,521

Foreign currency translation (32,303) (268)

Balance at end of the period 33,965,330 22,715,941

HB4 and breeding program

Intangible assets

Balance at beginning of the period (31,679,681)

Balance at end of the period (32,554,026)

HB4 and breeding program | Accumulated depreciation

Intangible assets

Balance at beginning of the period 3,278,744 1,568,554

Amortization of the period 855,094 799,644

Balance at end of the period 4,133,838 2,368,198

Integrated seed products

Intangible assets

Balance at beginning of the period (2,841,008)

Balance at end of the period (2,516,125)

Integrated seed products | Accumulated depreciation

Intangible assets

Balance at beginning of the period 378,800 43,997

Amortization of the period 86,762 22,242

Foreign currency translation (31,748) 488

Balance at end of the period 433,814 66,727

Microbiology product

Intangible assets

Balance at beginning of the period (49,508,801)

Balance at end of the period (50,829,622)

Microbiology product | Accumulated depreciation

Intangible assets

Balance at beginning of the period 6,136,227 3,063,073

Amortization of the period 1,402,972 313,970

Balance at end of the period 7,539,199 3,377,043

Trademarks and patents

Intangible assets

Balance at beginning of the period (59,760,753)

Balance at end of the period (57,429,133)

Trademarks and patents | Accumulated depreciation

Intangible assets

Balance at beginning of the period 7,892,481 3,916,004

Amortization of the period 2,332,908 2,136,403

Balance at end of the period 10,225,389 6,052,407

Software

Intangible assets

Balance at beginning of the period (1,987,690)

Balance at end of the period (1,923,055)

Software | Accumulated depreciation

Intangible assets

Balance at beginning of the period 3,594,721 3,008,388

Amortization of the period 282,764 285,881

Foreign currency translation (555) (756)

Balance at end of the period 3,876,930 3,293,513

Customer loyalty

Intangible assets

Balance at beginning of the period (23,006,023)

Balance at end of the period (22,491,552)

Customer loyalty | Accumulated depreciation

Intangible assets

Balance at beginning of the period 7,241,689 5,924,672

Amortization of the period 514,471 1,633,381

Balance at end of the period $ 7,756,160 $ 7,558,053

X

- Definition
The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfIntangibleAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_SoybeanHb4Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_EcoseedIntegratedProductsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_MicrobiologyProductMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 62 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Goodwill

Goodwill $ 112,163,432 $ 112,163,432

Rizobacter Argentina S.A.

Goodwill

Goodwill 28,080,271 28,080,271

Bioceres Crops S.A.

Goodwill

Goodwill 7,523,322 7,523,322

Pro farm Group, Inc.

Goodwill

Goodwill 76,089,749 76,089,749

Insumos Agroqumicos S.A.

Goodwill

Goodwill $ 470,090 $ 470,090

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 36
-IssueDate 2023-01-01
-Paragraph 134
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 36
-IssueDate 2023-01-01
-Paragraph 135
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_a&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B67
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Goodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_SignificantInvestmentsInSubsidiariesAxis=biox_RizobacterArgentinaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_SignificantInvestmentsInSubsidiariesAxis=biox_BioceresCropsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_SignificantInvestmentsInSubsidiariesAxis=biox_ProFarmGroupInc.Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_SignificantInvestmentsInSubsidiariesAxis=biox_InsumosAgroqumicosMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 63 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Investment properties $ 3,792,238 $ 3,589,749

X

- Definition
n/a
+ References
No definition available.
+ Details

Name: biox_ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 76
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InvestmentProperty

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 64 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Current

Trade creditors $ 103,683,392 $ 104,211,238

Taxes 3,556,073 3,561,058

Miscellaneous 141,142 953,301

Trade and other payable 164,003,202 150,807,674

Shareholders and other related parties

Current

Trade payable, related party 75,271 35,292

Parent company

Current

Trade payable, related party 161,860 644,191

Joint ventures and associates

Current

Trade payable, related party $ 56,385,464 $ 41,402,594

X

- Definition
The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current payables that the entity does not separately disclose in the same statement or note.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherCurrentPayables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph k
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentPayables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_TradeAndOtherCurrentPayablesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 70
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_JointVenturesAndAssociatesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 65 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Current

Corporate bonds $ 49,749,398 $ 35,547,510

Borrowings 113,520,778 107,639,659

Non-current

Corporate bonds 21,202,548 50,007,680

Borrowings 31,517,348 60,670,946

Bank borrowings

Current

Borrowings 52,942,957 61,303,952

Non-current

Borrowings 10,314,800 10,663,266

Trust debt securities

Current

Borrowings 7,188,607 7,296,506

Net loans payables - Parents companies and related parties

Current

Borrowings $ 3,639,816 $ 3,491,691

X

- Definition
The amount of bonds issued by the entity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_BondsIssued

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The non-current portion of non-current borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_LongtermBorrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The non-current portion of non-current bonds issued. [Refer: Bonds issued]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermBorrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: ifrs-full_BorrowingsByNameAxis=biox_BankBorrowingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BorrowingsByNameAxis=biox_TrustDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_ParentsCompaniesAndRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 66 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Current

Borrowings $ 113,520,778 $ 107,639,659

Corporate bonds 49,749,398 35,547,510

Non-current

Borrowings 31,517,348 60,670,946

Corporate bonds 21,202,548 50,007,680

Amortized cost

Current

Corporate bonds 49,749,398 35,547,510

Non-current

Corporate bonds 21,202,548 50,007,680

Fair value

Current

Corporate bonds 49,192,118 34,725,828

Non-current

Corporate bonds 20,670,511 47,014,542

Bank borrowings

Current

Borrowings 52,942,957 61,303,952

Non-current

Borrowings 10,314,800 10,663,266

Bank borrowings | Amortized cost

Current

Borrowings 52,942,957 61,303,952

Non-current

Borrowings 10,314,800 10,663,266

Bank borrowings | Fair value

Current

Borrowings 49,659,094 57,209,155

Non-current

Borrowings $ 8,698,322 $ 10,374,646

X

- Definition
The amount of bonds issued by the entity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_BondsIssued

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The non-current portion of non-current borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_LongtermBorrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The non-current portion of non-current bonds issued. [Refer: Bonds issued]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermBorrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BorrowingsByNameAxis=biox_BankBorrowingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 67 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details)
$ in Millions

Dec. 31, 2023

USD ($)

Secured Guaranteed Notes | At cost

Borrowings:

Borrowings $ 25.9

Secured Guaranteed Notes | Fair value

Borrowings:

Borrowings 26.9

Secured Convertible Guaranteed Notes | At cost

Borrowings:

Borrowings 52.1

Secured Convertible Guaranteed Notes | Fair value

Borrowings:

Borrowings $ 54.8

X

- Definition
The amount of outstanding funds that the entity is obligated to repay.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Borrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: ifrs-full_BorrowingsByNameAxis=biox_SecuredGuaranteedNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_AtCostMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BorrowingsByNameAxis=biox_SecuredConvertibleGuaranteedNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 68 R59.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Salaries, accrued incentives, vacations and social security $ 8,150,518 $ 9,388,639

Key management personnel 68,139 218,068

Employee benefits and social security $ 8,218,657 $ 9,606,707

X

- Definition
n/a
+ References
No definition available.
+ Details

Name: biox_ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current liability related to key management personnel.
+ References
No definition available.
+ Details

Name: biox_KeyManagementPersonnelBenefitsLiabilityCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current provisions for salaries, accrued incentives, vacations and social security.
+ References
No definition available.
+ Details

Name: biox_SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentProvisionsForEmployeeBenefits

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 69 R60.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Current

Advances from customers $ 4,466,515 $ 9,216,032

Deferred Revenue 17,632,863 15,659,630

Deferred revenue and advances from customers 22,099,378 24,875,662

Non-current

Advances from customers 272,334 620,893

Deferred revenue 1,863,506 1,436,912

Deferred revenue and advances from customers $ 2,135,840 $ 2,057,805

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentAccrualsAndCurrentDeferredIncomeIncludingCurrentContractLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current advances received representing current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentAdvances

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current contract liabilities for performance obligations satisfied over time. [Refer: Contract liabilities for performance obligations satisfied over time]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentAccrualsAndNoncurrentDeferredIncomeIncludingNoncurrentContractLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of non-current advances received representing non-current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentAdvances

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of non-current contract liabilities. [Refer: Contract liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 105
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_105&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentContractLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of non-current contract liabilities for performance obligations satisfied over time. [Refer: Contract liabilities for performance obligations satisfied over time]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 70 R61.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue (Details) - USD ($)
3 Months Ended 6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

Revenue

Royalties $ 649,341 $ 909,067

Revenues from contracts with customers $ 140,293,827 $ 94,548,714 256,476,632 221,391,962

Sale of goods and services

Revenue

Revenues from contracts with customers $ 255,827,291 $ 220,482,895

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 114
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_113_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RevenueFromContractsWithCustomers

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of income arising from royalties.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RevenueFromRoyalties

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: ifrs-full_ProductsAndServicesAxis=biox_GoodsAndServicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 71 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details) - USD ($)
3 Months Ended 6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Inventories as of the beginning of the period $ 111,990,145 $ 78,759,610

Business combination 11,064,908

Purchases of the period 144,999,639 138,186,645

Production costs 12,981,672 14,596,888

Foreign currency translation (28,273) (246,484)

Subtotal 269,943,183 242,361,567

Inventories as of the end of the period $ (109,616,865) $ (107,544,430) (109,616,865) (107,544,430)

Cost of sales $ 88,710,537 $ 59,141,259 $ 160,326,318 $ 134,817,137

X

- Definition
Amount of foreign currency translation on inventory
+ References
No definition available.
+ Details

Name: biox_ForeignCurrencyTranslationOnInventory

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of inventory before closing inventory (ie., Opening inventory plus purchases).
+ References
No definition available.
+ Details

Name: biox_InventoriesBeforeClosingInventory

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Additions to inventories as results of business combination.
+ References
No definition available.
+ Details

Name: biox_InventoriesFromBusinessCombination

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of manufacturing costs capitalized to inventory during the period.
+ References
No definition available.
+ Details

Name: biox_InventoryProductionCosts

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of inventory purchased during the year.
+ References
No definition available.
+ Details

Name: biox_PurchaseOfInventory

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 99
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CostOfSales

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InventoriesTotal

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_StatementOfComprehensiveIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 72 R63.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details) - USD ($)
3 Months Ended 6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

Costs and expenses

Depreciation of leased assets $ 1,711,256 $ 1,837,532

Total $ 3,643,077 $ 3,457,892 8,224,318 7,309,906

R&D capitalized 4,454,893 5,926,539

Total 12,679,211 13,236,445

Research and development expenses

Costs and expenses

Amortization of intangible assets 2,453,158 2,201,938

Analysis and storage 5,302 27,322

Import and export expenses 850

Depreciation of property, plant and equipment 312,453 287,180

Freight and haulage 14,278 4,732

Employee benefits and social securities 2,211,907 2,248,105

Maintenance 96,056 303,524

Energy and fuel 5,227 94,870

Supplies and materials 1,182,066 1,078,197

Mobility and travel 89,474 158,193

Share-based incentives 143,749 92,477

Publicity and advertising 9,568

Professional fees and outsourced services 994,197 574,614

Professional fees related parties 216,792 102,701

Office supplies 470,376 43,546

Information technology expenses 9,640 19,060

Insurance 19,586 25,738

Depreciation of leased assets 33,685

Miscellaneous 57 3,606

Total $ 8,224,318 $ 7,309,906

X

- Definition
The amount of advertising expense relating to production costs and selling general and administrative expenses.
+ References
No definition available.
+ Details

Name: biox_AdvertisingExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of analysis and storage.
+ References
No definition available.
+ Details

Name: biox_AnalysisAndStorage

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseLineItems

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of freight and haulage expenses.
+ References
No definition available.
+ Details

Name: biox_FreightAndHaulageExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of import and export expenses.
+ References
No definition available.
+ Details

Name: biox_ImportAndExportExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of information technology expenses.
+ References
No definition available.
+ Details

Name: biox_InformationTechnologyExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of miscellaneous expense of income expense.
+ References
No definition available.
+ Details

Name: biox_MiscellaneousExpenseOfIncomeExpense

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of professional fee expense with related parties.
+ References
No definition available.
+ Details

Name: biox_ProfessionalFeesExpenseRelatedParties

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of research and development expense capitalized.
+ References
No definition available.
+ Details

Name: biox_ResearchAndDevelopmentExpenseCapitalized

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of share-based incentives expenses.
+ References
No definition available.
+ Details

Name: biox_ShareBasedIncentivesExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of current supplies and materials purchased for production.
+ References
No definition available.
+ Details

Name: biox_SuppliesAndMaterials

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of research and development costs that an entity incurs.
+ References
No definition available.
+ Details

Name: biox_TotalResearchAndDevelopmentExpenseIncurred

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expenses that the entity classifies as being administrative.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 26
-IssueDate 2023-01-01
-Paragraph 35
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_vi&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 99
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdministrativeExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vi&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_vii&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 75
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DepreciationPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DepreciationRightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of expense arising from the consumption of fuel and energy.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FuelAndEnergyExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense arising from purchased insurance.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InsuranceExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of fees paid or payable for professional services.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfessionalFeesExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RepairsAndMaintenanceExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 126
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ResearchAndDevelopmentExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermEmployeeBenefitsExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense arising from travel.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TravelExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=biox_IfrsResearchAndDevelopmentExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 73 R64.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details) - USD ($)
6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Expenses classified by nature and function

Depreciation of leased assets $ 1,711,256 $ 1,837,532

Obsolescence 282,836 481,332

Production costs

Expenses classified by nature and function

Amortization of intangible assets 60,849 86,842

Analysis and storage 570 4,460

Commissions and royalties 421,677 109,703

Import and export expenses 43,902 265,121

Depreciation of property, plant and equipment 1,308,591 1,666,119

Depreciation of leased assets 699,044 230,478

Freight and haulage 634,188 1,201,183

Employee benefits and social securities 5,935,502 7,177,926

Maintenance 1,007,395 722,399

Energy and fuel 500,658 753,041

Supplies and materials 367,386 512,493

Mobility and travel 94,476 39,428

Publicity and advertising 1,300

Contingencies 1,239

Share-based incentives 339,904

Professional fees and outsourced services 963,972 1,133,009

Office supplies and registrations fees 80,236 23,309

Insurance 81,174 74,350

Information technology expenses 27,186 17,511

Obsolescence 282,836 481,332

Taxes 127,760 96,233

Miscellaneous 1,827 1,951

Total 12,981,672 14,596,888

Selling, general and administrative expenses

Expenses classified by nature and function

Amortization of intangible assets 2,960,964 2,902,741

Analysis and storage 153,163 237,341

Commissions and royalties 1,008,251 1,020,272

Import and export expenses 318,479 704,937

Depreciation of property, plant and equipment 935,378 1,006,857

Depreciation of leased assets 1,012,212 1,573,369

Impairment of receivables 296,051 468,992

Freight and haulage 6,878,364 5,002,384

Employee benefits and social securities 21,509,102 20,156,371

Maintenance 1,152,332 1,446,553

Energy and fuel 272,547 161,850

Supplies and materials 1,691,154 627,514

Mobility and travel 2,148,705 1,837,797

Publicity and advertising 2,305,251 3,235,737

Contingencies 47,851 39,847

Share-based incentives 8,043,561 1,969,868

Professional fees and outsourced services 3,542,038 7,122,701

Professional fees related parties 66,618 29,818

Office supplies and registrations fees 651,991 624,246

Insurance 1,102,142 1,306,282

Information technology expenses 1,924,633 1,566,952

Taxes 7,019,360 6,976,043

Miscellaneous 57,638 300,016

Total 65,097,785 60,318,488

Total

Expenses classified by nature and function

Amortization of intangible assets 3,021,813 2,989,583

Analysis and storage 153,733 241,801

Commissions and royalties 1,429,928 1,129,975

Import and export expenses 362,381 970,058

Depreciation of property, plant and equipment 2,243,969 2,672,976

Depreciation of leased assets 1,711,256 1,803,847

Impairment of receivables 296,051 468,992

Freight and haulage 7,512,552 6,203,567

Employee benefits and social securities 27,444,604 27,334,297

Maintenance 2,159,727 2,168,952

Energy and fuel 773,205 914,891

Supplies and materials 2,058,540 1,140,007

Mobility and travel 2,243,181 1,877,225

Publicity and advertising 2,306,551 3,235,737

Contingencies 49,090 39,847

Share-based incentives 8,383,465 1,969,868

Professional fees and outsourced services 4,506,010 8,255,710

Professional fees related parties 66,618 29,818

Office supplies and registrations fees 732,227 647,555

Insurance 1,183,316 1,380,632

Information technology expenses 1,951,819 1,584,463

Obsolescence 282,836 481,332

Taxes 7,147,120 7,072,276

Miscellaneous 59,465 301,967

Total $ 78,079,457 $ 74,915,376

X

- Definition
Adjustments for obsolescence to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForObsolescence

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of advertising expense relating to production costs and selling general and administrative expenses.
+ References
No definition available.
+ Details

Name: biox_AdvertisingExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of analysis and storage.
+ References
No definition available.
+ Details

Name: biox_AnalysisAndStorage

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of commissions and royalties.
+ References
No definition available.
+ Details

Name: biox_CommissionsAndRoyalties

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of contingencies.
+ References
No definition available.
+ Details

Name: biox_Contingencies

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of freight and haulage expenses.
+ References
No definition available.
+ Details

Name: biox_FreightAndHaulageExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of impairment loss recognised in profit or loss, trade receivables relating to production costs selling, general and administrative expenses.
+ References
No definition available.
+ Details

Name: biox_ImpairmentOfReceivables

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of import and export expenses.
+ References
No definition available.
+ Details

Name: biox_ImportAndExportExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of information technology expenses.
+ References
No definition available.
+ Details

Name: biox_InformationTechnologyExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of miscellaneous expense of income expense.
+ References
No definition available.
+ Details

Name: biox_MiscellaneousExpenseOfIncomeExpense

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of production cost relating to inventory and selling, general and administrative expenses.
+ References
No definition available.
+ Details

Name: biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of professional fee expense with related parties.
+ References
No definition available.
+ Details

Name: biox_ProfessionalFeesExpenseRelatedParties

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of share-based incentives expenses.
+ References
No definition available.
+ Details

Name: biox_ShareBasedIncentivesExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of current supplies and materials purchased for production.
+ References
No definition available.
+ Details

Name: biox_SuppliesAndMaterials

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of taxes.
+ References
No definition available.
+ Details

Name: biox_Taxes

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expenses that the entity classifies as being administrative.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 26
-IssueDate 2023-01-01
-Paragraph 35
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_vi&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 99
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdministrativeExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vi&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_vii&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 75
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DepreciationPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DepreciationRightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of expense arising from the consumption of fuel and energy.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FuelAndEnergyExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense arising from purchased insurance.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InsuranceExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of fees paid or payable for professional services.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfessionalFeesExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RepairsAndMaintenanceExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermEmployeeBenefitsExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense arising from travel.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TravelExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_CostOfSalesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_SellingGeneralAndAdministrativeExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=biox_ProductionCostAndSellingGeneralAndAdministrativeExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 74 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details) - USD ($)
3 Months Ended 6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Net result from commercialization of agricultural products $ (2,960,005) $ 144,515

Expenses recovery 236,106 232,977

Other income or expenses, net 325,661 391,036

Total $ (1,166,603) $ 290,487 $ (2,398,238) $ 768,528

X

- Definition
The amount of recovered expenses.
+ References
No definition available.
+ Details

Name: biox_ExpensesRecovery

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of other income or expenses net.
+ References
No definition available.
+ Details

Name: biox_OtherIncomeOrExpensesNet

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherOperatingIncomeExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of revenue arising from the sale of agricultural produce. [Refer: Revenue]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RevenueFromSaleOfAgriculturalProduce

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_StatementOfComprehensiveIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 75 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details) - USD ($)
3 Months Ended 6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

Financial costs

Interest expenses with the Parents $ (194,125) $ (299,468)

Interest expenses (9,994,912) (10,722,135)

Financial commissions (1,288,813) (1,517,729)

Financial costs (11,477,850) (12,539,332)

Other financial results

Exchange differences generated by assets (12,049,351) (12,771,727)

Exchange differences generated by liabilities 21,674,845 9,070,404

Changes in fair value of financial assets or liabilities and other financial results (13,727,825) (2,068,923)

Net gain of inflation effect on monetary items 766,135 281,083

Other financial results $ (3,454,061) $ (4,200,857) $ (3,336,196) $ (5,489,163)

X

- Definition
Amount of changes in fair value of financial assets or liabilities and other financial results
+ References
No definition available.
+ Details

Name: biox_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
No definition available
+ References
No definition available.
+ Details

Name: biox_FinanceCostsAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of interest expense on liabilities with parent.
+ References
No definition available.
+ Details

Name: biox_InterestExpenseOnLiabilitiesWithParent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Net gain of inflation effect on monetary items.
+ References
No definition available.
+ Details

Name: biox_NetGainOnInflationEffectOnMonetary

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: biox_OtherFinanceResultsAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of expense relating to fees and commissions.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FeeAndCommissionExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of costs associated with financing activities of the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinanceCosts

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of assets. [Refer: At fair value [member]]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of liabilities. [Refer: At fair value [member]]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of interest expense on other financial liabilities. [Refer: Interest expense; Other financial liabilities]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InterestExpenseOnOtherFinancialLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherFinanceIncomeCost

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 76 R67.htm IDEA: XBRL DOCUMENT v3.24.0.1

TAXATION - Taxes on income (Details) - USD ($)
3 Months Ended 6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

TAXATION

Current tax expense $ (3,845,338) $ (6,467,324)

Deferred tax (4,917,089) 769,775

Income tax expenses $ (8,333,387) $ (684,906) $ (8,762,427) $ (5,697,549)

X

- Definition
The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 80
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_80_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentTaxExpenseIncome

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph g
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DeferredTaxExpenseIncome

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 26
-IssueDate 2023-01-01
-Paragraph 35
-Subparagraph b
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 79
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B13
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncomeTaxExpenseContinuingOperations

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 77 R68.htm IDEA: XBRL DOCUMENT v3.24.0.1

TAXATION - Movement on the deferred income tax (Details) - USD ($)
6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

TAXATION

Beginning of the period deferred tax $ (28,472,383) $ (24,994,569)

Additions for business combination (16,704,771)

Charge for the period (4,917,089) 769,775

Conversion difference (361,293) (582,016)

Total net deferred tax $ (33,750,765) $ (41,511,581)

X

- Definition
The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph g
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph g
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DeferredTaxLiabilityAsset

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The increase (decrease) in deferred tax liability (asset) resulting from business combinations. [Refer: Deferred tax liability (asset)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) in deferred tax liability (asset) resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Deferred tax liability (asset)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 78 R69.htm IDEA: XBRL DOCUMENT v3.24.0.1

TAXATION - Reconciliation of the statutory tax rate (Details) - USD ($)
3 Months Ended 6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

TAXATION

Earnings before income tax-rate $ 7,322,464 $ 1,183,270

Income tax expense by applying tax rate in force in the respective countries (5,434,748) (5,182,386)

Share of profit or loss of subsidiaries, joint ventures and associates 1,219,030 225,376

Stock options charge (1,489,037) (298,851)

Non-deductible expenses (116,220) (543,505)

Unrecognized deferred tax (995,754)

Tax inflation adjustment 7,460,048 3,132,901

Result of inflation effect on monetary items and other finance results (11,000,459) (1,660,369)

Untaxed gains 598,959 33,052

Others (408,013)

Income tax expenses $ (8,333,387) $ (684,906) $ (8,762,427) $ (5,697,549)

X

- Definition
The amount that represents the inflation effect on monetary items and other finance results.
+ References
No definition available.
+ Details

Name: biox_ResultForInflationEffectOnMonetaryItemsAndOtherFinanceResults

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible and revenues that are exempt from taxation in determining taxable profit (tax loss).
+ References
No definition available.
+ Details

Name: biox_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to share of profit or loss of subsidies, joint ventures and associates.
+ References
No definition available.
+ Details

Name: biox_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount representing the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to stock option charge.
+ References
No definition available.
+ Details

Name: biox_TaxEffectOfStockOptionCharge

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to unrecognized deferred taxes.
+ References
No definition available.
+ Details

Name: biox_TaxEffectOfUnrecognizedDeferredTax

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of Tax Inflation Adjustment
+ References
No definition available.
+ Details

Name: biox_TaxInflationAdjustment

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AccountingProfit

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 26
-IssueDate 2023-01-01
-Paragraph 35
-Subparagraph b
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 79
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B13
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncomeTaxExpenseContinuingOperations

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to revenues that are exempt from taxation. [Refer: Accounting profit]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TaxEffectOfRevenuesExemptFromTaxation2011

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TaxExpenseIncomeAtApplicableTaxRate

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 79 R70.htm IDEA: XBRL DOCUMENT v3.24.0.1

EARNING PER SHARE (Details)
3 Months Ended 6 Months Ended

Dec. 31, 2023

USD ($)

$ / shares

shares

Dec. 31, 2022

USD ($)

category

$ / shares

shares

Dec. 31, 2023

USD ($)

$ / shares

shares

Dec. 31, 2022

USD ($)

category

$ / shares

shares

Numerator

(Loss) profit for the period (basic EPS) | $ $ 108,449 $ (8,156,746) $ (4,483,185) $ (7,658,449)

(Loss) profit for the period (diluted EPS) | $ $ 108,449 $ (8,156,746) $ (4,483,185) $ (7,658,449)

Denominator

Weighted average number of shares (basic EPS) | shares 62,839,961 61,657,343 62,839,961 61,657,343

Weighted average number of shares (diluted EPS) | shares 63,877,692 61,657,343 62,839,961 61,657,343

Basic (loss) profit attributable to ordinary equity holders of the parent | $ / shares $ 0.0017 $ (0.1323) $ (0.0713) $ (0.1242)

Diluted (loss) profit attributable to ordinary equity holders of the parent | $ / shares $ 0.0017 $ (0.1323) $ (0.0713) $ (0.1242)

Number of categories of dilutive potential shares | category 2 2

X

- Definition
The number of categories of dilutive potential shares.
+ References
No definition available.
+ Details

Name: biox_NumberOfCategoriesOfDilutiveShares

Namespace Prefix: biox_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 70
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustedWeightedAverageShares

Namespace Prefix: ifrs-full_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 67
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_BasicEarningsLossPerShare

Namespace Prefix: ifrs-full_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 67
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DilutedEarningsLossPerShare

Namespace Prefix: ifrs-full_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 70
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The profit (loss) attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 70
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 70
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_WeightedAverageShares

Namespace Prefix: ifrs-full_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 80 R71.htm IDEA: XBRL DOCUMENT v3.24.0.1

EQUITY INFORMATION (Details)
6 Months Ended

Dec. 31, 2023

shares

Vote

USD ($)

$ / shares

Disclosure of classes of share capital [line items]

Number of own shares repurchased | $ 2,258,016

Number of votes for each ordinary share | Vote 1

Equity compensation plan

Disclosure of classes of share capital [line items]

Number of total converted options outstanding 3,947,634

Ordinary shares

Disclosure of classes of share capital [line items]

Number of shares authorized 100,000,000

Par value per share | $ / shares $ 0.0001

Number of shares issued 62,828,025

Number of shares outstanding 62,828,025

Preference shares

Disclosure of classes of share capital [line items]

Number of shares authorized 1,000,000

Par value per share | $ / shares $ 0.0001

Number of shares issued 0

Number of shares outstanding 0

X

- Definition
Number of shares that have been repurchased.
+ References
No definition available.
+ Details

Name: biox_IfrsStockRepurchasedDuringPeriodShares

Namespace Prefix: biox_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents the number of votes for each ordinary share.
+ References
No definition available.
+ Details

Name: biox_VotesPerOrdinaryShare

Namespace Prefix: biox_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfClassesOfShareCapitalLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of share options outstanding in a share-based payment arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 45
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 45
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 45
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NumberOfOutstandingShareOptions

Namespace Prefix: ifrs-full_

Data Type: xbrli:decimalItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares authorised.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NumberOfSharesAuthorised

Namespace Prefix: ifrs-full_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares issued by the entity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NumberOfSharesIssued

Namespace Prefix: ifrs-full_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph a
-Clause iv
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NumberOfSharesOutstanding

Namespace Prefix: ifrs-full_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The nominal value per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph a
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ParValuePerShare

Namespace Prefix: ifrs-full_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=biox_EquityCompensationPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_PreferenceSharesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 81 R72.htm IDEA: XBRL DOCUMENT v3.24.0.1

CASH FLOW INFORMATION (Details) - USD ($)
6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Investment activities

Net assets acquisition by business combination $ 152,070,313

Investment in-kind in other related parties (Note 15) 1,434,802

Capitalization of interest on buildings in progress $ 47,542

Investing activities $ 47,542 153,505,115

Financing activities

Capitalization of convertible notes (Note 5.13) 12,211,638

Purchase of own shares (23,915,029)

Financing activities $ (11,703,391)

X

- Definition
The amount of cash inflow effect of capitalization of convertible notes.
+ References
No definition available.
+ Details

Name: biox_CapitalizationOfConvertibleFinancingActivities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of acquisition of own shares.
+ References
No definition available.
+ Details

Name: biox_IfrsPaymentsToPurchaseOfOwnShares

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of investment in kind in other related parties, non cash transactions investment activities.
+ References
No definition available.
+ Details

Name: biox_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount recognised as of the acquisition date for net assets acquired or liabilities assumed in a business combination.
+ References
No definition available.
+ Details

Name: biox_NetAssetsAcquisitionByBusinessCombination

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of non cash financing activities.
+ References
No definition available.
+ Details

Name: biox_NonCashFinancingActivities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: biox_NonCashFinancingActivitiesAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of non cash investing activities.
+ References
No definition available.
+ Details

Name: biox_NonCashInvestingActivities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: biox_NonCashInvestingActivitiesAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InterestCostsCapitalised

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

XML 82 R73.htm IDEA: XBRL DOCUMENT v3.24.0.1

JOINT VENTURES AND ASSOCIATES (Details) - USD ($)
3 Months Ended 6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

Jun. 30, 2023

JOINT VENTURES

Assets in joint ventures and associates $ 42,402,217 $ 42,402,217 $ 39,296,810

Liabilities in joint ventures and associates 115,983 115,983 622,823

Share of profit or loss of joint ventures and associates 2,052,296 $ 40,048 3,560,967 $ 882,288

Trigall Genetics S.A.

JOINT VENTURES

Liabilities in joint ventures and associates 115,983 115,983 622,823

Share of profit or loss of joint ventures and associates 506,840 595,889

Synertech Industrias S.A.

JOINT VENTURES

Assets in joint ventures and associates 39,205,548 39,205,548 36,026,710

Share of profit or loss of joint ventures and associates 3,178,839 349,012

Alfalfa Technologies S.R.L

JOINT VENTURES

Assets in joint ventures and associates 36,503 36,503 36,502

Moolec Science S.A.

JOINT VENTURES

Assets in joint ventures and associates $ 3,160,166 3,160,166 $ 3,233,598

Share of profit or loss of joint ventures and associates $ (124,712)

Indrasa Biotecnologia S.A.

JOINT VENTURES

Share of profit or loss of joint ventures and associates $ (62,613)

X

- Definition
The amount of investments accounted for using the equity method, asset position.
+ References
No definition available.
+ Details

Name: biox_InvestmentsAccountedForUsingEquityMethodAssets

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of investments accounted for using the equity method, liability position.
+ References
No definition available.
+ Details

Name: biox_InvestmentsAccountedForUsingEquityMethodLiability

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfJointVenturesLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: ifrs-full_JointVenturesAxis=biox_TrigallGeneticsS.a.Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_JointVenturesAxis=biox_SynertechIndustriasS.aMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_JointVenturesAxis=biox_AlfalfaTechnologiesS.r.lMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_JointVenturesAxis=biox_MoolecScienceS.a.Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_JointVenturesAxis=biox_IndrasaBiotecnologaS.a.Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 83 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1

JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details) - USD ($)
3 Months Ended 6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

JOINT VENTURES AND ASSOCIATES

As of the beginning of the period $ 38,673,987 $ 37,836,144

Share-based incentives 50,383

Sale of equity investee - Indrasa Biotecnologa S.A. (7,853)

Foreign currency translation 897 (21,946)

Share of profit or loss $ 2,052,296 $ 40,048 3,560,967 882,288

As of the end of the period $ 42,286,234 $ 38,688,633 $ 42,286,234 $ 38,688,633

X

- Definition
The increase in the amount of investment accounted under equity method related to share-based incentives.
+ References
No definition available.
+ Details

Name: biox_EquityMethodInvestmentIncreaseFromShareBasedIncentives

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The gains (losses) recognised in other comprehensive income on exchange differences on the translation from joint venture of financial statements of foreign operations, net of tax.
+ References
No definition available.
+ Details

Name: biox_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Adjustments for gain (loss) on disposals investments in subsidiaries, joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries, joint ventures and associates reported in separate financial statements; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B16
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B16&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InvestmentAccountedForUsingEquityMethod

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_InvestmentsAccountedForUsingEquityMethodAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 84 R75.htm IDEA: XBRL DOCUMENT v3.24.0.1

SEGMENT INFORMATION - Group's reporting segments (Details) - USD ($)
3 Months Ended 6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2023

Dec. 31, 2022

Revenues from contracts with customers

Sale of goods and services $ 140,293,827 $ 94,548,714 $ 256,476,632 $ 221,391,962

Royalties 649,341 909,067

Initial recognition and changes in the fair value of biological assets at the point of harvest (72,785) (138,529) 338,128 351,477

Total 256,814,760 221,743,439

Cost of sales $ (88,710,537) $ (59,141,259) (160,326,318) (134,817,137)

Gross profit per segment $ 96,488,442 $ 86,926,302

% Gross margin 38.00% 39.00%

Seed and integrated products

Revenues from contracts with customers

Royalties $ 649,341 $ 909,067

Initial recognition and changes in the fair value of biological assets at the point of harvest 77,353 56,530

Total 54,504,152 30,191,794

Cost of sales (36,216,288) (13,606,348)

Gross profit per segment $ 18,287,864 $ 16,585,446

% Gross margin 34.00% 55.00%

Crop protection

Revenues from contracts with customers

Initial recognition and changes in the fair value of biological assets at the point of harvest $ 141,457 $ 140,620

Total 127,170,923 116,404,147

Cost of sales (81,249,196) (79,703,474)

Gross profit per segment $ 45,921,727 $ 36,700,673

% Gross margin 36.00% 32.00%

Crop nutrition

Revenues from contracts with customers

Initial recognition and changes in the fair value of biological assets at the point of harvest $ 119,318 $ 154,327

Total 75,139,685 75,147,498

Cost of sales (42,860,834) (41,507,315)

Gross profit per segment $ 32,278,851 $ 33,640,183

% Gross margin 43.00% 45.00%

Sale of goods and services

Revenues from contracts with customers

Sale of goods and services $ 255,827,291 $ 220,482,895

Sale of goods and services | Seed and integrated products

Revenues from contracts with customers

Sale of goods and services 53,777,458 29,226,197

Sale of goods and services | Crop protection

Revenues from contracts with customers

Sale of goods and services 127,029,466 116,263,527

Sale of goods and services | Crop nutrition

Revenues from contracts with customers

Sale of goods and services $ 75,020,367 $ 74,993,171

X

- Definition
Percentage of gross margin and total revenue of the period during the entity.
+ References
No definition available.
+ Details

Name: biox_PercentageOfGrossMarginAndTotalRevenue

Namespace Prefix: biox_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 99
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CostOfSales

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GrossProfit

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 32
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 5
-IssueDate 2023-01-01
-Paragraph 33
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 33
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 34
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause v
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard
-URIDate 2023-03-23

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 102
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Revenue

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_RevenueAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 114
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_113_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RevenueFromContractsWithCustomers

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of income arising from royalties.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RevenueFromRoyalties

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: ifrs-full_SegmentsAxis=biox_SeedAndIntegratedProductsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_SegmentsAxis=biox_CropProtectionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_SegmentsAxis=biox_CropNutritionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ProductsAndServicesAxis=biox_GoodsAndServicesIncludingRightOfUseLicenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 85 R76.htm IDEA: XBRL DOCUMENT v3.24.0.1

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Amortized cost

Financial assets by category

Financial assets. $ 237,811,745 $ 218,918,004

Fair value

Financial assets by category

Financial assets. 17,109,884 11,922,317

Cash and cash equivalents | Amortized cost

Financial assets by category

Financial assets. 24,332,260 48,129,194

Cash and cash equivalents | Fair value

Financial assets by category

Financial assets. 69,677

Other financial assets | Amortized cost

Financial assets by category

Financial assets. 444,743 657,612

Other financial assets | Fair value

Financial assets by category

Financial assets. 17,040,207 11,922,317

Trade receivables | Amortized cost

Financial assets by category

Financial assets. 199,666,283 158,006,474

Other receivables | Amortized cost

Financial assets by category

Financial assets. $ 13,368,459 $ 12,124,724

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfFinancialAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity’s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity’s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity’s own equity instruments. For this purpose the entity’s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity’s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 25
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 35H
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 35M
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 35N
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 35I
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinancialAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=biox_CashAndEquivalentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=biox_OtherFinancialAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=biox_OtherReceivablesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 86 R77.htm IDEA: XBRL DOCUMENT v3.24.0.1

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Amortized cost

Financial liabilities by category

Financial liabilities $ 400,178,642 $ 404,988,396

Fair value

Financial liabilities by category

Financial liabilities 7,145,324 8,225,508

Trade and other payables | Amortized cost

Financial liabilities by category

Financial liabilities 156,857,878 142,582,166

Trade and other payables | Fair value

Financial liabilities by category

Financial liabilities 7,145,324 8,225,508

Borrowings | Amortized cost

Financial liabilities by category

Financial liabilities 145,038,126 168,310,605

secured notes | Amortized cost

Financial liabilities by category

Financial liabilities 77,998,071 75,213,146

Lease liability | Amortized cost

Financial liabilities by category

Financial liabilities 13,600,289 13,889,223

Consideration for acquisition of assets | Amortized cost

Financial liabilities by category

Financial liabilities $ 6,684,278 $ 4,993,256

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfFinancialLiabilitiesLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity’s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity’s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity’s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity’s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity’s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity’s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 25
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinancialLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialLiabilitiesAxis=biox_TradeAndOtherPayablesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialLiabilitiesAxis=biox_BorrowingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialLiabilitiesAxis=biox_SecuredDebtsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_ContingentConsiderationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 87 R78.htm IDEA: XBRL DOCUMENT v3.24.0.1

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

Trade and other payables | Level 2

Fair value by hierarchy

Financial liabilities, at fair value $ 7,145,324 $ 8,225,508

US Treasury bills | Level 1

Fair value by hierarchy

Financial assets at fair value 9,163,298

Mutual funds | Level 1

Fair value by hierarchy

Financial assets at fair value 14,736,104 1,596,539

Other investments | Level 1

Fair value by hierarchy

Financial assets at fair value $ 2,304,103 $ 1,162,480

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The fair value of financial assets. [Refer: At fair value [member]; Financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 25
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinancialAssetsAtFairValue

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 25
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinancialLiabilitiesAtFairValue

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: ifrs-full_ClassesOfFinancialLiabilitiesAxis=biox_TradeAndOtherPayablesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=biox_USTreasuryBillsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_InvestmentFundsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=biox_OtherInvestmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 88 R79.htm IDEA: XBRL DOCUMENT v3.24.0.1

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details) - Currency risk
6 Months Ended

Dec. 31, 2023

USD ($)

Currency risk

Foreign currency $ (6,210,949)

Percentage of that a devaluation or an appreciation of the US Dollar other currencies 10.00%

Effect in profit and loss due to designate devaluation or appreciation of US dollar $ 600,000

X

- Definition
The effect on profit and loss as a result of an increase in a designated risk component that was reasonably possible at the end of the reporting period. Excludes defined benefit plan obligation
+ References
No definition available.
+ Details

Name: biox_EffectInProfitAndLossDueToDesignateDevaluationOrAppreciationOfUsDollar

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Represent the percentage of that a devaluation or an appreciation of the US Dollar against other currencies.
+ References
No definition available.
+ Details

Name: biox_PercentageOfEstimatedOrAppreciationOfDevaluationOfOtherCurrency

Namespace Prefix: biox_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17LineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of risk exposure associated with financial instruments with a shared characteristic that identifies a concentration of risks. [Refer: Financial instruments, class [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph B8
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B8_c&doctype=Appendix&subtype=B
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Details

Name: ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 89 R80.htm IDEA: XBRL DOCUMENT v3.24.0.1

LEASES - Right-of-use leased asset (Details) - USD ($)
6 Months Ended 12 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Jun. 30, 2023

Right-of-use leased asset

Book value at the beginning of the period/year $ 13,936,575

Depreciation of the period/year 1,711,256 $ 1,837,532

Book value at the end of the period/year 13,704,217 $ 13,936,575

Right-of-use leased asset

Right-of-use leased asset

Book value at the beginning of the period/year 21,163,192 15,828,032 15,828,032

Additions of the period/year 1,842,539 3,154,950

Additions from business combination 3,005,000

Disposals (558,684) (1,839,921)

Exchange differences (129,169) 1,015,131

Book value at the end of the period/year 22,317,878 21,163,192

Depreciation

Right-of-use leased asset

Book value at the beginning of the period/year (7,226,617) $ (3,684,006) (3,684,006)

Disposals 305,474 171,870

Exchange differences 18,738 (148,587)

Depreciation of the period/year 1,711,256 3,565,894

Book value at the end of the period/year $ (8,613,661) $ (7,226,617)

X

- Definition
The amount of additions to right of use assets from business combination.
+ References
No definition available.
+ Details

Name: biox_AdditionsToRightOfUseAssetsFromBusinessCombination

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of effect of exchange differences on the deprecation of right of use assets.
+ References
No definition available.
+ Details

Name: biox_DepreciationRightOfUseAssetsExchangeDifferences

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of disposals to right-of-use assets
+ References
No definition available.
+ Details

Name: biox_DisposalsToRightOfUseAssets

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of additions to right-of-use assets. [Refer: Right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_h&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdditionsToRightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DepreciationRightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph j
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 90 R81.htm IDEA: XBRL DOCUMENT v3.24.0.1

LEASES - Lease liability (Details) - USD ($)
6 Months Ended 12 Months Ended

Dec. 31, 2023

Jun. 30, 2023

LEASES

Book value at the beginning of the period/year $ 13,889,223 $ 11,751,284

Additions of the period/year 1,842,539 3,154,950

Additions from business combination 3,245,000

Interest expenses, exchange differences and inflation effects 362,144 (406,494)

Payment of the period/year (2,493,617) (3,855,517)

Total 13,600,289 13,889,223

Lease Liabilities

Non-current 9,583,276 10,030,524

Current 4,017,013 3,858,699

Total $ 13,600,289 $ 13,889,223

X

- Definition
The amount of additions to lease liability from business combination.
+ References
No definition available.
+ Details

Name: biox_AdditionsToLeaseLiabilityFromBusinessCombination

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Lease liabilities additions from interest expense, exchange differences and inflation effects.
+ References
No definition available.
+ Details

Name: biox_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of additional liabilities during the period.
+ References
No definition available.
+ Details

Name: biox_LeasesLiabilitiesAdditions

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for payment of lease liabilities.
+ References
No definition available.
+ Details

Name: biox_PaymentsOfLeaseLiabilities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of current lease liabilities. [Refer: Lease liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentLeaseLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_LeaseLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_LeaseLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of non-current lease liabilities. [Refer: Lease liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentLeaseLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_PresentationOfLeasesForLesseeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 91 R82.htm IDEA: XBRL DOCUMENT v3.24.0.1

LEASES - Right-of-use asset by type (Details) - USD ($)
6 Months Ended

Dec. 31, 2023

Jun. 30, 2023

Jun. 30, 2022

Right-of-use leased asset

Right of use asset $ 13,704,217 $ 13,936,575

USD

Right-of-use leased asset

Incremental borrowing rate 1.94%

BRL

Right-of-use leased asset

Incremental borrowing rate 13.05%

Right-of-use leased asset

Right-of-use leased asset

Right of use asset $ 22,317,878 21,163,192 $ 15,828,032

Right-of-use leased asset | Machinery and equipment

Right-of-use leased asset

Right of use asset 3,655,741 3,655,741

Right-of-use leased asset | Vehicles

Right-of-use leased asset

Right of use asset 1,940,263 1,475,581

Right-of-use leased asset | Equipment and computer software

Right-of-use leased asset

Right of use asset 1,025,650 903,306

Right-of-use leased asset | Land and buildings

Right-of-use leased asset

Right of use asset $ 15,696,224 $ 15,128,564

X

- Definition
Percentage of incremental borrowing rate.
+ References
No definition available.
+ Details

Name: biox_PercentageOfIncrementalBorrowingRate

Namespace Prefix: biox_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph j
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: srt_CurrencyAxis=currency_USD

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_CurrencyAxis=currency_BRL

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfAssetsAxis=ifrs-full_MachineryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfAssetsAxis=ifrs-full_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandAndBuildingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 92 R83.htm IDEA: XBRL DOCUMENT v3.24.0.1

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details) - USD ($)
6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

In-kind contributions $ 1,434,802

Total $ (16,823,279) (22,144,968)

Joint ventures and associates

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Sales of goods and services 14,270,782 23,433,292

Purchases of goods and services (20,696,699) (43,850,427)

Key management personnel

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Sales of goods and services 362,017

Salaries, social security benefits and other benefits (9,667,629) (3,263,996)

Shareholders and other related parties

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Sales of goods and services 1,643,269 343,873

Purchases of goods and services (2,178,877) (305,061)

In-kind contributions 1,434,802

Parent company and related parties to Parent

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Interest expenses $ (194,125) $ (299,468)

X

- Definition
Amount of interest expenses.
+ References
No definition available.
+ Details

Name: biox_InterestExpensesRelatedPartyTransaction

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of investment in kind in other related parties, non cash transactions investment activities.
+ References
No definition available.
+ Details

Name: biox_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of goods purchased and the amount of services received by the entity in related party transactions.
+ References
No definition available.
+ Details

Name: biox_PurchasesOfGoodsAndServicesReceivedRelatedPartyTransactions

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The total amount of related party transactions.
+ References
No definition available.
+ Details

Name: biox_RelatedPartyTransactions

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of revenue arising from the sale of goods and rendering of services in related party transactions.
+ References
No definition available.
+ Details

Name: biox_RevenueFromSaleOfGoodsAndRenderingOfServicesRelatedPartyTransactions

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of salaries, social security benefits and other benefits.
+ References
No definition available.
+ Details

Name: biox_SalariesSocialSecurityBenefitsAndOtherBenefitsRelatedPartyTransactions

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_JointVenturesWhereEntityIsVenturerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_ParentCompaniesAndRelatedPartiesToParentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 93 R84.htm IDEA: XBRL DOCUMENT v3.24.0.1

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Other receivables $ 25,081,598 $ 28,824,998

Total 12,841,935 10,992,275

Shareholders and other related parties

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Other receivables 3,105,591 3,792,429

Trade debtors 1,223,994

Joint ventures and associates

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Other receivables 7,730,898 6,334,219

Trade debtors $ 781,452 $ 865,627

X

- Definition
The amount of trade receivables due from related parties.
+ References
No definition available.
+ Details

Name: biox_TradeReceivablesFromRelatedParties

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 20
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 18
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AmountsReceivableRelatedPartyTransactions

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current other receivables. [Refer: Other receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherCurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_JointVenturesWhereEntityIsVenturerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 94 R85.htm IDEA: XBRL DOCUMENT v3.24.0.1

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details) - USD ($)

Dec. 31, 2023

Jun. 30, 2023

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Total $ 60,330,550 $ 45,791,836

Parent company and related parties to Parent

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Trade payables/creditors (161,860) (644,191)

Net loans payables (3,639,816) (3,491,691)

Key management personnel

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Salaries, social security benefits and other benefits (68,139) (218,068)

Shareholders and other related parties

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Trade payables/creditors (75,271) (35,292)

Joint ventures and associates

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Trade payables/creditors $ (56,385,464) $ (41,402,594)

X

- Definition
The amount of loans payables to related party.
+ References
No definition available.
+ Details

Name: biox_LoansPayablesRelatedPartyTransactions

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of payables to related party pertaining to salaries, social security benefits and other.
+ References
No definition available.
+ Details

Name: biox_PayablesSalariesSocialSecurityBenefitsAndOther

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amounts payable resulting from related party transactions. [Refer: Related parties [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 20
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 18
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AmountsPayableRelatedPartyTransactions

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_ParentCompaniesAndRelatedPartiesToParentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_JointVenturesWhereEntityIsVenturerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 95 R86.htm IDEA: XBRL DOCUMENT v3.24.0.1

KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details) - USD ($)
6 Months Ended

Dec. 31, 2023

Dec. 31, 2022

KEY MANAGEMENT PERSONNEL COMPENSATION

Salaries, social security and other benefits $ 1,140,415 $ 1,201,651

Share-based incentives 8,527,214 2,062,345

Total $ 9,667,629 $ 3,263,996

X

- References
No definition available.
+ Details

Name: biox_KeyManagementPersonnelCompensationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 17
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_KeyManagementPersonnelCompensation

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 17
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 17
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 96 R87.htm IDEA: XBRL DOCUMENT v3.24.0.1

SHARE-BASED PAYMENT (Details)
$ / shares in Units, $ in Millions
1 Months Ended

Aug. 31, 2023

USD ($)

$ / shares

Past Share Option plan | Minimum

SHARE-BASED PAYMENT

Exercise price $ 11.93

Past Share Option plan | Maximum

SHARE-BASED PAYMENT

Exercise price 13.24

Base Share Option plan | Minimum

SHARE-BASED PAYMENT

Exercise price 10.47

Base Share Option plan | Maximum

SHARE-BASED PAYMENT

Exercise price $ 10.79

Performance Share Option plan | If EBITDA Reaches at Least US$120 Million

SHARE-BASED PAYMENT

Threshold earnings before interest | $ $ 120

Vesting percentage 0.00%

Performance Share Option plan | If EBITDA reaches at least US$150 million

SHARE-BASED PAYMENT

Threshold earnings before interest | $ $ 150

Performance Share Option plan | Minimum

SHARE-BASED PAYMENT

Exercise price $ 10.47

Performance Share Option plan | Maximum

SHARE-BASED PAYMENT

Exercise price $ 10.79

Performance Share Option plan | Maximum | If EBITDA reaches at least US$150 million

SHARE-BASED PAYMENT

Vesting percentage 100.00%

X

- Definition
Percentage of vesting of award under share-based payment arrangement.
+ References
No definition available.
+ Details

Name: biox_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage

Namespace Prefix: biox_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of threshold earnings before interest taxes depreciation and amortization.
+ References
No definition available.
+ Details

Name: biox_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The exercise price of share options granted.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ExercisePriceShareOptionsGranted2019

Namespace Prefix: ifrs-full_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=biox_PastShareOptionPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=biox_BaseShareOptionPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=biox_PerformanceShareOptionPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementScenarioAxis=biox_IfEbitdaReachesAtLeastUs120MillionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementScenarioAxis=biox_IfEbitdaReachesAtLeastUs150MillionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

EXCEL 98 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 99 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 100 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 103 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 448 362 1 false 101 0 false 8 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Sheet http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Statements 2 false false R3.htm 00200 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 3 false false R4.htm 00300 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Sheet http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Statements 4 false false R5.htm 00400 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 10101 - Disclosure - GENERAL INFORMATION Sheet http://www.biocerescrops.com/role/DisclosureGeneralInformation GENERAL INFORMATION Notes 6 false false R7.htm 10201 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PREPARATION Sheet http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparation ACCOUNTING STANDARDS AND BASIS OF PREPARATION Notes 7 false false R8.htm 10301 - Disclosure - NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB Sheet http://www.biocerescrops.com/role/DisclosureNewStandardsAmendmentsAndInterpretationsIssuedByIasb NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB Notes 8 false false R9.htm 10401 - Disclosure - SEASONALITY Sheet http://www.biocerescrops.com/role/DisclosureSeasonality SEASONALITY Notes 9 false false R10.htm 10501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPosition INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Notes 10 false false R11.htm 10601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncome INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Notes 11 false false R12.htm 10701 - Disclosure - TAXATION Sheet http://www.biocerescrops.com/role/DisclosureTaxation TAXATION Notes 12 false false R13.htm 10801 - Disclosure - EARNING PER SHARE Sheet http://www.biocerescrops.com/role/DisclosureEarningPerShare EARNING PER SHARE Notes 13 false false R14.htm 10901 - Disclosure - EQUITY INFORMATION Sheet http://www.biocerescrops.com/role/DisclosureEquityInformation EQUITY INFORMATION Notes 14 false false R15.htm 11001 - Disclosure - CASH FLOW INFORMATION Sheet http://www.biocerescrops.com/role/DisclosureCashFlowInformation CASH FLOW INFORMATION Notes 15 false false R16.htm 11101 - Disclosure - JOINT VENTURES AND ASSOCIATES Sheet http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociates JOINT VENTURES AND ASSOCIATES Notes 16 false false R17.htm 11201 - Disclosure - SEGMENT INFORMATION Sheet http://www.biocerescrops.com/role/DisclosureSegmentInformation SEGMENT INFORMATION Notes 17 false false R18.htm 11301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT Sheet http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagement FINANCIAL INSTRUMENTS - RISK MANAGEMENT Notes 18 false false R19.htm 11401 - Disclosure - LEASES Sheet http://www.biocerescrops.com/role/DisclosureLeases LEASES Notes 19 false false R20.htm 11501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS Sheet http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactions SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS Notes 20 false false R21.htm 11601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION Sheet http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensation KEY MANAGEMENT PERSONNEL COMPENSATION Notes 21 false false R22.htm 11701 - Disclosure - SHARE-BASED PAYMENT Sheet http://www.biocerescrops.com/role/DisclosureShareBasedPayment SHARE-BASED PAYMENT Notes 22 false false R23.htm 11801 - Disclosure - CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS Sheet http://www.biocerescrops.com/role/DisclosureContingenciesCommitmentsAndRestrictionsOnDistributionOfProfits CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS Notes 23 false false R24.htm 11901 - Disclosure - EVENTS OCCURRING AFTER THE REPORTING PERIOD Sheet http://www.biocerescrops.com/role/DisclosureEventsOccurringAfterReportingPeriod EVENTS OCCURRING AFTER THE REPORTING PERIOD Notes 24 false false R25.htm 20102 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Policies) Sheet http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Policies) Policies 25 false false R26.htm 30503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables) Tables http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPosition 26 false false R27.htm 30603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables) Tables http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncome 27 false false R28.htm 30703 - Disclosure - TAXATION (Tables) Sheet http://www.biocerescrops.com/role/DisclosureTaxationTables TAXATION (Tables) Tables http://www.biocerescrops.com/role/DisclosureTaxation 28 false false R29.htm 30803 - Disclosure - EARNING PER SHARE (Tables) Sheet http://www.biocerescrops.com/role/DisclosureEarningPerShareTables EARNING PER SHARE (Tables) Tables http://www.biocerescrops.com/role/DisclosureEarningPerShare 29 false false R30.htm 31003 - Disclosure - CASH FLOW INFORMATION (Tables) Sheet http://www.biocerescrops.com/role/DisclosureCashFlowInformationTables CASH FLOW INFORMATION (Tables) Tables http://www.biocerescrops.com/role/DisclosureCashFlowInformation 30 false false R31.htm 31103 - Disclosure - JOINT VENTURES AND ASSOCIATES (Tables) Sheet http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables JOINT VENTURES AND ASSOCIATES (Tables) Tables http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociates 31 false false R32.htm 31203 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.biocerescrops.com/role/DisclosureSegmentInformationTables SEGMENT INFORMATION (Tables) Tables http://www.biocerescrops.com/role/DisclosureSegmentInformation 32 false false R33.htm 31303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables) Sheet http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables) Tables http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagement 33 false false R34.htm 31403 - Disclosure - LEASES (Tables) Sheet http://www.biocerescrops.com/role/DisclosureLeasesTables LEASES (Tables) Tables http://www.biocerescrops.com/role/DisclosureLeases 34 false false R35.htm 31503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables) Sheet http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables) Tables http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactions 35 false false R36.htm 31603 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION (Tables) Sheet http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationTables KEY MANAGEMENT PERSONNEL COMPENSATION (Tables) Tables http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensation 36 false false R37.htm 40101 - Disclosure - GENERAL INFORMATION - (Details) Sheet http://www.biocerescrops.com/role/DisclosureGeneralInformationDetails GENERAL INFORMATION - (Details) Details http://www.biocerescrops.com/role/DisclosureGeneralInformation 37 false false R38.htm 40401 - Disclosure - SEASONALITY (Details) Sheet http://www.biocerescrops.com/role/DisclosureSeasonalityDetails SEASONALITY (Details) Details http://www.biocerescrops.com/role/DisclosureSeasonality 38 false false R39.htm 40501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details) Details 39 false false R40.htm 40502 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details) Details 40 false false R41.htm 40503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details) Details 41 false false R42.htm 40504 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details) Details 42 false false R43.htm 40505 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables 43 false false R44.htm 40506 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details) Details 44 false false R45.htm 40507 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details) Details 45 false false R46.htm 40508 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - net carrying amount (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - net carrying amount (Details) Details 46 false false R47.htm 40509 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - gross carrying amounts (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - gross carrying amounts (Details) Details 47 false false R48.htm 40510 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - accumulated depreciation (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - accumulated depreciation (Details) Details 48 false false R49.htm 40511 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details) Details 49 false false R50.htm 40512 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, net carrying amount (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, net carrying amount (Details) Details 50 false false R51.htm 40513 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, gross carrying amount (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, gross carrying amount (Details) Details 51 false false R52.htm 40514 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, accumulated amortization (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, accumulated amortization (Details) Details 52 false false R53.htm 40515 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables 53 false false R54.htm 40516 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInvestmentPropertiesDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details) Details 54 false false R55.htm 40517 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details) Details 55 false false R56.htm 40518 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables 56 false false R57.htm 40519 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details) Details 57 false false R58.htm 40520 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details) Notes http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables 58 false false R59.htm 40521 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details) Details 59 false false R60.htm 40522 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details) Details 60 false false R61.htm 40601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables 61 false false R62.htm 40602 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables 62 false false R63.htm 40603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details) Details 63 false false R64.htm 40604 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details) Details 64 false false R65.htm 40605 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details) Details 65 false false R66.htm 40606 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables 66 false false R67.htm 40701 - Disclosure - TAXATION - Taxes on income (Details) Sheet http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails TAXATION - Taxes on income (Details) Details 67 false false R68.htm 40702 - Disclosure - TAXATION - Movement on the deferred income tax (Details) Sheet http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails TAXATION - Movement on the deferred income tax (Details) Details 68 false false R69.htm 40703 - Disclosure - TAXATION - Reconciliation of the statutory tax rate (Details) Sheet http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails TAXATION - Reconciliation of the statutory tax rate (Details) Details 69 false false R70.htm 40801 - Disclosure - EARNING PER SHARE (Details) Sheet http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails EARNING PER SHARE (Details) Details http://www.biocerescrops.com/role/DisclosureEarningPerShareTables 70 false false R71.htm 40901 - Disclosure - EQUITY INFORMATION (Details) Sheet http://www.biocerescrops.com/role/DisclosureEquityInformationDetails EQUITY INFORMATION (Details) Details http://www.biocerescrops.com/role/DisclosureEquityInformation 71 false false R72.htm 41001 - Disclosure - CASH FLOW INFORMATION (Details) Sheet http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails CASH FLOW INFORMATION (Details) Details http://www.biocerescrops.com/role/DisclosureCashFlowInformationTables 72 false false R73.htm 41101 - Disclosure - JOINT VENTURES AND ASSOCIATES (Details) Sheet http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails JOINT VENTURES AND ASSOCIATES (Details) Details http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables 73 false false R74.htm 41102 - Disclosure - JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details) Sheet http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details) Details 74 false false R75.htm 41201 - Disclosure - SEGMENT INFORMATION - Group's reporting segments (Details) Sheet http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails SEGMENT INFORMATION - Group's reporting segments (Details) Details 75 false false R76.htm 41301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details) Sheet http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details) Details 76 false false R77.htm 41302 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details) Sheet http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details) Details 77 false false R78.htm 41303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details) Sheet http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details) Details 78 false false R79.htm 41304 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details) Sheet http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details) Details 79 false false R80.htm 41401 - Disclosure - LEASES - Right-of-use leased asset (Details) Sheet http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails LEASES - Right-of-use leased asset (Details) Details 80 false false R81.htm 41402 - Disclosure - LEASES - Lease liability (Details) Sheet http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails LEASES - Lease liability (Details) Details 81 false false R82.htm 41403 - Disclosure - LEASES - Right-of-use asset by type (Details) Sheet http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails LEASES - Right-of-use asset by type (Details) Details 82 false false R83.htm 41501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details) Sheet http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details) Details http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables 83 false false R84.htm 41502 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details) Sheet http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details) Details http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables 84 false false R85.htm 41503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details) Sheet http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details) Details http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables 85 false false R86.htm 41601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details) Sheet http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details) Details 86 false false R87.htm 41701 - Disclosure - SHARE-BASED PAYMENT (Details) Sheet http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails SHARE-BASED PAYMENT (Details) Details http://www.biocerescrops.com/role/DisclosureShareBasedPayment 87 false false All Reports Book All Reports biox-20231231.xsd biox-20231231_cal.xml biox-20231231_def.xml biox-20231231_lab.xml biox-20231231_pre.xml biox-20231231x6k.htm biox-20231231xex99d1.htm biox-20231231xex99d1001.jpg biox-20231231xex99d1002.jpg http://xbrl.sec.gov/dei/2023 https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full true true JSON 106 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "biox-20231231x6k.htm biox-20231231xex99d1.htm": { "nsprefix": "biox", "nsuri": "http://www.biocerescrops.com/20231231", "dts": { "schema": { "local": [ "biox-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "biox-20231231_cal.xml" ] }, "definitionLink": { "local": [ "biox-20231231_def.xml" ] }, "labelLink": { "local": [ "biox-20231231_lab.xml" ] }, "presentationLink": { "local": [ "biox-20231231_pre.xml" ] }, "inline": { "local": [ "biox-20231231x6k.htm", "biox-20231231xex99d1.htm" ] } }, "keyStandard": 231, "keyCustom": 131, "axisStandard": 23, "axisCustom": 0, "memberStandard": 43, "memberCustom": 54, "hidden": { "total": 9, "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 2, "http://xbrl.sec.gov/dei/2023": 7 }, "contextCount": 448, "entityCount": 1, "segmentCount": 101, "elementCount": 594, "unitCount": 8, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 1164, "http://xbrl.sec.gov/dei/2023": 8 }, "report": { "R1": { "role": "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231x6k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231x6k.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition", "longName": "00100 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "shortName": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:CurrentTaxAssets", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R3": { "role": "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome", "longName": "00200 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "shortName": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "Duration_10_1_2023_To_12_31_2023_UoS7_N7-50y04KkZer5O6A", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2023_To_12_31_2023_UoS7_N7-50y04KkZer5O6A", "name": "biox:ChangeInNetRealizableValueOfAgricultural", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R4": { "role": "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity", "longName": "00300 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "shortName": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "As_Of_6_30_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_sUMwsJ10uUC7rAZwYhhkrw", "name": "ifrs-full:Equity", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_sUMwsJ10uUC7rAZwYhhkrw", "name": "ifrs-full:Equity", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows", "longName": "00400 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "Duration_10_1_2023_To_12_31_2023_UoS7_N7-50y04KkZer5O6A", "name": "ifrs-full:ProfitLoss", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:AdjustmentsForIncomeTaxExpense", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R6": { "role": "http://www.biocerescrops.com/role/DisclosureGeneralInformation", "longName": "10101 - Disclosure - GENERAL INFORMATION", "shortName": "GENERAL INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparation", "longName": "10201 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PREPARATION", "shortName": "ACCOUNTING STANDARDS AND BASIS OF PREPARATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.biocerescrops.com/role/DisclosureNewStandardsAmendmentsAndInterpretationsIssuedByIasb", "longName": "10301 - Disclosure - NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB", "shortName": "NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.biocerescrops.com/role/DisclosureSeasonality", "longName": "10401 - Disclosure - SEASONALITY", "shortName": "SEASONALITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DisclosureOfSeasonalityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DisclosureOfSeasonalityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPosition", "longName": "10501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncome", "longName": "10601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.biocerescrops.com/role/DisclosureTaxation", "longName": "10701 - Disclosure - TAXATION", "shortName": "TAXATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.biocerescrops.com/role/DisclosureEarningPerShare", "longName": "10801 - Disclosure - EARNING PER SHARE", "shortName": "EARNING PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.biocerescrops.com/role/DisclosureEquityInformation", "longName": "10901 - Disclosure - EQUITY INFORMATION", "shortName": "EQUITY INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.biocerescrops.com/role/DisclosureCashFlowInformation", "longName": "11001 - Disclosure - CASH FLOW INFORMATION", "shortName": "CASH FLOW INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociates", "longName": "11101 - Disclosure - JOINT VENTURES AND ASSOCIATES", "shortName": "JOINT VENTURES AND ASSOCIATES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.biocerescrops.com/role/DisclosureSegmentInformation", "longName": "11201 - Disclosure - SEGMENT INFORMATION", "shortName": "SEGMENT INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagement", "longName": "11301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.biocerescrops.com/role/DisclosureLeases", "longName": "11401 - Disclosure - LEASES", "shortName": "LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactions", "longName": "11501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensation", "longName": "11601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION", "shortName": "KEY MANAGEMENT PERSONNEL COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.biocerescrops.com/role/DisclosureShareBasedPayment", "longName": "11701 - Disclosure - SHARE-BASED PAYMENT", "shortName": "SHARE-BASED PAYMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.biocerescrops.com/role/DisclosureContingenciesCommitmentsAndRestrictionsOnDistributionOfProfits", "longName": "11801 - Disclosure - CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS", "shortName": "CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfCommitmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfCommitmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.biocerescrops.com/role/DisclosureEventsOccurringAfterReportingPeriod", "longName": "11901 - Disclosure - EVENTS OCCURRING AFTER THE REPORTING PERIOD", "shortName": "EVENTS OCCURRING AFTER THE REPORTING PERIOD", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies", "longName": "20102 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Policies)", "shortName": "ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "25", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables", "longName": "30503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables", "longName": "30603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationTables", "longName": "30703 - Disclosure - TAXATION (Tables)", "shortName": "TAXATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.biocerescrops.com/role/DisclosureEarningPerShareTables", "longName": "30803 - Disclosure - EARNING PER SHARE (Tables)", "shortName": "EARNING PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.biocerescrops.com/role/DisclosureCashFlowInformationTables", "longName": "31003 - Disclosure - CASH FLOW INFORMATION (Tables)", "shortName": "CASH FLOW INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables", "longName": "31103 - Disclosure - JOINT VENTURES AND ASSOCIATES (Tables)", "shortName": "JOINT VENTURES AND ASSOCIATES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.biocerescrops.com/role/DisclosureSegmentInformationTables", "longName": "31203 - Disclosure - SEGMENT INFORMATION (Tables)", "shortName": "SEGMENT INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables", "longName": "31303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.biocerescrops.com/role/DisclosureLeasesTables", "longName": "31403 - Disclosure - LEASES (Tables)", "shortName": "LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables", "longName": "31503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables)", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationTables", "longName": "31603 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION (Tables)", "shortName": "KEY MANAGEMENT PERSONNEL COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.biocerescrops.com/role/DisclosureGeneralInformationDetails", "longName": "40101 - Disclosure - GENERAL INFORMATION - (Details)", "shortName": "GENERAL INFORMATION - (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "biox:MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs", "unitRef": "Unit_Standard_country_WPiB5wRbXUqq9Rxhqgbv9Q", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "biox:MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs", "unitRef": "Unit_Standard_country_WPiB5wRbXUqq9Rxhqgbv9Q", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.biocerescrops.com/role/DisclosureSeasonalityDetails", "longName": "40401 - Disclosure - SEASONALITY (Details)", "shortName": "SEASONALITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "biox:CustomersAndDistributorBulkOrdersPerYearMinimum", "unitRef": "Unit_Standard_item_c44VTB9bAk-BRnDSYLLt9Q", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "biox:DisclosureOfSeasonalityTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "biox:CustomersAndDistributorBulkOrdersPerYearMinimum", "unitRef": "Unit_Standard_item_c44VTB9bAk-BRnDSYLLt9Q", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "biox:DisclosureOfSeasonalityTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails", "longName": "40501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:Cash", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:Cash", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "longName": "40502 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfOtherFinancialAssetsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfOtherFinancialAssetsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "longName": "40503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:CurrentTradeReceivables", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfTradeReceivablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:CurrentTradeReceivables", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfTradeReceivablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "longName": "40504 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "biox:ReceivablesFromTaxCreditsCurrent", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfOtherReceivablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "biox:ReceivablesFromTaxCreditsCurrent", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfOtherReceivablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails", "longName": "40505 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:CurrentInventoriesInTransit", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:CurrentInventoriesInTransit", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "longName": "40506 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:BiologicalAssets", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2022_b_Qe2B0o5UWVJ4RMf-ScNA", "name": "ifrs-full:BiologicalAssets", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R45": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "longName": "40507 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": null }, "R46": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails", "longName": "40508 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - net carrying amount (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - net carrying amount (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": null }, "R47": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "longName": "40509 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - gross carrying amounts (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - gross carrying amounts (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2022_To_12_31_2022_8DqmDzEQNEmc2t-yo_HkeA", "name": "ifrs-full:AcquisitionsThroughBusinessCombinationsInvestmentProperty", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R48": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "longName": "40510 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - accumulated depreciation (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - accumulated depreciation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_SUyL2pjNvECOBj3iKNmxwA", "name": "ifrs-full:DisposalsPropertyPlantAndEquipment", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfDepreciationExpenseTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R49": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "longName": "40511 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": null }, "R50": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails", "longName": "40512 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, net carrying amount (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, net carrying amount (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "biox:DisclosureOfNetCarryingAmountOfOtherIntangibleAssetsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R51": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "longName": "40513 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, gross carrying amount (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, gross carrying amount (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_wZVPrMmrQEyafJPcdauhQQ", "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfGrossCarryingAmountOfIntangibleAssetsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R52": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "longName": "40514 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, accumulated amortization (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, accumulated amortization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_SUyL2pjNvECOBj3iKNmxwA", "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfAccumulatedAmortizationOfIntangibleAssets.TextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R53": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails", "longName": "40515 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:Goodwill", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_biox_RizobacterArgentinaMember_RQ0HGZemO0mMl8EdVQ3CbA", "name": "ifrs-full:Goodwill", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R54": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInvestmentPropertiesDetails", "longName": "40516 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:InvestmentProperty", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": null }, "R55": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "longName": "40517 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "longName": "40518 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:BondsIssued", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_ifrs-full_BorrowingsByNameAxis_biox_TrustDebtSecuritiesMember_R_41P_JgR0axLcaQiiXF2Q", "name": "ifrs-full:ShorttermBorrowings", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R57": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "longName": "40519 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:ShorttermBorrowings", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_IU4nO-06k0adlGLEwQEJGQ", "name": "ifrs-full:BondsIssued", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfCarryingValueOfBorrowingsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R58": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails", "longName": "40520 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "As_Of_12_31_2023_ifrs-full_BorrowingsByNameAxis_biox_SecuredGuaranteedNotesMember_ifrs-full_MeasurementAxis_ifrs-full_AtCostMember_2kY8E0D1DkerJusolC9FDw", "name": "ifrs-full:Borrowings", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_ifrs-full_BorrowingsByNameAxis_biox_SecuredGuaranteedNotesMember_ifrs-full_MeasurementAxis_ifrs-full_AtCostMember_2kY8E0D1DkerJusolC9FDw", "name": "ifrs-full:Borrowings", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails", "longName": "40521 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "biox:SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "biox:SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails", "longName": "40522 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:CurrentAdvances", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfPerformanceObligationsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:CurrentAdvances", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfPerformanceObligationsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails", "longName": "40601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:RevenueFromRoyalties", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_ifrs-full_ProductsAndServicesAxis_biox_GoodsAndServicesMember_wuNlW8WPz0ai0fJhwM00Cw", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R62": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails", "longName": "40602 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:InventoriesTotal", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:InventoriesTotal", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails", "longName": "40603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DepreciationRightofuseAssets", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:ResearchAndDevelopmentExpenseCapitalized", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R64": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "longName": "40604 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:DepreciationRightofuseAssets", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_CostOfSalesMember_RWlw2CCoZkqKFh92SJVXiA", "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R65": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails", "longName": "40605 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:RevenueFromSaleOfAgriculturalProduce", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:RevenueFromSaleOfAgriculturalProduce", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails", "longName": "40606 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:InterestExpenseOnLiabilitiesWithParent", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:InterestExpenseOnLiabilitiesWithParent", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails", "longName": "40701 - Disclosure - TAXATION - Taxes on income (Details)", "shortName": "TAXATION - Taxes on income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:CurrentTaxExpenseIncome", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:CurrentTaxExpenseIncome", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails", "longName": "40702 - Disclosure - TAXATION - Movement on the deferred income tax (Details)", "shortName": "TAXATION - Movement on the deferred income tax (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDeferredTaxesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDeferredTaxesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails", "longName": "40703 - Disclosure - TAXATION - Reconciliation of the statutory tax rate (Details)", "shortName": "TAXATION - Reconciliation of the statutory tax rate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:AccountingProfit", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:AccountingProfit", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails", "longName": "40801 - Disclosure - EARNING PER SHARE (Details)", "shortName": "EARNING PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "Duration_10_1_2023_To_12_31_2023_UoS7_N7-50y04KkZer5O6A", "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:EarningsPerShareExplanatory", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2023_To_12_31_2023_UoS7_N7-50y04KkZer5O6A", "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:EarningsPerShareExplanatory", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails", "longName": "40901 - Disclosure - EQUITY INFORMATION (Details)", "shortName": "EQUITY INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:IfrsStockRepurchasedDuringPeriodShares", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:IfrsStockRepurchasedDuringPeriodShares", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails", "longName": "41001 - Disclosure - CASH FLOW INFORMATION (Details)", "shortName": "CASH FLOW INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "Duration_7_1_2022_To_12_31_2022_8DqmDzEQNEmc2t-yo_HkeA", "name": "biox:NetAssetsAcquisitionByBusinessCombination", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2022_To_12_31_2022_8DqmDzEQNEmc2t-yo_HkeA", "name": "biox:NetAssetsAcquisitionByBusinessCombination", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails", "longName": "41101 - Disclosure - JOINT VENTURES AND ASSOCIATES (Details)", "shortName": "JOINT VENTURES AND ASSOCIATES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "biox:InvestmentsAccountedForUsingEquityMethodAssets", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2023_ifrs-full_JointVenturesAxis_biox_TrigallGeneticsS.a.Member_CgA_MF4wt0mKxZKMkP8OaA", "name": "biox:InvestmentsAccountedForUsingEquityMethodLiability", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock", "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R74": { "role": "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails", "longName": "41102 - Disclosure - JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details)", "shortName": "JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:InvestmentAccountedForUsingEquityMethod", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:InvestmentAccountedForUsingEquityMethod", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R75": { "role": "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails", "longName": "41201 - Disclosure - SEGMENT INFORMATION - Group's reporting segments (Details)", "shortName": "SEGMENT INFORMATION - Group's reporting segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "Duration_10_1_2023_To_12_31_2023_UoS7_N7-50y04KkZer5O6A", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:Revenue", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R76": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "longName": "41301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "As_Of_12_31_2023_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_IU4nO-06k0adlGLEwQEJGQ", "name": "ifrs-full:FinancialAssets", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_IU4nO-06k0adlGLEwQEJGQ", "name": "ifrs-full:FinancialAssets", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R77": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "longName": "41302 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "As_Of_12_31_2023_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_IU4nO-06k0adlGLEwQEJGQ", "name": "ifrs-full:FinancialLiabilities", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_IU4nO-06k0adlGLEwQEJGQ", "name": "ifrs-full:FinancialLiabilities", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R78": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "longName": "41303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_biox_TradeAndOtherPayablesMember_ifrs-full_LevelsOfFairValueHierarchyAxis_ifrs-full_Level2OfFairValueHierarchyMember_0PVwQ7AC40GNM4xlqXYPGw", "name": "ifrs-full:FinancialLiabilitiesAtFairValue", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_ifrs-full_ClassesOfFinancialLiabilitiesAxis_biox_TradeAndOtherPayablesMember_ifrs-full_LevelsOfFairValueHierarchyAxis_ifrs-full_Level2OfFairValueHierarchyMember_0PVwQ7AC40GNM4xlqXYPGw", "name": "ifrs-full:FinancialLiabilitiesAtFairValue", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R79": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails", "longName": "41304 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_Ov737kEShUO8XuUTFzSRKw", "name": "ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_Ov737kEShUO8XuUTFzSRKw", "name": "ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R80": { "role": "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails", "longName": "41401 - Disclosure - LEASES - Right-of-use leased asset (Details)", "shortName": "LEASES - Right-of-use leased asset (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:RightofuseAssets", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_wZVPrMmrQEyafJPcdauhQQ", "name": "ifrs-full:AdditionsToRightofuseAssets", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R81": { "role": "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails", "longName": "41402 - Disclosure - LEASES - Lease liability (Details)", "shortName": "LEASES - Lease liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "As_Of_6_30_2023_SOYuWQ2luEmo_KMIxyHtcw", "name": "ifrs-full:LeaseLiabilities", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2022_b_Qe2B0o5UWVJ4RMf-ScNA", "name": "ifrs-full:LeaseLiabilities", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R82": { "role": "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "longName": "41403 - Disclosure - LEASES - Right-of-use asset by type (Details)", "shortName": "LEASES - Right-of-use asset by type (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:RightofuseAssets", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_srt_CurrencyAxis_currency_USD_59i5gkU_GEKovEhd8F3Cmw", "name": "biox:PercentageOfIncrementalBorrowingRate", "unitRef": "Unit_Standard_pure_htczNZqotEqPjcxJe47p7A", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R83": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails", "longName": "41501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details)", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "Duration_7_1_2022_To_12_31_2022_8DqmDzEQNEmc2t-yo_HkeA", "name": "biox:InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "biox:RelatedPartyTransactions", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R84": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "longName": "41502 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details)", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:OtherCurrentReceivables", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:AmountsReceivableRelatedPartyTransactions", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "unique": true } }, "R85": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "longName": "41503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details)", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:AmountsPayableRelatedPartyTransactions", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_j3Vis0sr8USPiXSPY1nzPQ", "name": "ifrs-full:AmountsPayableRelatedPartyTransactions", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R86": { "role": "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails", "longName": "41601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details)", "shortName": "KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_12_31_2023_wUh97O5vi0K55ejEP3LNZg", "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "unitRef": "Unit_Standard_USD_dzIQie1FZU-fvxRl5PrPbA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } }, "R87": { "role": "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails", "longName": "41701 - Disclosure - SHARE-BASED PAYMENT (Details)", "shortName": "SHARE-BASED PAYMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "Duration_8_1_2023_To_8_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_biox_PastShareOptionPlanMember_cpSlK_Xk502fwcf8fOJrmA", "name": "ifrs-full:ExercisePriceShareOptionsGranted2019", "unitRef": "Unit_Divide_USD_shares_STueDeazA0uJcmC_x1R-7Q", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_8_1_2023_To_8_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_biox_PastShareOptionPlanMember_cpSlK_Xk502fwcf8fOJrmA", "name": "ifrs-full:ExercisePriceShareOptionsGranted2019", "unitRef": "Unit_Divide_USD_shares_STueDeazA0uJcmC_x1R-7Q", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20231231xex99d1.htm", "first": true, "unique": true } } }, "tag": { "ifrs-full_AccountingProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccountingProfit", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Accounting profit", "terseLabel": "Earnings before income tax-rate" } }, "en": { "role": { "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r50", "r51" ] }, "biox_AccountingStandardsAndBasisOfPreparationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AccountingStandardsAndBasisOfPreparationAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "ACCOUNTING STANDARDS AND BASIS OF PREPARATION" } } }, "auth_ref": [] }, "ifrs-full_AccumulatedDepreciationAndAmortisationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccumulatedDepreciationAndAmortisationMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated depreciation and amortisation [member]", "terseLabel": "Accumulated depreciation", "verboseLabel": "Depreciation" } }, "en": { "role": { "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]" } } }, "auth_ref": [ "r63", "r265", "r267", "r269", "r271" ] }, "ifrs-full_AccumulatedImpairmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccumulatedImpairmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Allowance for obsolescence", "terseLabel": "Allowance for obsolescence" } }, "en": { "role": { "documentation": "This member stands for accumulated impairment. [Refer: Impairment loss]" } } }, "auth_ref": [ "r175", "r183", "r249", "r265", "r267", "r269", "r271" ] }, "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Acquisitions through business combinations, intangible assets other than goodwill", "terseLabel": "Additions from business combination" } }, "en": { "role": { "documentation": "The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r95" ] }, "ifrs-full_AcquisitionsThroughBusinessCombinationsInvestmentProperty": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AcquisitionsThroughBusinessCombinationsInvestmentProperty", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Acquisitions through business combinations, investment property", "terseLabel": "Additions from business combination" } }, "en": { "role": { "documentation": "The increase in investment property resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Investment property]" } } }, "auth_ref": [ "r103", "r106" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Additions other than through business combinations, biological assets", "terseLabel": "Cost incurred during the period" } }, "en": { "role": { "documentation": "The amount of additions to biological assets, other than those acquired through business combinations. [Refer: Business combinations [member]; Biological assets]" } } }, "auth_ref": [ "r270" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Additions other than through business combinations, intangible assets other than goodwill", "negatedTerseLabel": "Amortization of the period", "terseLabel": "Additions" } }, "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r95" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Additions other than through business combinations, property, plant and equipment", "negatedLabel": "Depreciation of the period", "terseLabel": "Additions" } }, "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } } }, "auth_ref": [ "r56" ] }, "biox_AdditionsToLeaseLiabilityFromBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AdditionsToLeaseLiabilityFromBusinessCombination", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of additions to lease liability from business combination.", "label": "Additions to Lease Liability From Business Combination", "terseLabel": "Additions from business combination" } } }, "auth_ref": [] }, "biox_AdditionsToRightOfUseAssetsFromBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AdditionsToRightOfUseAssetsFromBusinessCombination", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of additions to right of use assets from business combination.", "label": "Additions to Right of Use Assets From Business Combination", "terseLabel": "Additions from business combination" } } }, "auth_ref": [] }, "ifrs-full_AdditionsToRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsToRightofuseAssets", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Additions to right-of-use assets", "terseLabel": "Additions of the period/year" } }, "en": { "role": { "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r157" ] }, "ifrs-full_AdjustedWeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustedWeightedAverageShares", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares - Diluted", "terseLabel": "Weighted average number of shares (diluted EPS)" } }, "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r86" ] }, "ifrs-full_AdjustmentsForAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForAmortisationExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for amortisation expense", "terseLabel": "Amortization of intangible assets" } }, "en": { "role": { "documentation": "Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]" } } }, "auth_ref": [ "r277" ] }, "biox_AdjustmentsForDecreaseIncreaseInDeferredRevenueAndAdvancesFromCustomers": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AdjustmentsForDecreaseIncreaseInDeferredRevenueAndAdvancesFromCustomers", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in deferred revenue and advances from customers to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Decrease (Increase) in Deferred Revenue and Advances from Customers", "terseLabel": "Deferred revenue and advances from customers" } } }, "auth_ref": [] }, "biox_AdjustmentsForDecreaseIncreaseInEmployeeBenefitsAndSocialSecurity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AdjustmentsForDecreaseIncreaseInEmployeeBenefitsAndSocialSecurity", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in employee benefits and social security to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Decrease (Increase) in Employee Benefits and Social Security", "terseLabel": "Employee benefits and social security" } } }, "auth_ref": [] }, "biox_AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxes", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in income and minimum presumed income taxes to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Decrease (Increase) in Income and Minimum Presumed Income Taxes", "terseLabel": "Income and minimum presumed income taxes payable" } } }, "auth_ref": [] }, "biox_AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in income and minimum presumed income taxes paid/payable to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments For Decrease Increase In Income And Minimum Presumed Income Taxes Payable", "terseLabel": "Income taxes paid" } } }, "auth_ref": [] }, "biox_AdjustmentsForDecreaseIncreaseInInflationEffectsOnWorkingCapitalAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AdjustmentsForDecreaseIncreaseInInflationEffectsOnWorkingCapitalAdjustments", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in Inflation effects on working capital adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Decrease (Increase) in Inflation Effects on Working Capital Adjustments", "terseLabel": "Inflation effects on working capital adjustments" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInInventories", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in inventories", "terseLabel": "Inventories and biological assets" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]" } } }, "auth_ref": [ "r274" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in other operating receivables", "terseLabel": "Other receivables" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r274" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in trade accounts receivable", "terseLabel": "Trade receivables" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r274" ] }, "ifrs-full_AdjustmentsForDepreciationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDepreciationExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for depreciation expense", "terseLabel": "Depreciation of property, plant and equipment" } }, "en": { "role": { "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r277" ] }, "ifrs-full_AdjustmentsForFinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForFinanceCosts", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 24.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for finance costs", "terseLabel": "Financial results" } }, "en": { "role": { "documentation": "Adjustments for finance costs to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance costs; Profit (loss)]" } } }, "auth_ref": [ "r276" ] }, "biox_AdjustmentsForGainLossOfParticipationInJointVenturesAndAssociates": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AdjustmentsForGainLossOfParticipationInJointVenturesAndAssociates", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for gain (loss) of participation in joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments For Gain (Loss) of Participation In Joint Ventures and Associates", "negatedLabel": "Loss of participation in joint ventures and associates" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates", "terseLabel": "Sale of equity investee - Indrasa Biotecnologa S.A." } }, "en": { "role": { "documentation": "Adjustments for gain (loss) on disposals investments in subsidiaries, joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries, joint ventures and associates reported in separate financial statements; Profit (loss)]" } } }, "auth_ref": [ "r277" ] }, "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Impairment loss recognised in profit or loss, trade receivables", "terseLabel": "Allowance for impairment of trade debtors" } }, "en": { "role": { "documentation": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]" } } }, "auth_ref": [ "r275" ] }, "ifrs-full_AdjustmentsForIncomeTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncomeTaxExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 25.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for income tax expense", "terseLabel": "Income tax" } }, "en": { "role": { "documentation": "Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r120" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for increase (decrease) in trade and other payables", "terseLabel": "Trade and other payables" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]" } } }, "auth_ref": [ "r277" ] }, "ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for losses (gains) on disposal of non-current assets", "terseLabel": "Gain or loss on sale of equipment and intangible assets" } }, "en": { "role": { "documentation": "Adjustments for losses (gains) on disposal of non-current assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Non-current assets; Profit (loss)]" } } }, "auth_ref": [ "r272" ] }, "biox_AdjustmentsForObsolescence": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AdjustmentsForObsolescence", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 12.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for obsolescence to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Obsolescence", "terseLabel": "Allowance for obsolescence", "verboseLabel": "Obsolescence" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForProvisions", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for provisions", "terseLabel": "Provisions for contingencies" } }, "en": { "role": { "documentation": "Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]" } } }, "auth_ref": [ "r275" ] }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForReconcileProfitLossAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile loss to net cash flows", "verboseLabel": "Adjustments to reconcile profit to net cash flows" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for share-based payments", "terseLabel": "Share-based incentive and stock options" } }, "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r275" ] }, "biox_AdjustmentsForTransactionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AdjustmentsForTransactionExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for transaction expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Transaction Expenses", "terseLabel": "Transactional expenses" } } }, "auth_ref": [] }, "ifrs-full_AdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdministrativeExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 15.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Administrative expenses", "terseLabel": "Office supplies", "verboseLabel": "Office supplies and registrations fees" } }, "en": { "role": { "documentation": "The amount of expenses that the entity classifies as being administrative." } } }, "auth_ref": [ "r47", "r79", "r213" ] }, "biox_AdvancesToSuppliersNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AdvancesToSuppliersNonCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherNoncurrentReceivables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of non-current receivables from advances to suppliers.", "label": "Advances to suppliers, Non Current", "terseLabel": "Reimbursements over exports" } } }, "auth_ref": [] }, "biox_AdvertisingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AdvertisingExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 11.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of advertising expense relating to production costs and selling general and administrative expenses.", "label": "Advertising Expenses", "terseLabel": "Publicity and advertising" } } }, "auth_ref": [] }, "ifrs-full_AggregatedMeasurementMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AggregatedMeasurementMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Aggregated measurement [member]" } }, "en": { "role": { "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used." } } }, "auth_ref": [ "r102", "r111", "r144" ] }, "biox_AlfalfaTechnologiesS.r.lMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AlfalfaTechnologiesS.r.lMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Alfalfa Technologies S.R.L.", "label": "Alfalfa Technologies S.R.L", "terseLabel": "Alfalfa Technologies S.R.L" } } }, "auth_ref": [] }, "currency_AllCurrenciesDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "AllCurrenciesDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "All Currencies [Domain]" } } }, "auth_ref": [] }, "ifrs-full_AllLevelsOfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AllLevelsOfFairValueHierarchyMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "All levels of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r64", "r145" ] }, "ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AllowanceAccountForCreditLossesOfFinancialAssets", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Allowance account for credit losses of financial assets", "negatedTerseLabel": "Allowance for impairment of trade debtors" } }, "en": { "role": { "documentation": "The amount of an allowance account used to record impairments to financial assets due to credit losses. [Refer: Financial assets]" } } }, "auth_ref": [ "r210" ] }, "biox_AllowanceForReturnOfGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AllowanceForReturnOfGoods", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of allowance for return of goods.", "label": "Allowance for return of goods", "negatedTerseLabel": "Allowance for credit notes to be issued" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Amortisation, intangible assets other than goodwill", "terseLabel": "Amortization of intangible assets" } }, "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r96" ] }, "ifrs-full_AmountsPayableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmountsPayableRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Amounts payable, related party transactions", "terseLabel": "Total" } }, "en": { "role": { "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r70", "r77" ] }, "ifrs-full_AmountsReceivableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmountsReceivableRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Amounts receivable, related party transactions", "terseLabel": "Total" } }, "en": { "role": { "documentation": "The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r70", "r77" ] }, "biox_AnalysisAndStorage": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "AnalysisAndStorage", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of analysis and storage.", "label": "Analysis and Storage", "terseLabel": "Analysis and storage" } } }, "auth_ref": [] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r23", "r144", "r145", "r146", "r196", "r200" ] }, "ifrs-full_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AssetsAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "ASSETS.", "terseLabel": "ASSETS" } } }, "auth_ref": [] }, "ifrs-full_AtCostMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AtCostMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "At cost" } }, "en": { "role": { "documentation": "This member stands for measurement based on cost. Cost is the amount of cash or cash equivalents paid or the fair value of the other consideration given to acquire an asset at the time of its acquisition or construction, or, when applicable, the amount attributed to that asset when initially recognised in accordance with the specific requirements of other IFRSs." } } }, "auth_ref": [ "r102", "r111", "r113" ] }, "ifrs-full_AtFairValueMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AtFairValueMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Fair value", "terseLabel": "Fair value" } }, "en": { "role": { "documentation": "This member stands for measurement based on fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date." } } }, "auth_ref": [ "r102", "r111", "r144" ] }, "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Attribution of expenses by nature to their function [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r254", "r257" ] }, "currency_BRL": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "BRL", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "BRL" } } }, "auth_ref": [] }, "biox_BankBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "BankBorrowingsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for bank borrowings.", "label": "Bank borrowings", "terseLabel": "Bank borrowings" } } }, "auth_ref": [] }, "biox_BaseShareOptionPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "BaseShareOptionPlanMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Base Share Option plan.", "label": "Base Share Option plan" } } }, "auth_ref": [] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Basic earnings (loss) per share", "terseLabel": "Basic (loss) profit attributable to ordinary equity holders of the parent" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r83", "r84" ] }, "biox_BioceresCropsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "BioceresCropsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Bioceres Crops.", "label": "Bioceres Crops [Member]", "terseLabel": "Bioceres Crops S.A.", "verboseLabel": "Bioceres Crops S.A." } } }, "auth_ref": [] }, "ifrs-full_BiologicalAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BiologicalAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Biological assets", "periodEndLabel": "End of period", "periodStartLabel": "Beginning of the period", "terseLabel": "Biological assets" } }, "en": { "role": { "documentation": "The amount of living animals or plants recognised as assets." } } }, "auth_ref": [ "r14", "r111", "r230" ] }, "ifrs-full_BiologicalAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BiologicalAssetsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Biological assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r270" ] }, "biox_BiologicalAssetsBarleyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "BiologicalAssetsBarleyMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for barley biological assets.", "label": "Barley" } } }, "auth_ref": [] }, "biox_BiologicalAssetsCornMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "BiologicalAssetsCornMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for corn biological assets.", "label": "Corn", "terseLabel": "Corn" } } }, "auth_ref": [] }, "ifrs-full_BiologicalAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BiologicalAssetsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Biological assets [member]" } }, "en": { "role": { "documentation": "This member stands for living animals or plants. It also represents the standard value for the 'Biological assets' axis if no other member is used." } } }, "auth_ref": [ "r270" ] }, "biox_BiologicalAssetsSoybeanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "BiologicalAssetsSoybeanMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for soybean biological assets.", "label": "Soybean", "terseLabel": "Soybean" } } }, "auth_ref": [] }, "biox_BiologicalAssetsWheatMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "BiologicalAssetsWheatMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for wheat biological assets.", "label": "Wheat", "terseLabel": "Wheat" } } }, "auth_ref": [] }, "ifrs-full_BondsIssued": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BondsIssued", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Bonds issued", "verboseLabel": "Corporate bonds" } }, "en": { "role": { "documentation": "The amount of bonds issued by the entity." } } }, "auth_ref": [ "r257" ] }, "biox_BorrowingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "BorrowingMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to borrowings.", "label": "Borrowings [Member]", "terseLabel": "Borrowings" } } }, "auth_ref": [] }, "ifrs-full_Borrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Borrowings", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings" } }, "en": { "role": { "documentation": "The amount of outstanding funds that the entity is obligated to repay." } } }, "auth_ref": [ "r259" ] }, "ifrs-full_BorrowingsByNameAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r282" ] }, "ifrs-full_BorrowingsByNameMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [member]" } }, "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "auth_ref": [ "r282" ] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Bottom of range [Member]", "terseLabel": "Minimum" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r148", "r162", "r172", "r243", "r244", "r282" ] }, "biox_BusinessInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "BusinessInformationAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Business Information [Abstract]", "terseLabel": "Business information" } } }, "auth_ref": [] }, "biox_CapitalizationOfConvertibleFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "CapitalizationOfConvertibleFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of cash inflow effect of capitalization of convertible notes.", "label": "Capitalization Of Convertible Financing Activities", "terseLabel": "Capitalization of convertible notes (Note 5.13)" } } }, "auth_ref": [] }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r55", "r60", "r94", "r98", "r104", "r105", "r107", "r111", "r112", "r175", "r183", "r184" ] }, "ifrs-full_CarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Carrying amount [member]" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r60", "r98", "r104", "r107", "r111", "r175", "r183", "r184" ] }, "ifrs-full_Cash": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Cash", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Cash", "terseLabel": "Cash at bank and on hand" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } } }, "auth_ref": [ "r279" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 6.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "terseLabel": "Cash and cash equivalents", "totalLabel": "Cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r17", "r121", "r139" ] }, "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents if different from statement of financial position", "periodEndLabel": "Cash and cash equivalents as of the end of the period", "periodStartLabel": "Cash and cash equivalents as of beginning of the period" } }, "en": { "role": { "documentation": "The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r279" ] }, "biox_CashAndEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "CashAndEquivalentsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for cash and cash equivalents.", "label": "Cash and cash equivalents [member]", "terseLabel": "Cash and cash equivalents" } } }, "auth_ref": [] }, "biox_CashFlowsFromObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "CashFlowsFromObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of aggregate cash flows from obtaining control of subsidiaries or other businesses, classified as investing activities.", "label": "Cash Flows From Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities", "terseLabel": "Net cash received from business combination" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) financing activities", "totalLabel": "Net cash flows (used) generated by financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } } }, "auth_ref": [ "r114", "r122" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "FINANCING ACTIVITIES" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities", "totalLabel": "Net cash flows used by investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } } }, "auth_ref": [ "r114", "r122" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "INVESTMENT ACTIVITIES" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities", "totalLabel": "Net cash flows generated by operating activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } } }, "auth_ref": [ "r114", "r122" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "OPERATING ACTIVITIES" } } }, "auth_ref": [] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r76" ] }, "biox_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of changes in fair value of financial assets or liabilities and other financial results", "label": "Change in Fair Value of Financial Assets or Liabilities or Other Financial Results", "terseLabel": "Changes in fair value of financial assets or liabilities and other financial results" } } }, "auth_ref": [] }, "biox_ChangeInNetRealizableValueOfAgricultural": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ChangeInNetRealizableValueOfAgricultural", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "documentation": "Change in the net realizable value of agricultural.", "label": "Change In The Net Realizable Value Of Agricultural", "terseLabel": "Changes in the net realizable value of agricultural products after harvest" } } }, "auth_ref": [] }, "biox_ChangesInNonControllingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ChangesInNonControllingInterestMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "The member stands for the changes in non-controlling interest.", "label": "Changes in non-controlling interest" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfAssetsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Classes of assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r88", "r89", "r147", "r159" ] }, "ifrs-full_ClassesOfAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfAssetsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Assets [member]" } }, "en": { "role": { "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used." } } }, "auth_ref": [ "r88", "r147", "r159" ] }, "ifrs-full_ClassesOfFinancialAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialAssetsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r168", "r187", "r188", "r208", "r209" ] }, "ifrs-full_ClassesOfFinancialLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialLiabilitiesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r187", "r188", "r208", "r209" ] }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r99" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r61" ] }, "ifrs-full_ClassesOfShareCapitalAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Classes of share capital [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r33" ] }, "ifrs-full_ClassesOfShareCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Share capital [member]" } }, "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } } }, "auth_ref": [ "r33" ] }, "biox_CommissionsAndRoyalties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "CommissionsAndRoyalties", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of commissions and royalties.", "label": "Commissions and Royalties", "terseLabel": "Commissions and royalties" } } }, "auth_ref": [] }, "biox_ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "documentation": "n/a", "label": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION" } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income", "totalLabel": "Total comprehensive (loss) profit" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r1", "r37", "r126", "r128", "r136", "r241" ] }, "ifrs-full_ComprehensiveIncomeAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAttributableToAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Total comprehensive (loss) profit attributable to:" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income, attributable to non-controlling interests", "terseLabel": "Non-controlling interests" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]" } } }, "auth_ref": [ "r1", "r40" ] }, "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income, attributable to owners of parent", "terseLabel": "Equity holders of the parent" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]" } } }, "auth_ref": [ "r1", "r41" ] }, "ifrs-full_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComputerEquipmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Equipment and computer software [member]", "terseLabel": "Equipment and computer software" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r264" ] }, "ifrs-full_ComputerSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComputerSoftwareMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Software", "terseLabel": "Software" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r228" ] }, "biox_ConsiderationForAcquisitionOfAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ConsiderationForAcquisitionOfAssetsCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as current.", "label": "Consideration for Acquisition of Assets, Current", "terseLabel": "Consideration for acquisition" } } }, "auth_ref": [] }, "biox_ConsiderationForAcquisitionOfAssetsNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ConsiderationForAcquisitionOfAssetsNonCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as non-current.", "label": "Consideration for Acquisition of Assets, Non Current", "terseLabel": "Consideration for acquisition" } } }, "auth_ref": [] }, "ifrs-full_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ConstructionInProgressMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Buildings in progress", "terseLabel": "Buildings in progress" } }, "en": { "role": { "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r264" ] }, "biox_Contingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "Contingencies", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of contingencies.", "label": "Contingencies", "terseLabel": "Contingencies" } } }, "auth_ref": [] }, "biox_ContingenciesCommitmentsAndRestrictionsOnDistributionOfProfitsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ContingenciesCommitmentsAndRestrictionsOnDistributionOfProfitsAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS" } } }, "auth_ref": [] }, "ifrs-full_ContingentConsiderationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ContingentConsiderationMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Consideration for acquisition of assets" } }, "en": { "role": { "documentation": "This member stands for an obligation of the acquirer to transfer additional assets or equity interests to the former owners of an acquiree as part of the exchange for control of the acquiree if specified future events occur or conditions are met." } } }, "auth_ref": [ "r281" ] }, "ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Trademarks and patents", "terseLabel": "Trademarks and patents" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing copyrights, patents and other industrial property rights, service and operating rights. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r229" ] }, "ifrs-full_CostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CostOfSales", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails": { "parentTag": "ifrs-full_GrossProfit", "weight": -1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Cost of sales", "negatedLabel": "Cost of sales", "terseLabel": "Cost of sales" } }, "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } } }, "auth_ref": [ "r0", "r47" ] }, "ifrs-full_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CostOfSalesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Cost of sales [member]", "terseLabel": "Production costs" } }, "en": { "role": { "documentation": "This member stands for the amount of all expenses directly or indirectly attributed to goods or services sold. This member is used to attribute an expense by nature to a functional line item in the statement of profit or loss." } } }, "auth_ref": [ "r254", "r257" ] }, "biox_CropNutritionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "CropNutritionMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Crop nutrition.", "label": "Crop nutrition", "terseLabel": "Crop nutrition" } } }, "auth_ref": [] }, "biox_CropProtectionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "CropProtectionMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Crop protection.", "label": "Crop protection", "terseLabel": "Crop protection" } } }, "auth_ref": [] }, "srt_CurrencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CurrencyAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Currency [Axis]" } } }, "auth_ref": [] }, "ifrs-full_CurrencyRiskMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrencyRiskMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Currency risk" } }, "en": { "role": { "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r163", "r164", "r165", "r166", "r192" ] }, "ifrs-full_CurrentAccrualsAndCurrentDeferredIncomeIncludingCurrentContractLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAccrualsAndCurrentDeferredIncomeIncludingCurrentContractLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Current accruals and current deferred income including current contract liabilities [abstract]", "terseLabel": "Current" } } }, "auth_ref": [] }, "ifrs-full_CurrentAdvances": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAdvances", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Current advances received, representing current contract liabilities for performance obligations satisfied at point in time", "terseLabel": "Advances from customers" } }, "en": { "role": { "documentation": "The amount of current advances received representing current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]" } } }, "auth_ref": [ "r259", "r260" ] }, "ifrs-full_CurrentAdvancesToSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAdvancesToSuppliers", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Current advances to suppliers", "terseLabel": "Prepayments to suppliers" } }, "en": { "role": { "documentation": "The amount of current advances made to suppliers before goods or services are received." } } }, "auth_ref": [ "r257" ] }, "ifrs-full_CurrentAgriculturalProduce": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAgriculturalProduce", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Current agricultural produce", "terseLabel": "Agricultural products" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of harvested produce of the entity's biological assets. [Refer: Biological assets; Inventories]" } } }, "auth_ref": [ "r266" ] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Total current assets", "totalLabel": "Total current assets" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r25", "r132", "r241" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS", "terseLabel": "Current" } } }, "auth_ref": [] }, "ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Current contract liabilities for performance obligations satisfied over time", "terseLabel": "Deferred Revenue" } }, "en": { "role": { "documentation": "The amount of current contract liabilities for performance obligations satisfied over time. [Refer: Contract liabilities for performance obligations satisfied over time]" } } }, "auth_ref": [ "r259", "r260" ] }, "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentDeferredIncomeIncludingCurrentContractLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 3.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current deferred income including current contract liabilities", "terseLabel": "Deferred revenue and advances from customers", "totalLabel": "Deferred revenue and advances from customers" } }, "en": { "role": { "documentation": "The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]" } } }, "auth_ref": [ "r259", "r260" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_CurrentInventoriesInTransit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentInventoriesInTransit", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Current inventories in transit", "terseLabel": "Goods in transit" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of inventories in transit. [Refer: Inventories]" } } }, "auth_ref": [ "r266" ] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails": { "parentTag": "ifrs-full_LeaseLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current lease liabilities", "terseLabel": "Lease liabilities", "verboseLabel": "Current" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r155" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current liabilities", "totalLabel": "Total current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r26", "r134", "r241" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES.", "terseLabel": "Current", "verboseLabel": "CURRENT LIABILITIES" } } }, "auth_ref": [] }, "ifrs-full_CurrentMaterialsAndSuppliesToBeConsumedInProductionProcessOrRenderingServices": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentMaterialsAndSuppliesToBeConsumedInProductionProcessOrRenderingServices", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Current materials and supplies to be consumed in production process or rendering services", "terseLabel": "Supplies" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of materials and supplies to be consumed in a production process or while rendering services. [Refer: Inventories]" } } }, "auth_ref": [ "r266" ] }, "ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails" ], "lang": { "en-us": { "role": { "label": "Current payables on social security and taxes other than income tax", "terseLabel": "Taxes" } }, "en": { "role": { "documentation": "The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]" } } }, "auth_ref": [ "r260" ] }, "ifrs-full_CurrentPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPrepaidExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Current prepaid expenses", "terseLabel": "Prepaid expenses and other receivables" } }, "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } } }, "auth_ref": [ "r257" ] }, "ifrs-full_CurrentProvisionsForEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentProvisionsForEmployeeBenefits", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 4.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Employee Benefits and Social Security, Current", "terseLabel": "Employee benefits and social security", "totalLabel": "Employee benefits and social security" } }, "en": { "role": { "documentation": "The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]" } } }, "auth_ref": [ "r28" ] }, "ifrs-full_CurrentTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current tax assets", "terseLabel": "Income and minimum presumed recoverable income taxes" } }, "en": { "role": { "documentation": "The excess of amount paid for current tax in respect of current and prior periods over the amount due for those periods. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } } }, "auth_ref": [ "r19" ] }, "ifrs-full_CurrentTaxAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current tax assets, non-current", "terseLabel": "Income and minimum presumed recoverable income taxes" } }, "en": { "role": { "documentation": "The non-current amount of current tax assets. [Refer: Current tax assets]" } } }, "auth_ref": [ "r19" ] }, "ifrs-full_CurrentTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxExpenseIncome", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Current tax expense (income)", "negatedLabel": "Current tax expense" } }, "en": { "role": { "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } } }, "auth_ref": [ "r220" ] }, "ifrs-full_CurrentTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current tax liabilities", "terseLabel": "Income tax payable" } }, "en": { "role": { "documentation": "The amount of current tax for current and prior periods to the extent unpaid. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } } }, "auth_ref": [ "r19" ] }, "ifrs-full_CurrentTradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTradeReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Current trade receivables", "terseLabel": "Trade debtors" } }, "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r215", "r217" ] }, "ifrs-full_CustomerrelatedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CustomerrelatedIntangibleAssetsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Customer loyalty", "terseLabel": "Customer loyalty" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships." } } }, "auth_ref": [ "r268" ] }, "biox_CustomersAndDistributorBulkOrdersPerYearMaximum": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "CustomersAndDistributorBulkOrdersPerYearMaximum", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSeasonalityDetails" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of bulk orders per year of some customers and distributors of the entity.", "label": "Customers and Distributor Bulk Orders Per Year, Maximum", "terseLabel": "Some customers and distributers order per year, maximum" } } }, "auth_ref": [] }, "biox_CustomersAndDistributorBulkOrdersPerYearMinimum": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "CustomersAndDistributorBulkOrdersPerYearMinimum", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSeasonalityDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum number of bulk orders per year of some customers and distributors of the entity.", "label": "Customers and Distributor Bulk Orders Per Year, Minimum", "terseLabel": "Some customers and distributers order per year, minimum" } } }, "auth_ref": [] }, "biox_DecreaseDueToHarvestAndDisposalsBiologicalAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DecreaseDueToHarvestAndDisposalsBiologicalAssets", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "The decrease in biological assets due to the detachment of produce from the assets or the cessation of the assets' life processes and disposals.", "label": "Decrease Due to Harvest and Disposals, biological assets", "negatedLabel": "Decrease due to harvest/disposals" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets", "terseLabel": "Deferred tax assets" } }, "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r20", "r24", "r52" ] }, "ifrs-full_DeferredTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxExpenseIncome", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax expense (income)", "negatedLabel": "Deferred tax" } }, "en": { "role": { "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]" } } }, "auth_ref": [ "r53" ] }, "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax expense (income) recognised in profit or loss", "verboseLabel": "Charge for the period" } }, "en": { "role": { "documentation": "The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]" } } }, "auth_ref": [ "r53" ] }, "ifrs-full_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Deferred tax liabilities", "terseLabel": "Deferred tax liabilities" } }, "en": { "role": { "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]" } } }, "auth_ref": [ "r20", "r24", "r52" ] }, "ifrs-full_DeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxLiabilityAsset", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax liability (asset)", "periodEndLabel": "Total net deferred tax", "periodStartLabel": "Beginning of the period deferred tax" } }, "en": { "role": { "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]" } } }, "auth_ref": [ "r52" ] }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationPropertyPlantAndEquipment", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 4.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation, property, plant and equipment", "terseLabel": "Depreciation of property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]" } } }, "auth_ref": [ "r58", "r62" ] }, "biox_DepreciationRightOfUseAssetsExchangeDifferences": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DepreciationRightOfUseAssetsExchangeDifferences", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of effect of exchange differences on the deprecation of right of use assets.", "label": "Depreciation right of use assets, exchange differences", "terseLabel": "Exchange differences" } } }, "auth_ref": [] }, "ifrs-full_DepreciationRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationRightofuseAssets", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 6.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 18.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation, right-of-use assets", "terseLabel": "Depreciation of leased assets", "verboseLabel": "Depreciation of the period/year" } }, "en": { "role": { "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]" } } }, "auth_ref": [ "r156" ] }, "biox_DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "documentation": "The description of the entity's accounting policy for the basis of measurement, preparation, and presentation of the financial statements.", "label": "Basis of measurement" } } }, "auth_ref": [] }, "biox_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DescriptionOfAccountingPolicyForChangesInAccountingPoliciesTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "documentation": "The description of the entity's changes in accounting policies.", "label": "Changes in accounting policies" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "label": "Foreign currency" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for foreign currency translation." } } }, "auth_ref": [ "r258" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "label": "Functional currency" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for the currency of the primary economic environment in which the entity operates." } } }, "auth_ref": [ "r258" ] }, "biox_DescriptionOfAccountingPolicyForPresentationCurrencyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DescriptionOfAccountingPolicyForPresentationCurrencyTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "documentation": "The description of the entity's accounting policy for the currency used in presenting financial statements to regulatory agencies.", "label": "Presentation currency" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations", "presentation": [ "http://www.biocerescrops.com/role/DisclosureNewStandardsAmendmentsAndInterpretationsIssuedByIasb" ], "lang": { "en-us": { "role": { "label": "Disclosure of expected impact of initial application of new standards or interpretations [text block]", "terseLabel": "NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB" } }, "en": { "role": { "documentation": "The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have." } } }, "auth_ref": [ "r124" ] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Diluted earnings (loss) per share", "terseLabel": "Diluted (loss) profit attributable to ordinary equity holders of the parent" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r83", "r84" ] }, "biox_DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparation" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on accounting standards and basis of presentation.", "label": "Disclosure Of Accounting Standards And Basis Of Presentation [Text Block]", "terseLabel": "ACCOUNTING STANDARDS AND BASIS OF PREPARATION" } } }, "auth_ref": [] }, "biox_DisclosureOfAccumulatedAmortizationOfIntangibleAssets.TextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfAccumulatedAmortizationOfIntangibleAssets.TextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "he disclosure of detailed information about accumulated amortization of intangible assets.", "label": "Disclosure of accumulated amortization of intangible assets. [text block]", "terseLabel": "Schedule of accumulated amortization of intangibles" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of attribution of expenses by nature to their function [line items]", "terseLabel": "Expenses classified by nature and function" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of attribution of expenses by nature to their function [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to attribution of expenses by nature to analysis of expenses by function in the statement of profit or loss." } } }, "auth_ref": [ "r254", "r257" ] }, "biox_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of salaries and social security payables.", "label": "Disclosure of Benefits and Social Security Payables [Table Text Block]", "terseLabel": "Schedule of employee benefits and social security" } } }, "auth_ref": [] }, "biox_DisclosureOfCarryingValueOfBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfCarryingValueOfBorrowingsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about carrying value of borrowings.", "label": "Disclosure of carrying value of borrowings explanatory", "terseLabel": "Schedule of carrying value of borrowings" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCashAndCashEquivalentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of cash and cash equivalents [text block]", "terseLabel": "Schedule of cash and cash equivalents" } }, "en": { "role": { "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r253" ] }, "ifrs-full_DisclosureOfCashFlowStatementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCashFlowStatementExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformation" ], "lang": { "en-us": { "role": { "label": "Disclosure of cash flow statement [text block]", "terseLabel": "CASH FLOW INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for a statement of cash flows." } } }, "auth_ref": [ "r123" ] }, "biox_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of investments in joint ventures and affiliates.", "label": "Disclosure of Changes in Investment in Joint Ventures and Affiliates [Table Text Block]", "terseLabel": "Schedule of changes in joint ventures" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalAbstract", "lang": { "en-us": { "role": { "label": "EQUITY INFORMATION" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to classes of share capital." } } }, "auth_ref": [ "r33" ] }, "ifrs-full_DisclosureOfCommitmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCommitmentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureContingenciesCommitmentsAndRestrictionsOnDistributionOfProfits" ], "lang": { "en-us": { "role": { "label": "Disclosure of commitments [text block]", "verboseLabel": "CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS" } }, "en": { "role": { "documentation": "The disclosure of commitments." } } }, "auth_ref": [ "r253" ] }, "biox_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of compensation of directors and other members of key management personnel.", "label": "Disclosure of Compensation of Directors and Other Members of Key Management Personnel [Table Text Block]", "verboseLabel": "Schedule of compensation of directors and other members of key management personnel" } } }, "auth_ref": [] }, "biox_DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of components of Consolidated Statements of Financial Position.", "label": "Disclosure Of Components Of Consolidated Statements Of Financial Position", "terseLabel": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfCostOfSalesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCostOfSalesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of cost of sales [text block]", "terseLabel": "Schedule of cost of sales" } }, "en": { "role": { "documentation": "The disclosure of the cost of sales. [Refer: Cost of sales]" } } }, "auth_ref": [ "r253" ] }, "ifrs-full_DisclosureOfDeferredTaxesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDeferredTaxesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of deferred taxes [text block]", "verboseLabel": "Schedule of net deferred tax" } }, "en": { "role": { "documentation": "The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]" } } }, "auth_ref": [ "r253" ] }, "biox_DisclosureOfDepreciationExpenseTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfDepreciationExpenseTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of depreciation.", "label": "Disclosure of depreciation expense [text block]", "terseLabel": "Schedule of accumulated depreciation" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [text block]", "terseLabel": "Schedule of borrowings" } }, "en": { "role": { "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r282" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [line items]", "terseLabel": "Borrowings:" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } } }, "auth_ref": [ "r282" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [text block]", "terseLabel": "Schedule of intangible assets" } }, "en": { "role": { "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r99" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [text block]", "terseLabel": "Schedule of property plant and equipment" } }, "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r61" ] }, "biox_DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.", "label": "Disclosure of Detailed Information about Research and Development Expense [Line Items]", "terseLabel": "Costs and expenses" } } }, "auth_ref": [] }, "biox_DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseTable": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to details of research and development expense.", "label": "Disclosure of Detailed Information about Research and Development Expense [Table]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [text block]", "terseLabel": "Schedule of revenue from contracts with customers" } }, "en": { "role": { "documentation": "The disclosure of the disaggregation of revenue from contracts with customers. [Refer: Revenue from contracts with customers]" } } }, "auth_ref": [ "r151" ] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [line items]", "terseLabel": "Revenue" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } } }, "auth_ref": [ "r151" ] }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEarningsPerShareExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShare" ], "lang": { "en-us": { "role": { "label": "Disclosure of earnings per share [text block]", "verboseLabel": "EARNING PER SHARE" } }, "en": { "role": { "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r87" ] }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformation" ], "lang": { "en-us": { "role": { "label": "Disclosure of entity's operating segments [text block]", "terseLabel": "SEGMENT INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for operating segments." } } }, "auth_ref": [ "r207" ] }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEventsOccurringAfterReportingPeriod" ], "lang": { "en-us": { "role": { "label": "Disclosure of events after reporting period [text block]", "terseLabel": "EVENTS OCCURRING AFTER THE REPORTING PERIOD" } }, "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } } }, "auth_ref": [ "r48" ] }, "ifrs-full_DisclosureOfExpensesByNatureExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfExpensesByNatureExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of expenses by nature [text block]", "terseLabel": "Schedule of expenses classified by nature and function" } }, "en": { "role": { "documentation": "The disclosure of expenses by nature. [Refer: Expenses, by nature]" } } }, "auth_ref": [ "r253" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [line items]", "terseLabel": "Fair value by hierarchy" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } } }, "auth_ref": [ "r147" ] }, "ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value of financial instruments [text block]", "terseLabel": "Schedule of fair value by hierarchy" } }, "en": { "role": { "documentation": "The disclosure of the fair value of financial instruments. [Refer: Financial instruments, class [member]; At fair value [member]]" } } }, "auth_ref": [ "r253" ] }, "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinanceIncomeExpenseExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of finance income (cost) [text block]", "terseLabel": "Schedule of net financial cost" } }, "en": { "role": { "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]" } } }, "auth_ref": [ "r253" ] }, "ifrs-full_DisclosureOfFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialAssetsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial assets [text block]", "terseLabel": "Schedule of financial assets by category" } }, "en": { "role": { "documentation": "The disclosure of financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r189" ] }, "ifrs-full_DisclosureOfFinancialAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial assets [line items]", "terseLabel": "Financial assets by category" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to financial assets." } } }, "auth_ref": [ "r189" ] }, "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [text block]", "terseLabel": "Schedule financial liabilities by category" } }, "en": { "role": { "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r189" ] }, "ifrs-full_DisclosureOfFinancialLiabilitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [line items]", "terseLabel": "Financial liabilities by category" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to financial liabilities." } } }, "auth_ref": [ "r189" ] }, "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialRiskManagementExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagement" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial risk management [text block]", "terseLabel": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT" } }, "en": { "role": { "documentation": "The disclosure of the entity's financial risk management practices and policies." } } }, "auth_ref": [ "r253" ] }, "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureGeneralInformation" ], "lang": { "en-us": { "role": { "label": "Disclosure of general information about financial statements [text block]", "terseLabel": "GENERAL INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for general information about financial statements." } } }, "auth_ref": [ "r8" ] }, "biox_DisclosureOfGrossCarryingAmountOfIntangibleAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfGrossCarryingAmountOfIntangibleAssetsTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about gross carrying amount of intangible assets.", "label": "Disclosure of gross carrying amount of intangible assets [text block]", "terseLabel": "Schedule of gross carrying amounts of intangibles" } } }, "auth_ref": [] }, "biox_DisclosureOfGrossCarryingAmountTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfGrossCarryingAmountTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of gross carrying amount of each asset class.", "label": "Disclosure of gross carrying amount [text block]", "terseLabel": "Schedule of gross carrying amount" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIncomeTaxExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxation" ], "lang": { "en-us": { "role": { "label": "Disclosure of income tax [text block]", "terseLabel": "TAXATION" } }, "en": { "role": { "documentation": "The entire disclosure for income taxes." } } }, "auth_ref": [ "r54" ] }, "biox_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of information about components of consolidated statement of comprehensive income.", "label": "Disclosure of Information About Components of Consolidated Statements of Comprehensive Income [Text Block]", "terseLabel": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensation" ], "lang": { "en-us": { "role": { "label": "Disclosure of information about key management personnel [text block]", "terseLabel": "KEY MANAGEMENT PERSONNEL COMPENSATION" } }, "en": { "role": { "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r253" ] }, "ifrs-full_DisclosureOfIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [line items]", "terseLabel": "Intangible assets" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of intangible assets." } } }, "auth_ref": [ "r99" ] }, "ifrs-full_DisclosureOfInvestmentPropertyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInvestmentPropertyExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of investment property [text block]", "terseLabel": "Schedule of investment properties" } }, "en": { "role": { "documentation": "The entire disclosure for investment property." } } }, "auth_ref": [ "r108" ] }, "biox_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables" ], "lang": { "en-us": { "role": { "documentation": "Information pertains to disclosure of investments in associates and joint ventures.", "label": "Disclosure of Investments in Joint Ventures and Affiliates [Table Text Block]", "terseLabel": "Schedule of investments in joint ventures and associates" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfJointVenturesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfJointVenturesLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of joint ventures [line items]", "terseLabel": "JOINT VENTURES" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfJointVenturesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfJointVenturesTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of joint ventures [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to joint ventures." } } }, "auth_ref": [ "r81", "r82", "r143" ] }, "ifrs-full_DisclosureOfLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfLeasesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeases" ], "lang": { "en-us": { "role": { "label": "Disclosure of leases [text block]", "terseLabel": "LEASES" } }, "en": { "role": { "documentation": "The entire disclosure for leases." } } }, "auth_ref": [ "r160", "r161" ] }, "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of nature and extent of risks arising from financial instruments [text block]", "terseLabel": "Schedule of net exposure" } }, "en": { "role": { "documentation": "The disclosure of information that enables users of financial statements to evaluate the nature and extent of risks arising from financial instruments to which the entity is exposed. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r179" ] }, "biox_DisclosureOfNetCarryingAmountOfOtherIntangibleAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfNetCarryingAmountOfOtherIntangibleAssetsTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about other intangible assets.", "label": "Disclosure of net carrying amount of other intangible assets [Text block]", "terseLabel": "Schedule of net carrying amount of intangibles" } } }, "auth_ref": [] }, "biox_DisclosureOfNetCarryingAmountTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfNetCarryingAmountTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of net carrying amount of each asset class.", "label": "Disclosure of net carrying amount [text block]", "terseLabel": "Schedule of net carrying amount" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract", "lang": { "en-us": { "role": { "label": "EVENTS OCCURRING AFTER THE REPORTING PERIOD" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOperatingSegmentsAbstract", "lang": { "en-us": { "role": { "label": "SEGMENT INFORMATION" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOperatingSegmentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [text block]", "terseLabel": "Schedule of operating results group's reporting segments" } }, "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } } }, "auth_ref": [ "r196" ] }, "ifrs-full_DisclosureOfOperatingSegmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOperatingSegmentsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [line items]", "terseLabel": "SEGMENT INFORMATION" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOperatingSegmentsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to operating segments." } } }, "auth_ref": [ "r196" ] }, "biox_DisclosureOfOtherFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfOtherFinancialAssetsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of other financial assets.", "label": "Disclosure of other financial assets explanatory", "terseLabel": "Schedule of other financial assets" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherOperatingIncomeExpenseExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of other operating income (expense) [text block]", "terseLabel": "Schedule of other income or expenses, net" } }, "en": { "role": { "documentation": "The disclosure of other operating income or expense. [Refer: Other operating income (expense)]" } } }, "auth_ref": [ "r253" ] }, "biox_DisclosureOfOtherReceivablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfOtherReceivablesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about other receivables.", "label": "Disclosure of Other Receivables [Table Text Block]", "terseLabel": "Schedule of other receivables" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPerformanceObligationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPerformanceObligationsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of performance obligations [text block]", "terseLabel": "Schedule of deferred revenue and advances from customers" } }, "en": { "role": { "documentation": "The disclosure of performance obligations in contracts with customers. [Refer: Performance obligations [member]]" } } }, "auth_ref": [ "r153" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [line items]", "terseLabel": "Property, plant and equipment" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } } }, "auth_ref": [ "r61" ] }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of quantitative information about right-of-use assets [line items]", "terseLabel": "Right-of-use leased asset" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of quantitative information about right-of-use assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to right-of-use assets." } } }, "auth_ref": [ "r159" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in biological assets [text block]", "terseLabel": "Schedule of changes in biological assets" } }, "en": { "role": { "documentation": "The disclosure of the reconciliation of changes in biological assets. [Refer: Biological assets]" } } }, "auth_ref": [ "r111" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in biological assets [line items]", "terseLabel": "Inventory", "verboseLabel": "Biological assets" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInBiologicalAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in biological assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in biological assets." } } }, "auth_ref": [ "r111" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [text block]", "terseLabel": "Schedule of carrying amount of goodwill" } }, "en": { "role": { "documentation": "The disclosure of the reconciliation of changes in goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r175" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [line items]", "terseLabel": "Goodwill" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill." } } }, "auth_ref": [ "r175" ] }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRelatedPartyExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactions" ], "lang": { "en-us": { "role": { "label": "Disclosure of related party [text block]", "verboseLabel": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS" } }, "en": { "role": { "documentation": "The entire disclosure for related parties." } } }, "auth_ref": [ "r78" ] }, "ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of research and development expense [text block]", "terseLabel": "Schedule of R&D classified by nature" } }, "en": { "role": { "documentation": "The disclosure of research and development expense. [Refer: Research and development expense]" } } }, "auth_ref": [ "r253" ] }, "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract", "lang": { "en-us": { "role": { "label": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT" } } }, "auth_ref": [] }, "biox_DisclosureOfSeasonalityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfSeasonalityAbstract", "lang": { "en-us": { "role": { "documentation": "No definition availability.", "label": "SEASONALITY" } } }, "auth_ref": [] }, "biox_DisclosureOfSeasonalityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfSeasonalityTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSeasonality" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of the seasonality of the entity's business.", "label": "Disclosure of Seasonality [Text Block]", "terseLabel": "SEASONALITY" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17LineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17LineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of sensitivity analysis to changes in risk variables that arise from contracts within scope of IFRS 17 [line items]", "terseLabel": "Currency risk" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of sensitivity analysis to changes in risk variables that arise from contracts within scope of IFRS 17 [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the sensitivity analysis to changes in risk variables that arise from contracts within the scope of IFRS 17." } } }, "auth_ref": [ "r167" ] }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformation" ], "lang": { "en-us": { "role": { "label": "Disclosure of share capital, reserves and other equity interest [text block]", "terseLabel": "EQUITY INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } } }, "auth_ref": [ "r34" ] }, "biox_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of share of profit / (loss) joint ventures and affiliates.", "label": "Disclosure of Share of Profit or Loss in Joint Ventures and Affiliates [Table Text Block]", "terseLabel": "Schedule of share of profit or loss of joint ventures and associates" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPayment" ], "lang": { "en-us": { "role": { "label": "Disclosure of share-based payment arrangements [text block]", "terseLabel": "SHARE-BASED PAYMENT" } }, "en": { "role": { "documentation": "The entire disclosure for share-based payment arrangements." } } }, "auth_ref": [ "r169" ] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract", "lang": { "en-us": { "role": { "label": "SHARE-BASED PAYMENT" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]", "terseLabel": "SHARE-BASED PAYMENT" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements." } } }, "auth_ref": [ "r173" ] }, "biox_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "Definition: Tabular disclosure of components of trade and other payables.", "label": "Disclosure Of Trade And Other Payables Components [Table Text Block]", "terseLabel": "Schedule of trade and other payable" } } }, "auth_ref": [] }, "biox_DisclosureOfTradeReceivablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisclosureOfTradeReceivablesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of current and non-current trade receivables.", "label": "Disclosure of Trade Receivables [Table Text Block]", "terseLabel": "Schedule of trade receivables" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract", "lang": { "en-us": { "role": { "label": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [text block]", "verboseLabel": "Schedule of transactions between the group and related parties, and the related balances owed" } }, "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r71" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [line items]", "terseLabel": "Components of Consolidated Statement of Financial Position", "verboseLabel": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } } }, "auth_ref": [ "r76" ] }, "biox_Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of roll forward of right of use leased assets and lease liability", "label": "Disclosure Of Right Of Use Leased Assets And Lease Liability [Table Text Block]", "terseLabel": "Schedule of right of use leased assets and lease liability from beginning of year to end of year" } } }, "auth_ref": [] }, "ifrs-full_DisposalsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisposalsPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Disposals, property, plant and equipment", "negatedTerseLabel": "Disposals", "terseLabel": "Disposals" } }, "en": { "role": { "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r57" ] }, "biox_DisposalsToRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DisposalsToRightOfUseAssets", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of disposals to right-of-use assets", "label": "Disposals To Right-of-use Assets", "negatedLabel": "Disposals" } } }, "auth_ref": [] }, "ifrs-full_DividendsPaid": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsPaid", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Dividends recognised as distributions to owners", "negatedLabel": "Distribution of dividends by subsidiary" } }, "en": { "role": { "documentation": "The amount of dividends recognised as distributions to owners." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_DividendsPaidClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsPaidClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Dividends paid, classified as financing activities", "negatedLabel": "Cash dividend distributed by subsidiary" } }, "en": { "role": { "documentation": "The cash outflow for dividends paid by the entity, classified as financing activities." } } }, "auth_ref": [ "r119" ] }, "biox_DocumentAndEntityInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "DocumentAndEntityInformationAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "EARNING PER SHARE", "terseLabel": "(Loss) profit per share" } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareTables" ], "lang": { "en-us": { "role": { "label": "Earnings per share [text block]", "terseLabel": "Schedule of earnings per share" } }, "en": { "role": { "documentation": "The disclosure of earnings per share." } } }, "auth_ref": [ "r83" ] }, "biox_EcoseedIntegratedProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "EcoseedIntegratedProductsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to Eco seed integrated products.", "label": "Eco seed integrated products", "terseLabel": "Integrated seed products" } } }, "auth_ref": [] }, "biox_EffectInProfitAndLossDueToDesignateDevaluationOrAppreciationOfUsDollar": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "EffectInProfitAndLossDueToDesignateDevaluationOrAppreciationOfUsDollar", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "The effect on profit and loss as a result of an increase in a designated risk component that was reasonably possible at the end of the reporting period. Excludes defined benefit plan obligation", "label": "Effect in profit and loss due to designate devaluation or appreciation of US dollar" } } }, "auth_ref": [] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of exchange rate changes on cash and cash equivalents", "terseLabel": "Effect of exchange rate changes on cash and equivalents" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r117", "r118" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r252" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r252" ] }, "ifrs-full_EntitysTotalForJointVenturesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForJointVenturesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "label": "Entity's total for joint ventures [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Joint ventures' axis if no other member is used." } } }, "auth_ref": [ "r81", "r82", "r143" ] }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForRelatedPartiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Entity's total for related parties [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r76" ] }, "ifrs-full_EntitysTotalForSubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForSubsidiariesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Entity's total for subsidiaries [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "auth_ref": [ "r81", "r82", "r142" ] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total equity" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r23", "r29", "r125", "r127", "r144", "r145", "r146" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "EQUITY.", "verboseLabel": "EQUITY" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity and liabilities", "totalLabel": "Total equity and liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r23" ] }, "ifrs-full_EquityAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity attributable to owners of parent", "terseLabel": "Equity attributable to owners of the parent" } }, "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } } }, "auth_ref": [ "r22" ] }, "ifrs-full_EquityAttributableToOwnersOfParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAttributableToOwnersOfParentMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Equity / (deficit) attributable to owners of the parent" } }, "en": { "role": { "documentation": "This member stands for equity attributable to the owners of the parent." } } }, "auth_ref": [ "r6" ] }, "biox_EquityCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "EquityCompensationPlanMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Member stands for equity compensation plan.", "label": "Equity Compensation Plan [Member]", "terseLabel": "Equity compensation plan" } } }, "auth_ref": [] }, "ifrs-full_EquityMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Equity [member]" } }, "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r6" ] }, "biox_EquityMethodInvestmentIncreaseFromShareBasedIncentives": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "EquityMethodInvestmentIncreaseFromShareBasedIncentives", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "The increase in the amount of investment accounted under equity method related to share-based incentives.", "label": "Equity Method Investment Increase From Share Based Incentives", "terseLabel": "Share-based incentives" } } }, "auth_ref": [] }, "ifrs-full_ExercisePriceShareOptionsGranted2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExercisePriceShareOptionsGranted2019", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price, share options granted", "terseLabel": "Exercise price" } }, "en": { "role": { "documentation": "The exercise price of share options granted." } } }, "auth_ref": [ "r174" ] }, "biox_ExpensesRecovery": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ExpensesRecovery", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of recovered expenses.", "label": "Expenses Recovery", "terseLabel": "Expenses recovery" } } }, "auth_ref": [] }, "ifrs-full_FeeAndCommissionExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FeeAndCommissionExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Fee and commission expense", "negatedLabel": "Financial commissions" } }, "en": { "role": { "documentation": "The amount of expense relating to fees and commissions." } } }, "auth_ref": [ "r262" ] }, "ifrs-full_FinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceCosts", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Finance costs", "negatedTotalLabel": "Financial costs" } }, "en": { "role": { "documentation": "The amount of costs associated with financing activities of the entity." } } }, "auth_ref": [ "r43" ] }, "biox_FinanceCostsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "FinanceCostsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available", "label": "Finance Costs [Abstract]", "terseLabel": "Financial costs" } } }, "auth_ref": [] }, "ifrs-full_FinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncomeCost", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Finance income (cost)", "verboseLabel": "Financial cost" } }, "en": { "role": { "documentation": "The amount of income or cost associated with interest and other financing activities of the entity." } } }, "auth_ref": [ "r262" ] }, "ifrs-full_FinanceIncomeReceivedClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncomeReceivedClassifiedAsOperatingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Finance income received, classified as operating activities", "terseLabel": "Interest collected" } }, "en": { "role": { "documentation": "The cash inflow from finance income received, classified as operating activities. [Refer: Finance income]" } } }, "auth_ref": [ "r278" ] }, "ifrs-full_FinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssets", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets." } }, "en": { "role": { "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]" } } }, "auth_ref": [ "r178", "r183", "r184", "r186", "r249" ] }, "ifrs-full_FinancialAssetsAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsAtFairValue", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets, at fair value", "terseLabel": "Financial assets at fair value" } }, "en": { "role": { "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]" } } }, "auth_ref": [ "r178" ] }, "ifrs-full_FinancialAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets" } }, "en": { "role": { "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]" } } }, "auth_ref": [ "r168", "r187", "r188", "r208", "r209" ] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities.", "verboseLabel": "Financial liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r178" ] }, "ifrs-full_FinancialLiabilitiesAtAmortisedCostMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtAmortisedCostMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Amortized cost", "terseLabel": "Amortized cost" } }, "en": { "role": { "documentation": "This member stands for the financial liabilities measured at amortised cost class. [Refer: Financial liabilities at amortised cost]" } } }, "auth_ref": [ "r190" ] }, "ifrs-full_FinancialLiabilitiesAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtFairValue", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities, at fair value" } }, "en": { "role": { "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]" } } }, "auth_ref": [ "r178" ] }, "ifrs-full_FinancialLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities" } }, "en": { "role": { "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r187", "r188", "r208", "r209" ] }, "ifrs-full_FixturesAndFittingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FixturesAndFittingsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Fixture and fittings", "terseLabel": "Fixture and fittings" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r223" ] }, "biox_ForeignCurrencyTranslationOnInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ForeignCurrencyTranslationOnInventory", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation on inventory", "label": "Foreign Currency Translation on Inventory", "negatedLabel": "Foreign currency translation" } } }, "auth_ref": [] }, "biox_FreightAndHaulageExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "FreightAndHaulageExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 5.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of freight and haulage expenses.", "label": "Freight and Haulage Expenses", "terseLabel": "Freight and haulage" } } }, "auth_ref": [] }, "ifrs-full_FuelAndEnergyExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FuelAndEnergyExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 8.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Fuel and energy expense", "terseLabel": "Energy and fuel" } }, "en": { "role": { "documentation": "The amount of expense arising from the consumption of fuel and energy." } } }, "auth_ref": [ "r257" ] }, "ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Gains (losses) on change in fair value less costs to sell of biological assets for current period", "negatedLabel": "Changes in the net realizable value of agricultural products after harvest" } }, "en": { "role": { "documentation": "The gains (losses) arising during the current period on the change in fair value less costs to sell of biological assets. [Refer: Biological assets]" } } }, "auth_ref": [ "r109" ] }, "biox_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation from joint venture of financial statements of foreign operations, net of tax.", "label": "Gains Losses On Exchange Differences On Translation From Joint Venture Net Of Tax", "verboseLabel": "Foreign currency translation" } } }, "auth_ref": [] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Gains (losses) on exchange differences on translation, net of tax", "terseLabel": "Foreign exchange differences on translation of foreign operations" } }, "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r46" ] }, "ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Gains (losses) on fair value adjustment attributable to price changes, biological assets", "terseLabel": "Initial recognition and changes in the fair value of biological assets" } }, "en": { "role": { "documentation": "The gains (losses) arising from changes in fair value less costs to sell of biological assets due to price changes in the market. [Refer: Biological assets]" } } }, "auth_ref": [ "r231", "r232" ] }, "ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnFairValueAdjustmentBiologicalAssets", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Gains (losses) on fair value adjustment, biological assets", "terseLabel": "Initial recognition and changes in the fair value of biological assets at the point of harvest", "verboseLabel": "Initial recognition and changes in the fair value of biological assets at the point of harvest" } }, "en": { "role": { "documentation": "The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]" } } }, "auth_ref": [ "r110" ] }, "ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Gains (losses) recognised in profit or loss on exchange differences, fair value measurement, assets", "terseLabel": "Exchange differences generated by assets" } }, "en": { "role": { "documentation": "The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of assets. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r280" ] }, "ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Gains (losses) recognised in profit or loss on exchange differences, fair value measurement, liabilities", "terseLabel": "Exchange differences generated by liabilities" } }, "en": { "role": { "documentation": "The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of liabilities. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r280" ] }, "biox_GeneralInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "GeneralInformationAbstract", "lang": { "en-us": { "role": { "documentation": "No Definition Available", "label": "GENERAL INFORMATION" } } }, "auth_ref": [] }, "biox_GoodsAndServicesIncludingRightOfUseLicenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "GoodsAndServicesIncludingRightOfUseLicenseMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for goods and services, including rights of use license.", "label": "Goods And Services, Including Right Of Use License [Member]", "terseLabel": "Sale of goods and services" } } }, "auth_ref": [] }, "biox_GoodsAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "GoodsAndServicesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for goods and services.", "label": "Goods And Services [Member]", "terseLabel": "Sale of goods and services" } } }, "auth_ref": [] }, "ifrs-full_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Goodwill", "terseLabel": "Goodwill" } }, "en": { "role": { "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r11", "r90", "r92", "r175" ] }, "ifrs-full_GrossCarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossCarryingAmountMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Gross carrying amount [member]", "terseLabel": "Gross carrying amount", "verboseLabel": "Right-of-use leased asset" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r55", "r94", "r105", "r112", "r175", "r184", "r186", "r249" ] }, "ifrs-full_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Gross profit", "totalLabel": "Gross profit per segment" } }, "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } } }, "auth_ref": [ "r213" ] }, "biox_IfEbitdaReachesAtLeastUs120MillionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "IfEbitdaReachesAtLeastUs120MillionMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for scenario, if EBITDA reaches at least US$120 million.", "label": "If EBITDA Reaches at Least US$120 Million" } } }, "auth_ref": [] }, "biox_IfEbitdaReachesAtLeastUs150MillionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "IfEbitdaReachesAtLeastUs150MillionMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for scenario, if EBITDA reaches at least US$150 million.", "label": "If EBITDA reaches at least US$150 million" } } }, "auth_ref": [] }, "biox_IfrsPaymentsToPurchaseOfOwnShares": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "IfrsPaymentsToPurchaseOfOwnShares", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of acquisition of own shares.", "label": "ifrs Payments to Purchase of Own Shares", "negatedLabel": "Purchase of own shares" } } }, "auth_ref": [] }, "biox_IfrsResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "IfrsResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research And Development Expense [Member]", "terseLabel": "Research and development expenses" } } }, "auth_ref": [] }, "biox_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Ifrs Schedule Of Components Of Income Tax Expense Benefit [Table Text Block]", "terseLabel": "Schedule of current tax" } } }, "auth_ref": [] }, "biox_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "IFRS Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of reconciliation of the statutory tax rate to the effective tax rate" } } }, "auth_ref": [] }, "biox_IfrsScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "IfrsScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Ifrs Schedule of Inventory Current Table Text Block", "terseLabel": "Schedule of inventories" } } }, "auth_ref": [] }, "biox_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "IFRS Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Vesting percentage" } } }, "auth_ref": [] }, "biox_IfrsStockRepurchasedDuringPeriodShares": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "IfrsStockRepurchasedDuringPeriodShares", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased.", "label": "Ifrs Stock Repurchased During Period Shares", "terseLabel": "Number of own shares repurchased" } } }, "auth_ref": [] }, "biox_ImpairmentOfReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ImpairmentOfReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss, trade receivables relating to production costs selling, general and administrative expenses.", "label": "Impairment Of Receivables", "terseLabel": "Impairment of receivables" } } }, "auth_ref": [] }, "biox_ImportAndExportExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ImportAndExportExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 3.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of import and export expenses.", "label": "Import and Export Expenses", "terseLabel": "Import and export expenses" } } }, "auth_ref": [] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails", "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Tax expense (income), continuing operations", "negatedLabel": "Income tax", "negatedTotalLabel": "Income tax expenses" } }, "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } } }, "auth_ref": [ "r45", "r49", "r50", "r51", "r80", "r140", "r195" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes", "totalLabel": "Net (decrease) increase in cash and cash equivalents" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r121" ] }, "biox_IncreaseDecreaseThroughBusinessCombinationTransactionsEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "IncreaseDecreaseThroughBusinessCombinationTransactionsEquity", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in equity resulting from business combination transactions.", "label": "Increase (Decrease) Through Business Combination Transactions, Equity", "terseLabel": "Business combination" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through business combinations, deferred tax liability (asset)", "terseLabel": "Additions for business combination" } }, "en": { "role": { "documentation": "The increase (decrease) in deferred tax liability (asset) resulting from business combinations. [Refer: Deferred tax liability (asset)]" } } }, "auth_ref": [ "r263" ] }, "biox_IncreaseDecreaseThroughCapitalizationOfConvertibleNotesEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "IncreaseDecreaseThroughCapitalizationOfConvertibleNotesEquity", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in equity resulting from capitalization of convertible notes", "label": "Increase (Decrease) Through Capitalization of Convertible Notes, Equity", "terseLabel": "Capitalization of convertible notes" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, deferred tax liability (asset)", "terseLabel": "Conversion difference" } }, "en": { "role": { "documentation": "The increase (decrease) in deferred tax liability (asset) resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Deferred tax liability (asset)]" } } }, "auth_ref": [ "r263" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill", "negatedTerseLabel": "Foreign currency translation", "terseLabel": "Foreign currency translation" } }, "en": { "role": { "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r97" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, property, plant and equipment", "negatedLabel": "Foreign currency translation", "terseLabel": "Foreign currency translation" } }, "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r59" ] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through share-based payment transactions, equity", "terseLabel": "Share-based incentives" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r4" ] }, "ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughTreasuryShareTransactions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through treasury share transactions, equity", "terseLabel": "Purchase of own shares" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]" } } }, "auth_ref": [ "r5" ] }, "biox_IndrasaBiotecnologaS.a.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "IndrasaBiotecnologaS.a.Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Indrasa Biotecnologia S.A.", "label": "Indrasa Biotecnologia S.A.", "terseLabel": "Indrasa Biotecnologia S.A." } } }, "auth_ref": [] }, "biox_InflationEffectsOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "InflationEffectsOnCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The effect of inflation effects on cash and cash equivalents.", "label": "Inflation Effects on Cash and Cash Equivalents", "terseLabel": "Inflation effects on cash and cash equivalents" } } }, "auth_ref": [] }, "biox_InformationTechnologyExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "InformationTechnologyExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 16.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of information technology expenses.", "label": "Information Technology Expenses", "terseLabel": "Information technology expenses" } } }, "auth_ref": [] }, "biox_InsumosAgroqumicosMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "InsumosAgroqumicosMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Insumos Agroqumicos.", "label": "Insumos Agroqumicos S.A." } } }, "auth_ref": [] }, "ifrs-full_InsuranceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InsuranceExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 17.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Insurance expense", "terseLabel": "Insurance" } }, "en": { "role": { "documentation": "The amount of expense arising from purchased insurance." } } }, "auth_ref": [ "r257" ] }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Intangible assets", "negatedPeriodEndLabel": "Balance at end of the period", "negatedPeriodStartLabel": "Balance at beginning of the period", "periodEndLabel": "Balance at end of the period", "periodStartLabel": "Balance at beginning of the period", "terseLabel": "Intangible assets" } }, "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r11", "r98" ] }, "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwillMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets other than goodwill [member]", "terseLabel": "Intangible assets" } }, "en": { "role": { "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r99", "r227", "r246" ] }, "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsWithIndefiniteUsefulLife", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets with indefinite useful life", "terseLabel": "Intangible assets not subject to amortization" } }, "en": { "role": { "documentation": "The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r91", "r93", "r100" ] }, "ifrs-full_InterestCostsCapitalised": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestCostsCapitalised", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Interest costs capitalised", "terseLabel": "Capitalization of interest on buildings in progress", "verboseLabel": "Capitalized financial costs" } }, "en": { "role": { "documentation": "The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset." } } }, "auth_ref": [ "r257" ] }, "biox_InterestExpenseOnLiabilitiesWithParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "InterestExpenseOnLiabilitiesWithParent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of interest expense on liabilities with parent.", "label": "Interest Expense on Liabilities with Parent", "negatedLabel": "Interest expenses with the Parents" } } }, "auth_ref": [] }, "ifrs-full_InterestExpenseOnOtherFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseOnOtherFinancialLiabilities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Interest expense on other financial liabilities", "negatedLabel": "Interest expenses" } }, "en": { "role": { "documentation": "The amount of interest expense on other financial liabilities. [Refer: Interest expense; Other financial liabilities]" } } }, "auth_ref": [ "r257" ] }, "biox_InterestExpensesRelatedPartyTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "InterestExpensesRelatedPartyTransaction", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of interest expenses.", "label": "Interest Expenses Related Party Transaction", "terseLabel": "Interest expenses" } } }, "auth_ref": [] }, "ifrs-full_InterestPaidClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestPaidClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest paid, classified as financing activities", "negatedLabel": "Interest payments" } }, "en": { "role": { "documentation": "The cash outflow for interest paid, classified as financing activities." } } }, "auth_ref": [ "r119" ] }, "ifrs-full_Inventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Inventories", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current inventories", "terseLabel": "Inventories" } }, "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } } }, "auth_ref": [ "r15", "r65", "r215" ] }, "biox_InventoriesBeforeClosingInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "InventoriesBeforeClosingInventory", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of inventory before closing inventory (ie., Opening inventory plus purchases).", "label": "Inventories Before Closing Inventory", "terseLabel": "Subtotal" } } }, "auth_ref": [] }, "biox_InventoriesExcludingAgriculturalProduce": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "InventoriesExcludingAgriculturalProduce", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of current inventories excluding agricultural produce.", "label": "Inventories, Excluding Agricultural Produce", "terseLabel": "Net of agricultural products" } } }, "auth_ref": [] }, "biox_InventoriesFromBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "InventoriesFromBusinessCombination", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Additions to inventories as results of business combination.", "label": "Inventories From Business Combination", "terseLabel": "Business combination" } } }, "auth_ref": [] }, "ifrs-full_InventoriesTotal": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InventoriesTotal", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "label": "Inventories.", "negatedPeriodEndLabel": "Inventories as of the end of the period", "periodStartLabel": "Inventories as of the beginning of the period" } }, "en": { "role": { "documentation": "The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]" } } }, "auth_ref": [ "r15" ] }, "biox_InventoryProductionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "InventoryProductionCosts", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of manufacturing costs capitalized to inventory during the period.", "label": "Inventory Production Costs", "terseLabel": "Production costs" } } }, "auth_ref": [] }, "ifrs-full_InvestmentAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentAccountedForUsingEquityMethod", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Investments accounted for using equity method", "periodEndLabel": "As of the end of the period", "periodStartLabel": "As of the beginning of the period" } }, "en": { "role": { "documentation": "The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]" } } }, "auth_ref": [ "r13", "r141", "r197" ] }, "ifrs-full_InvestmentFundsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentFundsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Mutual funds" } }, "en": { "role": { "documentation": "This member stands for investment funds." } } }, "auth_ref": [ "r242" ] }, "biox_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashInvestingActivities", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of investment in kind in other related parties, non cash transactions investment activities.", "label": "Investment in Kind in Other Related Parties, Non Cash Transactions Investment Activities", "terseLabel": "Investment in-kind in other related parties (Note 15)", "verboseLabel": "In-kind contributions" } } }, "auth_ref": [] }, "ifrs-full_InvestmentProperty": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentProperty", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInvestmentPropertiesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Investment property", "terseLabel": "Investment properties" } }, "en": { "role": { "documentation": "The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business." } } }, "auth_ref": [ "r10", "r104", "r107" ] }, "ifrs-full_InvestmentsAccountedForUsingEquityMethodAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentsAccountedForUsingEquityMethodAbstract", "lang": { "en-us": { "role": { "label": "JOINT VENTURES AND ASSOCIATES" } } }, "auth_ref": [] }, "biox_InvestmentsAccountedForUsingEquityMethodAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "InvestmentsAccountedForUsingEquityMethodAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The amount of investments accounted for using the equity method, asset position.", "label": "Investments Accounted For Using Equity Method, Assets", "terseLabel": "Investments in joint ventures and associates", "verboseLabel": "Assets in joint ventures and associates" } } }, "auth_ref": [] }, "biox_InvestmentsAccountedForUsingEquityMethodLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "InvestmentsAccountedForUsingEquityMethodLiability", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The amount of investments accounted for using the equity method, liability position.", "label": "Investments accounted for using equity method, liability", "terseLabel": "Joint ventures and associates", "verboseLabel": "Liabilities in joint ventures and associates" } } }, "auth_ref": [] }, "biox_InvestmentsInJointVenturesAndAssociatesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "InvestmentsInJointVenturesAndAssociatesTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociates" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on investments in joint ventures and associates.", "label": "Investments In Joint Ventures And Associates [Text Block]", "terseLabel": "JOINT VENTURES AND ASSOCIATES" } } }, "auth_ref": [] }, "ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Investments other than investments accounted for using equity method", "terseLabel": "Other investments" } }, "en": { "role": { "documentation": "The amount of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method]" } } }, "auth_ref": [ "r259" ] }, "ifrs-full_IssueOfConvertibleInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssueOfConvertibleInstruments", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issue of convertible instruments", "terseLabel": "Issuance of convertible notes" } }, "en": { "role": { "documentation": "The change in equity resulting from the issuing of convertible instruments." } } }, "auth_ref": [ "r255" ] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issued capital" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r6" ] }, "biox_JointVenturesAndAssociatesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "JointVenturesAndAssociatesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to Joint Ventures and Associates.", "label": "Joint ventures and associates", "terseLabel": "Joint ventures and associates" } } }, "auth_ref": [] }, "ifrs-full_JointVenturesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "JointVenturesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "label": "Joint ventures [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r81", "r82", "r143" ] }, "ifrs-full_JointVenturesWhereEntityIsVenturerMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "JointVenturesWhereEntityIsVenturerMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Joint ventures [member]", "terseLabel": "Joint ventures and associates" } }, "en": { "role": { "documentation": "This member stands for joint ventures in which the entity is a joint venturer. A venturer is a party to a joint venture and has joint control over that joint venture. [Refer: Joint ventures [member]]" } } }, "auth_ref": [ "r73" ] }, "biox_KeyManagementPersonnelBenefitsLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "KeyManagementPersonnelBenefitsLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails": { "parentTag": "ifrs-full_CurrentProvisionsForEmployeeBenefits", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of current liability related to key management personnel.", "label": "Key Management Personnel Benefits Liability, Current", "terseLabel": "Key management personnel" } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensation", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails" ], "lang": { "en-us": { "role": { "label": "Key management personnel compensation.", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r69" ] }, "biox_KeyManagementPersonnelCompensationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "KeyManagementPersonnelCompensationAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "KEY MANAGEMENT PERSONNEL COMPENSATION" } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails" ], "lang": { "en-us": { "role": { "label": "Key management personnel compensation, share-based payment", "terseLabel": "Share-based incentives" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r68" ] }, "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails" ], "lang": { "en-us": { "role": { "label": "Key management personnel compensation, short-term employee benefits", "verboseLabel": "Salaries, social security and other benefits" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r67" ] }, "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelOfEntityOrParentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Key management personnel [member]", "terseLabel": "Key management personnel" } }, "en": { "role": { "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity." } } }, "auth_ref": [ "r74" ] }, "ifrs-full_LandAndBuildingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LandAndBuildingsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Land and buildings [member]", "terseLabel": "Land and buildings" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing land and depreciable buildings and similar structures for use in operations. [Refer: Buildings; Land; Property, plant and equipment]" } } }, "auth_ref": [ "r221" ] }, "ifrs-full_LeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities", "periodEndLabel": "Total", "periodStartLabel": "Book value at the beginning of the period/year", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } } }, "auth_ref": [ "r155" ] }, "ifrs-full_LeaseLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities [abstract]", "terseLabel": "Lease Liabilities" } } }, "auth_ref": [] }, "biox_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Lease liabilities additions from interest expense, exchange differences and inflation effects.", "label": "Lease Liabilities, Interest Expense, Exchange Differences And Inflation Effects", "terseLabel": "Interest expenses, exchange differences and inflation effects" } } }, "auth_ref": [] }, "ifrs-full_LeaseLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilitiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Lease liability" } }, "en": { "role": { "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r239", "r240" ] }, "biox_LeasesLiabilitiesAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "LeasesLiabilitiesAdditions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of additional liabilities during the period.", "label": "Leases Liabilities Additions", "terseLabel": "Additions of the period/year" } } }, "auth_ref": [] }, "ifrs-full_Level1OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level1OfFairValueHierarchyMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Level 1" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } } }, "auth_ref": [ "r64", "r145" ] }, "ifrs-full_Level2OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level2OfFairValueHierarchyMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Level 2" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } } }, "auth_ref": [ "r145" ] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r64", "r145" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r23", "r144", "r145", "r146", "r196", "r201" ] }, "ifrs-full_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "LIABILITIES.", "terseLabel": "LIABILITIES" } } }, "auth_ref": [] }, "ifrs-full_LineItemsByFunctionMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LineItemsByFunctionMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Line items by function [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value of the \u2018Attribution of expenses by nature to their function' axis if no other member is used." } } }, "auth_ref": [ "r254", "r257" ] }, "biox_LoanReceivableNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "LoanReceivableNonCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherNoncurrentReceivables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the non current amount of loan receivable.", "label": "Loan Receivable Non Current", "terseLabel": "Loan receivables" } } }, "auth_ref": [] }, "biox_LoansPayablesRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "LoansPayablesRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of loans payables to related party.", "label": "Loans Payables, Related Party Transactions", "negatedLabel": "Net loans payables" } } }, "auth_ref": [] }, "ifrs-full_LongtermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LongtermBorrowings", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current portion of non-current borrowings", "terseLabel": "Borrowings" } }, "en": { "role": { "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r259" ] }, "ifrs-full_MachineryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MachineryMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Machinery and equipment [member]", "terseLabel": "Machinery and equipment" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing long-lived, depreciable machinery used in operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r222" ] }, "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MajorComponentsOfTaxExpenseIncomeAbstract", "lang": { "en-us": { "role": { "label": "TAXATION" } } }, "auth_ref": [] }, "ifrs-full_MeasurementAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MeasurementAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Measurement [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r102", "r111", "r144" ] }, "biox_MicrobiologicalProductsProducedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "MicrobiologicalProductsProducedMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to microbiological products produced.", "label": "Manufactured products", "terseLabel": "Manufactured products" } } }, "auth_ref": [] }, "biox_MicrobiologicalResaleProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "MicrobiologicalResaleProductsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to Microbiological resale products.", "label": "Resale products", "terseLabel": "Resale products" } } }, "auth_ref": [] }, "biox_MicrobiologyProductMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "MicrobiologyProductMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to microbiology products.", "label": "Microbiology product", "terseLabel": "Microbiology product" } } }, "auth_ref": [] }, "biox_MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs", "presentation": [ "http://www.biocerescrops.com/role/DisclosureGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum number of countries where the entity has marketed agricultural inputs.", "label": "Minimum Number of Countries Where Entity Marketed Agricultural Inputs", "terseLabel": "Number of countries where Group's agricultural inputs are marketed" } } }, "auth_ref": [] }, "biox_MiscellaneousExpenseOfIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "MiscellaneousExpenseOfIncomeExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 19.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 24.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of miscellaneous expense of income expense.", "label": "Miscellaneous Expense of Income Expense", "terseLabel": "Miscellaneous" } } }, "auth_ref": [] }, "biox_MoolecScienceS.a.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "MoolecScienceS.a.Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information about Moolec Science S.A.", "label": "Moolec Science S.A.", "terseLabel": "Moolec Science S.A." } } }, "auth_ref": [] }, "biox_MutualFundsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "MutualFundsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of an investment program funded by shareholders that trades in diversified holdings and is professionally managed.", "label": "Mutual Funds At Carrying Value", "terseLabel": "Mutual funds" } } }, "auth_ref": [] }, "biox_NetAssetsAcquisitionByBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "NetAssetsAcquisitionByBusinessCombination", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount recognised as of the acquisition date for net assets acquired or liabilities assumed in a business combination.", "label": "Net Assets Acquisition By Business Combination", "negatedLabel": "Net assets acquisition by business combination" } } }, "auth_ref": [] }, "biox_NetGainOnInflationEffectOnMonetary": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "NetGainOnInflationEffectOnMonetary", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "Net gain of inflation effect on monetary items.", "label": "Net Gain on Inflation Effect on Monetary", "terseLabel": "Net gain of inflation effect on monetary items" } } }, "auth_ref": [] }, "biox_NewStandardsAmendmentsAndInterpretationsIssuedByIasbAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "NewStandardsAmendmentsAndInterpretationsIssuedByIasbAbstract", "lang": { "en-us": { "role": { "documentation": "n/a", "label": "NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB" } } }, "auth_ref": [] }, "biox_NonCashFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "NonCashFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of non cash financing activities.", "label": "Non Cash Financing Activities", "totalLabel": "Financing activities" } } }, "auth_ref": [] }, "biox_NonCashFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "NonCashFinancingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Non Cash Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "auth_ref": [] }, "biox_NonCashInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "NonCashInvestingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of non cash investing activities.", "label": "Non Cash Investing Activities", "totalLabel": "Investing activities" } } }, "auth_ref": [] }, "biox_NonCashInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "NonCashInvestingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Investment activities.", "terseLabel": "Investment activities" } } }, "auth_ref": [] }, "ifrs-full_NoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncontrollingInterests", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests.", "terseLabel": "Non-controlling interest" } }, "en": { "role": { "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r21", "r129", "r131" ] }, "ifrs-full_NoncontrollingInterestsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncontrollingInterestsMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Non-controlling Interests" } }, "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_NoncurrentAccrualsAndNoncurrentDeferredIncomeIncludingNoncurrentContractLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAccrualsAndNoncurrentDeferredIncomeIncludingNoncurrentContractLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Non-current accruals and non-current deferred income including non-current contract liabilities [abstract]", "terseLabel": "Non-current" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAdvances": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAdvances", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": "ifrs-full_NoncurrentContractLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Non-current advances received, representing non-current contract liabilities for performance obligations satisfied at point in time", "terseLabel": "Advances from customers" } }, "en": { "role": { "documentation": "The amount of non-current advances received representing non-current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]" } } }, "auth_ref": [ "r259", "r260" ] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current assets", "totalLabel": "Total non-current assets" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r25", "r133", "r241" ] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "NON-CURRENT ASSETS..", "terseLabel": "NON-CURRENT ASSETS", "verboseLabel": "Non-current" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentContractLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 8.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current contract liabilities", "terseLabel": "Deferred revenue and advances from customers", "totalLabel": "Deferred revenue and advances from customers" } }, "en": { "role": { "documentation": "The amount of non-current contract liabilities. [Refer: Contract liabilities]" } } }, "auth_ref": [ "r149" ] }, "ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": "ifrs-full_NoncurrentContractLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Non-current contract liabilities for performance obligations satisfied over time", "terseLabel": "Deferred revenue" } }, "en": { "role": { "documentation": "The amount of non-current contract liabilities for performance obligations satisfied over time. [Refer: Contract liabilities for performance obligations satisfied over time]" } } }, "auth_ref": [ "r259", "r260" ] }, "ifrs-full_NoncurrentFinancialAssetsAvailableforsale": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentFinancialAssetsAvailableforsale", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": "ifrs-full_OtherNoncurrentFinancialAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Non-current financial assets available-for-sale", "terseLabel": "Shares of Bioceres S.A." } }, "en": { "role": { "documentation": "The amount of non-current financial assets available-for-sale. [Refer: Financial assets available-for-sale; Non-current financial assets]" } } }, "auth_ref": [ "r211" ] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails": { "parentTag": "ifrs-full_LeaseLiabilities", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current lease liabilities", "terseLabel": "Lease liabilities", "verboseLabel": "Non-current" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r155" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities", "totalLabel": "Total non-current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r26", "r135", "r241" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "NON-CURRENT LIABILITIES.", "terseLabel": "Non-current", "verboseLabel": "NON-CURRENT LIABILITIES" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentPortionOfNoncurrentBondsIssued", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Non-current portion of non-current bonds issued", "terseLabel": "Corporate bonds" } }, "en": { "role": { "documentation": "The non-current portion of non-current bonds issued. [Refer: Bonds issued]" } } }, "auth_ref": [ "r257" ] }, "biox_NumberOfCategoriesOfDilutiveShares": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "NumberOfCategoriesOfDilutiveShares", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of categories of dilutive potential shares.", "label": "Number of Categories of Dilutive Shares", "terseLabel": "Number of categories of dilutive potential shares" } } }, "auth_ref": [] }, "ifrs-full_NumberOfOutstandingShareOptions": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOutstandingShareOptions", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number of share options outstanding in share-based payment arrangement", "verboseLabel": "Number of total converted options outstanding" } }, "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r170", "r171", "r172" ] }, "ifrs-full_NumberOfSharesAuthorised": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesAuthorised", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares authorised", "terseLabel": "Number of shares authorized" } }, "en": { "role": { "documentation": "The number of shares authorised." } } }, "auth_ref": [ "r30" ] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares issued", "terseLabel": "Number of shares issued" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r255" ] }, "ifrs-full_NumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesOutstanding", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares outstanding", "terseLabel": "Number of shares outstanding" } }, "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } } }, "auth_ref": [ "r32" ] }, "ifrs-full_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OfficeEquipmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Office equipment", "terseLabel": "Office equipment" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r224" ] }, "biox_OmnibusEquityIncentivePlan2023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "OmnibusEquityIncentivePlan2023Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for 2023 Omnibus Equity Incentive Plan.", "label": "Omnibus Equity Incentive Plan 2023" } } }, "auth_ref": [] }, "ifrs-full_OrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OrdinarySharesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Ordinary shares [member]", "terseLabel": "Ordinary shares" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used." } } }, "auth_ref": [ "r83", "r261" ] }, "ifrs-full_OtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncome", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income", "totalLabel": "Other comprehensive (loss) income", "verboseLabel": "Other comprehensive income (loss)" } }, "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } } }, "auth_ref": [ "r3", "r36", "r46", "r138" ] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Gains (Losses) on Exchange Differences on Translation From Joint Venture, net of tax", "terseLabel": "Foreign exchange differences on translation of foreign operations from joint ventures" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, related to exchange differences on translation of the financial statements of a parent company or a stand-alone entity to a different presentation currency. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r46" ] }, "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax", "totalLabel": "Items that may be subsequently reclassified to profit and loss" } }, "en": { "role": { "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r218", "r219" ] }, "ifrs-full_OtherCurrentFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentFinancialAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 5.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other current financial assets", "terseLabel": "Other financial assets", "totalLabel": "Other financial assets" } }, "en": { "role": { "documentation": "The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]" } } }, "auth_ref": [ "r12" ] }, "ifrs-full_OtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentPayables", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails" ], "lang": { "en-us": { "role": { "label": "Other current payables", "terseLabel": "Miscellaneous" } }, "en": { "role": { "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r259" ] }, "ifrs-full_OtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 4.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other current receivables", "terseLabel": "Other receivables", "totalLabel": "Other receivables" } }, "en": { "role": { "documentation": "The amount of current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r217" ] }, "biox_OtherCurrentReceivablesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "OtherCurrentReceivablesOther", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of other current receivables, other.", "label": "Other Current Receivables, Other", "terseLabel": "Miscellaneous" } } }, "auth_ref": [] }, "ifrs-full_OtherFinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherFinanceIncomeCost", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other finance income (cost)", "terseLabel": "Other financial results", "totalLabel": "Other financial results" } }, "en": { "role": { "documentation": "The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]" } } }, "auth_ref": [ "r262" ] }, "biox_OtherFinanceResultsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "OtherFinanceResultsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Other Finance Results [Abstract]", "terseLabel": "Other financial results" } } }, "auth_ref": [] }, "biox_OtherFinancialAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "OtherFinancialAssetsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for financial assets that the entity does not separately disclose in the same statement or note.", "label": "Other financial assets" } } }, "auth_ref": [] }, "biox_OtherIncomeOrExpensesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "OtherIncomeOrExpensesNet", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of other income or expenses net.", "label": "Other Income Or Expenses Net", "terseLabel": "Other income or expenses, net" } } }, "auth_ref": [] }, "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Other inflows (outflows) of cash, classified as financing activities", "terseLabel": "Other financial proceeds or payments, net" } }, "en": { "role": { "documentation": "Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r116" ] }, "biox_OtherInvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "OtherInvestmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for other investment member.", "label": "Other investments" } } }, "auth_ref": [] }, "ifrs-full_OtherLongtermProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherLongtermProvisions", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current provisions", "terseLabel": "Provisions" } }, "en": { "role": { "documentation": "The amount of non-current provisions other than provisions for employee benefits. [Refer: Non-current provisions]" } } }, "auth_ref": [ "r28" ] }, "biox_OtherMarketableSecuritiesClassifiedAsNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "OtherMarketableSecuritiesClassifiedAsNonCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": "ifrs-full_OtherNoncurrentFinancialAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of non-current other marketable securities classified as non-current.", "label": "Other marketable securities classified as non current", "verboseLabel": "Other investments" } } }, "auth_ref": [] }, "biox_OtherNonCurrentReceivablesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "OtherNonCurrentReceivablesOther", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherNoncurrentReceivables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents other non-current receivables.", "label": "Other Non-Current Receivables Other", "terseLabel": "Miscellaneous" } } }, "auth_ref": [] }, "ifrs-full_OtherNoncurrentFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherNoncurrentFinancialAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 10.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other non-current financial assets", "terseLabel": "Other financial assets", "totalLabel": "Other financial assets" } }, "en": { "role": { "documentation": "The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]" } } }, "auth_ref": [ "r12" ] }, "ifrs-full_OtherNoncurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherNoncurrentReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 9.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other non-current receivables", "terseLabel": "Other receivables", "totalLabel": "Other receivables" } }, "en": { "role": { "documentation": "The amount of non-current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r217" ] }, "ifrs-full_OtherOperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherOperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other operating income (expense)", "terseLabel": "Other income or expenses, net", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r262" ] }, "ifrs-full_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Other receivables", "verboseLabel": "Deferred checks" } }, "en": { "role": { "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r217" ] }, "biox_OtherReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "OtherReceivablesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for receivables that the entity does not separately disclose in the same statement or note.", "label": "Other receivables [member]", "terseLabel": "Other receivables" } } }, "auth_ref": [] }, "ifrs-full_OtherRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherRelatedPartiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Other related parties [member]", "terseLabel": "Shareholders and other related parties" } }, "en": { "role": { "documentation": "This member stands for related parties that the entity does not separately disclose in the same statement or note. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r75" ] }, "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Other tax effects for reconciliation between accounting profit and tax expense (income)", "negatedLabel": "Others" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r50" ] }, "biox_OwnSharesTradingPremiumMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "OwnSharesTradingPremiumMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "The member stands for the own shares trading premium.", "label": "Own shares trading premium" } } }, "auth_ref": [] }, "ifrs-full_ParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ParValuePerShare", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Par value per share", "terseLabel": "Par value per share" } }, "en": { "role": { "documentation": "The nominal value per share." } } }, "auth_ref": [ "r31" ] }, "biox_ParentCompaniesAndRelatedPartiesToParentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ParentCompaniesAndRelatedPartiesToParentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands parent companies and related parties to parent of an entity.", "label": "Parent companies and related parties to Parent [member]", "terseLabel": "Parent company and related parties to Parent" } } }, "auth_ref": [] }, "ifrs-full_ParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ParentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails" ], "lang": { "en-us": { "role": { "label": "Parent company", "terseLabel": "Parent company" } }, "en": { "role": { "documentation": "This member stands for an entity that controls one or more entities." } } }, "auth_ref": [ "r72" ] }, "biox_ParentsCompaniesAndRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ParentsCompaniesAndRelatedPartiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for parent companies and related parties to parents.", "label": "Parents companies and related parties", "terseLabel": "Net loans payables - Parents companies and related parties" } } }, "auth_ref": [] }, "biox_PastShareOptionPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "PastShareOptionPlanMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Past Share Option plan.", "label": "Past Share Option plan" } } }, "auth_ref": [] }, "biox_PayablesSalariesSocialSecurityBenefitsAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "PayablesSalariesSocialSecurityBenefitsAndOther", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of payables to related party pertaining to salaries, social security benefits and other.", "label": "Payables, Salaries, Social Security Benefits And Other", "negatedLabel": "Salaries, social security benefits and other benefits" } } }, "auth_ref": [] }, "ifrs-full_PaymentsForDevelopmentProjectExpenditure": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsForDevelopmentProjectExpenditure", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments for development project expenditure", "negatedLabel": "Capitalized development expenditures" } }, "en": { "role": { "documentation": "The cash outflow for expenditure related to development projects." } } }, "auth_ref": [ "r273" ] }, "biox_PaymentsOfLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "PaymentsOfLeaseLiabilities", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The cash outflow for payment of lease liabilities.", "label": "Payments Of Lease Liabilities", "terseLabel": "Payment of the period/year" } } }, "auth_ref": [] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments of lease liabilities, classified as financing activities", "negatedLabel": "Leased assets payments" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r238" ] }, "ifrs-full_PaymentsToAcquireOrRedeemEntitysShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsToAcquireOrRedeemEntitysShares", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to acquire or redeem entity's shares", "negatedLabel": "Purchase of own shares" } }, "en": { "role": { "documentation": "The cash outflow to acquire or redeem entity's shares." } } }, "auth_ref": [ "r235" ] }, "biox_PercentageOfEstimatedOrAppreciationOfDevaluationOfOtherCurrency": { "xbrltype": "percentItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "PercentageOfEstimatedOrAppreciationOfDevaluationOfOtherCurrency", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Represent the percentage of that a devaluation or an appreciation of the US Dollar against other currencies.", "label": "Percentage of Estimated or an Appreciation of the Devaluation of Other Currency", "terseLabel": "Percentage of that a devaluation or an appreciation of the US Dollar other currencies" } } }, "auth_ref": [] }, "biox_PercentageOfGrossMarginAndTotalRevenue": { "xbrltype": "percentItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "PercentageOfGrossMarginAndTotalRevenue", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of gross margin and total revenue of the period during the entity.", "label": "Percentage Of Gross Margin And Total Revenue", "terseLabel": "% Gross margin" } } }, "auth_ref": [] }, "biox_PercentageOfIncrementalBorrowingRate": { "xbrltype": "percentItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "PercentageOfIncrementalBorrowingRate", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of incremental borrowing rate.", "label": "Percentage Of Incremental Borrowing Rate", "terseLabel": "Incremental borrowing rate" } } }, "auth_ref": [] }, "biox_PerformanceShareOptionPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "PerformanceShareOptionPlanMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Performance Share Option plan.", "label": "Performance Share Option plan" } } }, "auth_ref": [] }, "ifrs-full_PreferenceSharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PreferenceSharesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Preference shares [member]", "terseLabel": "Preference shares" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are senior in some aspects to ordinary shares, but subordinate to debt instruments in terms of claim. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r261" ] }, "ifrs-full_PresentationOfLeasesForLesseeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PresentationOfLeasesForLesseeAbstract", "lang": { "en-us": { "role": { "label": "LEASES" } } }, "auth_ref": [] }, "biox_ProFarmGroupInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ProFarmGroupInc.Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Pro farm Group, Inc.", "label": "Pro farm Group, Inc. [Member]", "terseLabel": "Pro farm Group, Inc." } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from borrowings, classified as financing activities", "terseLabel": "Proceeds from borrowings" } }, "en": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]" } } }, "auth_ref": [ "r236" ] }, "biox_ProceedsFromFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ProceedsFromFinancialAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The cash inflow (outflow) generated from financial assets that the entity classifies as investing activities.", "label": "Investment in financial assets" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sales of property, plant and equipment, classified as investing activities", "terseLabel": "Proceeds from sale of property, plant and equipment" } }, "en": { "role": { "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r234" ] }, "biox_ProductionCostAndSellingGeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ProductionCostAndSellingGeneralAndAdministrativeExpenseMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for the amount of expense relating to production costs and selling, general and administrative activities of the entity. This member is used to attribute an expense by nature to a functional line item in the statement of profit or loss.", "label": "Production Cost and Selling, General and Administrative Expense [Member]", "terseLabel": "Total" } } }, "auth_ref": [] }, "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of production cost relating to inventory and selling, general and administrative expenses.", "label": "Production Costs and Selling General and Administrative Expenses", "totalLabel": "Total" } } }, "auth_ref": [] }, "ifrs-full_ProductsAndServicesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProductsAndServicesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Products and services [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r204", "r245" ] }, "ifrs-full_ProductsAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProductsAndServicesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Products and services [member]" } }, "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } } }, "auth_ref": [ "r204", "r245" ] }, "ifrs-full_ProfessionalFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfessionalFeesExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 13.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Professional fees expense", "terseLabel": "Professional fees and outsourced services" } }, "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } } }, "auth_ref": [ "r257" ] }, "biox_ProfessionalFeesExpenseRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ProfessionalFeesExpenseRelatedParties", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 14.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of professional fee expense with related parties.", "label": "Professional Fees Expense, Related Parties", "terseLabel": "Professional fees related parties" } } }, "auth_ref": [] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 26.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Result for the year", "terseLabel": "Loss for the period", "totalLabel": "(Loss) profit for the period", "verboseLabel": "(Loss) profit for the period" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r2", "r35", "r115", "r126", "r128", "r196", "r199", "r241", "r247" ] }, "ifrs-full_ProfitLossAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "(Loss) profit for the period attributable to:" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to non-controlling interests", "terseLabel": "Non-controlling interests" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]" } } }, "auth_ref": [ "r38", "r130" ] }, "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to ordinary equity holders of parent entity", "verboseLabel": "(Loss) profit for the period (basic EPS)" } }, "en": { "role": { "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r85" ] }, "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to ordinary equity holders of parent entity [abstract]", "terseLabel": "Numerator" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to ordinary equity holders of parent entity including dilutive effects", "verboseLabel": "(Loss) profit for the period (diluted EPS)" } }, "en": { "role": { "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r85" ] }, "ifrs-full_ProfitLossAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to owners of parent", "terseLabel": "Equity holders of the parent" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r39" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss) before tax", "totalLabel": "(Loss) profit before income tax" } }, "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r176", "r212", "r213", "r250", "r251" ] }, "ifrs-full_ProfitLossFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossFromOperatingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from operating activities", "totalLabel": "Operating profit" } }, "en": { "role": { "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r226", "r262" ] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment", "negatedLabel": "As of the beginning of period", "negatedPeriodEndLabel": "As of the end of period", "periodEndLabel": "As of the end of period", "periodStartLabel": "As of the beginning of period", "terseLabel": "Property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r9", "r60" ] }, "ifrs-full_PropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment [member]" } }, "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r61", "r227", "r246" ] }, "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Purchase of intangible assets, classified as investing activities", "negatedLabel": "Purchase of intangible assets" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r233" ] }, "biox_PurchaseOfInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "PurchaseOfInventory", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of inventory purchased during the year.", "label": "Purchase of inventory", "terseLabel": "Purchases of the period" } } }, "auth_ref": [] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Purchase of property, plant and equipment, classified as investing activities", "negatedLabel": "Purchase of property, plant and equipment" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r233" ] }, "biox_PurchasesOfGoodsAndServicesReceivedRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "PurchasesOfGoodsAndServicesReceivedRelatedPartyTransactions", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of goods purchased and the amount of services received by the entity in related party transactions.", "label": "Purchases of Goods and Services Received Related Party Transactions", "negatedLabel": "Purchases of goods and services" } } }, "auth_ref": [] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r148", "r162", "r172", "r243", "r244", "r282" ] }, "ifrs-full_RangesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Ranges [member]" } }, "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r148", "r162", "r172", "r243", "r244", "r282" ] }, "biox_ReceivablesForPpESalesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ReceivablesForPpESalesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for receivables for PP&E sales", "label": "Receivables For PP&E Sales [Member]", "terseLabel": "Receivables for PP&E sales" } } }, "auth_ref": [] }, "biox_ReceivablesFromReimbursementOfExpenditureCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ReceivablesFromReimbursementOfExpenditureCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of expenditure that is to be reimbursed.", "label": "Receivables from Reimbursement of Expenditure, Current", "terseLabel": "Reimbursements over exports" } } }, "auth_ref": [] }, "biox_ReceivablesFromTaxCreditsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ReceivablesFromTaxCreditsCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of current tax credit receivables.", "label": "Receivables from Tax Credits, Current", "terseLabel": "Taxes" } } }, "auth_ref": [] }, "biox_ReceivablesFromTaxCreditsNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ReceivablesFromTaxCreditsNonCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherNoncurrentReceivables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of non-current tax credit receivables.", "label": "Receivables from Tax Credits, Non-Current", "terseLabel": "Taxes" } } }, "auth_ref": [] }, "biox_RelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "RelatedPartyTransactions", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The total amount of related party transactions.", "label": "Related Party Transactions", "totalLabel": "Total" } } }, "auth_ref": [] }, "ifrs-full_RepairsAndMaintenanceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepairsAndMaintenanceExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 7.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Repairs and maintenance expense", "terseLabel": "Maintenance" } }, "en": { "role": { "documentation": "The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts." } } }, "auth_ref": [ "r262" ] }, "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of borrowings, classified as financing activities", "negatedLabel": "Repayment of borrowings and financed payments" } }, "en": { "role": { "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]" } } }, "auth_ref": [ "r237" ] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "biox_TotalResearchAndDevelopmentExpenseIncurred", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Research and development expense", "negatedLabel": "Research and development expenses", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } } }, "auth_ref": [ "r101" ] }, "biox_ResearchAndDevelopmentExpenseCapitalized": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ResearchAndDevelopmentExpenseCapitalized", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "biox_TotalResearchAndDevelopmentExpenseIncurred", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of research and development expense capitalized.", "label": "Research and Development Expense Capitalized", "terseLabel": "R&D capitalized" } } }, "auth_ref": [] }, "ifrs-full_ReserveOfEquityComponentOfConvertibleInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfEquityComponentOfConvertibleInstrumentsMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Convertible instruments" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing components of convertible instruments classified as equity." } } }, "auth_ref": [ "r256" ] }, "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfExchangeDifferencesOnTranslationMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation reserve" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r66", "r214" ] }, "biox_ResultForInflationEffectOnMonetaryItemsAndOtherFinanceResults": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ResultForInflationEffectOnMonetaryItemsAndOtherFinanceResults", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount that represents the inflation effect on monetary items and other finance results.", "label": "Result for Inflation Effect on Monetary Items And Other Finance Results", "negatedLabel": "Result of inflation effect on monetary items and other finance results" } } }, "auth_ref": [] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Retained deficit" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r6", "r214" ] }, "biox_RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "This member stands for revaluation of PP&E and effect of tax rate change.", "label": "Revaluation of PP&E and effect of tax rate change" } } }, "auth_ref": [] }, "ifrs-full_Revenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Revenue", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails": { "parentTag": "ifrs-full_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Revenues", "terseLabel": "Total" } }, "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } } }, "auth_ref": [ "r42", "r137", "r176", "r193", "r198", "r204", "r205", "r206", "r212", "r213", "r241" ] }, "ifrs-full_RevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Revenue [abstract]", "verboseLabel": "Revenues from contracts with customers" } } }, "auth_ref": [] }, "ifrs-full_RevenueFromContractsWithCustomers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromContractsWithCustomers", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Revenue from contracts with customers", "terseLabel": "Revenues from contracts with customers", "verboseLabel": "Sale of goods and services" } }, "en": { "role": { "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration." } } }, "auth_ref": [ "r150", "r151" ] }, "ifrs-full_RevenueFromRoyalties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromRoyalties", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Royalty income", "terseLabel": "Royalties" } }, "en": { "role": { "documentation": "The amount of income arising from royalties." } } }, "auth_ref": [ "r257" ] }, "ifrs-full_RevenueFromSaleOfAgriculturalProduce": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromSaleOfAgriculturalProduce", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails" ], "lang": { "en-us": { "role": { "label": "Revenue from sale of agricultural produce", "terseLabel": "Net result from commercialization of agricultural products" } }, "en": { "role": { "documentation": "The amount of revenue arising from the sale of agricultural produce. [Refer: Revenue]" } } }, "auth_ref": [ "r257" ] }, "biox_RevenueFromSaleOfGoodsAndRenderingOfServicesRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "RevenueFromSaleOfGoodsAndRenderingOfServicesRelatedPartyTransactions", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of revenue arising from the sale of goods and rendering of services in related party transactions.", "label": "Revenue from Sale of Goods and Rendering of Services, Related Party Transactions", "verboseLabel": "Sales of goods and services" } } }, "auth_ref": [] }, "biox_RgRsOxWheatMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "RgRsOxWheatMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for RG/RS/OX wheat.", "label": "RG/RS/OX Wheat [member]", "terseLabel": "RG/RS/OX Wheat" } } }, "auth_ref": [] }, "biox_RightOfUseLeasedAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "RightOfUseLeasedAssetsTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of right-of-use leased assets.", "label": "Right Of Use Leased Assets [Table Text Block]", "terseLabel": "Schedule of right-of-use leased assets" } } }, "auth_ref": [] }, "ifrs-full_RightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RightofuseAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets", "periodEndLabel": "Book value at the end of the period/year", "periodStartLabel": "Book value at the beginning of the period/year", "terseLabel": "Right of use asset" } }, "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } } }, "auth_ref": [ "r154", "r158" ] }, "ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RiskExposureAssociatedWithInstrumentsSharingCharacteristic", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Risk exposure associated with instruments sharing characteristic", "verboseLabel": "Foreign currency" } }, "en": { "role": { "documentation": "The amount of risk exposure associated with financial instruments with a shared characteristic that identifies a concentration of risks. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r191" ] }, "biox_RizobacterArgentinaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "RizobacterArgentinaMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Rizobacter Argentina S.A.", "label": "Rizobacter Argentina S.A.", "verboseLabel": "Rizobacter Argentina S.A." } } }, "auth_ref": [] }, "biox_SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails": { "parentTag": "ifrs-full_CurrentProvisionsForEmployeeBenefits", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of current provisions for salaries, accrued incentives, vacations and social security.", "label": "Salaries, Accrued Incentives, Vacations and Social Security, Current", "terseLabel": "Salaries, accrued incentives, vacations and social security" } } }, "auth_ref": [] }, "biox_SalariesSocialSecurityBenefitsAndOtherBenefitsRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "SalariesSocialSecurityBenefitsAndOtherBenefitsRelatedPartyTransactions", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of salaries, social security benefits and other benefits.", "label": "Salaries, Social Security Benefits and Other Benefits, Related Party Transactions", "negatedLabel": "Salaries, social security benefits and other benefits" } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "auth_ref": [] }, "biox_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of significant non-cash transactions related to investing and financing activities.", "label": "Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities", "terseLabel": "Schedule of significant non-cash transactions related to investing and financing activities" } } }, "auth_ref": [] }, "biox_SecuredConvertibleGuaranteedNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "SecuredConvertibleGuaranteedNotesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Secured Convertible Guaranteed Notes.", "label": "Secured Convertible Guaranteed Notes [Member]", "terseLabel": "Secured Convertible Guaranteed Notes" } } }, "auth_ref": [] }, "biox_SecuredDebtNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "SecuredDebtNonCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "Amount of secured debt, non-current.", "label": "Secured Debt, Non-Current", "terseLabel": "Secured notes" } } }, "auth_ref": [] }, "biox_SecuredDebtsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "SecuredDebtsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for secured debts.", "label": "Secured Debts [Member]", "verboseLabel": "secured notes" } } }, "auth_ref": [] }, "biox_SecuredGuaranteedNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "SecuredGuaranteedNotesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Secured Guaranteed Notes.", "label": "Secured Guaranteed Notes [Member]", "terseLabel": "Secured Guaranteed Notes" } } }, "auth_ref": [] }, "biox_SeedAndIntegratedProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "SeedAndIntegratedProductsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Seed and integrated products.", "label": "Seed and integrated products", "terseLabel": "Seed and integrated products" } } }, "auth_ref": [] }, "biox_SeedsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "SeedsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to seeds.", "label": "Seeds", "terseLabel": "Seeds" } } }, "auth_ref": [] }, "ifrs-full_SegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SegmentsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Segments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r89", "r152", "r196", "r225", "r248" ] }, "ifrs-full_SegmentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SegmentsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Segments [member]" } }, "en": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used." } } }, "auth_ref": [ "r89", "r152", "r203", "r225", "r248" ] }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expense", "negatedLabel": "Selling, general and administrative expenses" } }, "en": { "role": { "documentation": "The amount of expense relating to selling, general and administrative activities of the entity." } } }, "auth_ref": [ "r262" ] }, "ifrs-full_SellingGeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SellingGeneralAndAdministrativeExpenseMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expense [member]", "terseLabel": "Selling, general and administrative expenses" } }, "en": { "role": { "documentation": "This member stands for the amount of expense relating to selling, general and administrative activities of the entity. This member is used to attribute an expense by nature to a functional line item in the statement of profit or loss." } } }, "auth_ref": [ "r254", "r257" ] }, "biox_ShareBasedIncentivesExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ShareBasedIncentivesExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 12.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of share-based incentives expenses.", "label": "Share Based Incentives Expenses", "terseLabel": "Share-based incentives" } } }, "auth_ref": [] }, "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails", "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Share of profit (loss) of associates and joint ventures accounted for using equity method", "negatedLabel": "Share of profit or loss of joint ventures and associates", "terseLabel": "Share of profit or loss of joint ventures and associates", "verboseLabel": "Share of profit or loss" } }, "en": { "role": { "documentation": "The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]" } } }, "auth_ref": [ "r44", "r194", "r202" ] }, "ifrs-full_SharePremiumMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SharePremiumMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Share premium" } }, "en": { "role": { "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_SharebasedPaymentArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SharebasedPaymentArrangementsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails", "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Share-based payment arrangements [member]" } }, "en": { "role": { "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used." } } }, "auth_ref": [ "r173" ] }, "biox_ShortTermInvestmentsNotClassifiedAsCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ShortTermInvestmentsNotClassifiedAsCashEquivalents", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of short-term investments held by the entity that are not classified as cash equivalents.", "label": "Short Term Investments Not Classified As Cash Equivalents", "terseLabel": "US Treasury bills" } } }, "auth_ref": [] }, "ifrs-full_ShorttermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermBorrowings", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current borrowings", "terseLabel": "Borrowings" } }, "en": { "role": { "documentation": "The amount of current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r259" ] }, "ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermDepositsNotClassifiedAsCashEquivalents", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Short-term deposits, not classified as cash equivalents", "terseLabel": "Restricted short-term deposits" } }, "en": { "role": { "documentation": "The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]" } } }, "auth_ref": [ "r259" ] }, "ifrs-full_ShorttermEmployeeBenefitsExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermEmployeeBenefitsExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 6.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Short-term employee benefits expense", "terseLabel": "Employee benefits and social securities" } }, "en": { "role": { "documentation": "The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services." } } }, "auth_ref": [ "r257" ] }, "ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermInvestmentsClassifiedAsCashEquivalents", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Short-term investments, classified as cash equivalents", "verboseLabel": "Mutual funds" } }, "en": { "role": { "documentation": "A classification of cash equivalents representing short-term investments. [Refer: Cash equivalents]" } } }, "auth_ref": [ "r279" ] }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r81", "r82", "r142" ] }, "biox_SoybeanHb4Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "SoybeanHb4Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to Soybeans HB4.", "label": "Soybean HB4 and breeding program", "terseLabel": "HB4 and breeding program" } } }, "auth_ref": [] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "lang": { "en-us": { "role": { "label": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityLineItems", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [line items]", "terseLabel": "Statement of changes in equity" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_StatementOfComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" } } }, "auth_ref": [] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION" } } }, "auth_ref": [] }, "biox_StatementOfNonCashTransactionsCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "StatementOfNonCashTransactionsCashFlowsAbstract", "lang": { "en-us": { "role": { "documentation": "It represents the information pertaining to non cash transactions in cash flow.", "label": "CASH FLOW INFORMATION" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [] }, "biox_StockOptionsAndShareBasedIncentivesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "StockOptionsAndShareBasedIncentivesMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Stock Options And Share Based Incentives.", "label": "Stock options and share based incentives" } } }, "auth_ref": [] }, "biox_SunflowerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "SunflowerMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for sunflower biological assets.", "label": "Sunflower" } } }, "auth_ref": [] }, "biox_SuppliesAndMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "SuppliesAndMaterials", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 9.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of current supplies and materials purchased for production.", "label": "Supplies and Materials", "terseLabel": "Supplies and materials" } } }, "auth_ref": [] }, "biox_SynertechIndustriasS.aMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "SynertechIndustriasS.aMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Synertech Industrias S.A.", "label": "Synertech Industrias S.A.", "terseLabel": "Synertech Industrias S.A." } } }, "auth_ref": [] }, "ifrs-full_TaxEffectOfRevenuesExemptFromTaxation2011": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfRevenuesExemptFromTaxation2011", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Tax effect of revenues exempt from taxation", "terseLabel": "Untaxed gains" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to revenues that are exempt from taxation. [Refer: Accounting profit]" } } }, "auth_ref": [ "r50" ] }, "biox_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible and revenues that are exempt from taxation in determining taxable profit (tax loss).", "label": "Tax Effect of Revenues Exempt from Taxation and Expenses Not Deductible in Determining Taxable Profit (Tax Loss)", "negatedLabel": "Non-deductible expenses" } } }, "auth_ref": [] }, "biox_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to share of profit or loss of subsidies, joint ventures and associates.", "label": "Tax Effect of Share Of Profit Or Loss Of Subsidies, Joint Ventures And Associates", "negatedLabel": "Share of profit or loss of subsidiaries, joint ventures and associates" } } }, "auth_ref": [] }, "biox_TaxEffectOfStockOptionCharge": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "TaxEffectOfStockOptionCharge", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount representing the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to stock option charge.", "label": "Tax Effect Of Stock Option Charge", "negatedLabel": "Stock options charge" } } }, "auth_ref": [] }, "biox_TaxEffectOfUnrecognizedDeferredTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "TaxEffectOfUnrecognizedDeferredTax", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to unrecognized deferred taxes.", "label": "Tax Effect of Unrecognized Deferred Tax", "negatedLabel": "Unrecognized deferred tax" } } }, "auth_ref": [] }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxExpenseIncomeAtApplicableTaxRate", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Tax expense (income) at applicable tax rate", "negatedLabel": "Income tax expense by applying tax rate in force in the respective countries" } }, "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r50" ] }, "biox_TaxInflationAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "TaxInflationAdjustment", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of Tax Inflation Adjustment", "label": "Tax Inflation Adjustment", "negatedLabel": "Tax inflation adjustment" } } }, "auth_ref": [] }, "biox_Taxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "Taxes", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of taxes.", "label": "Taxes", "terseLabel": "Taxes" } } }, "auth_ref": [] }, "biox_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of threshold earnings before interest taxes depreciation and amortization.", "label": "Threshold Earnings Before Interest, Taxes, Depreciation, and Amortization", "terseLabel": "Threshold earnings before interest" } } }, "auth_ref": [] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Top of range [member]", "terseLabel": "Maximum" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r148", "r162", "r172", "r243", "r244", "r282" ] }, "biox_TotalResearchAndDevelopmentExpenseIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "TotalResearchAndDevelopmentExpenseIncurred", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of research and development costs that an entity incurs.", "label": "Total Research And Development Expense Incurred", "totalLabel": "Total" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayables", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 7.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade and other current payables", "terseLabel": "Trade and other payables", "totalLabel": "Trade and other payable" } }, "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } } }, "auth_ref": [ "r18" ] }, "ifrs-full_TradeAndOtherCurrentPayablesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails" ], "lang": { "en-us": { "role": { "label": "Trade and other current payables [abstract]", "terseLabel": "Current" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToRelatedParties", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Trade Payables, Related Party Transactions", "negatedLabel": "Trade payables/creditors", "terseLabel": "Trade payable, related party" } }, "en": { "role": { "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]" } } }, "auth_ref": [ "r260" ] }, "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails" ], "lang": { "en-us": { "role": { "label": "Current trade payables", "terseLabel": "Trade creditors" } }, "en": { "role": { "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]" } } }, "auth_ref": [ "r216", "r260" ] }, "ifrs-full_TradeAndOtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 7.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade and other current receivables", "terseLabel": "Trade receivables", "totalLabel": "Trade receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } } }, "auth_ref": [ "r16", "r27" ] }, "biox_TradeAndOtherPayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "TradeAndOtherPayablesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for trade and other payables.", "label": "Trade and other payables" } } }, "auth_ref": [] }, "biox_TradeReceivablesFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "TradeReceivablesFromRelatedParties", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of trade receivables due from related parties.", "label": "Trade Receivables From Related Parties", "terseLabel": "Trade debtors", "verboseLabel": "Shareholders and other related parties (Note 15)" } } }, "auth_ref": [] }, "ifrs-full_TradeReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeReceivablesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Trade receivables" } }, "en": { "role": { "documentation": "This member stands for trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r182", "r185", "r249", "r257" ] }, "ifrs-full_TravelExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TravelExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 10.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Travel expense", "terseLabel": "Mobility and travel" } }, "en": { "role": { "documentation": "The amount of expense arising from travel." } } }, "auth_ref": [ "r257" ] }, "ifrs-full_TreasurySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TreasurySharesMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Cost of own shares held" } }, "en": { "role": { "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } } }, "auth_ref": [ "r6" ] }, "biox_TrigallGeneticsS.a.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "TrigallGeneticsS.a.Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Trigall Genetics S.A.", "label": "Trigall Genetics S.A.", "terseLabel": "Trigall Genetics S.A." } } }, "auth_ref": [] }, "biox_TrustDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "TrustDebtSecuritiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Trust Debt Securities.", "label": "Trust debt securities", "terseLabel": "Trust debt securities" } } }, "auth_ref": [] }, "ifrs-full_TypesOfRisksAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Types of risks [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r163", "r164", "r165", "r167", "r177", "r180", "r181" ] }, "ifrs-full_TypesOfRisksMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Risks [member]" } }, "en": { "role": { "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used." } } }, "auth_ref": [ "r163", "r164", "r165", "r167", "r177", "r180", "r181" ] }, "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfSharebasedPaymentArrangementsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails", "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Types of share-based payment arrangements [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r173" ] }, "currency_USD": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "USD", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "USD" } } }, "auth_ref": [] }, "biox_USTreasuryBillsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "USTreasuryBillsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for US Treasury bills.", "label": "US Treasury bills" } } }, "auth_ref": [] }, "ifrs-full_VehiclesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "VehiclesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Vehicles [member]", "terseLabel": "Vehicles" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r264" ] }, "biox_VotesPerOrdinaryShare": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "VotesPerOrdinaryShare", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of votes for each ordinary share.", "label": "Votes Per Ordinary Share", "terseLabel": "Number of votes for each ordinary share" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares outstanding", "verboseLabel": "Weighted average number of shares (basic EPS)" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r86" ] }, "ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]", "terseLabel": "Denominator" } } }, "auth_ref": [] }, "biox_WorkingCapitalAdjustmentsOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20231231", "localname": "WorkingCapitalAdjustmentsOperatingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Working capital adjustments" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2023-03-23" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2023-03-23" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2023-03-23" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard", "URIDate": "2023-03-23" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "107", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_107&doctype=Standard", "URIDate": "2023-03-23" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "51", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_51&doctype=Standard", "URIDate": "2023-03-23" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2023-03-23" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_b&doctype=Standard", "URIDate": "2023-03-23" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2023-03-23" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_d&doctype=Standard", "URIDate": "2023-03-23" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_e&doctype=Standard", "URIDate": "2023-03-23" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard", "URIDate": "2023-03-23" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_h&doctype=Standard", "URIDate": "2023-03-23" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2023-03-23" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2023-03-23" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "n", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_n&doctype=Standard", "URIDate": "2023-03-23" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "o", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard", "URIDate": "2023-03-23" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "q", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_q&doctype=Standard", "URIDate": "2023-03-23" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_r&doctype=Standard", "URIDate": "2023-03-23" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "56", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard", "URIDate": "2023-03-23" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard", "URIDate": "2023-03-23" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_d&doctype=Standard", "URIDate": "2023-03-23" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2023-03-23" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2023-03-23" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2023-03-23" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2023-03-23" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard", "URIDate": "2023-03-23" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard", "URIDate": "2023-03-23" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2023-03-23" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2023-03-23" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard", "URIDate": "2023-03-23" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2023-03-23" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2023-03-23" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2023-03-23" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2023-03-23" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2023-03-23" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard", "URIDate": "2023-03-23" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2023-03-23" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "75", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_b&doctype=Standard", "URIDate": "2023-03-23" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142&doctype=Standard", "URIDate": "2023-03-23" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2023-03-23" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_b&doctype=Standard", "URIDate": "2023-03-23" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2023-03-23" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18&doctype=Standard", "URIDate": "2023-03-23" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_a&doctype=Standard", "URIDate": "2023-03-23" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_e&doctype=Standard", "URIDate": "2023-03-23" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_f&doctype=Standard", "URIDate": "2023-03-23" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_g&doctype=Standard", "URIDate": "2023-03-23" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard", "URIDate": "2023-03-23" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2023-03-23" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2023-03-23" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard", "URIDate": "2023-03-23" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_a&doctype=Standard", "URIDate": "2023-03-23" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2023-03-23" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI", "URIDate": "2023-03-23" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard", "URIDate": "2023-03-23" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "130", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "134", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_a&doctype=Standard", "URIDate": "2023-03-23" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "134", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_b&doctype=Standard", "URIDate": "2023-03-23" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "135", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_a&doctype=Standard", "URIDate": "2023-03-23" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "135", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_b&doctype=Standard", "URIDate": "2023-03-23" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2023-03-23" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2023-03-23" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard", "URIDate": "2023-03-23" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "122", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_122_a&doctype=Standard", "URIDate": "2023-03-23" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard", "URIDate": "2023-03-23" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "32A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2023-03-23" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "76", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76_b&doctype=Standard", "URIDate": "2023-03-23" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard", "URIDate": "2023-03-23" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2023-03-23" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2023-03-23" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS40_g74-79_TI", "URIDate": "2023-03-23" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "40", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_40&doctype=Standard", "URIDate": "2023-03-23" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50_a&doctype=Standard", "URIDate": "2023-03-23" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard", "URIDate": "2023-03-23" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard", "URIDate": "2023-03-23" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard", "URIDate": "2023-03-23" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard", "URIDate": "2023-03-23" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2023-03-23" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Presentation of a statement of cash flows", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI", "URIDate": "2023-03-23" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "30", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_30_b&doctype=Standard", "URIDate": "2023-03-23" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2023-03-23" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2023-03-23" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2023-en-r&anchor=para_22&doctype=Standard", "URIDate": "2023-03-23" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_e&doctype=Standard", "URIDate": "2023-03-23" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_f&doctype=Standard", "URIDate": "2023-03-23" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B16&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2023-03-23" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2023-03-23" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2023-03-23" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard", "URIDate": "2023-03-23" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "105", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_105&doctype=Standard", "URIDate": "2023-03-23" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_113_a&doctype=Standard", "URIDate": "2023-03-23" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard", "URIDate": "2023-03-23" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_115&doctype=Standard", "URIDate": "2023-03-23" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_119&doctype=Standard", "URIDate": "2023-03-23" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2023-03-23" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2023-03-23" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_h&doctype=Standard", "URIDate": "2023-03-23" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2023-03-23" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI", "URIDate": "2023-03-23" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Presentation", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI", "URIDate": "2023-03-23" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard", "URIDate": "2023-03-23" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "124", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_124&doctype=Standard", "URIDate": "2023-03-23" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "125", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_125&doctype=Standard", "URIDate": "2023-03-23" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "128", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "128", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a&doctype=Standard", "URIDate": "2023-03-23" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "C32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_C32&doctype=Appendix&subtype=C", "URIDate": "2023-03-23" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "44", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_44&doctype=Standard", "URIDate": "2023-03-23" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2023-03-23" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "21C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21C&doctype=Standard", "URIDate": "2023-03-23" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard", "URIDate": "2023-03-23" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2023-03-23" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2023-03-23" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2023-03-23" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42I&doctype=Standard", "URIDate": "2023-03-23" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard", "URIDate": "2023-03-23" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B2", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B2_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B8", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B8_c&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Defined terms", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI", "URIDate": "2023-03-23" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2023-03-23" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard", "URIDate": "2023-03-23" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2023-03-23" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2023-03-23" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2023-03-23" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2023-03-23" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2023-03-23" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2023-03-23" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard", "URIDate": "2023-03-23" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2023-03-23" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI", "URIDate": "2023-03-23" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.34&doctype=Standard", "URIDate": "2023-03-23" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.42", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.42&doctype=Standard", "URIDate": "2023-03-23" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_d&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r212": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard", "URIDate": "2023-03-23" }, "r213": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r214": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r215": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard", "URIDate": "2023-03-23" }, "r216": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard", "URIDate": "2023-03-23" }, "r217": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r218": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82A&doctype=Standard", "URIDate": "2023-03-23" }, "r219": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r220": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "80", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_80_a&doctype=Standard", "URIDate": "2023-03-23" }, "r221": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_b&doctype=Standard", "URIDate": "2023-03-23" }, "r222": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_c&doctype=Standard", "URIDate": "2023-03-23" }, "r223": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_g&doctype=Standard", "URIDate": "2023-03-23" }, "r224": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_h&doctype=Standard", "URIDate": "2023-03-23" }, "r225": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_d&doctype=Standard", "URIDate": "2023-03-23" }, "r226": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "32", "IssueDate": "2023-01-01", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r227": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r228": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_c&doctype=Standard", "URIDate": "2023-03-23" }, "r229": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_e&doctype=Standard", "URIDate": "2023-03-23" }, "r230": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "43", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_43&doctype=Standard", "URIDate": "2023-03-23" }, "r231": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "51", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_51&doctype=Standard", "URIDate": "2023-03-23" }, "r232": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Section": "Example 1 XYZ Dairy Ltd", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS41_IE_ex1_TI", "URIDate": "2023-03-23" }, "r233": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2023-03-23" }, "r234": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2023-03-23" }, "r235": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r236": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2023-03-23" }, "r237": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_d&doctype=Standard", "URIDate": "2023-03-23" }, "r238": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r239": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44C&doctype=Standard", "URIDate": "2023-03-23" }, "r240": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Section": "C Reconciliation of liabilities arising from financing activities", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI", "URIDate": "2023-03-23" }, "r241": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r242": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B23", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B23_c&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r243": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r244": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r245": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r246": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r247": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2023-03-23" }, "r248": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_c&doctype=Standard", "URIDate": "2023-03-23" }, "r249": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2023-03-23" }, "r250": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r251": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r252": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r253": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2023-03-23" }, "r254": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard", "URIDate": "2023-03-23" }, "r255": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2023-03-23" }, "r256": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r257": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2023-03-23" }, "r258": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r259": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r260": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard", "URIDate": "2023-03-23" }, "r261": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r262": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard", "URIDate": "2023-03-23" }, "r263": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81&doctype=Standard", "URIDate": "2023-03-23" }, "r264": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard", "URIDate": "2023-03-23" }, "r265": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2023-03-23" }, "r266": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard", "URIDate": "2023-03-23" }, "r267": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2023-03-23" }, "r268": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119&doctype=Standard", "URIDate": "2023-03-23" }, "r269": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2023-03-23" }, "r270": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard", "URIDate": "2023-03-23" }, "r271": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r272": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "14", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_14&doctype=Standard", "URIDate": "2023-03-23" }, "r273": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16&doctype=Standard", "URIDate": "2023-03-23" }, "r274": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2023-03-23" }, "r275": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2023-03-23" }, "r276": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_c&doctype=Standard", "URIDate": "2023-03-23" }, "r277": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r278": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard", "URIDate": "2023-03-23" }, "r279": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r280": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r281": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r282": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" } } } ZIP 107 0001104659-24-028810-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-028810-xbrl.zip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̀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
0_<12]T MP-F*H)CW>'=>I.Q*@1+=C(]P>T)Q:]FG3"A,( ^@E%=,/P&A $KB*!0C/U*< MQ^+P9[6\A1]H>@ =/_J,K'>ET'B;DZ$;TF?J$/DFE_!W+ M2UD??8:.@_Z8<#4]5 -K?4M^V!G"\N*?9[L *?.XWEB(SJELE;550!80C3]7 MJ>]'--:![EJQ"T3C7!7 ]R,:5O9U/8QN)@-XS<)Q+ 2^'^$ >N/,>_O>CVA8 M7O8$:WL[I8/KE@[RG5F5, IB-WT*$(^SU9#>CWB8NG,S]24@%Z\G%Z?[FH!H MG*O(^'Y$(XU1]&![,[6%ZQ:-=Y;XRJ^4 )(!\EZ%^%4)TB< R3A7Y?']2$;S MUM)>MUJ7?#\BHV_BE&!_6KC\H>"<:IF*:B\#/_:TS_]255TWC+J/03F5*(M$N1Y4!1E$'A(1^YZ(I?]:NW197CU0U*QV M78H]*QKJQC]W4OI"%B/%TY1 DR6Q)FN'YL#2D?I<@HSM;N@0_:"_8.]*62-) M^IOYM]A0%@R9E#%8SF1/MHP@A(S8<>2J[ZY]+TLZ"0:7HY7=6>&# &@22GU8@/NU81"X; M?4$)HDPS6 %O_[YEP/V6\+PU D]-" "!9T"@D'BY<0M'QRW3CXV5*A.0'C MB(5"6L-I[Q+Q&Y8T$4,.L+Y$6H(L,HM#M\T/4NPA\-T7K$R15)E!B7?E:-X8 M^LB;\SRO#WW?!@R/%=?[3[^.%XP'YP,TOS7ZG/ 8=\>+OH6LM_!D05-3J,M7 M//@2D5^MT::]Z:9K<59E4<6G:[(^D)<9'M$T]*.(,H4#-+YACB5O3;DI-%ZA M%_IMP"C0E3 .]D=_] 2VH#><-;;C0PRWI9:RB41,3]87C?WJ,$GXKM$=<&V% M&,^,N@[)9N:!(GAF!0D,3JU@,=T"G% O!L%WOV!&)P2>"E1[J&WB#L:5-]Z M'4YQQ@'/B8)CSTJWDB2JO&@XNP@A6L. P 6]B NZ.S9YU2S#T+-K!?10\$;?SB4Y8=*6=8?@PP9I6WO#WBVBH8_' ME_ ]QZNN2AIM%.(@?]->A!MAH-;S6#!+Q)!,&7\B$0-@^&HP!&7S,^5AAOI6 M<>(<8X+1#_QURHE]WU&\B/6T;/ ZB_VRU_G%#H(Q4G9#)=*/I8O["@73'UGQ MK-N%K;D8Q],:H[O2)6"95,7I'*6-%N?JYG1:6R[;W"&SD"BJ[!&VUK M,?1!'H=Y31[-\C)PF<'AU/:]FX3H;V<4?MP?#ZS::R!J(0]TM +[A#09M_!A MUX!$M<=> AH,I\>XC7G2K&XT.I(A&@\SV9 ((\=82A#EVF<_@D2SM;5??4M MW'DR&N\;(M[E53*OC_%:'.21H4S)R!'E(U]&4!E#SM*9W9V: M,.GTR3H\$?$*O SY2JOS I71]-2LAJ+7]./?(S-5UTLSQT .@;ZRSZ+9/*]T MI%#XA()1*@J\C=J8"T.->45E-M5ZQ1_(3-;'?4'[^I&A]-I''-XTE)[HQA95 M<;ER5O,JIW@Q,D XKY) +R@3G@E)4*QO2-> ^W ;:;GQA)P-6729(BEU64D, M*5/4SZPTP-/-7&/T##QE:T30<[CC@+VO?1_1#:K+9W3WBN%46F[@055JC^.0 M%+GA;J6^O=('N$:0BK2OQVRG.3QI!"@X/9[]E)BC DKR+1 M,%E&8!B [')-O%<%,N"9W.YE2("]@+V O>=M;P/L?;?LO;J$-6 O2**^21+U MV9TUC:6+K >362+%BK=HA2W"GO@O*/"?*X99(5%["W$56-_/ENJ6;4?U71;# M9'TX:-:!4T9Q',0PE^NPN2J@ 3T*].CY]"A=V[BU S?H<:Z*1M#>EQNV?@6% MV4BUA06S7G$\T>@3\XZL^@Z;Z3SR>3KOUWT?;BI5CG[[1_=5XM#R]#!,V>XN M+.]TM^M-=H)=O;[XX2%^'UF%7$5K2):N_I'RN4=(]1M 'JJ?'[:?#<0]LZ\/ M:PM8C%6&1IH]/ X&,@)G[2%(F<0OF#@&P'M>7R8 WMLVDEP"=U;G(-(-9#OB MVJ(HUVEBIS3P''?Y08!8&2.H,D%>,.0!Z'O>08!7A;YS!T9 ")YW%AT0@H\C M!#\\%NVJA.#:[/";]%)9C/P6)PF4$ MN,5O?T[:5<$1Z.2W.24(" $0 B $'T@(?GAF$1""CR0$MY"C!D( \J57%Z>] M6<_()6*U&6)+LK(1"7L_;NZ%I,_P\"2/U?+S6PB\S%!,&;MDYP@ Y?..:[DJ M4 +-##3S;7:A7$*+[JA>O%+YP1:N>IU6;^YVY]W.L09,/E>+_EDORM4WGIS* M^-8AIV;)-S*6WQ\F7_+\*)W.7[WTKU*6-3[?R;4?67N @TBNOMOD,2P>W;"0 M@>''JB8B43_0FH,%%U/PD*IRZJ3!+&4$R=M-B N>L_>1$05:0*^]C>2/ 379 M-.=1L+=PCMPV^3H4(6-)SP&5]9&@911!RC@-SOD!YY( ]KZ#]_U 1F MO>!H!L!>L'P]UVS%QS-\,[9>W4I/,!>D$_ZZ&7V/\XRU;O]57N_H(
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end XML 108 biox-20231231x6k_htm.xml IDEA: XBRL DOCUMENT 0001769484 2023-07-01 2023-12-31 0001769484 ifrs-full:ParentMember 2023-12-31 0001769484 ifrs-full:ParentMember 2023-06-30 0001769484 biox:TrustDebtSecuritiesMember 2023-12-31 0001769484 biox:ParentsCompaniesAndRelatedPartiesMember 2023-12-31 0001769484 biox:TrustDebtSecuritiesMember 2023-06-30 0001769484 biox:ParentsCompaniesAndRelatedPartiesMember 2023-06-30 0001769484 biox:TrigallGeneticsS.a.Member 2023-07-01 2023-12-31 0001769484 biox:SynertechIndustriasS.aMember 2023-07-01 2023-12-31 0001769484 biox:MoolecScienceS.a.Member 2023-07-01 2023-12-31 0001769484 biox:TrigallGeneticsS.a.Member 2022-07-01 2022-12-31 0001769484 biox:SynertechIndustriasS.aMember 2022-07-01 2022-12-31 0001769484 biox:IndrasaBiotecnologaS.a.Member 2022-07-01 2022-12-31 0001769484 ifrs-full:CurrencyRiskMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-06-30 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember biox:SeedAndIntegratedProductsMember 2023-07-01 2023-12-31 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember biox:CropProtectionMember 2023-07-01 2023-12-31 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember biox:CropNutritionMember 2023-07-01 2023-12-31 0001769484 biox:GoodsAndServicesMember 2023-07-01 2023-12-31 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember 2023-07-01 2023-12-31 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember biox:SeedAndIntegratedProductsMember 2022-07-01 2022-12-31 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember biox:CropProtectionMember 2022-07-01 2022-12-31 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember biox:CropNutritionMember 2022-07-01 2022-12-31 0001769484 biox:GoodsAndServicesMember 2022-07-01 2022-12-31 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:VehiclesMember 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:OfficeEquipmentMember 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:MachineryMember 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:LandAndBuildingsMember 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:FixturesAndFittingsMember 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerEquipmentMember 2023-12-31 0001769484 ifrs-full:VehiclesMember 2023-12-31 0001769484 ifrs-full:OfficeEquipmentMember 2023-12-31 0001769484 ifrs-full:MachineryMember 2023-12-31 0001769484 ifrs-full:LandAndBuildingsMember 2023-12-31 0001769484 ifrs-full:FixturesAndFittingsMember 2023-12-31 0001769484 ifrs-full:ConstructionInProgressMember 2023-12-31 0001769484 ifrs-full:ComputerEquipmentMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:VehiclesMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:OfficeEquipmentMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:MachineryMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:LandAndBuildingsMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:FixturesAndFittingsMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerEquipmentMember 2023-06-30 0001769484 ifrs-full:VehiclesMember 2023-06-30 0001769484 ifrs-full:OfficeEquipmentMember 2023-06-30 0001769484 ifrs-full:MachineryMember 2023-06-30 0001769484 ifrs-full:LandAndBuildingsMember 2023-06-30 0001769484 ifrs-full:FixturesAndFittingsMember 2023-06-30 0001769484 ifrs-full:ConstructionInProgressMember 2023-06-30 0001769484 ifrs-full:ComputerEquipmentMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:VehiclesMember 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:OfficeEquipmentMember 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:MachineryMember 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:LandAndBuildingsMember 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:FixturesAndFittingsMember 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerEquipmentMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:VehiclesMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:OfficeEquipmentMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:MachineryMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:LandAndBuildingsMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:FixturesAndFittingsMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerEquipmentMember 2022-06-30 0001769484 ifrs-full:RetainedEarningsMember 2023-07-01 2023-12-31 0001769484 ifrs-full:RetainedEarningsMember 2022-07-01 2022-12-31 0001769484 ifrs-full:OtherRelatedPartiesMember 2023-06-30 0001769484 biox:ReceivablesForPpESalesMember 2023-06-30 0001769484 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-07-01 2023-12-31 0001769484 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-07-01 2022-12-31 0001769484 ifrs-full:PreferenceSharesMember 2023-12-31 0001769484 ifrs-full:OrdinarySharesMember 2023-12-31 0001769484 biox:EquityCompensationPlanMember 2023-12-31 0001769484 biox:BankBorrowingsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-12-31 0001769484 biox:BankBorrowingsMember ifrs-full:AtFairValueMember 2023-12-31 0001769484 biox:BankBorrowingsMember 2023-12-31 0001769484 biox:BankBorrowingsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:BankBorrowingsMember ifrs-full:AtFairValueMember 2023-06-30 0001769484 biox:BankBorrowingsMember 2023-06-30 0001769484 ifrs-full:ReserveOfEquityComponentOfConvertibleInstrumentsMember 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedImpairmentMember 2023-12-31 0001769484 biox:SeedsMember 2023-12-31 0001769484 biox:MicrobiologicalResaleProductsMember 2023-12-31 0001769484 biox:MicrobiologicalProductsProducedMember 2023-12-31 0001769484 ifrs-full:AccumulatedImpairmentMember 2023-06-30 0001769484 biox:SeedsMember 2023-06-30 0001769484 biox:MicrobiologicalResaleProductsMember 2023-06-30 0001769484 biox:MicrobiologicalProductsProducedMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:SoybeanHb4Member 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:RgRsOxWheatMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:MicrobiologyProductMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:EcoseedIntegratedProductsMember 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:SoybeanHb4Member 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:MicrobiologyProductMember 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:EcoseedIntegratedProductsMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember 2023-12-31 0001769484 ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-12-31 0001769484 ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-12-31 0001769484 ifrs-full:ComputerSoftwareMember 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2023-12-31 0001769484 biox:SoybeanHb4Member 2023-12-31 0001769484 biox:RgRsOxWheatMember 2023-12-31 0001769484 biox:MicrobiologyProductMember 2023-12-31 0001769484 biox:EcoseedIntegratedProductsMember 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:SoybeanHb4Member 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:RgRsOxWheatMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:MicrobiologyProductMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:EcoseedIntegratedProductsMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:SoybeanHb4Member 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:MicrobiologyProductMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:EcoseedIntegratedProductsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember 2023-06-30 0001769484 ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-06-30 0001769484 ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-06-30 0001769484 ifrs-full:ComputerSoftwareMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2023-06-30 0001769484 biox:SoybeanHb4Member 2023-06-30 0001769484 biox:RgRsOxWheatMember 2023-06-30 0001769484 biox:MicrobiologyProductMember 2023-06-30 0001769484 biox:EcoseedIntegratedProductsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:SoybeanHb4Member 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:RgRsOxWheatMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:MicrobiologyProductMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:EcoseedIntegratedProductsMember 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:SoybeanHb4Member 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:MicrobiologyProductMember 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:EcoseedIntegratedProductsMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:SoybeanHb4Member 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:RgRsOxWheatMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:MicrobiologyProductMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:EcoseedIntegratedProductsMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:SoybeanHb4Member 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:MicrobiologyProductMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:EcoseedIntegratedProductsMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-06-30 0001769484 ifrs-full:TreasurySharesMember 2023-07-01 2023-12-31 0001769484 ifrs-full:TreasurySharesMember 2022-07-01 2022-12-31 0001769484 ifrs-full:SharePremiumMember 2023-07-01 2023-12-31 0001769484 ifrs-full:IssuedCapitalMember 2023-07-01 2023-12-31 0001769484 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-07-01 2023-12-31 0001769484 biox:StockOptionsAndShareBasedIncentivesMember 2023-07-01 2023-12-31 0001769484 biox:OwnSharesTradingPremiumMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:EcoseedIntegratedProductsMember 2023-07-01 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:EcoseedIntegratedProductsMember 2022-07-01 2022-12-31 0001769484 biox:RizobacterArgentinaMember 2023-12-31 0001769484 biox:ProFarmGroupInc.Member 2023-12-31 0001769484 biox:InsumosAgroqumicosMember 2023-12-31 0001769484 biox:BioceresCropsMember 2023-12-31 0001769484 biox:RizobacterArgentinaMember 2023-06-30 0001769484 biox:ProFarmGroupInc.Member 2023-06-30 0001769484 biox:InsumosAgroqumicosMember 2023-06-30 0001769484 biox:BioceresCropsMember 2023-06-30 0001769484 biox:TradeAndOtherPayablesMember ifrs-full:Level2OfFairValueHierarchyMember 2023-12-31 0001769484 biox:TradeAndOtherPayablesMember ifrs-full:Level2OfFairValueHierarchyMember 2023-06-30 0001769484 ifrs-full:LeaseLiabilitiesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-12-31 0001769484 ifrs-full:ContingentConsiderationMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-12-31 0001769484 biox:TradeAndOtherPayablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-12-31 0001769484 biox:TradeAndOtherPayablesMember ifrs-full:AtFairValueMember 2023-12-31 0001769484 biox:SecuredDebtsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-12-31 0001769484 biox:BorrowingMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-12-31 0001769484 ifrs-full:LeaseLiabilitiesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 ifrs-full:ContingentConsiderationMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:TradeAndOtherPayablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:TradeAndOtherPayablesMember ifrs-full:AtFairValueMember 2023-06-30 0001769484 biox:SecuredDebtsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:BorrowingMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 ifrs-full:InvestmentFundsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001769484 biox:OtherInvestmentMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001769484 ifrs-full:InvestmentFundsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-06-30 0001769484 biox:USTreasuryBillsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-06-30 0001769484 biox:OtherInvestmentMember ifrs-full:Level1OfFairValueHierarchyMember 2023-06-30 0001769484 ifrs-full:TradeReceivablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-12-31 0001769484 biox:OtherReceivablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-12-31 0001769484 biox:OtherFinancialAssetsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-12-31 0001769484 biox:OtherFinancialAssetsMember ifrs-full:AtFairValueMember 2023-12-31 0001769484 biox:CashAndEquivalentsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-12-31 0001769484 biox:CashAndEquivalentsMember ifrs-full:AtFairValueMember 2023-12-31 0001769484 ifrs-full:TradeReceivablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:OtherReceivablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:OtherFinancialAssetsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:OtherFinancialAssetsMember ifrs-full:AtFairValueMember 2023-06-30 0001769484 biox:CashAndEquivalentsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 ifrs-full:TopOfRangeMember biox:PerformanceShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 ifrs-full:TopOfRangeMember biox:PastShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 ifrs-full:TopOfRangeMember biox:BaseShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 ifrs-full:BottomOfRangeMember biox:PerformanceShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 ifrs-full:BottomOfRangeMember biox:PastShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 ifrs-full:BottomOfRangeMember biox:BaseShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 ifrs-full:TreasurySharesMember 2023-12-31 0001769484 ifrs-full:SharePremiumMember 2023-12-31 0001769484 ifrs-full:RetainedEarningsMember 2023-12-31 0001769484 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-12-31 0001769484 ifrs-full:ReserveOfEquityComponentOfConvertibleInstrumentsMember 2023-12-31 0001769484 ifrs-full:NoncontrollingInterestsMember 2023-12-31 0001769484 ifrs-full:IssuedCapitalMember 2023-12-31 0001769484 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-12-31 0001769484 biox:StockOptionsAndShareBasedIncentivesMember 2023-12-31 0001769484 biox:RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember 2023-12-31 0001769484 biox:OwnSharesTradingPremiumMember 2023-12-31 0001769484 biox:ChangesInNonControllingInterestMember 2023-12-31 0001769484 ifrs-full:TreasurySharesMember 2023-06-30 0001769484 ifrs-full:SharePremiumMember 2023-06-30 0001769484 ifrs-full:RetainedEarningsMember 2023-06-30 0001769484 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-06-30 0001769484 ifrs-full:ReserveOfEquityComponentOfConvertibleInstrumentsMember 2023-06-30 0001769484 ifrs-full:NoncontrollingInterestsMember 2023-06-30 0001769484 ifrs-full:IssuedCapitalMember 2023-06-30 0001769484 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-06-30 0001769484 biox:StockOptionsAndShareBasedIncentivesMember 2023-06-30 0001769484 biox:RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember 2023-06-30 0001769484 biox:OwnSharesTradingPremiumMember 2023-06-30 0001769484 biox:ChangesInNonControllingInterestMember 2023-06-30 0001769484 ifrs-full:TreasurySharesMember 2022-12-31 0001769484 ifrs-full:SharePremiumMember 2022-12-31 0001769484 ifrs-full:RetainedEarningsMember 2022-12-31 0001769484 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-12-31 0001769484 ifrs-full:ReserveOfEquityComponentOfConvertibleInstrumentsMember 2022-12-31 0001769484 ifrs-full:NoncontrollingInterestsMember 2022-12-31 0001769484 ifrs-full:IssuedCapitalMember 2022-12-31 0001769484 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-12-31 0001769484 biox:StockOptionsAndShareBasedIncentivesMember 2022-12-31 0001769484 biox:RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember 2022-12-31 0001769484 biox:OwnSharesTradingPremiumMember 2022-12-31 0001769484 biox:ChangesInNonControllingInterestMember 2022-12-31 0001769484 ifrs-full:TreasurySharesMember 2022-06-30 0001769484 ifrs-full:SharePremiumMember 2022-06-30 0001769484 ifrs-full:RetainedEarningsMember 2022-06-30 0001769484 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-06-30 0001769484 ifrs-full:ReserveOfEquityComponentOfConvertibleInstrumentsMember 2022-06-30 0001769484 ifrs-full:NoncontrollingInterestsMember 2022-06-30 0001769484 ifrs-full:IssuedCapitalMember 2022-06-30 0001769484 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-06-30 0001769484 biox:StockOptionsAndShareBasedIncentivesMember 2022-06-30 0001769484 biox:RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember 2022-06-30 0001769484 biox:OwnSharesTradingPremiumMember 2022-06-30 0001769484 biox:ChangesInNonControllingInterestMember 2022-06-30 0001769484 ifrs-full:NoncontrollingInterestsMember 2023-07-01 2023-12-31 0001769484 ifrs-full:NoncontrollingInterestsMember 2022-07-01 2022-12-31 0001769484 biox:JointVenturesAndAssociatesMember 2023-12-31 0001769484 biox:JointVenturesAndAssociatesMember 2023-06-30 0001769484 biox:SecuredGuaranteedNotesMember ifrs-full:AtFairValueMember 2023-12-31 0001769484 biox:SecuredGuaranteedNotesMember ifrs-full:AtCostMember 2023-12-31 0001769484 biox:SecuredConvertibleGuaranteedNotesMember ifrs-full:AtFairValueMember 2023-12-31 0001769484 biox:SecuredConvertibleGuaranteedNotesMember ifrs-full:AtCostMember 2023-12-31 0001769484 ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-12-31 0001769484 ifrs-full:AtFairValueMember 2023-12-31 0001769484 ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 ifrs-full:AtFairValueMember 2023-06-30 0001769484 biox:SunflowerMember 2023-12-31 0001769484 biox:BiologicalAssetsSoybeanMember 2023-12-31 0001769484 biox:BiologicalAssetsCornMember 2023-12-31 0001769484 biox:SunflowerMember 2023-06-30 0001769484 biox:BiologicalAssetsWheatMember 2023-06-30 0001769484 biox:BiologicalAssetsSoybeanMember 2023-06-30 0001769484 biox:BiologicalAssetsCornMember 2023-06-30 0001769484 biox:BiologicalAssetsBarleyMember 2023-06-30 0001769484 biox:SunflowerMember 2022-12-31 0001769484 biox:BiologicalAssetsSoybeanMember 2022-12-31 0001769484 biox:BiologicalAssetsCornMember 2022-12-31 0001769484 2022-12-31 0001769484 biox:SunflowerMember 2022-06-30 0001769484 biox:BiologicalAssetsWheatMember 2022-06-30 0001769484 biox:BiologicalAssetsSoybeanMember 2022-06-30 0001769484 biox:BiologicalAssetsCornMember 2022-06-30 0001769484 biox:BiologicalAssetsBarleyMember 2022-06-30 0001769484 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-07-01 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2023-07-01 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2023-07-01 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-07-01 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2023-07-01 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2023-07-01 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:VehiclesMember 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:OfficeEquipmentMember 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:MachineryMember 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:LandAndBuildingsMember 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:FixturesAndFittingsMember 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerEquipmentMember 2023-07-01 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:VehiclesMember 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:OfficeEquipmentMember 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:MachineryMember 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:LandAndBuildingsMember 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:FixturesAndFittingsMember 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerEquipmentMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-07-01 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-07-01 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:SoybeanHb4Member 2023-07-01 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:MicrobiologyProductMember 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:SoybeanHb4Member 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:MicrobiologyProductMember 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:EcoseedIntegratedProductsMember 2023-07-01 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:SoybeanHb4Member 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:SoybeanHb4Member 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:MicrobiologyProductMember 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:EcoseedIntegratedProductsMember 2022-07-01 2022-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-07-01 2022-12-31 0001769484 biox:SunflowerMember 2023-07-01 2023-12-31 0001769484 biox:BiologicalAssetsSoybeanMember 2023-07-01 2023-12-31 0001769484 biox:BiologicalAssetsCornMember 2023-07-01 2023-12-31 0001769484 biox:SunflowerMember 2022-07-01 2022-12-31 0001769484 biox:BiologicalAssetsSoybeanMember 2022-07-01 2022-12-31 0001769484 biox:BiologicalAssetsCornMember 2022-07-01 2022-12-31 0001769484 ifrs-full:MachineryMember 2022-07-01 2022-12-31 0001769484 ifrs-full:LandAndBuildingsMember 2022-07-01 2022-12-31 0001769484 ifrs-full:FixturesAndFittingsMember 2022-07-01 2022-12-31 0001769484 ifrs-full:ConstructionInProgressMember 2022-07-01 2022-12-31 0001769484 ifrs-full:ComputerEquipmentMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember biox:MicrobiologyProductMember 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember 2022-07-01 2022-12-31 0001769484 ifrs-full:OtherRelatedPartiesMember 2023-12-31 0001769484 ifrs-full:JointVenturesWhereEntityIsVenturerMember 2023-12-31 0001769484 ifrs-full:JointVenturesWhereEntityIsVenturerMember 2023-06-30 0001769484 biox:IfEbitdaReachesAtLeastUs150MillionMember biox:PerformanceShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2023-07-01 2023-12-31 0001769484 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2022-07-01 2022-12-31 0001769484 ifrs-full:OtherRelatedPartiesMember 2023-07-01 2023-12-31 0001769484 ifrs-full:JointVenturesWhereEntityIsVenturerMember 2023-07-01 2023-12-31 0001769484 ifrs-full:JointVenturesWhereEntityIsVenturerMember 2022-07-01 2022-12-31 0001769484 currency:USD 2023-07-01 2023-12-31 0001769484 currency:BRL 2023-07-01 2023-12-31 0001769484 biox:SeedAndIntegratedProductsMember 2023-07-01 2023-12-31 0001769484 biox:CropProtectionMember 2023-07-01 2023-12-31 0001769484 biox:CropNutritionMember 2023-07-01 2023-12-31 0001769484 biox:SeedAndIntegratedProductsMember 2022-07-01 2022-12-31 0001769484 biox:CropProtectionMember 2022-07-01 2022-12-31 0001769484 biox:CropNutritionMember 2022-07-01 2022-12-31 0001769484 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2023-12-31 0001769484 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2023-06-30 0001769484 biox:ParentCompaniesAndRelatedPartiesToParentMember 2023-12-31 0001769484 biox:ParentCompaniesAndRelatedPartiesToParentMember 2023-06-30 0001769484 biox:TrigallGeneticsS.a.Member 2023-12-31 0001769484 biox:TrigallGeneticsS.a.Member 2023-06-30 0001769484 biox:SynertechIndustriasS.aMember 2023-12-31 0001769484 biox:MoolecScienceS.a.Member 2023-12-31 0001769484 biox:AlfalfaTechnologiesS.r.lMember 2023-12-31 0001769484 biox:SynertechIndustriasS.aMember 2023-06-30 0001769484 biox:MoolecScienceS.a.Member 2023-06-30 0001769484 biox:AlfalfaTechnologiesS.r.lMember 2023-06-30 0001769484 ifrs-full:OtherRelatedPartiesMember 2022-07-01 2022-12-31 0001769484 biox:ParentCompaniesAndRelatedPartiesToParentMember 2023-07-01 2023-12-31 0001769484 biox:ParentCompaniesAndRelatedPartiesToParentMember 2022-07-01 2022-12-31 0001769484 ifrs-full:SharePremiumMember 2022-07-01 2022-12-31 0001769484 ifrs-full:IssuedCapitalMember 2022-07-01 2022-12-31 0001769484 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-07-01 2022-12-31 0001769484 biox:StockOptionsAndShareBasedIncentivesMember 2022-07-01 2022-12-31 0001769484 biox:IfEbitdaReachesAtLeastUs150MillionMember ifrs-full:TopOfRangeMember biox:PerformanceShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 biox:IfEbitdaReachesAtLeastUs120MillionMember biox:PerformanceShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 ifrs-full:CurrencyRiskMember 2023-07-01 2023-12-31 0001769484 ifrs-full:GrossCarryingAmountMember 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2023-07-01 2023-12-31 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-07-01 2023-06-30 0001769484 biox:BiologicalAssetsWheatMember 2023-07-01 2023-12-31 0001769484 biox:BiologicalAssetsBarleyMember 2023-07-01 2023-12-31 0001769484 biox:BiologicalAssetsWheatMember 2022-07-01 2022-12-31 0001769484 biox:BiologicalAssetsBarleyMember 2022-07-01 2022-12-31 0001769484 2023-10-01 2023-12-31 0001769484 2022-10-01 2022-12-31 0001769484 biox:IfrsResearchAndDevelopmentExpenseMember 2023-07-01 2023-12-31 0001769484 ifrs-full:SellingGeneralAndAdministrativeExpenseMember 2023-07-01 2023-12-31 0001769484 ifrs-full:SellingGeneralAndAdministrativeExpenseMember 2022-07-01 2022-12-31 0001769484 biox:IfrsResearchAndDevelopmentExpenseMember 2022-07-01 2022-12-31 0001769484 2023-12-31 0001769484 2023-06-30 0001769484 ifrs-full:CostOfSalesMember 2023-07-01 2023-12-31 0001769484 biox:ProductionCostAndSellingGeneralAndAdministrativeExpenseMember 2023-07-01 2023-12-31 0001769484 ifrs-full:CostOfSalesMember 2022-07-01 2022-12-31 0001769484 biox:ProductionCostAndSellingGeneralAndAdministrativeExpenseMember 2022-07-01 2022-12-31 0001769484 2022-07-01 2022-12-31 0001769484 ifrs-full:GrossCarryingAmountMember 2022-07-01 2023-06-30 0001769484 2022-07-01 2023-06-30 iso4217:USD biox:item pure biox:country biox:category biox:Vote shares iso4217:USD shares Bioceres Crop Solutions Corp. 0001769484 --06-30 2024 Q2 false 2023-12-31 6-K 62828025 0 24401937 48129194 17040207 12135020 199666283 158006474 25081598 28824998 1120881 9444898 123738148 140426975 938370 146842 391987424 397114401 444743 444909 1619642 2546241 3794 16286 9273827 7312964 42402217 39296810 3792238 3589749 71388129 67853835 172743513 173783956 112163432 112163432 13704217 13936575 427535752 420944757 819523176 818059158 164003202 150807674 113520778 107639659 8218657 9606707 22099378 24875662 864954 509034 4082708 1415099 4017013 3858699 316806690 298712534 31517348 60670946 2135840 2057805 115983 622823 43024592 35785347 478490 891769 2601570 3578157 77998071 75213146 9583276 10030524 167455170 188850517 484261860 487563051 300541772 298594088 34719544 31902019 335261316 330496107 819523176 818059158 140293827 94548714 256476632 221391962 -72785 -138529 338128 351477 88710537 59141259 160326318 134817137 -746242 -1509023 -2192558 -1736959 3643077 3457892 8224318 7309906 31164937 28413577 65097785 60318488 2052296 40048 3560967 882288 -1166603 290487 -2398238 768528 16841942 2218969 22136510 19211765 -3815993 -5759485 -11477850 -12539332 -3454061 -4200857 -3336196 -5489163 9571888 -7741373 7322464 1183270 8333387 684906 8762427 5697549 1238501 -8426279 -1439963 -4514279 108449 -8156746 -4483185 -7658449 1130052 -269533 3043222 3144170 1238501 -8426279 -1439963 -4514279 0.0017 -0.1323 -0.0713 -0.1242 0.0017 -0.1323 -0.0713 -0.1242 1238501 -8426279 -1439963 -4514279 485703 585882 -444254 616907 485703 585882 -444254 616907 897 -122814 897 -21946 484806 708696 -445151 638853 1724204 -7840397 -1884217 -3897372 510976 -7779559 -4853354 -7377844 1213228 -60838 2969137 3480472 1724204 -7840397 -1884217 -3897372 4637 158819506 -255893 -916202 3767925 175745 -3530926 -32682893 969402 1007272 127358573 30940275 158298848 5 631778 135361 1806100 2573244 2573244 1640 153357564 1620140 154979344 154979344 153 12211485 12211638 12211638 -26206394 -26206394 -26206394 9109516 9109516 9109516 452129 452129 -7658449 -7658449 3144170 -4514279 280605 280605 336302 616907 6435 325020333 -255893 -780841 7194165 9285261 -29737320 -40341342 1250007 1007272 272648077 33968618 306616695 6493 327028559 -255893 -780841 6645442 9285261 -30553591 -13903017 1282377 -160702 298594088 31902019 330496107 4 526017 7009405 7535426 7535426 -734388 -734388 -734388 151612 151612 -4483185 -4483185 3043222 -1439963 -370169 -370169 -74085 -444254 6497 327554576 -255893 -780841 13654847 9285261 -31287979 -18386202 912208 -160702 300541772 34719544 335261316 -1439963 -4514279 8762427 5697549 14814046 18028495 2556422 2960156 5474971 5191521 1711256 1837532 3634992 8527214 2062345 3560967 882288 -7853 49090 39847 296051 468992 282836 481332 -338128 -351477 -2192558 -1736959 -33521 -111728 -38431478 -63042799 3281861 -6589310 8670430 -3869723 13725208 -23455328 11867420 12216345 -1388050 2185006 -2698249 53775013 -2772608 1204931 3493607 323421 658967 35849786 8886971 45268 118914 4373265 -16363130 -13813944 6070237 3824078 4454893 5926539 219829 148075 -27062821 -19220457 69810628 136880982 79250768 78971568 12168664 9678974 -1288813 -3588240 734388 2291365 2493617 1553958 151612 452129 -26277234 40344748 -17490269 30011262 -10495 -56375 48129194 33475266 -6226493 5119869 24401937 68550022 1. GENERAL INFORMATIONBioceres Crop Solutions Corp. (NASDAQ:BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. To do this, Bioceres’ products create economic incentives for farmers and other stakeholders to adopt environmentally friendly production practices. Bioceres has a unique biotech platform with high impact, patented technologies for seeds and microbial ag inputs, as well as next generation crop nutrition and protection solutions.Bioceres is a global company with an extensive geographic footprint. The Group’s agricultural inputs are marketed across more than 45 countries, primarily in South America, the United States and Europe.Unless the context otherwise requires, “we”, “us”, “our”, “Bioceres”, “BIOX”, “the Group”, and “Bioceres Crop Solutions” will refer to Bioceres Crop Solutions Corp. and its subsidiaries. 45 2. ACCOUNTING STANDARDS AND BASIS OF PREPARATIONStatement of compliance with IFRS as issued by IASBThese unaudited interim condensed consolidated financial statements for the six-month period ended December 31, 2023, have been prepared in accordance with Accounting Standard IAS 34 Interim Financial Reporting.These unaudited interim condensed consolidated financial statements do not include all notes of the type normally included in an annual financial statement. Accordingly, these unaudited interim condensed consolidated financial statements are to be read in conjunction with the consolidated financial statements for the fiscal year ended June 30, 2023.Authorization for the issue of the consolidated financial statementsThese unaudited interim condensed consolidated financial statements of the Group as of December 31, 2023, June 30, 2023 and for the three and six month periods ended December 31, 2023 and 2022 were authorized by the Board of Directors of Bioceres Crop Solutions Corp. on February 28, 2024.Basis of measurementThe consolidated financial statements of the Group have been prepared using:<div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;">●Going concern basis of accounting, considering the conclusion of the assessment made by the Group’s Management about the ability of the Group and its subsidiaries to continue as a going concern, in accordance with the requirements of paragraph 25 of IAS 1, “Presentation of Financial Statements”.</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;">●Accrual basis of accounting (except for cash flows information). Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there are no cash flows.</div><div style="margin-top:12pt;"></div>Functional currency and presentation currency<table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a)</td><td style="padding:0pt;">Functional currency</td></tr></table>Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic market in which the entity operates (i.e., “the functional currency”).<table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b)</td><td style="padding:0pt;">Presentation currency</td></tr></table>The consolidated financial statements of the Group are presented in US dollars. <table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c)</td><td style="padding:0pt;">Foreign currency</td></tr></table>Transactions entered into by Group entities in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting period. Exchange differences arising from the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising from the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the consolidated statement of profit or loss and other comprehensive income as part of the gain or loss recognized upon such disposal.Changes in accounting policiesIn previous years, the Group presented the sum of revenues from contracts with customers, initial recognition and changes in fair value of biological assets at the point of harvest, and changes in the net realizable value of agricultural products after harvest in a caption “Total” to assist investors to understand the performance of the Group’s comprehensive income for each fiscal year. As of the current period, that caption has been removed from the consolidated statements of comprehensive income to be aligned with comparable companies of the industry.The accounting policies adopted in the preparation of these unaudited interim condensed consolidated financial statements are consistent with those adopted for the preparation of the consolidated financial statements as of June 30, 2023. Basis of measurementThe consolidated financial statements of the Group have been prepared using:<div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;">●Going concern basis of accounting, considering the conclusion of the assessment made by the Group’s Management about the ability of the Group and its subsidiaries to continue as a going concern, in accordance with the requirements of paragraph 25 of IAS 1, “Presentation of Financial Statements”.</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;">●Accrual basis of accounting (except for cash flows information). Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there are no cash flows.</div><div style="margin-top:12pt;"></div> <table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a)</td><td style="padding:0pt;">Functional currency</td></tr></table>Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic market in which the entity operates (i.e., “the functional currency”). <table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b)</td><td style="padding:0pt;">Presentation currency</td></tr></table>The consolidated financial statements of the Group are presented in US dollars. <table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c)</td><td style="padding:0pt;">Foreign currency</td></tr></table>Transactions entered into by Group entities in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting period. Exchange differences arising from the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising from the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the consolidated statement of profit or loss and other comprehensive income as part of the gain or loss recognized upon such disposal. Changes in accounting policiesIn previous years, the Group presented the sum of revenues from contracts with customers, initial recognition and changes in fair value of biological assets at the point of harvest, and changes in the net realizable value of agricultural products after harvest in a caption “Total” to assist investors to understand the performance of the Group’s comprehensive income for each fiscal year. As of the current period, that caption has been removed from the consolidated statements of comprehensive income to be aligned with comparable companies of the industry.The accounting policies adopted in the preparation of these unaudited interim condensed consolidated financial statements are consistent with those adopted for the preparation of the consolidated financial statements as of June 30, 2023. 3. NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASBa)The following new standards, amendments and interpretations became applicable for the current reporting period and adopted by the Group. <table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendment to IAS 12 –Deferred tax related to assets and liabilities arising from a single transaction.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">International Tax Reform—Pillar Two Model Rules (Amendments to IAS 12)</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendments to IAS 1 and IFRS Practice Statement 2- Disclosure of Accounting Policies</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendments to IAS 8-Definition of Accounting Estimates</td></tr></table><div style="margin-top:12pt;"></div>These new standards and amendments did not have any material impact on the Group.b)The following new standards are not yet adopted by the Group.<table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendments to IFRS 16- Lease Liability in a Sale and Leaseback. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendments to IAS1 – Non- current liabilities with covenants. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendments to IAS 7- Statement of Cash Flows & to IFRS 7- Financial Instruments: Disclosures. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendments to IAS 21- The Effects of Changes in Foreign Exchange Ratestitled Lack of Exchangeability. The amendments are effective for annual reporting periods beginning on or after 1 January 2025.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendment to IAS 7 and IFRS 7 - Supplier Financing. The amendments are effective for annual periods beginning on or after January 1, 2024.</td></tr></table>These amendments are not expected to have material impact on the Group. 4. SEASONALITYOur revenues fluctuate depending on the timing of orders from our distributors and customers and on prevailing market prices, which influence the purchase decisions of growers, the end users of our seed and integrated products, crop protection products and crop nutrition products. Given the cyclicality of crop planting and harvesting, as well as growing seasons, which vary from year to year, our business is highly seasonal. This results in substantial fluctuations in quarterly sales and profitability. Our portfolio is highly oriented to crop planting. Generally, our sales are concentrated in the third and fourth quarters of each calendar year, when demand for our seed and integrated products, crop protection products and crop nutrition products increases as growers begin planting their summer crops in South America, while winter crop season occurs in the Northern hemisphere. With our seed and integrated products business, we contract with growers and seed suppliers based upon our anticipated market demand. Generally, in our seed and integrated products business we stock the seed during the harvest season and ship from inventory throughout the year, with the objective of selling most of the inventory from the current year’s harvest before the next year’s, with our crop protection and our crop nutrition business following a similar cycle to the seed cycle. Milestone, royalty, and license revenues are also likely to fluctuate from period to period given the seasonality of agriculture and time required to progress from one milestone to the next.Our seed and integrated products, crop protection and crop nutrition businesses are also affected by unpredictable weather conditions such as heavy rains, hail, floods, freezing conditions, windstorms, drought or fire, as well as other hazardous situations beyond our control, which may cause our sales and operating results to fluctuate significantly. In addition, disruptions that cause delays by growers in harvesting or planting can result in the movement of orders to a future quarter, which also causes fluctuations in our quarterly operating results. Finally, some of our customers and distributors order in bulk only one or two times a year, which may further cause our seed product revenues to fluctuate from period to period. 1 2 5. INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION5.1. Cash and cash equivalents<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Cash at bank and on hand</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 24,332,260</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 48,129,194</td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 69,677</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 24,401,937</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 48,129,194</td></tr></table>5.2. Other financial assets<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Restricted short-term deposits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 212,703</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">US Treasury bills</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,163,298</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 14,736,104</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,596,539</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,304,103</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,162,480</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 17,040,207</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,135,020</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shares of Bioceres S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 444,410</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 444,635</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 333</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 274</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 444,743</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 444,909</td></tr></table>5.3. Trade receivables<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 206,838,287</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 160,269,233</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Allowance for impairment of trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (7,523,261)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (7,425,604)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shareholders and other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,223,994</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Allowance for credit notes to be issued</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (3,928,835)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (3,694,019)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trade debtors - Joint ventures and associates (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 781,452</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 865,627</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Deferred checks</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,274,646</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,991,237</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 199,666,283</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 158,006,474</td></tr></table>The book value is reasonably approximate to the fair value given its short-term nature.5.4. Other receivables<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 5,490,671</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 6,113,764</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Receivables for PP&E sales</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 156,423</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shareholders and other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,105,591</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,792,429</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other receivables - Joint ventures and associates (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 7,500,898</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 6,104,219</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Prepayments to suppliers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,820,065</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 10,956,831</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Reimbursements over exports</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,558</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,558</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Prepaid expenses and other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 4,022,045</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,302,221</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,131,770</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 388,553</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 25,081,598</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,824,998</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 873,699</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Reimbursements over exports</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,363,902</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,290,227</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Loans receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 230,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 230,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 25,740</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 152,315</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,619,642</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,546,241</td></tr></table>5.5. Inventories<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Seeds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 7,508,251</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,542,159</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Resale products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 64,271,825</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 58,544,931</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Manufactured products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 21,131,225</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 25,881,761</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Goods in transit</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,408,487</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,620,606</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Supplies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 17,878,874</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 24,893,187</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Agricultural products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 14,121,283</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 28,436,830</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Allowance for obsolescence</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,581,797)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,492,499)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 123,738,148</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 140,426,975</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Net of agricultural products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 109,616,865</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 111,990,145</td></tr></table>5.6. Biological assetsChanges in Biological assets:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Soybean</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Corn</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Barley</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Sunflower</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 87,785</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 59,057</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"> 146,842</td></tr><tr><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> 231,523</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> 106,605</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"> 338,128</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Costs incurred during the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"> 581,227</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 301,686</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 55,457</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"> 938,370</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;margin:0pt;padding:0pt;">Decrease due to harvest/disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (319,308)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (165,662)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (484,970)</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Period ended December 31, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 581,227</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 301,686</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 55,457</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 938,370</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Soybean</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Corn</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Barley</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Sunflower</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 44,413</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 12,900</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"> 57,313</td></tr><tr><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> 191,481</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> 159,996</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"> 351,477</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Costs incurred during the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"> 290,667</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 263,428</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 389,282</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 126,293</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 27,005</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"> 1,096,675</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;margin:0pt;padding:0pt;">Decrease due to harvest/disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (625,176)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (299,189)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (924,365)</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Period ended December 31, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 290,667</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 263,428</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 27,005</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 581,100</td></tr></table>5.7. Property, plant and equipmentProperty, plant and equipment as of December 31, 2023 and June 30, 2023 included the following:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Gross carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 99,485,867</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 93,634,779</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Accumulated depreciation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (28,097,738)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (25,780,944)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 71,388,129</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 67,853,835</td></tr></table>Net carrying amount for each class of assets is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> amount</td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 280,108</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 263,892</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,177,685</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,032,853</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 190,697</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 174,399</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,469,766</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,862,949</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 13,556,213</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 14,463,756</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 35,745,539</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 36,144,792</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 16,968,121</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,911,194</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 71,388,129</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 67,853,835</td></tr></table>1. Gross carrying amount as of December 31, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:57.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">beginning</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Foreign </td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">As of the</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">end of the</td></tr><tr><td style="vertical-align:bottom;width:40.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td></tr><tr><td style="vertical-align:middle;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 968,088</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 52,158</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (3,291)</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 1,016,955</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 5,492,319</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 556,237</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (126,068)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (411)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 5,922,077</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 974,509</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 101,224</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (7,575)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 1,068,158</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 7,663,899</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 10,483</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (8,976)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (9,384)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 7,656,022</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 23,513,047</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 275,297</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (26,864)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 23,761,480</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 43,111,723</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 10,351</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (29,020)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 43,093,054</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Buildings in progress (a)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,911,194</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,112,029</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (55,102)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 16,968,121</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 93,634,779</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,117,779</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (135,044)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (131,647)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 99,485,867</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;">Includes capitalized financial costs of $47,542 corresponding to the period ended December 31, 2023.</td></tr></table>2. Accumulated depreciation as of December 31, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:57.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Depreciation</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">as of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Accumulated</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">as of the end</td></tr><tr><td style="vertical-align:bottom;width:40.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td></tr><tr><td style="vertical-align:middle;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 704,196</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 33,828</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (1,177)</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 736,847</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 3,459,466</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (117,055)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 416,309</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (14,328)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 3,744,392</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 800,110</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 83,364</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (6,013)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 877,461</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 4,800,950</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (6,242)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 394,798</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (3,250)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 5,186,256</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 9,049,291</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 1,185,336</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (29,360)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 10,205,267</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,966,931</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 442,787</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (62,203)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,347,515</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 25,780,944</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (123,297)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,556,422</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (116,331)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,097,738</td></tr></table>3. Gross carrying amount as of December 31, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:65.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">As of the</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">beginning</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> from business </td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> end of the</td></tr><tr><td style="vertical-align:bottom;width:33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">combination</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> period</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 908,004</td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"> 305</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> 724</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 909,033</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">5,261,979</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"> 84,209</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (3,948)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 5,282,496</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 925,349</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"> 111,226</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 12,469</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> (32,824)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 1,016,220</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 7,606,389</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"> 34,256</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 5,379</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> 12,143</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 7,658,167</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 13,017,830</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"> 1,128,712</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 7,047,496</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> (7,186)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> (14,677)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 21,172,175</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 40,659,129</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 4,750,136</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (28,269)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 45,380,996</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,142,774</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,465,370</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,285,092</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (17,027)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,876,209</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 71,521,454</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,824,078</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 13,100,572</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (66,930)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (83,878)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 88,295,296</td></tr></table>4. Accumulated depreciation as of December 31, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:64.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Depreciation</td></tr><tr><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">as of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">Accumulated</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:32.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">Of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">as of the end</td></tr><tr><td style="vertical-align:bottom;width:32.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals </td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td></tr><tr><td style="vertical-align:bottom;width:32.5%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 638,466</td><td style="vertical-align:middle;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 30,827</td><td style="vertical-align:middle;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> (466)</td><td style="vertical-align:middle;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 668,827</td></tr><tr><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"> 2,596,905</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> 457,562</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> (1,178)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> 2,993,545</td></tr><tr><td style="vertical-align:bottom;width:32.5%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 693,673</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 73,094</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> (1,549)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 765,218</td></tr><tr><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"> 4,059,470</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> 370,828</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> (355)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> 4,429,943</td></tr><tr><td style="vertical-align:bottom;width:32.5%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 7,205,870</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 1,575,862</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> (9,845)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 8,771,887</td></tr><tr><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,418,745</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 451,983</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 473</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,871,201</td></tr><tr><td style="vertical-align:bottom;width:32.5%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 21,613,129</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,960,156</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (12,920)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 24,500,621</td></tr></table>The depreciation charge is included in Notes 6.3 and 6.4. The Group has no commitments to purchase property, plant and equipment items.5.8. Intangible assetsIntangible assets as of December 31, 2023 and June 30, 2023 included the following:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Gross carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 206,708,843</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 202,306,618</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Accumulated amortization</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (33,965,330)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (28,522,662)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 172,743,513</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 173,783,956</td></tr></table>Net carrying amount of each class of intangible assets is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">amount</td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023 (1)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023 (1)</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"> HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 32,554,026</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 31,679,681</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 2,516,125</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 2,841,008</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 50,829,622</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 49,508,801</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 57,429,133</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 59,760,753</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,923,055</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,987,690</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 22,491,552</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 23,006,023</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">RG/RS/OX Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 172,743,513</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 173,783,956</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;">Includes $32.2 million as of December 31, 2023 and $27.4 million as of June 30, 2023 of intangible assets not subject to amortization.</td></tr></table><div style="margin-top:12pt;"></div>1. Gross carrying amount as of December 31, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:50.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">As of the</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> end of the</td></tr><tr><td style="vertical-align:bottom;width:47.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 34,958,425</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 1,729,439</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 36,687,864</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 3,219,808</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> (269,869)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 2,949,939</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 55,645,028</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 2,725,454</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> (1,661)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 58,368,821</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 67,653,234</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 1,288</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 67,654,522</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 5,582,411</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 218,541</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> (967)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 5,799,985</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 30,247,712</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 30,247,712</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">RG/RS/OX Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 202,306,618</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 4,674,722</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (272,497)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 206,708,843</td></tr></table>2. Accumulated amortization as of December 31, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:50.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortization</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Accumulated as</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">as of beginning </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">of the end of the</td></tr><tr><td style="vertical-align:middle;width:47.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td></tr><tr><td style="vertical-align:middle;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 3,278,744</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 855,094</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 4,133,838</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 378,800</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 86,762</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> (31,748)</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 433,814</td></tr><tr><td style="vertical-align:middle;width:47.43%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:middle;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 6,136,227</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 1,402,972</td><td style="vertical-align:middle;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 7,539,199</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 7,892,481</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 2,332,908</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 10,225,389</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 3,594,721</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 282,764</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> (555)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 3,876,930</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,241,689</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 514,471</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,756,160</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,522,662</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 5,474,971</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (32,303)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 33,965,330</td></tr></table>3. Gross carrying amount as of December 31, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:56.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;">Additions from</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">beginning </td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;">business</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;">Foreign currency</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;">As of the end of</td></tr><tr><td style="vertical-align:middle;width:41.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">combination</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td></tr><tr><td style="vertical-align:bottom;width:41.66%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 31,371,088</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"> 1,738,631</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 33,109,719</td></tr><tr><td style="vertical-align:bottom;width:41.66%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products </td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 3,181,155</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> 8,296</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 3,189,451</td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:41.66%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 8,855,421</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"> 4,187,908</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> 39,613,280</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> (2,279)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 52,654,330</td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:41.66%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 12,183,045</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"> 49,783</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> 55,420,441</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 67,653,269</td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 5,176,373</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"> 98,292</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> (954)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 5,273,711</td></tr><tr><td style="vertical-align:bottom;width:41.66%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 28,462,475</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> 1,785,237</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 30,247,712</td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;">RG/RS/OX Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td></tr><tr><td style="vertical-align:bottom;width:41.66%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 94,229,557</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,074,614</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 96,818,958</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 5,063</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 197,128,192</td></tr></table>4. Accumulated amortization as of December 31, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:50.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortization</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">Accumulated as</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Accumulated </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">of beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">as of the end</td></tr><tr><td style="vertical-align:middle;width:47.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td></tr><tr><td style="vertical-align:middle;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 1,568,554</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 799,644</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 2,368,198</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 43,997</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 22,242</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 488</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 66,727</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Crop nutrition </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 3,063,073</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 313,970</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 3,377,043</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Other intangible assets </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;">3,916,004</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 2,136,403</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 6,052,407</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Software </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 3,008,388</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 285,881</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> (756)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 3,293,513</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">5,924,672</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">1,633,381</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">7,558,053</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">17,524,688</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">5,191,521</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (268)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">22,715,941</td></tr></table>The amortization charge is included in Notes 6.3 and 6.4.5.9. Goodwill<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Rizobacter Argentina S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 28,080,271</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 28,080,271</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Bioceres Crops S.A. </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,523,322</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,523,322</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Pro farm Group, Inc.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 76,089,749</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 76,089,749</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Insumos Agroquímicos S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 470,090</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 470,090</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 112,163,432</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 112,163,432</td></tr></table>There were no indicators of goodwill impairment. 5.10. Investment properties<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Investment properties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,792,238</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,589,749</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,792,238</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,589,749</td></tr></table>5.11. Trade and other payables<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 103,683,392</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 104,211,238</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shareholders and other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 75,271</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 35,292</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors - Parent company (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 161,860</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 644,191</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trade creditors - Joint ventures and associates (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 56,385,464</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 41,402,594</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,556,073</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,561,058</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 141,142</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 953,301</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 164,003,202</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 150,807,674</td></tr></table>5.12. Borrowings<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 52,942,957</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 61,303,952</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Corporate bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 49,749,398</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 35,547,510</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trust debt securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,188,607</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,296,506</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net loans payables- Parents companies and related parties to Parent (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,639,816</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,491,691</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 113,520,778</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 107,639,659</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 10,314,800</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 10,663,266</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Corporate bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,202,548</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 50,007,680</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">31,517,348</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">60,670,946</td></tr></table>The carrying value of some borrowings as of December 31, 2023 are measured at amortized cost differ from their fair value. The following fair values measured are based on discounted cash flows (Level 3) due to the use of unobservable inputs, including own credit risk.<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:42.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Fair value</td></tr><tr><td style="vertical-align:bottom;width:42.51%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.51%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"> 52,942,957</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"> 49,659,094</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"> 61,303,952</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;margin:0pt;padding:0pt;"> 57,209,155</td></tr><tr><td style="vertical-align:bottom;width:42.51%;background:#cceeff;margin:0pt;padding:0pt;">Corporate Bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"> 49,749,398</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"> 49,192,118</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"> 35,547,510</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;background:#cceeff;margin:0pt;padding:0pt;"> 34,725,828</td></tr><tr><td style="vertical-align:bottom;width:42.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.51%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.51%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"> 10,314,800</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"> 8,698,322</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"> 10,663,266</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;margin:0pt;padding:0pt;"> 10,374,646</td></tr><tr><td style="vertical-align:bottom;width:42.51%;background:#cceeff;margin:0pt;padding:0pt;">Corporate Bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"> 21,202,548</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"> 20,670,511</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"> 50,007,680</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;background:#cceeff;margin:0pt;padding:0pt;"> 47,014,542</td></tr></table>5.13. Secured NotesSecured Guaranteed NotesThe carrying value of $25.9 million of the Secured Guaranteed Notes as of December 31, 2023 are measured at amortized cost. Its fair value based on discounted cash flows, using a fair interest rate, would amount to $26.9 million.Secured Convertible Guaranteed Notes The carrying value of $52.1 million of the Secured Convertible Guaranteed Notes as of December 31, 2023 are measured at amortized cost. Its fair value based on discounted cash flows, using a fair interest rate, would amount to $54.8 million.Under the terms of the Secured Convertible Guaranteed Notes, the Group is in compliance with covenants.5.14. Employee benefits and social security<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, accrued incentives, vacations and social security</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 8,150,518</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,388,639</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Key management personnel (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 68,139</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 218,068</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,218,657</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 9,606,707</td></tr></table>5.15. Deferred revenue and advances from customers<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Advances from customers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 4,466,515</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 9,216,032</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Deferred revenue</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 17,632,863</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,659,630</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 22,099,378</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 24,875,662</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Advances from customers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 272,334</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 620,893</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Deferred revenue</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,863,506</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,436,912</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">2,135,840</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,057,805</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Cash at bank and on hand</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 24,332,260</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 48,129,194</td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 69,677</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 24,401,937</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 48,129,194</td></tr></table> 24332260 48129194 69677 24401937 48129194 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Restricted short-term deposits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 212,703</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">US Treasury bills</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,163,298</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 14,736,104</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,596,539</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,304,103</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,162,480</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 17,040,207</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,135,020</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shares of Bioceres S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 444,410</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 444,635</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 333</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 274</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 444,743</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 444,909</td></tr></table> 212703 9163298 14736104 1596539 2304103 1162480 17040207 12135020 444410 444635 333 274 444743 444909 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 206,838,287</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 160,269,233</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Allowance for impairment of trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (7,523,261)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (7,425,604)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shareholders and other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,223,994</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Allowance for credit notes to be issued</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (3,928,835)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (3,694,019)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trade debtors - Joint ventures and associates (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 781,452</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 865,627</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Deferred checks</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,274,646</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,991,237</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 199,666,283</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 158,006,474</td></tr></table> 206838287 160269233 7523261 7425604 1223994 3928835 3694019 781452 865627 2274646 7991237 199666283 158006474 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 5,490,671</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 6,113,764</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Receivables for PP&E sales</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 156,423</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shareholders and other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,105,591</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,792,429</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other receivables - Joint ventures and associates (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 7,500,898</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 6,104,219</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Prepayments to suppliers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,820,065</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 10,956,831</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Reimbursements over exports</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,558</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,558</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Prepaid expenses and other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 4,022,045</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,302,221</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,131,770</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 388,553</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 25,081,598</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,824,998</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 873,699</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Reimbursements over exports</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,363,902</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,290,227</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Loans receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 230,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 230,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 25,740</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 152,315</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,619,642</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,546,241</td></tr></table> 5490671 6113764 156423 3105591 3792429 7500898 6104219 3820065 10956831 10558 10558 4022045 1302221 1131770 388553 25081598 28824998 873699 1363902 1290227 230000 230000 25740 152315 1619642 2546241 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Seeds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 7,508,251</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,542,159</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Resale products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 64,271,825</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 58,544,931</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Manufactured products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 21,131,225</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 25,881,761</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Goods in transit</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,408,487</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,620,606</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Supplies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 17,878,874</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 24,893,187</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Agricultural products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 14,121,283</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 28,436,830</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Allowance for obsolescence</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,581,797)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,492,499)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 123,738,148</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 140,426,975</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Net of agricultural products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 109,616,865</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 111,990,145</td></tr></table> 7508251 1542159 64271825 58544931 21131225 25881761 1408487 3620606 17878874 24893187 14121283 28436830 -2581797 -2492499 123738148 140426975 109616865 111990145 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Soybean</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Corn</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Barley</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Sunflower</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 87,785</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 59,057</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"> 146,842</td></tr><tr><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> 231,523</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> 106,605</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"> 338,128</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Costs incurred during the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"> 581,227</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 301,686</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 55,457</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"> 938,370</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;margin:0pt;padding:0pt;">Decrease due to harvest/disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (319,308)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (165,662)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (484,970)</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Period ended December 31, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 581,227</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 301,686</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 55,457</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 938,370</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Soybean</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Corn</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Barley</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Sunflower</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 44,413</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 12,900</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"> 57,313</td></tr><tr><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> 191,481</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> 159,996</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"> 351,477</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Costs incurred during the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"> 290,667</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 263,428</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 389,282</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 126,293</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 27,005</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"> 1,096,675</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;margin:0pt;padding:0pt;">Decrease due to harvest/disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (625,176)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (299,189)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (924,365)</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Period ended December 31, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 290,667</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 263,428</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 27,005</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 581,100</td></tr></table> 0 0 87785 59057 0 146842 231523 106605 338128 581227 301686 55457 938370 319308 165662 484970 581227 301686 55457 938370 0 0 44413 12900 0 57313 191481 159996 351477 290667 263428 389282 126293 27005 1096675 625176 299189 924365 290667 263428 27005 581100 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Gross carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 99,485,867</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 93,634,779</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Accumulated depreciation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (28,097,738)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (25,780,944)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 71,388,129</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 67,853,835</td></tr></table> 99485867 93634779 -28097738 -25780944 71388129 67853835 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> amount</td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 280,108</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 263,892</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,177,685</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,032,853</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 190,697</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 174,399</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,469,766</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,862,949</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 13,556,213</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 14,463,756</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 35,745,539</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 36,144,792</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 16,968,121</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,911,194</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 71,388,129</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 67,853,835</td></tr></table> 280108 263892 2177685 2032853 190697 174399 2469766 2862949 13556213 14463756 35745539 36144792 16968121 11911194 71388129 67853835 1. Gross carrying amount as of December 31, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:57.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">beginning</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Foreign </td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">As of the</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">end of the</td></tr><tr><td style="vertical-align:bottom;width:40.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td></tr><tr><td style="vertical-align:middle;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 968,088</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 52,158</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (3,291)</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 1,016,955</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 5,492,319</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 556,237</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (126,068)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (411)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 5,922,077</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 974,509</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 101,224</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (7,575)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 1,068,158</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 7,663,899</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 10,483</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (8,976)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (9,384)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 7,656,022</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 23,513,047</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 275,297</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (26,864)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 23,761,480</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 43,111,723</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 10,351</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (29,020)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 43,093,054</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Buildings in progress (a)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,911,194</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,112,029</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (55,102)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 16,968,121</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 93,634,779</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,117,779</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (135,044)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (131,647)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 99,485,867</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;">Includes capitalized financial costs of $47,542 corresponding to the period ended December 31, 2023.</td></tr></table>3. Gross carrying amount as of December 31, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:65.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">As of the</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">beginning</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> from business </td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> end of the</td></tr><tr><td style="vertical-align:bottom;width:33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">combination</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> period</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 908,004</td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"> 305</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> 724</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 909,033</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">5,261,979</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"> 84,209</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (3,948)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 5,282,496</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 925,349</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"> 111,226</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 12,469</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> (32,824)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 1,016,220</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 7,606,389</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"> 34,256</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 5,379</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> 12,143</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 7,658,167</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 13,017,830</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"> 1,128,712</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 7,047,496</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> (7,186)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> (14,677)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 21,172,175</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 40,659,129</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 4,750,136</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (28,269)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 45,380,996</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,142,774</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,465,370</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,285,092</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (17,027)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,876,209</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 71,521,454</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,824,078</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 13,100,572</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (66,930)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (83,878)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 88,295,296</td></tr></table> 968088 52158 -3291 1016955 5492319 556237 126068 -411 5922077 974509 101224 -7575 1068158 7663899 10483 8976 -9384 7656022 23513047 275297 -26864 23761480 43111723 10351 -29020 43093054 11911194 5112029 -55102 16968121 93634779 6117779 135044 -131647 99485867 47542 2. Accumulated depreciation as of December 31, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:57.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Depreciation</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">as of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Accumulated</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">as of the end</td></tr><tr><td style="vertical-align:bottom;width:40.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td></tr><tr><td style="vertical-align:middle;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 704,196</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 33,828</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (1,177)</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 736,847</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 3,459,466</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (117,055)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 416,309</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (14,328)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 3,744,392</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 800,110</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 83,364</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (6,013)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 877,461</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 4,800,950</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (6,242)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 394,798</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (3,250)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 5,186,256</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 9,049,291</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 1,185,336</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (29,360)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 10,205,267</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,966,931</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 442,787</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (62,203)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,347,515</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 25,780,944</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (123,297)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,556,422</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (116,331)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,097,738</td></tr></table>4. Accumulated depreciation as of December 31, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:64.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Depreciation</td></tr><tr><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">as of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">Accumulated</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:32.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">Of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;">as of the end</td></tr><tr><td style="vertical-align:bottom;width:32.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals </td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td></tr><tr><td style="vertical-align:bottom;width:32.5%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 638,466</td><td style="vertical-align:middle;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 30,827</td><td style="vertical-align:middle;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> (466)</td><td style="vertical-align:middle;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 668,827</td></tr><tr><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"> 2,596,905</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> 457,562</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> (1,178)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> 2,993,545</td></tr><tr><td style="vertical-align:bottom;width:32.5%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 693,673</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 73,094</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> (1,549)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 765,218</td></tr><tr><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"> 4,059,470</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> 370,828</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> (355)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:10.77%;margin:0pt;padding:0pt;"> 4,429,943</td></tr><tr><td style="vertical-align:bottom;width:32.5%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 7,205,870</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 1,575,862</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> (9,845)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;background:#cceeff;margin:0pt;padding:0pt;"> 8,771,887</td></tr><tr><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,418,745</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 451,983</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 473</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,871,201</td></tr><tr><td style="vertical-align:bottom;width:32.5%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 21,613,129</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:10.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,960,156</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (12,920)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 24,500,621</td></tr></table> -704196 -33828 1177 -736847 -3459466 -117055 -416309 14328 -3744392 -800110 -83364 6013 -877461 -4800950 -6242 -394798 3250 -5186256 -9049291 -1185336 29360 -10205267 -6966931 -442787 62203 -7347515 -25780944 -123297 -2556422 116331 -28097738 908004 305 724 909033 5261979 84209 59744 -3948 5282496 925349 111226 12469 -32824 1016220 7606389 34256 5379 12143 7658167 13017830 1128712 7047496 7186 -14677 21172175 40659129 4750136 -28269 45380996 3142774 2465370 1285092 -17027 6876209 71521454 3824078 13100572 66930 -83878 88295296 -638466 -30827 466 -668827 -2596905 -59744 -457562 1178 -2993545 -693673 -73094 1549 -765218 -4059470 -370828 355 -4429943 -7205870 -1575862 9845 -8771887 -6418745 -451983 -473 -6871201 -21613129 -59744 -2960156 12920 -24500621 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Gross carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 206,708,843</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 202,306,618</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Accumulated amortization</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (33,965,330)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (28,522,662)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 172,743,513</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 173,783,956</td></tr></table> 206708843 202306618 -33965330 -28522662 172743513 173783956 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">amount</td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023 (1)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023 (1)</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"> HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 32,554,026</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 31,679,681</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 2,516,125</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 2,841,008</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 50,829,622</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 49,508,801</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 57,429,133</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 59,760,753</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,923,055</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,987,690</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 22,491,552</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 23,006,023</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">RG/RS/OX Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 172,743,513</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 173,783,956</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;">Includes $32.2 million as of December 31, 2023 and $27.4 million as of June 30, 2023 of intangible assets not subject to amortization.</td></tr></table><div style="margin-top:12pt;"></div> 32554026 31679681 2516125 2841008 50829622 49508801 57429133 59760753 1923055 1987690 22491552 23006023 5000000 5000000 172743513 173783956 32200000 27400000 1. Gross carrying amount as of December 31, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:50.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">As of the</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> end of the</td></tr><tr><td style="vertical-align:bottom;width:47.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 34,958,425</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 1,729,439</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 36,687,864</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 3,219,808</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> (269,869)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 2,949,939</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 55,645,028</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 2,725,454</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> (1,661)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 58,368,821</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 67,653,234</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 1,288</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 67,654,522</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 5,582,411</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 218,541</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> (967)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 5,799,985</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 30,247,712</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 30,247,712</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">RG/RS/OX Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 202,306,618</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 4,674,722</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (272,497)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 206,708,843</td></tr></table>3. Gross carrying amount as of December 31, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:56.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;">Additions from</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:41.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">beginning </td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;">business</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;">Foreign currency</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;">As of the end of</td></tr><tr><td style="vertical-align:middle;width:41.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">combination</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td></tr><tr><td style="vertical-align:bottom;width:41.66%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 31,371,088</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"> 1,738,631</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 33,109,719</td></tr><tr><td style="vertical-align:bottom;width:41.66%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products </td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 3,181,155</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> 8,296</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 3,189,451</td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:41.66%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 8,855,421</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"> 4,187,908</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> 39,613,280</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> (2,279)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 52,654,330</td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:41.66%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 12,183,045</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"> 49,783</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> 55,420,441</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 67,653,269</td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 5,176,373</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;margin:0pt;padding:0pt;"> 98,292</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> (954)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 5,273,711</td></tr><tr><td style="vertical-align:bottom;width:41.66%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 28,462,475</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> 1,785,237</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 30,247,712</td></tr><tr><td style="vertical-align:bottom;width:41.66%;margin:0pt;padding:0pt;">RG/RS/OX Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td></tr><tr><td style="vertical-align:bottom;width:41.66%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 94,229,557</td><td style="vertical-align:bottom;white-space:nowrap;width:1.68%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.28%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,074,614</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 96,818,958</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 5,063</td><td style="vertical-align:bottom;white-space:nowrap;width:1.76%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 197,128,192</td></tr></table> 34958425 1729439 36687864 3219808 -269869 2949939 55645028 2725454 -1661 58368821 67653234 1288 67654522 5582411 218541 -967 5799985 30247712 30247712 5000000 5000000 202306618 4674722 -272497 206708843 2. Accumulated amortization as of December 31, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:50.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortization</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Accumulated as</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">as of beginning </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">of the end of the</td></tr><tr><td style="vertical-align:middle;width:47.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td></tr><tr><td style="vertical-align:middle;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 3,278,744</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 855,094</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 4,133,838</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 378,800</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 86,762</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> (31,748)</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 433,814</td></tr><tr><td style="vertical-align:middle;width:47.43%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:middle;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 6,136,227</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 1,402,972</td><td style="vertical-align:middle;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 7,539,199</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 7,892,481</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 2,332,908</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 10,225,389</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 3,594,721</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 282,764</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> (555)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 3,876,930</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,241,689</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 514,471</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,756,160</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,522,662</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 5,474,971</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (32,303)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 33,965,330</td></tr></table>4. Accumulated amortization as of December 31, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:50.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortization</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">Accumulated as</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Accumulated </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">of beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">as of the end</td></tr><tr><td style="vertical-align:middle;width:47.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td></tr><tr><td style="vertical-align:middle;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 1,568,554</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 799,644</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 2,368,198</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 43,997</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 22,242</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 488</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 66,727</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Crop nutrition </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 3,063,073</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 313,970</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 3,377,043</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Other intangible assets </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;">3,916,004</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 2,136,403</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 6,052,407</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Software </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 3,008,388</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 285,881</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> (756)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 3,293,513</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">5,924,672</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">1,633,381</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">7,558,053</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">17,524,688</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">5,191,521</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (268)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">22,715,941</td></tr></table> -3278744 -855094 -4133838 -378800 -86762 31748 -433814 -6136227 -1402972 -7539199 -7892481 -2332908 -10225389 -3594721 -282764 555 -3876930 -7241689 -514471 -7756160 -28522662 -5474971 32303 -33965330 31371088 1738631 33109719 3181155 8296 3189451 8855421 4187908 39613280 -2279 52654330 12183045 49783 55420441 67653269 5176373 98292 -954 5273711 28462475 1785237 30247712 5000000 5000000 94229557 6074614 96818958 5063 197128192 -1568554 -799644 -2368198 -43997 -22242 -488 -66727 -3063073 -313970 -3377043 -3916004 -2136403 -6052407 -3008388 -285881 756 -3293513 -5924672 -1633381 -7558053 -17524688 -5191521 268 -22715941 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Rizobacter Argentina S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 28,080,271</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 28,080,271</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Bioceres Crops S.A. </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,523,322</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,523,322</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Pro farm Group, Inc.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 76,089,749</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 76,089,749</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Insumos Agroquímicos S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 470,090</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 470,090</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 112,163,432</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 112,163,432</td></tr></table> 28080271 28080271 7523322 7523322 76089749 76089749 470090 470090 112163432 112163432 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Investment properties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,792,238</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,589,749</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,792,238</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,589,749</td></tr></table> 3792238 3589749 3792238 3589749 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 103,683,392</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 104,211,238</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shareholders and other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 75,271</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 35,292</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors - Parent company (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 161,860</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 644,191</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trade creditors - Joint ventures and associates (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 56,385,464</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 41,402,594</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,556,073</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,561,058</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 141,142</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 953,301</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 164,003,202</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 150,807,674</td></tr></table> 103683392 104211238 75271 35292 161860 644191 56385464 41402594 3556073 3561058 141142 953301 164003202 150807674 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 52,942,957</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 61,303,952</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Corporate bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 49,749,398</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 35,547,510</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trust debt securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,188,607</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,296,506</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net loans payables- Parents companies and related parties to Parent (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,639,816</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,491,691</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 113,520,778</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 107,639,659</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 10,314,800</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 10,663,266</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Corporate bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,202,548</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 50,007,680</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">31,517,348</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">60,670,946</td></tr></table> 52942957 61303952 49749398 35547510 7188607 7296506 3639816 3491691 113520778 107639659 10314800 10663266 21202548 50007680 31517348 60670946 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:42.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Fair value</td></tr><tr><td style="vertical-align:bottom;width:42.51%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.51%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"> 52,942,957</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"> 49,659,094</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"> 61,303,952</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;margin:0pt;padding:0pt;"> 57,209,155</td></tr><tr><td style="vertical-align:bottom;width:42.51%;background:#cceeff;margin:0pt;padding:0pt;">Corporate Bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"> 49,749,398</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"> 49,192,118</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"> 35,547,510</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;background:#cceeff;margin:0pt;padding:0pt;"> 34,725,828</td></tr><tr><td style="vertical-align:bottom;width:42.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.51%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.51%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"> 10,314,800</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;margin:0pt;padding:0pt;"> 8,698,322</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;margin:0pt;padding:0pt;"> 10,663,266</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;margin:0pt;padding:0pt;"> 10,374,646</td></tr><tr><td style="vertical-align:bottom;width:42.51%;background:#cceeff;margin:0pt;padding:0pt;">Corporate Bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"> 21,202,548</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.79%;background:#cceeff;margin:0pt;padding:0pt;"> 20,670,511</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.99%;background:#cceeff;margin:0pt;padding:0pt;"> 50,007,680</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.8%;background:#cceeff;margin:0pt;padding:0pt;"> 47,014,542</td></tr></table> 52942957 49659094 61303952 57209155 49749398 49192118 35547510 34725828 10314800 8698322 10663266 10374646 21202548 20670511 50007680 47014542 25900000 26900000 52100000 54800000 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, accrued incentives, vacations and social security</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 8,150,518</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,388,639</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Key management personnel (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 68,139</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 218,068</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,218,657</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 9,606,707</td></tr></table> 8150518 9388639 68139 218068 8218657 9606707 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Advances from customers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 4,466,515</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 9,216,032</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Deferred revenue</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 17,632,863</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,659,630</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 22,099,378</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 24,875,662</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Advances from customers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 272,334</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 620,893</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Deferred revenue</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,863,506</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,436,912</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">2,135,840</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,057,805</td></tr></table> 4466515 9216032 17632863 15659630 22099378 24875662 272334 620893 1863506 1436912 2135840 2057805 6. INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME6.1. Revenue from contracts with customers<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Sale of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 255,827,291</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 220,482,895</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 649,341</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 909,067</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 256,476,632</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 221,391,962</td></tr></table>Transactions of sales of goods and services with joint ventures and with shareholders and other related parties are reported in Note 15.6.2. Cost of sales<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Inventories as of the beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 111,990,145</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 78,759,610</td></tr><tr><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;">Business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 11,064,908</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Purchases of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 144,999,639</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 138,186,645</td></tr><tr><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;">Production costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 12,981,672</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 14,596,888</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Foreign currency translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (28,273)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (246,484)</td></tr><tr><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;">Subtotal</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 269,943,183</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 242,361,567</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Inventories as of the end of the period (*)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (109,616,865)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (107,544,430)</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.67%;margin:0pt;padding:0pt;">Cost of sales </td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">160,326,318</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 134,817,137</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div>(*)Net of agricultural products.6.3. R&D classified by nature<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Research and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Research and</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">development</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">development</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">expenses</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Amortization of intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 2,453,158</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 2,201,938</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Analysis and storage </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 5,302</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 27,322</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Import and export expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 850</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation of property, plant and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 312,453</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 287,180</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Freight and haulage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 14,278</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 4,732</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Employee benefits and social securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,211,907</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,248,105</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Maintenance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 96,056</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 303,524</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Energy and fuel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 5,227</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 94,870</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Supplies and materials</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,182,066</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,078,197</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Mobility and travel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 89,474</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 158,193</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 143,749</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 92,477</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Publicity and advertising </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 9,568</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Professional fees and outsourced services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 994,197</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 574,614</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Professional fees related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 216,792</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 102,701</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Office supplies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 470,376</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 43,546</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Information technology expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 9,640</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 19,060</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 19,586</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 25,738</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation of leased assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 33,685</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 57</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,606</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,224,318</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 7,309,906</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">R&D capitalized (Note 5.8)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 4,454,893</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 5,926,539</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">R&D profit and loss</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,224,318</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,309,906</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,679,211</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 13,236,445</td></tr></table>6.4. Expenses classified by nature and function<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Selling, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">general and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Production </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">administrative</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;width:58.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Amortization of intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 60,849</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 2,960,964</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 3,021,813</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Analysis and storage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 570</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 153,163</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 153,733</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Commissions and royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 421,677</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,008,251</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,429,928</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Import and export expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 43,902</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 318,479</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 362,381</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Depreciation of property, plant and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,308,591</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 935,378</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 2,243,969</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Depreciation of leased assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 699,044</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,012,212</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,711,256</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Impairment of receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 296,051</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 296,051</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Freight and haulage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 634,188</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 6,878,364</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 7,512,552</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Employee benefits and social securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 5,935,502</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 21,509,102</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 27,444,604</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Maintenance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,007,395</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,152,332</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 2,159,727</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Energy and fuel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 500,658</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 272,547</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 773,205</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Supplies and materials</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 367,386</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,691,154</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 2,058,540</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Mobility and travel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 94,476</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 2,148,705</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 2,243,181</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Publicity and advertising</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,300</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 2,305,251</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 2,306,551</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Contingencies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,239</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 47,851</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 49,090</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 339,904</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 8,043,561</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 8,383,465</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Professional fees and outsourced services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 963,972</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 3,542,038</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 4,506,010</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Professional fees related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 66,618</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 66,618</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Office supplies and registrations fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 80,236</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 651,991</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 732,227</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 81,174</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,102,142</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,183,316</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Information technology expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 27,186</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,924,633</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,951,819</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Obsolescence</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 282,836</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 282,836</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 127,760</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 7,019,360</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 7,147,120</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,827</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 57,638</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 59,465</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,981,672</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 65,097,785</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 78,079,457</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Selling, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">general and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Production </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">administrative</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;width:58.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Amortization of intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 86,842</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 2,902,741</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 2,989,583</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Analysis and storage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 4,460</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 237,341</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 241,801</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Commissions and royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 109,703</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,020,272</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,129,975</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Import and export expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 265,121</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 704,937</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 970,058</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Depreciation of property, plant and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,666,119</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,006,857</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 2,672,976</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Depreciation of leased assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 230,478</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,573,369</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,803,847</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Impairment of receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 468,992</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 468,992</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Freight and haulage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,201,183</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 5,002,384</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 6,203,567</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Employee benefits and social securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 7,177,926</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 20,156,371</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 27,334,297</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Maintenance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 722,399</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,446,553</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 2,168,952</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Energy and fuel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 753,041</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 161,850</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 914,891</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Supplies and materials</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 512,493</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 627,514</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,140,007</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Mobility and travel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 39,428</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,837,797</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,877,225</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Publicity and advertising</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 3,235,737</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 3,235,737</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Contingencies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 39,847</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 39,847</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,969,868</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,969,868</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Professional fees and outsourced services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,133,009</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 7,122,701</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 8,255,710</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Professional fees related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 29,818</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 29,818</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Office supplies and registrations fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 23,309</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 624,246</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 647,555</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 74,350</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,306,282</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,380,632</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Information technology expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 17,511</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,566,952</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,584,463</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Obsolescence</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 481,332</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 481,332</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 96,233</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 6,976,043</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 7,072,276</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,951</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 300,016</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 301,967</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 14,596,888</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 60,318,488</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 74,915,376</td></tr></table>6.5. Other income or expenses, net<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:73.42%;background:#cceeff;margin:0pt;padding:0pt;">Net result from commercialization of agricultural products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"> (2,960,005)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;background:#cceeff;margin:0pt;padding:0pt;"> 144,515</td></tr><tr><td style="vertical-align:bottom;width:73.42%;margin:0pt;padding:0pt;">Expenses recovery</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"> 236,106</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"> 232,977</td></tr><tr><td style="vertical-align:bottom;width:73.42%;background:#cceeff;margin:0pt;padding:0pt;">Other income or expenses, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 325,661</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 391,036</td></tr><tr><td style="vertical-align:bottom;width:73.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (2,398,238)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 768,528</td></tr></table>6.6. Finance results<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Financial costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Interest expenses with the Parents (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (194,125)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (299,468)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Interest expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (9,994,912)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (10,722,135)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Financial commissions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (1,288,813)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (1,517,729)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (11,477,850)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (12,539,332)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other financial results</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Exchange differences generated by assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (12,049,351)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (12,771,727)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Exchange differences generated by liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 21,674,845</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,070,404</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Changes in fair value of financial assets or liabilities and other financial results</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (13,727,825)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (2,068,923)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net gain of inflation effect on monetary items</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 766,135</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 281,083</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (3,336,196)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (5,489,163)</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Sale of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 255,827,291</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 220,482,895</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 649,341</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 909,067</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 256,476,632</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 221,391,962</td></tr></table> 255827291 220482895 649341 909067 256476632 221391962 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Inventories as of the beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 111,990,145</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 78,759,610</td></tr><tr><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;">Business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 11,064,908</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Purchases of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 144,999,639</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 138,186,645</td></tr><tr><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;">Production costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 12,981,672</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 14,596,888</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Foreign currency translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (28,273)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (246,484)</td></tr><tr><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;">Subtotal</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 269,943,183</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 242,361,567</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Inventories as of the end of the period (*)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (109,616,865)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (107,544,430)</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.67%;margin:0pt;padding:0pt;">Cost of sales </td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">160,326,318</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 134,817,137</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div>(*)Net of agricultural products. 111990145 78759610 11064908 144999639 138186645 12981672 14596888 28273 246484 269943183 242361567 109616865 107544430 160326318 134817137 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Research and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Research and</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">development</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">development</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">expenses</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Amortization of intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 2,453,158</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 2,201,938</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Analysis and storage </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 5,302</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 27,322</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Import and export expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 850</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation of property, plant and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 312,453</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 287,180</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Freight and haulage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 14,278</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 4,732</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Employee benefits and social securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,211,907</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,248,105</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Maintenance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 96,056</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 303,524</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Energy and fuel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 5,227</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 94,870</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Supplies and materials</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,182,066</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,078,197</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Mobility and travel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 89,474</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 158,193</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 143,749</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 92,477</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Publicity and advertising </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 9,568</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Professional fees and outsourced services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 994,197</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 574,614</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Professional fees related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 216,792</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 102,701</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Office supplies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 470,376</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 43,546</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Information technology expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 9,640</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 19,060</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 19,586</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 25,738</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation of leased assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 33,685</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 57</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,606</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,224,318</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 7,309,906</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">R&D capitalized (Note 5.8)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 4,454,893</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 5,926,539</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">R&D profit and loss</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,224,318</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,309,906</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,679,211</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 13,236,445</td></tr></table> 2453158 2201938 5302 27322 850 312453 287180 14278 4732 2211907 2248105 96056 303524 5227 94870 1182066 1078197 89474 158193 143749 92477 9568 994197 574614 216792 102701 470376 43546 9640 19060 19586 25738 33685 57 3606 8224318 7309906 4454893 5926539 8224318 7309906 12679211 13236445 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Selling, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">general and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Production </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">administrative</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;width:58.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Amortization of intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 60,849</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 2,960,964</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 3,021,813</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Analysis and storage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 570</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 153,163</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 153,733</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Commissions and royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 421,677</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,008,251</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,429,928</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Import and export expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 43,902</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 318,479</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 362,381</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Depreciation of property, plant and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,308,591</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 935,378</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 2,243,969</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Depreciation of leased assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 699,044</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,012,212</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,711,256</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Impairment of receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 296,051</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 296,051</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Freight and haulage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 634,188</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 6,878,364</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 7,512,552</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Employee benefits and social securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 5,935,502</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 21,509,102</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 27,444,604</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Maintenance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,007,395</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,152,332</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 2,159,727</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Energy and fuel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 500,658</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 272,547</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 773,205</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Supplies and materials</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 367,386</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,691,154</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 2,058,540</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Mobility and travel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 94,476</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 2,148,705</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 2,243,181</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Publicity and advertising</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,300</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 2,305,251</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 2,306,551</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Contingencies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,239</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 47,851</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 49,090</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 339,904</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 8,043,561</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 8,383,465</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Professional fees and outsourced services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 963,972</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 3,542,038</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 4,506,010</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Professional fees related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 66,618</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 66,618</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Office supplies and registrations fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 80,236</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 651,991</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 732,227</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 81,174</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,102,142</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,183,316</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Information technology expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 27,186</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,924,633</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,951,819</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Obsolescence</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 282,836</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 282,836</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 127,760</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 7,019,360</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 7,147,120</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,827</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 57,638</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 59,465</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,981,672</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 65,097,785</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 78,079,457</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Selling, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">general and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Production </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">administrative</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;width:58.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Amortization of intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 86,842</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 2,902,741</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 2,989,583</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Analysis and storage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 4,460</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 237,341</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 241,801</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Commissions and royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 109,703</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,020,272</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,129,975</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Import and export expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 265,121</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 704,937</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 970,058</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Depreciation of property, plant and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,666,119</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,006,857</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 2,672,976</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Depreciation of leased assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 230,478</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,573,369</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,803,847</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Impairment of receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 468,992</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 468,992</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Freight and haulage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,201,183</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 5,002,384</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 6,203,567</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Employee benefits and social securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 7,177,926</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 20,156,371</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 27,334,297</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Maintenance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 722,399</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,446,553</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 2,168,952</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Energy and fuel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 753,041</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 161,850</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 914,891</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Supplies and materials</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 512,493</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 627,514</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,140,007</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Mobility and travel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 39,428</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,837,797</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,877,225</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Publicity and advertising</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 3,235,737</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 3,235,737</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Contingencies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 39,847</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 39,847</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,969,868</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,969,868</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Professional fees and outsourced services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,133,009</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 7,122,701</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 8,255,710</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Professional fees related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 29,818</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 29,818</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Office supplies and registrations fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 23,309</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 624,246</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 647,555</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 74,350</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,306,282</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,380,632</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Information technology expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 17,511</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,566,952</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,584,463</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Obsolescence</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 481,332</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 481,332</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 96,233</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 6,976,043</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 7,072,276</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,951</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 300,016</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 301,967</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 14,596,888</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 60,318,488</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 74,915,376</td></tr></table> 60849 2960964 3021813 570 153163 153733 421677 1008251 1429928 43902 318479 362381 1308591 935378 2243969 699044 1012212 1711256 296051 296051 634188 6878364 7512552 5935502 21509102 27444604 1007395 1152332 2159727 500658 272547 773205 367386 1691154 2058540 94476 2148705 2243181 1300 2305251 2306551 1239 47851 49090 339904 8043561 8383465 963972 3542038 4506010 66618 66618 80236 651991 732227 81174 1102142 1183316 27186 1924633 1951819 282836 282836 127760 7019360 7147120 1827 57638 59465 12981672 65097785 78079457 86842 2902741 2989583 4460 237341 241801 109703 1020272 1129975 265121 704937 970058 1666119 1006857 2672976 230478 1573369 1803847 468992 468992 1201183 5002384 6203567 7177926 20156371 27334297 722399 1446553 2168952 753041 161850 914891 512493 627514 1140007 39428 1837797 1877225 3235737 3235737 39847 39847 1969868 1969868 1133009 7122701 8255710 29818 29818 23309 624246 647555 74350 1306282 1380632 17511 1566952 1584463 481332 481332 96233 6976043 7072276 1951 300016 301967 14596888 60318488 74915376 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:73.42%;background:#cceeff;margin:0pt;padding:0pt;">Net result from commercialization of agricultural products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"> (2,960,005)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;background:#cceeff;margin:0pt;padding:0pt;"> 144,515</td></tr><tr><td style="vertical-align:bottom;width:73.42%;margin:0pt;padding:0pt;">Expenses recovery</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"> 236,106</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;margin:0pt;padding:0pt;"> 232,977</td></tr><tr><td style="vertical-align:bottom;width:73.42%;background:#cceeff;margin:0pt;padding:0pt;">Other income or expenses, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 325,661</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 391,036</td></tr><tr><td style="vertical-align:bottom;width:73.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (2,398,238)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.19%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.78%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 768,528</td></tr></table> -2960005 144515 236106 232977 325661 391036 -2398238 768528 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Financial costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Interest expenses with the Parents (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (194,125)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (299,468)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Interest expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (9,994,912)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (10,722,135)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Financial commissions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (1,288,813)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (1,517,729)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (11,477,850)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (12,539,332)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other financial results</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Exchange differences generated by assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (12,049,351)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (12,771,727)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Exchange differences generated by liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 21,674,845</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,070,404</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Changes in fair value of financial assets or liabilities and other financial results</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (13,727,825)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (2,068,923)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net gain of inflation effect on monetary items</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 766,135</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 281,083</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (3,336,196)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (5,489,163)</td></tr></table> 194125 299468 9994912 10722135 1288813 1517729 11477850 12539332 -12049351 -12771727 21674845 9070404 -13727825 -2068923 766135 281083 -3336196 -5489163 7. TAXATIONTaxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual earnings.<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current tax expense</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (3,845,338)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (6,467,324)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (4,917,089)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 769,775</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (8,762,427)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (5,697,549)</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Beginning of the period deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (28,472,383)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (24,994,569)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Additions for business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (16,704,771)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Charge for the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (4,917,089)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 769,775</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Conversion difference</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (361,293)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (582,016)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total net deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (33,750,765)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (41,511,581)</td></tr></table>The tax on the Group’s profit before tax differs from the theoretical amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Earning before income tax-rate</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,322,464</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,183,270</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Income tax expense by applying tax rate in force in the respective countries</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (5,434,748)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (5,182,386)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Share of profit or loss of subsidiaries, joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,219,030</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 225,376</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Stock options charge</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (1,489,037)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (298,851)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-deductible expenses </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (116,220)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (543,505)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Unrecognized deferred tax 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (995,754)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Tax inflation adjustment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 7,460,048</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,132,901</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Result of inflation effect on monetary items and other finance results</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (11,000,459)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (1,660,369)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Untaxed gains</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 598,959</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 33,052</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Others</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (408,013)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Income tax expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (8,762,427)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (5,697,549)</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div>1 Corresponds mainly to Pro Farm Group Inc. <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current tax expense</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (3,845,338)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (6,467,324)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (4,917,089)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 769,775</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (8,762,427)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (5,697,549)</td></tr></table> 3845338 6467324 4917089 -769775 8762427 5697549 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Beginning of the period deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (28,472,383)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (24,994,569)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Additions for business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (16,704,771)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Charge for the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (4,917,089)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 769,775</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Conversion difference</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (361,293)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (582,016)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total net deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (33,750,765)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (41,511,581)</td></tr></table> -28472383 -24994569 -16704771 -4917089 769775 -361293 -582016 -33750765 -41511581 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Earning before income tax-rate</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,322,464</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,183,270</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Income tax expense by applying tax rate in force in the respective countries</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (5,434,748)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (5,182,386)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Share of profit or loss of subsidiaries, joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,219,030</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 225,376</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Stock options charge</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (1,489,037)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (298,851)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-deductible expenses </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (116,220)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (543,505)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Unrecognized deferred tax 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (995,754)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Tax inflation adjustment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 7,460,048</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,132,901</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Result of inflation effect on monetary items and other finance results</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (11,000,459)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (1,660,369)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Untaxed gains</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 598,959</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 33,052</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Others</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (408,013)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Income tax expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (8,762,427)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (5,697,549)</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div>1 Corresponds mainly to Pro Farm Group Inc. 7322464 1183270 5434748 5182386 -1219030 -225376 1489037 298851 116220 543505 995754 -7460048 -3132901 11000459 1660369 598959 33052 408013 8762427 5697549 8. EARNING PER SHAREThe numerators and denominators used in the calculation of basic EPS and diluted EPS are presented below:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three -month period ended</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Six-month period ended </td></tr><tr><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:51.55%;background:#cceeff;margin:0pt;padding:0pt;">Numerator</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;">(Loss) profit for the period (basic EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> 108,449</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> (8,156,746)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> (4,483,185)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"> (7,658,449)</td></tr><tr><td style="vertical-align:bottom;width:51.55%;background:#cceeff;margin:0pt;padding:0pt;">(Loss) profit for the period (diluted EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> 108,449</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> (8,156,746)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> (4,483,185)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"> (7,658,449)</td></tr><tr><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;">Denominator</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:51.55%;background:#cceeff;margin:0pt;padding:0pt;">Weighted average number of shares (basic EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> 62,839,961</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> 61,657,343</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> 62,839,961</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"> 61,657,343</td></tr><tr><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;">Weighted average number of shares (diluted EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> 63,877,692</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> 61,657,343</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> 62,839,961</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"> 61,657,343</td></tr><tr><td style="vertical-align:bottom;width:51.55%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;">Basic (loss) profit attributable to ordinary equity holders of the parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> 0.0017</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> (0.1323)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> (0.0713)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"> (0.1242)</td></tr><tr><td style="vertical-align:bottom;width:51.55%;background:#cceeff;margin:0pt;padding:0pt;">Diluted (loss) profit attributable to ordinary equity holders of the parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> 0.0017</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> (0.1323)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> (0.0713)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"> (0.1242)</td></tr></table>For the three and six month period ended December 31, 2022 diluted EPS was equal to basic EPS as the effect of potential ordinary shares would be antidilutive.For the three month period ended December 31, 2022, diluted earnings per share was calculated by adjusting the weighted average number of shares outstanding to assume conversion of all dilutive potential shares. The Group had two categories of dilutive potential shares, share-based incentives and the convertible notes.The stock options were included in the diluted EPS calculation for the three period ended December 31, 2023 only for the tranches in which the average market price of ordinary shares during the periods was higher than the assumed proceeds per option. Convertible notes outstanding were not included in the diluted EPS calculations for the three period ended December 31, 2023 because the interest (net of tax and other changes in income or expense) per ordinary share obtainable on conversion exceeds basic earnings per share. <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.1%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Three -month period ended</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Six-month period ended </td></tr><tr><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:51.55%;background:#cceeff;margin:0pt;padding:0pt;">Numerator</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;">(Loss) profit for the period (basic EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> 108,449</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> (8,156,746)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> (4,483,185)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"> (7,658,449)</td></tr><tr><td style="vertical-align:bottom;width:51.55%;background:#cceeff;margin:0pt;padding:0pt;">(Loss) profit for the period (diluted EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> 108,449</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> (8,156,746)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> (4,483,185)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"> (7,658,449)</td></tr><tr><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;">Denominator</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:51.55%;background:#cceeff;margin:0pt;padding:0pt;">Weighted average number of shares (basic EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> 62,839,961</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> 61,657,343</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> 62,839,961</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"> 61,657,343</td></tr><tr><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;">Weighted average number of shares (diluted EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> 63,877,692</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> 61,657,343</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> 62,839,961</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"> 61,657,343</td></tr><tr><td style="vertical-align:bottom;width:51.55%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:51.55%;margin:0pt;padding:0pt;">Basic (loss) profit attributable to ordinary equity holders of the parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> 0.0017</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> (0.1323)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;margin:0pt;padding:0pt;"> (0.0713)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;margin:0pt;padding:0pt;"> (0.1242)</td></tr><tr><td style="vertical-align:bottom;width:51.55%;background:#cceeff;margin:0pt;padding:0pt;">Diluted (loss) profit attributable to ordinary equity holders of the parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> 0.0017</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> (0.1323)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.98%;background:#cceeff;margin:0pt;padding:0pt;"> (0.0713)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.94%;background:#cceeff;margin:0pt;padding:0pt;"> (0.1242)</td></tr></table> 108449 -8156746 -4483185 -7658449 108449 -8156746 -4483185 -7658449 62839961 61657343 62839961 61657343 63877692 61657343 62839961 61657343 0.0017 -0.1323 -0.0713 -0.1242 0.0017 -0.1323 -0.0713 -0.1242 2 2 9. EQUITY INFORMATIONCapital issuedAs of December 31, 2023, we had (i) 100,000,000 ordinary shares ($0.0001 par value) authorized, (ii) 62,828,025 ordinary shares issued and outstanding, (iii) 1,000,000 preferred shares ($0.0001 par value) authorized, (iv) no preferred shares issued and outstanding, (v) 3,947,634 ordinary shares reserved for our equity compensation plans. Of the total issued shares, we have repurchased 2,258,016 shares of our own.Holders of the ordinary shares are entitled to one vote for each ordinary share. 100000000 0.0001 62828025 1000000 0.0001 0 3947634 2258016 1 10. CASH FLOW INFORMATIONSignificant non-cash transactions related to investing and financing activities are as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Investment activities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;">Net assets acquisition by business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"> 152,070,313</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Investment in-kind in other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> 1,434,802</td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;">Capitalization of interest on buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 47,542</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 47,542</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 153,505,115</td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Financing activities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;">Capitalization of convertible notes (Note 5.13)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"> 12,211,638</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Purchase of own shares</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (23,915,029)</td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (11,703,391)</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Investment activities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;">Net assets acquisition by business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"> 152,070,313</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Investment in-kind in other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> 1,434,802</td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;">Capitalization of interest on buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 47,542</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 47,542</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 153,505,115</td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Financing activities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;">Capitalization of convertible notes (Note 5.13)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"> 12,211,638</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Purchase of own shares</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (23,915,029)</td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (11,703,391)</td></tr></table> -152070313 1434802 47542 47542 153505115 12211638 23915029 -11703391 11. JOINT VENTURES AND ASSOCIATES<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;">Synertech Industrias S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"> 39,205,548</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"> 36,026,710</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Alfalfa Technologies S.R.L.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> 36,503</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> 36,502</td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;">Moolec Science S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,160,166</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,233,598</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 42,402,217</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 39,296,810</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;">Trigall Genetics S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 115,983</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 622,823</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 115,983</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 622,823</td></tr></table>Changes in joint ventures investments and affiliates:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">As of the beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 38,673,987</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 37,836,144</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 50,383</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Sale of equity investee - Indrasa Biotecnología S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (7,853)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Foreign currency translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 897</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (21,946)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Share of profit or loss</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,560,967</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 882,288</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">As of the end of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 42,286,234</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 38,688,633</td></tr></table>Share of profit or loss of joint ventures and affiliates:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trigall Genetics S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 506,840</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 595,889</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Synertech Industrias S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,178,839</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 349,012</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Moolec Science S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (124,712)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Indrasa Biotecnología S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (62,613)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,560,967</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 882,288</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;">Synertech Industrias S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"> 39,205,548</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"> 36,026,710</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Alfalfa Technologies S.R.L.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> 36,503</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> 36,502</td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;">Moolec Science S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,160,166</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,233,598</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 42,402,217</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 39,296,810</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;">Liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:60.5%;margin:0pt;padding:0pt;">Trigall Genetics S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 115,983</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 622,823</td></tr><tr><td style="vertical-align:bottom;width:60.5%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 115,983</td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:17.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 622,823</td></tr></table> 39205548 36026710 36503 36502 3160166 3233598 42402217 39296810 115983 622823 115983 622823 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">As of the beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 38,673,987</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 37,836,144</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 50,383</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Sale of equity investee - Indrasa Biotecnología S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (7,853)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Foreign currency translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 897</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (21,946)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Share of profit or loss</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,560,967</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 882,288</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">As of the end of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 42,286,234</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 38,688,633</td></tr></table> 38673987 37836144 50383 -7853 897 -21946 3560967 882288 42286234 38688633 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trigall Genetics S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 506,840</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 595,889</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Synertech Industrias S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,178,839</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 349,012</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Moolec Science S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (124,712)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Indrasa Biotecnología S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (62,613)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,560,967</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 882,288</td></tr></table> 506840 595889 3178839 349012 -124712 -62613 3560967 882288 12. SEGMENT INFORMATIONThe tables present information with respect to the Group´s reporting segments:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:10.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:9.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;margin:0pt;padding:0pt;">Seed and</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;margin:0pt;padding:0pt;">integrated</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Period ended December 31, 2023</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">products</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">protection</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">nutrition</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Consolidated</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;background:#cceeff;margin:0pt;padding:0pt;">Revenues from contracts with customers</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.53%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;">Sale of goods and services</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;margin:0pt;padding:0pt;"> 53,777,458</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;margin:0pt;padding:0pt;"> 127,029,466</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;margin:0pt;padding:0pt;"> 75,020,367</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;margin:0pt;padding:0pt;"> 255,827,291</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;background:#cceeff;margin:0pt;padding:0pt;">Royalties</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"> 649,341</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"> 649,341</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;">Others</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.34%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:50.86%;background:#cceeff;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 77,353</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 141,457</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 119,318</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 338,128</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 54,504,152</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 127,170,923</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 75,139,685</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 256,814,760</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.53%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;">Cost of sales</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (36,216,288)</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (81,249,196)</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (42,860,834)</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (160,326,318)</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;background:#cceeff;margin:0pt;padding:0pt;">Gross profit per segment </td><td style="vertical-align:bottom;white-space:normal;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 18,287,864</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 45,921,727</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 32,278,851</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 96,488,442</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:50.86%;margin:0pt;padding:0pt;">% Gross margin</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.34%;margin:0pt;padding:0pt;"> 34</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;margin:0pt;padding:0pt;"> 36</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;margin:0pt;padding:0pt;"> 43</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;margin:0pt;padding:0pt;"> 38</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;">%</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;">Seed and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;">integrated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;width:50.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Period ended December 31, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">protection</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Consolidated</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;background:#cceeff;margin:0pt;padding:0pt;">Revenues from contracts with customers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;">Sale of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 29,226,197</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 116,263,527</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 74,993,171</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 220,482,895</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;background:#cceeff;margin:0pt;padding:0pt;">Royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"> 909,067</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"> 909,067</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;">Others</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;background:#cceeff;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 56,530</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 140,620</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 154,327</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 351,477</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 30,191,794</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 116,404,147</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 75,147,498</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 221,743,439</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;">Cost of sales</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (13,606,348)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (79,703,474)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (41,507,315)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (134,817,137)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;background:#cceeff;margin:0pt;padding:0pt;">Gross profit per segment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 16,585,446</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 36,700,673</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 33,640,183</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 86,926,302</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:50.89%;margin:0pt;padding:0pt;">% Gross margin</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 55</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 32</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 45</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 39</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;">%</td></tr></table>As of the current period, changes in the net realizable value of agricultural products after harvest have been excluded from segment information since those results depend on market fluctuations which are beyond the Group’s operating control. The Group has recast the comparative amounts. <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:10.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:9.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:9.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;margin:0pt;padding:0pt;">Seed and</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;margin:0pt;padding:0pt;">integrated</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Period ended December 31, 2023</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">products</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">protection</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">nutrition</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Consolidated</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;background:#cceeff;margin:0pt;padding:0pt;">Revenues from contracts with customers</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.53%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;">Sale of goods and services</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;margin:0pt;padding:0pt;"> 53,777,458</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;margin:0pt;padding:0pt;"> 127,029,466</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;margin:0pt;padding:0pt;"> 75,020,367</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;margin:0pt;padding:0pt;"> 255,827,291</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;background:#cceeff;margin:0pt;padding:0pt;">Royalties</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"> 649,341</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"> 649,341</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;">Others</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.34%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.77%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.53%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:50.86%;background:#cceeff;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 77,353</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 141,457</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 119,318</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 338,128</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 54,504,152</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 127,170,923</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 75,139,685</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 256,814,760</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.34%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.77%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.53%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;margin:0pt;padding:0pt;">Cost of sales</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (36,216,288)</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (81,249,196)</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (42,860,834)</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (160,326,318)</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.86%;background:#cceeff;margin:0pt;padding:0pt;">Gross profit per segment </td><td style="vertical-align:bottom;white-space:normal;width:1.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 18,287,864</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:9.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 45,921,727</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 32,278,851</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 96,488,442</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:50.86%;margin:0pt;padding:0pt;">% Gross margin</td><td style="vertical-align:bottom;white-space:normal;width:1.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:normal;width:10.34%;margin:0pt;padding:0pt;"> 34</td><td style="vertical-align:bottom;white-space:normal;width:1.48%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:normal;width:9.77%;margin:0pt;padding:0pt;"> 36</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:normal;width:9.53%;margin:0pt;padding:0pt;"> 43</td><td style="vertical-align:bottom;white-space:normal;width:2.36%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:normal;width:10.41%;margin:0pt;padding:0pt;"> 38</td><td style="vertical-align:bottom;white-space:normal;width:1.44%;margin:0pt;padding:0pt;">%</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;">Seed and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;">integrated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;width:50.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Period ended December 31, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">protection</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Consolidated</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;background:#cceeff;margin:0pt;padding:0pt;">Revenues from contracts with customers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;">Sale of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 29,226,197</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 116,263,527</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 74,993,171</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 220,482,895</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;background:#cceeff;margin:0pt;padding:0pt;">Royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"> 909,067</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"> 909,067</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;">Others</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;background:#cceeff;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 56,530</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 140,620</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 154,327</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 351,477</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 30,191,794</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 116,404,147</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 75,147,498</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 221,743,439</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;margin:0pt;padding:0pt;">Cost of sales</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (13,606,348)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (79,703,474)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (41,507,315)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (134,817,137)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:50.89%;background:#cceeff;margin:0pt;padding:0pt;">Gross profit per segment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 16,585,446</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 36,700,673</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 33,640,183</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 86,926,302</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:50.89%;margin:0pt;padding:0pt;">% Gross margin</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 55</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 32</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 45</td><td style="vertical-align:bottom;white-space:nowrap;width:2.1%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"> 39</td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;">%</td></tr></table> 53777458 127029466 75020367 255827291 649341 649341 77353 141457 119318 338128 54504152 127170923 75139685 256814760 36216288 81249196 42860834 160326318 18287864 45921727 32278851 96488442 0.34 0.36 0.43 0.38 29226197 116263527 74993171 220482895 909067 909067 56530 140620 154327 351477 30191794 116404147 75147498 221743439 13606348 79703474 41507315 134817137 16585446 36700673 33640183 86926302 0.55 0.32 0.45 0.39 13. FINANCIAL INSTRUMENTS – RISK MANAGEMENTFinancial instruments by categoryThe following tables show additional information required under IFRS 7 on the financial assets and liabilities recorded as of December 31, 2023, and June 30, 2023.Financial assets by category<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;margin:0pt;padding:0pt;">Mandatorily measured at fair</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">value through profit or loss</td></tr><tr><td style="vertical-align:bottom;width:42.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Financial asset</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Cash and cash equivalents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 24,332,260</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 48,129,194</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 69,677</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Other financial assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 444,743</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 657,612</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 17,040,207</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 11,922,317</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Trade receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 199,666,283</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 158,006,474</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Other receivables (*)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,368,459</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 12,124,724</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 237,811,745</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 218,918,004</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 17,109,884</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 11,922,317</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(*)</td><td style="padding:0pt;">Advances expenses and tax balances are not included.</td></tr></table>Financial liabilities by category<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;margin:0pt;padding:0pt;">Mandatorily measured at fair</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">value through profit or loss</td></tr><tr><td style="vertical-align:bottom;width:42.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Financial liability</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 156,857,878</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 142,582,166</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 7,145,324</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 8,225,508</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 145,038,126</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 168,310,605</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Secured notes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 77,998,071</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 75,213,146</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Lease liability</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 13,600,289</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 13,889,223</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Consideration for acquisition of assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,684,278</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,993,256</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 400,178,642</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 404,988,396</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 7,145,324</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,225,508</td></tr></table>Financial instruments measured at fair value<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Measurement at fair value at 12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td></tr><tr><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.62%;background:#cceeff;margin:0pt;padding:0pt;">Financial assets at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;">US Treasury bills</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.62%;background:#cceeff;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"> 14,736,104</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"> 2,304,103</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.62%;background:#cceeff;margin:0pt;padding:0pt;">Financial liability at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.62%;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"> 7,145,324</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Measurement at fair value at 06/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td></tr><tr><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.62%;background:#cceeff;margin:0pt;padding:0pt;">Financial assets at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;">US Treasury bills</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"> 9,163,298</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.62%;background:#cceeff;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"> 1,596,539</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"> 1,162,480</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.62%;background:#cceeff;margin:0pt;padding:0pt;">Financial liability at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.62%;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"> 8,225,508</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"> —</td></tr></table>Estimation of fair valueThe fair value of marketable securities, mutual funds and US Treasury Bills is calculated using the market approach using quoted prices in active markets for identical assets. The quoted marked price used for financial assets held by the Group is the current bid price. These instruments are included in level 1.The Group’s financial liabilities, which were not traded in an active market, were determined using valuation techniques that maximize the use of available market information, and thus rely as little as possible on specific estimates of the entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instruments are included in level 2.If one or more of the significant inputs is not based on observable market data, the instruments are included in level 3.The Group’s policy is to recognize transfers between different categories of the fair value hierarchy at the time they occur or when there are changes in the circumstances that cause the transfer. There were no transfers between levels of the fair value hierarchy. There were no changes in economic or business circumstances affecting fair value.Financial instruments not measured at fair valueThe financial instruments not measured at fair value include cash and cash equivalents, trade accounts receivable, other accounts receivable, trade payables and other debts, borrowings, financed payments and convertible notes.The carrying value of financial instruments not measured at fair value does not differ significantly from their fair value, except for borrowings (Note 5.12).Management estimates that the carrying value of the financial instruments measured at amortized cost approximates their fair value.Currency riskForeign currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rate. Currency on foreign exchange risk arises when the Group enters into transactions denominated in a currency other than its functional currency. The table below sets forth our net exposure to currency risk as of December 31, 2023:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:86.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Net foreign currency position</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td></tr><tr><td style="vertical-align:bottom;width:86.4%;background:#cceeff;margin:0pt;padding:0pt;">Amount expressed in US$</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"> (6,210,949)</td></tr></table>Considering only this net currency exposure as of December 31, 2023 if an US Dollar revaluation or depreciation in relation to other foreign currencies with the remaining variables remaining constant, would have a positive or a negative impact on comprehensive income as a result of foreign exchange gains or losses. We estimate that a devaluation or an appreciation of the US Dollar other currencies of 10% during the period ended December 31, 2023 would have resulted in a net pre-tax loss or gain of approximately $0.6 million. <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;margin:0pt;padding:0pt;">Mandatorily measured at fair</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">value through profit or loss</td></tr><tr><td style="vertical-align:bottom;width:42.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Financial asset</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Cash and cash equivalents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 24,332,260</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 48,129,194</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 69,677</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Other financial assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 444,743</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 657,612</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 17,040,207</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 11,922,317</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Trade receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 199,666,283</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 158,006,474</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Other receivables (*)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,368,459</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 12,124,724</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 237,811,745</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 218,918,004</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 17,109,884</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 11,922,317</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(*)</td><td style="padding:0pt;">Advances expenses and tax balances are not included.</td></tr></table> 24332260 48129194 69677 444743 657612 17040207 11922317 199666283 158006474 13368459 12124724 237811745 218918004 17109884 11922317 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;margin:0pt;padding:0pt;">Mandatorily measured at fair</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">value through profit or loss</td></tr><tr><td style="vertical-align:bottom;width:42.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Financial liability</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 156,857,878</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 142,582,166</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 7,145,324</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 8,225,508</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 145,038,126</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 168,310,605</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Secured notes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 77,998,071</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 75,213,146</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Lease liability</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 13,600,289</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 13,889,223</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Consideration for acquisition of assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,684,278</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,993,256</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 400,178,642</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 404,988,396</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 7,145,324</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,225,508</td></tr></table> 156857878 142582166 7145324 8225508 145038126 168310605 77998071 75213146 13600289 13889223 6684278 4993256 400178642 404988396 7145324 8225508 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Measurement at fair value at 12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td></tr><tr><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.62%;background:#cceeff;margin:0pt;padding:0pt;">Financial assets at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;">US Treasury bills</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.62%;background:#cceeff;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"> 14,736,104</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"> 2,304,103</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.62%;background:#cceeff;margin:0pt;padding:0pt;">Financial liability at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.62%;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"> 7,145,324</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Measurement at fair value at 06/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td></tr><tr><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.62%;background:#cceeff;margin:0pt;padding:0pt;">Financial assets at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;">US Treasury bills</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"> 9,163,298</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.62%;background:#cceeff;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"> 1,596,539</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.62%;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"> 1,162,480</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.62%;background:#cceeff;margin:0pt;padding:0pt;">Financial liability at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.62%;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.68%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.3%;margin:0pt;padding:0pt;"> 8,225,508</td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.29%;margin:0pt;padding:0pt;"> —</td></tr></table> 14736104 2304103 7145324 9163298 1596539 1162480 8225508 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:86.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Net foreign currency position</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td></tr><tr><td style="vertical-align:bottom;width:86.4%;background:#cceeff;margin:0pt;padding:0pt;">Amount expressed in US$</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"> (6,210,949)</td></tr></table> -6210949 0.10 600000 14. LEASES<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Right-of-use leased asset</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Book value at the beginning of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 21,163,192</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 15,828,032</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Additions of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,842,539</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,154,950</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Additions from business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,005,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (558,684)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (1,839,921)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Exchange differences</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (129,169)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,015,131</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Book value at the end of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 22,317,878</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,163,192</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Depreciation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Book value at the beginning of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 7,226,617</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,684,006</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,711,256</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,565,894</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (305,474)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (171,870)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Exchange differences</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (18,738)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 148,587</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Accumulated depreciation at the end of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,613,661</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,226,617</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,704,217</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,936,575</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Lease liability</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Book value at the beginning of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 13,889,223</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 11,751,284</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Additions of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,842,539</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,154,950</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Additions from business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,245,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Interest expenses, exchange differences and inflation effects</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 362,144</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (406,494)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Payments of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,493,617)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (3,855,517)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,600,289</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,889,223</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Lease Liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,583,276</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,030,524</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,017,013</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,858,699</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,600,289</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,889,223</td></tr></table>The recognized right-of-use assets relate to the following types of assets:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,655,741</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,655,741</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,940,263</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,475,581</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,025,650</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 903,306</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,696,224</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,128,564</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 22,317,878</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,163,192</td></tr></table>The incremental borrowing rate used was 1.94 % in US$ and 13.05% in reais. <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Right-of-use leased asset</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Book value at the beginning of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 21,163,192</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 15,828,032</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Additions of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,842,539</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,154,950</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Additions from business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,005,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (558,684)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (1,839,921)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Exchange differences</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (129,169)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,015,131</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Book value at the end of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 22,317,878</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,163,192</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Depreciation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Book value at the beginning of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 7,226,617</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,684,006</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,711,256</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,565,894</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (305,474)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (171,870)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Exchange differences</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (18,738)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 148,587</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Accumulated depreciation at the end of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,613,661</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,226,617</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,704,217</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,936,575</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Lease liability</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Book value at the beginning of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 13,889,223</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 11,751,284</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Additions of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,842,539</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,154,950</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Additions from business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,245,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Interest expenses, exchange differences and inflation effects</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 362,144</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (406,494)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Payments of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,493,617)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (3,855,517)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,600,289</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,889,223</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Lease Liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,583,276</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,030,524</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,017,013</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,858,699</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,600,289</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,889,223</td></tr></table> 21163192 15828032 1842539 3154950 3005000 558684 1839921 -129169 1015131 22317878 21163192 -7226617 -3684006 1711256 3565894 -305474 -171870 18738 -148587 -8613661 -7226617 13704217 13936575 13889223 11751284 1842539 3154950 3245000 362144 -406494 -2493617 -3855517 13600289 13889223 9583276 10030524 4017013 3858699 13600289 13889223 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,655,741</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,655,741</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,940,263</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,475,581</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,025,650</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 903,306</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,696,224</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,128,564</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 22,317,878</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,163,192</td></tr></table> 3655741 3655741 1940263 1475581 1025650 903306 15696224 15128564 22317878 21163192 0.0194 0.1305 15. SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONSDuring the period ended December 31, 2023, and 2022, the transactions between the Group and related parties, and the related balances owed by and to them, are as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Value of transactions for the period ended</td></tr><tr><td style="vertical-align:bottom;width:36.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Party</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Transaction type</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Sales and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 14,270,782</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> 23,433,292</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Purchases of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (20,696,699)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (43,850,427)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Key management personnel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, social security benefits and other benefits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (9,667,629)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (3,263,996)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Key management personnel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Sales and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> 362,017</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Sales of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 1,643,269</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> 343,873</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Purchases of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (2,178,877)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (305,061)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">In-kind contributions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> 1,434,802</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Parent company and related parties to Parent (Note 6.6)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Interest expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (194,125)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (299,468)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (16,823,279)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (22,144,968)</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amounts receivable from related parties</td></tr><tr><td style="vertical-align:bottom;width:36.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Party</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Transaction type</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 1,223,994</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> 3,105,591</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> 3,792,429</td></tr><tr><td style="vertical-align:bottom;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 781,452</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> 865,627</td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,730,898</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,334,219</td></tr><tr><td style="vertical-align:bottom;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,841,935</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 10,992,275</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amounts payable to related parties</td></tr><tr><td style="vertical-align:bottom;width:36.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Party</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Transaction type</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2022</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Parent company and related parties to Parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (161,860)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (644,191)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Parent company and related parties to Parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Net loans payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (3,639,816)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (3,491,691)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Key management personnel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, social security benefits and other benefits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (68,139)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (218,068)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (75,271)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (35,292)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (56,385,464)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (41,402,594)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (60,330,550)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (45,791,836)</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Value of transactions for the period ended</td></tr><tr><td style="vertical-align:bottom;width:36.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Party</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Transaction type</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Sales and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 14,270,782</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> 23,433,292</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Purchases of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (20,696,699)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (43,850,427)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Key management personnel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, social security benefits and other benefits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (9,667,629)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (3,263,996)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Key management personnel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Sales and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> 362,017</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Sales of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 1,643,269</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> 343,873</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Purchases of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (2,178,877)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (305,061)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">In-kind contributions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> 1,434,802</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Parent company and related parties to Parent (Note 6.6)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Interest expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (194,125)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (299,468)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (16,823,279)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (22,144,968)</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amounts receivable from related parties</td></tr><tr><td style="vertical-align:bottom;width:36.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Party</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Transaction type</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 1,223,994</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> 3,105,591</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> 3,792,429</td></tr><tr><td style="vertical-align:bottom;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 781,452</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> 865,627</td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,730,898</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,334,219</td></tr><tr><td style="vertical-align:bottom;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,841,935</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 10,992,275</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amounts payable to related parties</td></tr><tr><td style="vertical-align:bottom;width:36.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Party</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Transaction type</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2022</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Parent company and related parties to Parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (161,860)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (644,191)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Parent company and related parties to Parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Net loans payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (3,639,816)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (3,491,691)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Key management personnel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, social security benefits and other benefits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (68,139)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (218,068)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (75,271)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (35,292)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (56,385,464)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (41,402,594)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (60,330,550)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (45,791,836)</td></tr></table> 14270782 23433292 20696699 43850427 9667629 3263996 362017 1643269 343873 2178877 305061 1434802 -194125 -299468 -16823279 -22144968 1223994 3105591 3792429 781452 865627 7730898 6334219 12841935 10992275 161860 644191 3639816 3491691 68139 218068 75271 35292 56385464 41402594 60330550 45791836 16. KEY MANAGEMENT PERSONNEL COMPENSATIONThe compensation of directors and other members of key management personnel, including social contributions and other benefits, were as follows for the period ended December 31, 2023, and 2022.<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, social security and other benefits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,140,415</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,201,651</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,527,214</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,062,345</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 9,667,629</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,263,996</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">12/31/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, social security and other benefits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,140,415</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,201,651</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,527,214</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,062,345</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 9,667,629</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,263,996</td></tr></table> 1140415 1201651 8527214 2062345 9667629 3263996 17. SHARE-BASED PAYMENTPursuant to the 2023 Omnibus Equity Incentive Plan approved on May 12, 2023, in August 2023 the Board has granted the following stock options plan to certain directors, executives and management of the Group. <table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;">Past Share Option plan: immediately vested options with a strike price between $11.93 and $13.24.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;">Base Share Option plan: to vest and become exercisable in equal installments on June 30, 2023, June 30, 2024, and June 30, 2025, with a strike price between $10.47 and $10.79.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;">Performance Share Option plan: to vest and become exercisable if the Group’s fiscal year 2025 EBITDA reaches at least US$120 million, at 0% of the award, and linearly thereafter up to 100% of the awarded options when reaching at least US$150 million. These options have also a strike price of between $10.47 and $10.79.</td></tr></table><div style="margin-top:10pt;"></div>The fair value of the stock options at the grant date was estimated using the “Black-Scholes” model considering the terms and conditions under which the stock options were granted and adjusted to consider the possible dilutive effect of the future exercise of options. As of December 31, 2023, the expenses associated with share-based incentive plans are included in results within “Share-based incentives” along with the associated increase in net worth. 11.93 13.24 10.47 10.79 120000000 0 1 150000000 10.47 10.79 18. CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITSThere were no other significant changes to the contingencies, commitments and restrictions on the distribution of profits from the disclosure made in the Consolidated financial statement as of June 30, 2023. 19. EVENTS OCCURRING AFTER THE REPORTING PERIODSubsequent to December 31, 2023, there have been no other situations or circumstances that may require significant adjustments or further disclosure in these consolidated financial statements that were not mentioned above.

Document and Entity Information	6 Months Ended
Document and Entity Information	Dec. 31, 2023
Document and Entity Information [Abstract]
Document Type	6-K
Entity Registrant Name	Bioceres Crop Solutions Corp.
Entity Central Index Key	0001769484
Document Period End Date	Dec. 31, 2023
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($)	Dec. 31, 2023	Jun. 30, 2023
CURRENT ASSETS
Cash and cash equivalents	$ 24,401,937	$ 48,129,194
Other financial assets	17,040,207	12,135,020
Trade receivables	199,666,283	158,006,474
Other receivables	25,081,598	28,824,998
Income and minimum presumed recoverable income taxes	1,120,881	9,444,898
Inventories	123,738,148	140,426,975
Biological assets	938,370	146,842
Total current assets	391,987,424	397,114,401
NON-CURRENT ASSETS
Other financial assets	444,743	444,909
Other receivables	1,619,642	2,546,241
Income and minimum presumed recoverable income taxes	3,794	16,286
Deferred tax assets	9,273,827	7,312,964
Investments in joint ventures and associates	42,402,217	39,296,810
Investment properties	3,792,238	3,589,749
Property, plant and equipment	71,388,129	67,853,835
Intangible assets	172,743,513	173,783,956
Goodwill	112,163,432	112,163,432
Right of use asset	13,704,217	13,936,575
Total non-current assets	427,535,752	420,944,757
Total assets	819,523,176	818,059,158
CURRENT LIABILITIES
Trade and other payables	164,003,202	150,807,674
Borrowings	113,520,778	107,639,659
Employee benefits and social security	8,218,657	9,606,707
Deferred revenue and advances from customers	22,099,378	24,875,662
Income tax payable	864,954	509,034
Consideration for acquisition	4,082,708	1,415,099
Lease liabilities	4,017,013	3,858,699
Total current liabilities	316,806,690	298,712,534
NON-CURRENT LIABILITIES
Borrowings	31,517,348	60,670,946
Deferred revenue and advances from customers	2,135,840	2,057,805
Joint ventures and associates	115,983	622,823
Deferred tax liabilities	43,024,592	35,785,347
Provisions	478,490	891,769
Consideration for acquisition	2,601,570	3,578,157
Secured notes	77,998,071	75,213,146
Lease liabilities	9,583,276	10,030,524
Total non-current liabilities	167,455,170	188,850,517
Total liabilities	484,261,860	487,563,051
EQUITY
Equity attributable to owners of the parent	300,541,772	298,594,088
Non-controlling interest	34,719,544	31,902,019
Total equity	335,261,316	330,496,107
Total equity and liabilities	$ 819,523,176	$ 818,059,158

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Revenues from contracts with customers	$ 140,293,827	$ 94,548,714	$ 256,476,632	$ 221,391,962
Initial recognition and changes in the fair value of biological assets at the point of harvest	(72,785)	(138,529)	338,128	351,477
Cost of sales	(88,710,537)	(59,141,259)	(160,326,318)	(134,817,137)
Changes in the net realizable value of agricultural products after harvest	(746,242)	(1,509,023)	(2,192,558)	(1,736,959)
Research and development expenses	(3,643,077)	(3,457,892)	(8,224,318)	(7,309,906)
Selling, general and administrative expenses	(31,164,937)	(28,413,577)	(65,097,785)	(60,318,488)
Share of profit or loss of joint ventures and associates	2,052,296	40,048	3,560,967	882,288
Other income or expenses, net	(1,166,603)	290,487	(2,398,238)	768,528
Operating profit	16,841,942	2,218,969	22,136,510	19,211,765
Financial cost	(3,815,993)	(5,759,485)	(11,477,850)	(12,539,332)
Other financial results	(3,454,061)	(4,200,857)	(3,336,196)	(5,489,163)
(Loss) profit before income tax	9,571,888	(7,741,373)	7,322,464	1,183,270
Income tax	(8,333,387)	(684,906)	(8,762,427)	(5,697,549)
(Loss) profit for the period	1,238,501	(8,426,279)	(1,439,963)	(4,514,279)
(Loss) profit for the period attributable to:
Equity holders of the parent	108,449	(8,156,746)	(4,483,185)	(7,658,449)
Non-controlling interests	1,130,052	(269,533)	3,043,222	3,144,170
(Loss) profit for the period	$ 1,238,501	$ (8,426,279)	$ (1,439,963)	$ (4,514,279)
(Loss) profit per share
Basic (loss) profit attributable to ordinary equity holders of the parent	$ 0.0017	$ (0.1323)	$ (0.0713)	$ (0.1242)
Diluted (loss) profit attributable to ordinary equity holders of the parent	$ 0.0017	$ (0.1323)	$ (0.0713)	$ (0.1242)
(Loss) profit for the period	$ 1,238,501	$ (8,426,279)	$ (1,439,963)	$ (4,514,279)
Other comprehensive (loss) income	485,703	585,882	(444,254)	616,907
Items that may be subsequently reclassified to profit and loss	485,703	585,882	(444,254)	616,907
Foreign exchange differences on translation of foreign operations from joint ventures	897	(122,814)	897	(21,946)
Foreign exchange differences on translation of foreign operations	484,806	708,696	(445,151)	638,853
Total comprehensive (loss) profit	1,724,204	(7,840,397)	(1,884,217)	(3,897,372)
Total comprehensive (loss) profit attributable to:
Equity holders of the parent	510,976	(7,779,559)	(4,853,354)	(7,377,844)
Non-controlling interests	1,213,228	(60,838)	2,969,137	3,480,472
Total comprehensive (loss) profit	$ 1,724,204	$ (7,840,397)	$ (1,884,217)	$ (3,897,372)

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)	Equity / (deficit) attributable to owners of the parent	Issued capital	Share premium	Changes in non-controlling interest	Own shares trading premium	Stock options and share based incentives	Convertible instruments	Cost of own shares held	Retained deficit	Foreign currency translation reserve	Revaluation of PP&E and effect of tax rate change	Non-controlling Interests	Total
Balance at Jun. 30, 2022	$ 127,358,573	$ 4,637	$ 158,819,506	$ (255,893)	$ (916,202)	$ 3,767,925	$ 175,745	$ (3,530,926)	$ (32,682,893)	$ 969,402	$ 1,007,272	$ 30,940,275	$ 158,298,848
Share-based incentives	2,573,244	5	631,778		135,361	1,806,100							2,573,244
Business combination	154,979,344	1,640	153,357,564			1,620,140							154,979,344
Capitalization of convertible notes	12,211,638	153	12,211,485										12,211,638
Purchase of own shares	(26,206,394)							(26,206,394)					(26,206,394)
Issuance of convertible notes	9,109,516						9,109,516						9,109,516
Distribution of dividends by subsidiary												(452,129)	(452,129)
(Loss) profit for the period	(7,658,449)								(7,658,449)			3,144,170	(4,514,279)
Other comprehensive income (loss)	280,605									280,605		336,302	616,907
Balance at Dec. 31, 2022	272,648,077	6,435	325,020,333	(255,893)	(780,841)	7,194,165	9,285,261	(29,737,320)	(40,341,342)	1,250,007	1,007,272	33,968,618	306,616,695
Balance at Jun. 30, 2023	298,594,088	6,493	327,028,559	(255,893)	(780,841)	6,645,442	9,285,261	(30,553,591)	(13,903,017)	1,282,377	(160,702)	31,902,019	330,496,107
Share-based incentives	7,535,426	4	526,017			7,009,405							7,535,426
Purchase of own shares	(734,388)							(734,388)					(734,388)
Distribution of dividends by subsidiary												(151,612)	(151,612)
(Loss) profit for the period	(4,483,185)								(4,483,185)			3,043,222	(1,439,963)
Other comprehensive income (loss)	(370,169)									(370,169)		(74,085)	(444,254)
Balance at Dec. 31, 2023	$ 300,541,772	$ 6,497	$ 327,554,576	$ (255,893)	$ (780,841)	$ 13,654,847	$ 9,285,261	$ (31,287,979)	$ (18,386,202)	$ 912,208	$ (160,702)	$ 34,719,544	$ 335,261,316

GENERAL INFORMATION - (Details)	Dec. 31, 2023 country
Business information
Number of countries where Group's agricultural inputs are marketed	45

SEASONALITY (Details)	Dec. 31, 2023 item
SEASONALITY
Some customers and distributers order per year, minimum	1
Some customers and distributers order per year, maximum	2

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
Cash at bank and on hand	$ 24,332,260	$ 48,129,194
Mutual funds	69,677
Cash and cash equivalents	$ 24,401,937	$ 48,129,194

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Current
Restricted short-term deposits		$ 212,703
US Treasury bills		9,163,298
Mutual funds	$ 14,736,104	1,596,539
Other investments	2,304,103	1,162,480
Other financial assets	17,040,207	12,135,020
Non-current
Shares of Bioceres S.A.	444,410	444,635
Other investments	333	274
Other financial assets	$ 444,743	$ 444,909

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Components of Consolidated Statement of Financial Position
Trade debtors	$ 206,838,287	$ 160,269,233
Allowance for impairment of trade debtors	(7,523,261)	(7,425,604)
Allowance for credit notes to be issued	(3,928,835)	(3,694,019)
Deferred checks	2,274,646	7,991,237
Trade receivables	199,666,283	158,006,474
Shareholders and other related parties
Components of Consolidated Statement of Financial Position
Shareholders and other related parties (Note 15)	1,223,994
Joint ventures and associates
Components of Consolidated Statement of Financial Position
Trade debtors	$ 781,452	$ 865,627

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Current
Taxes	$ 5,490,671	$ 6,113,764
Prepayments to suppliers	3,820,065	10,956,831
Reimbursements over exports	10,558	10,558
Prepaid expenses and other receivables	4,022,045	1,302,221
Miscellaneous	1,131,770	388,553
Other receivables	25,081,598	28,824,998
Non-current
Taxes		873,699
Reimbursements over exports	1,363,902	1,290,227
Loan receivables	230,000	230,000
Miscellaneous	25,740	152,315
Other receivables	1,619,642	2,546,241
Receivables for PP&E sales
Current
Other receivables		156,423
Shareholders and other related parties
Current
Other receivables	3,105,591	3,792,429
Joint ventures and associates
Current
Other receivables	$ 7,500,898	$ 6,104,219

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Inventory
Goods in transit	$ 1,408,487	$ 3,620,606
Supplies	17,878,874	24,893,187
Agricultural products	14,121,283	28,436,830
Inventories	123,738,148	140,426,975
Net of agricultural products	109,616,865	111,990,145
Seeds
Inventory
Inventories	7,508,251	1,542,159
Resale products
Inventory
Inventories	64,271,825	58,544,931
Manufactured products
Inventory
Inventories	21,131,225	25,881,761
Allowance for obsolescence
Inventory
Inventories	$ (2,581,797)	$ (2,492,499)

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Property, plant and equipment
Property, plant and equipment	$ 71,388,129	$ 67,853,835
Gross carrying amount
Property, plant and equipment
Property, plant and equipment	99,485,867	93,634,779	$ 88,295,296	$ 71,521,454
Accumulated depreciation
Property, plant and equipment
Property, plant and equipment	$ (28,097,738)	$ (25,780,944)	$ (24,500,621)	$ (21,613,129)

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Intangible assets
Intangible assets	$ 172,743,513	$ 173,783,956
Gross carrying amount
Intangible assets
Intangible assets	206,708,843	202,306,618	$ 197,128,192	$ 94,229,557
Accumulated depreciation
Intangible assets
Intangible assets	$ (33,965,330)	$ (28,522,662)	$ (22,715,941)	$ (17,524,688)

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Goodwill
Goodwill	$ 112,163,432	$ 112,163,432
Rizobacter Argentina S.A.
Goodwill
Goodwill	28,080,271	28,080,271
Bioceres Crops S.A.
Goodwill
Goodwill	7,523,322	7,523,322
Pro farm Group, Inc.
Goodwill
Goodwill	76,089,749	76,089,749
Insumos Agroqumicos S.A.
Goodwill
Goodwill	$ 470,090	$ 470,090

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
Investment properties	$ 3,792,238	$ 3,589,749

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Current
Trade creditors	$ 103,683,392	$ 104,211,238
Taxes	3,556,073	3,561,058
Miscellaneous	141,142	953,301
Trade and other payable	164,003,202	150,807,674
Shareholders and other related parties
Current
Trade payable, related party	75,271	35,292
Parent company
Current
Trade payable, related party	161,860	644,191
Joint ventures and associates
Current
Trade payable, related party	$ 56,385,464	$ 41,402,594

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Current
Corporate bonds	$ 49,749,398	$ 35,547,510
Borrowings	113,520,778	107,639,659
Non-current
Corporate bonds	21,202,548	50,007,680
Borrowings	31,517,348	60,670,946
Bank borrowings
Current
Borrowings	52,942,957	61,303,952
Non-current
Borrowings	10,314,800	10,663,266
Trust debt securities
Current
Borrowings	7,188,607	7,296,506
Net loans payables - Parents companies and related parties
Current
Borrowings	$ 3,639,816	$ 3,491,691

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Current
Borrowings	$ 113,520,778	$ 107,639,659
Corporate bonds	49,749,398	35,547,510
Non-current
Borrowings	31,517,348	60,670,946
Corporate bonds	21,202,548	50,007,680
Amortized cost
Current
Corporate bonds	49,749,398	35,547,510
Non-current
Corporate bonds	21,202,548	50,007,680
Fair value
Current
Corporate bonds	49,192,118	34,725,828
Non-current
Corporate bonds	20,670,511	47,014,542
Bank borrowings
Current
Borrowings	52,942,957	61,303,952
Non-current
Borrowings	10,314,800	10,663,266
Bank borrowings \| Amortized cost
Current
Borrowings	52,942,957	61,303,952
Non-current
Borrowings	10,314,800	10,663,266
Bank borrowings \| Fair value
Current
Borrowings	49,659,094	57,209,155
Non-current
Borrowings	$ 8,698,322	$ 10,374,646

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details) $ in Millions	Dec. 31, 2023 USD ($)
Secured Guaranteed Notes \| At cost
Borrowings:
Borrowings	$ 25.9
Secured Guaranteed Notes \| Fair value
Borrowings:
Borrowings	26.9
Secured Convertible Guaranteed Notes \| At cost
Borrowings:
Borrowings	52.1
Secured Convertible Guaranteed Notes \| Fair value
Borrowings:
Borrowings	$ 54.8

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
Salaries, accrued incentives, vacations and social security	$ 8,150,518	$ 9,388,639
Key management personnel	68,139	218,068
Employee benefits and social security	$ 8,218,657	$ 9,606,707

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Current
Advances from customers	$ 4,466,515	$ 9,216,032
Deferred Revenue	17,632,863	15,659,630
Deferred revenue and advances from customers	22,099,378	24,875,662
Non-current
Advances from customers	272,334	620,893
Deferred revenue	1,863,506	1,436,912
Deferred revenue and advances from customers	$ 2,135,840	$ 2,057,805

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details) - USD ($)	6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Expenses classified by nature and function
Depreciation of leased assets	$ 1,711,256	$ 1,837,532
Obsolescence	282,836	481,332
Production costs
Expenses classified by nature and function
Amortization of intangible assets	60,849	86,842
Analysis and storage	570	4,460
Commissions and royalties	421,677	109,703
Import and export expenses	43,902	265,121
Depreciation of property, plant and equipment	1,308,591	1,666,119
Depreciation of leased assets	699,044	230,478
Freight and haulage	634,188	1,201,183
Employee benefits and social securities	5,935,502	7,177,926
Maintenance	1,007,395	722,399
Energy and fuel	500,658	753,041
Supplies and materials	367,386	512,493
Mobility and travel	94,476	39,428
Publicity and advertising	1,300
Contingencies	1,239
Share-based incentives	339,904
Professional fees and outsourced services	963,972	1,133,009
Office supplies and registrations fees	80,236	23,309
Insurance	81,174	74,350
Information technology expenses	27,186	17,511
Obsolescence	282,836	481,332
Taxes	127,760	96,233
Miscellaneous	1,827	1,951
Total	12,981,672	14,596,888
Selling, general and administrative expenses
Expenses classified by nature and function
Amortization of intangible assets	2,960,964	2,902,741
Analysis and storage	153,163	237,341
Commissions and royalties	1,008,251	1,020,272
Import and export expenses	318,479	704,937
Depreciation of property, plant and equipment	935,378	1,006,857
Depreciation of leased assets	1,012,212	1,573,369
Impairment of receivables	296,051	468,992
Freight and haulage	6,878,364	5,002,384
Employee benefits and social securities	21,509,102	20,156,371
Maintenance	1,152,332	1,446,553
Energy and fuel	272,547	161,850
Supplies and materials	1,691,154	627,514
Mobility and travel	2,148,705	1,837,797
Publicity and advertising	2,305,251	3,235,737
Contingencies	47,851	39,847
Share-based incentives	8,043,561	1,969,868
Professional fees and outsourced services	3,542,038	7,122,701
Professional fees related parties	66,618	29,818
Office supplies and registrations fees	651,991	624,246
Insurance	1,102,142	1,306,282
Information technology expenses	1,924,633	1,566,952
Taxes	7,019,360	6,976,043
Miscellaneous	57,638	300,016
Total	65,097,785	60,318,488
Total
Expenses classified by nature and function
Amortization of intangible assets	3,021,813	2,989,583
Analysis and storage	153,733	241,801
Commissions and royalties	1,429,928	1,129,975
Import and export expenses	362,381	970,058
Depreciation of property, plant and equipment	2,243,969	2,672,976
Depreciation of leased assets	1,711,256	1,803,847
Impairment of receivables	296,051	468,992
Freight and haulage	7,512,552	6,203,567
Employee benefits and social securities	27,444,604	27,334,297
Maintenance	2,159,727	2,168,952
Energy and fuel	773,205	914,891
Supplies and materials	2,058,540	1,140,007
Mobility and travel	2,243,181	1,877,225
Publicity and advertising	2,306,551	3,235,737
Contingencies	49,090	39,847
Share-based incentives	8,383,465	1,969,868
Professional fees and outsourced services	4,506,010	8,255,710
Professional fees related parties	66,618	29,818
Office supplies and registrations fees	732,227	647,555
Insurance	1,183,316	1,380,632
Information technology expenses	1,951,819	1,584,463
Obsolescence	282,836	481,332
Taxes	7,147,120	7,072,276
Miscellaneous	59,465	301,967
Total	$ 78,079,457	$ 74,915,376

TAXATION - Taxes on income (Details) - USD ($)	3 Months Ended		6 Months Ended
TAXATION - Taxes on income (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
TAXATION
Current tax expense			$ (3,845,338)	$ (6,467,324)
Deferred tax			(4,917,089)	769,775
Income tax expenses	$ (8,333,387)	$ (684,906)	$ (8,762,427)	$ (5,697,549)

EARNING PER SHARE (Details)	3 Months Ended		6 Months Ended
EARNING PER SHARE (Details)	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) category $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) category $ / shares shares
Numerator
(Loss) profit for the period (basic EPS) \| $	$ 108,449	$ (8,156,746)	$ (4,483,185)	$ (7,658,449)
(Loss) profit for the period (diluted EPS) \| $	$ 108,449	$ (8,156,746)	$ (4,483,185)	$ (7,658,449)
Denominator
Weighted average number of shares (basic EPS) \| shares	62,839,961	61,657,343	62,839,961	61,657,343
Weighted average number of shares (diluted EPS) \| shares	63,877,692	61,657,343	62,839,961	61,657,343
Basic (loss) profit attributable to ordinary equity holders of the parent \| $ / shares	$ 0.0017	$ (0.1323)	$ (0.0713)	$ (0.1242)
Diluted (loss) profit attributable to ordinary equity holders of the parent \| $ / shares	$ 0.0017	$ (0.1323)	$ (0.0713)	$ (0.1242)
Number of categories of dilutive potential shares \| category		2		2

EQUITY INFORMATION (Details)	6 Months Ended
EQUITY INFORMATION (Details)	Dec. 31, 2023 shares Vote USD ($) $ / shares
Disclosure of classes of share capital [line items]
Number of own shares repurchased \| $	2,258,016
Number of votes for each ordinary share \| Vote	1
Equity compensation plan
Disclosure of classes of share capital [line items]
Number of total converted options outstanding	3,947,634
Ordinary shares
Disclosure of classes of share capital [line items]
Number of shares authorized	100,000,000
Par value per share \| $ / shares	$ 0.0001
Number of shares issued	62,828,025
Number of shares outstanding	62,828,025
Preference shares
Disclosure of classes of share capital [line items]
Number of shares authorized	1,000,000
Par value per share \| $ / shares	$ 0.0001
Number of shares issued	0
Number of shares outstanding	0

CASH FLOW INFORMATION (Details) - USD ($)	6 Months Ended
CASH FLOW INFORMATION (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Investment activities
Net assets acquisition by business combination		$ 152,070,313
Investment in-kind in other related parties (Note 15)		1,434,802
Capitalization of interest on buildings in progress	$ 47,542
Investing activities	$ 47,542	153,505,115
Financing activities
Capitalization of convertible notes (Note 5.13)		12,211,638
Purchase of own shares		(23,915,029)
Financing activities		$ (11,703,391)

JOINT VENTURES AND ASSOCIATES (Details) - USD ($)	3 Months Ended		6 Months Ended
JOINT VENTURES AND ASSOCIATES (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2023
JOINT VENTURES
Assets in joint ventures and associates	$ 42,402,217		$ 42,402,217		$ 39,296,810
Liabilities in joint ventures and associates	115,983		115,983		622,823
Share of profit or loss of joint ventures and associates	2,052,296	$ 40,048	3,560,967	$ 882,288
Trigall Genetics S.A.
JOINT VENTURES
Liabilities in joint ventures and associates	115,983		115,983		622,823
Share of profit or loss of joint ventures and associates			506,840	595,889
Synertech Industrias S.A.
JOINT VENTURES
Assets in joint ventures and associates	39,205,548		39,205,548		36,026,710
Share of profit or loss of joint ventures and associates			3,178,839	349,012
Alfalfa Technologies S.R.L
JOINT VENTURES
Assets in joint ventures and associates	36,503		36,503		36,502
Moolec Science S.A.
JOINT VENTURES
Assets in joint ventures and associates	$ 3,160,166		3,160,166		$ 3,233,598
Share of profit or loss of joint ventures and associates			$ (124,712)
Indrasa Biotecnologia S.A.
JOINT VENTURES
Share of profit or loss of joint ventures and associates				$ (62,613)

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Amortized cost
Financial assets by category
Financial assets.	$ 237,811,745	$ 218,918,004
Fair value
Financial assets by category
Financial assets.	17,109,884	11,922,317
Cash and cash equivalents \| Amortized cost
Financial assets by category
Financial assets.	24,332,260	48,129,194
Cash and cash equivalents \| Fair value
Financial assets by category
Financial assets.	69,677
Other financial assets \| Amortized cost
Financial assets by category
Financial assets.	444,743	657,612
Other financial assets \| Fair value
Financial assets by category
Financial assets.	17,040,207	11,922,317
Trade receivables \| Amortized cost
Financial assets by category
Financial assets.	199,666,283	158,006,474
Other receivables \| Amortized cost
Financial assets by category
Financial assets.	$ 13,368,459	$ 12,124,724

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Amortized cost
Financial liabilities by category
Financial liabilities	$ 400,178,642	$ 404,988,396
Fair value
Financial liabilities by category
Financial liabilities	7,145,324	8,225,508
Trade and other payables \| Amortized cost
Financial liabilities by category
Financial liabilities	156,857,878	142,582,166
Trade and other payables \| Fair value
Financial liabilities by category
Financial liabilities	7,145,324	8,225,508
Borrowings \| Amortized cost
Financial liabilities by category
Financial liabilities	145,038,126	168,310,605
secured notes \| Amortized cost
Financial liabilities by category
Financial liabilities	77,998,071	75,213,146
Lease liability \| Amortized cost
Financial liabilities by category
Financial liabilities	13,600,289	13,889,223
Consideration for acquisition of assets \| Amortized cost
Financial liabilities by category
Financial liabilities	$ 6,684,278	$ 4,993,256

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details) - USD ($)	Dec. 31, 2023	Jun. 30, 2023
Trade and other payables \| Level 2
Fair value by hierarchy
Financial liabilities, at fair value	$ 7,145,324	$ 8,225,508
US Treasury bills \| Level 1
Fair value by hierarchy
Financial assets at fair value		9,163,298
Mutual funds \| Level 1
Fair value by hierarchy
Financial assets at fair value	14,736,104	1,596,539
Other investments \| Level 1
Fair value by hierarchy
Financial assets at fair value	$ 2,304,103	$ 1,162,480